<SEC-DOCUMENT>0001493152-23-008751.txt : 20230324
<SEC-HEADER>0001493152-23-008751.hdr.sgml : 20230324
<ACCEPTANCE-DATETIME>20230323212055
ACCESSION NUMBER:		0001493152-23-008751
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		45
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230324
DATE AS OF CHANGE:		20230323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALPHATIME ACQUISITION CORP
		CENTRAL INDEX KEY:			0001889106
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41584
		FILM NUMBER:		23757529

	BUSINESS ADDRESS:	
		STREET 1:		500 5TH AVENUE, SUITE 938
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10110
		BUSINESS PHONE:		(347) 627-0058

	MAIL ADDRESS:	
		STREET 1:		500 5TH AVENUE, SUITE 938
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ATMC="http://alphatimeacquisitioncorp.com/20221231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_ATMC_alphatimeacquisitioncorp.com_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001889106 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DDocumentTransitionReport_false -->
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCentralIndexKey">0001889106</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0062" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl0091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-12-31" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" id="xdx2ixbrl0117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" id="xdx2ixbrl0122" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0182" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-14_us-gaap_CommonStockMember" id="xdx2ixbrl0189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-14_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0190" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-14_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-14" id="xdx2ixbrl0192" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-14_us-gaap_CommonStockMember" id="xdx2ixbrl0194" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0198" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-09-152021-12-31" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0222" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0223" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-09-152021-12-31" id="xdx2ixbrl0259" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-09-152021-12-31" id="xdx2ixbrl0262" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-09-14" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATMC:DeferredOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2021-09-152021-12-31" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATMC:IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ATMC:BonusIssueAllotmentToSponsor" contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0285" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atmc-20221231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-14_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-14_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-14_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152021-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-05</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-05</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-08</xbrli:startDate>
        <xbrli:endDate>2023-01-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PostBusinessCombinationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ATMC:PostBusinessCombinationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_IPOMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-04_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-27</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-072022-01-08_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-07</xbrli:startDate>
        <xbrli:endDate>2022-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-072022-01-08_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-07</xbrli:startDate>
        <xbrli:endDate>2022-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08_srt_MaximumMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-05</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-03_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATMC:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-292021-09-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATMC:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-29</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-152022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-15</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-04_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-022023-01-04_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-02</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-082023-01-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-08</xbrli:startDate>
        <xbrli:endDate>2023-01-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-30_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292022-12-30_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2022-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292022-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2022-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-272022-09-28_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-27</xbrli:startDate>
        <xbrli:endDate>2022-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-272021-09-28_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-27</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-072022-01-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-07</xbrli:startDate>
        <xbrli:endDate>2022-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-05_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-052023-01-06_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-05</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001889106</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0116" toRefs="Footnote000165"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0117" toRefs="Footnote000165"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0121" toRefs="Footnote000165"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0122" toRefs="Footnote000165"></ix:relationship>
  <ix:relationship fromRefs="Fact000132" toRefs="Footnote000166"></ix:relationship>
  <ix:relationship fromRefs="Fact000133" toRefs="Footnote000166"></ix:relationship>
  <ix:relationship fromRefs="Fact000179" toRefs="Footnote000184"></ix:relationship>
  <ix:relationship fromRefs="Fact000180" toRefs="Footnote000184"></ix:relationship>
  <ix:relationship fromRefs="Fact000196" toRefs="Footnote000233"></ix:relationship>
  <ix:relationship fromRefs="Fact000197" toRefs="Footnote000233"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0198" toRefs="Footnote000233"></ix:relationship>
  <ix:relationship fromRefs="Fact000199" toRefs="Footnote000233"></ix:relationship>
  <ix:relationship fromRefs="Fact000203" toRefs="Footnote000236"></ix:relationship>
  <ix:relationship fromRefs="Fact000204" toRefs="Footnote000236"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0205" toRefs="Footnote000236"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0206" toRefs="Footnote000236"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0282" toRefs="Footnote000287"></ix:relationship>
  <ix:relationship fromRefs="Fact000283" toRefs="Footnote000287"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20220101__20221231_zKKteUfbdaC5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_908_edei--DocumentAnnualReport_c20220101__20221231_zjauwOCJddnj"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>
Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended <span id="xdx_90B_edei--DocumentPeriodEndDate_c20220101__20221231_zpTXVkuRaef6"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_90E_edei--CurrentFiscalYearEndDate_c20220101__20221231_zAhfDpIFxBZ"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_90D_edei--DocumentFiscalYearFocus_c20220101__20221231_z9LgrQXp9ip5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></span></ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File Number <span id="xdx_90C_edei--EntityFileNumber_c20220101__20221231_zIy3BPggqhTc"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityFileNumber">001-41584</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; text-transform: uppercase"><b><span id="xdx_90D_edei--EntityRegistrantName_c20220101__20221231_zPb6PU4qhqa6"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityRegistrantName">ALPHATIME
ACQUISITION CORP</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20220101__20221231_zrjHlEQMM0l9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Cayman
    Islands</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction<br />
    of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <br />
    Identification No.)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_90B_edei--EntityAddressAddressLine1_c20220101__20221231_zhALAiKpsglf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine1">500
                                            5<sup>th</sup> Avenue</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
                                            <span id="xdx_909_edei--EntityAddressAddressLine2_c20220101__20221231_zclxj70TYCeh"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine2">Suite
                                            938</ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20220101__20221231_zHtDcIHlwi23"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressCityOrTown">New
    York</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20220101__20221231_zNJ3xSqZxtg7"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20220101__20221231_zhDdXLJesnMf"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressPostalZipCode">10110</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zip
    code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--CityAreaCode_c20220101__20221231_zN9k0rQ4hSNb"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CityAreaCode">(347)</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20220101__20221231_zrktC1623cOa"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:LocalPhoneNumber">627-0058</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Issuer&#8217;s
Telephone Number, Including Area Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of Each Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbols</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of Each Exchange on Which Registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--Security12bTitle_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_zuoIJlnleKJ8"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" name="dei:Security12bTitle">Units,
    each consisting of one ordinary share, one redeemable warrant and one right</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_zeeuKhaozTU3"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" name="dei:TradingSymbol">ATMCU</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_908_edei--SecurityExchangeName_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_zvN9HFGXTxhf"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.0001PerShareMember_zEnvcCr3MBQf"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember" name="dei:Security12bTitle">Ordinary
    Shares, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.0001PerShareMember_zVZX5L3ejoo4"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember" name="dei:TradingSymbol">ATMC</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90D_edei--SecurityExchangeName_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesParValue0.0001PerShareMember_zwdpW98RHB75"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--Security12bTitle_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_zEhukXIkTiL4"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" name="dei:Security12bTitle">Warrants,
    each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_zFR37jOtadH2"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" name="dei:TradingSymbol">ATMCW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90F_edei--SecurityExchangeName_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_zawL4HaNvOY1"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--Security12bTitle_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_z4rR5faj5l2c"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" name="dei:Security12bTitle">Rights,
    each right entitling the holder thereof to one-tenth of one ordinary share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_zoCVF6ICHfn6"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" name="dei:TradingSymbol">ATMCR</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_900_edei--SecurityExchangeName_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_zxPyV5sHonv"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(g) of the Act: </b>None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_90C_edei--EntityWellKnownSeasonedIssuer_c20220101__20221231_zGR2tDGQnyrd"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes &#9744; <span id="xdx_900_edei--EntityVoluntaryFilers_c20220101__20221231_zKDKwyOas15j"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934
during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirement for the past 90 days. <span id="xdx_903_edei--EntityCurrentReportingStatus_c20220101__20221231_zYRiF0mYflXf"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
<span id="xdx_905_edei--EntityInteractiveDataCurrent_c20220101__20221231_zWgbU6VVnLD9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityFilerCategory_c20220101__20221231_zEE42jybICJf"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntitySmallBusiness_c20220101__20221231_zTo50VIRflB5"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20220101__20221231_zbCXgTRGNFTg"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90F_edei--EntityExTransitionPeriod_c20220101__20221231_zdjRWc3zRN38"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_906_edei--IcfrAuditorAttestationFlag_c20220101__20221231_zUzw2x4SXTji"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <span id="xdx_906_edei--EntityShellCompany_c20220101__20221231_zy59CmL7C6cb"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:EntityShellCompany">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the Registrant&#8217;s ordinary shares outstanding, other than shares held by persons who may be deemed affiliates
of the Registrant, as of the last day of the Registrant&#8217;s most recently completed second fiscal quarter was $<span id="xdx_900_edei--EntityPublicFloat_iI_c20220630_ztUzRfUODlyh"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span>. The Registrant&#8217;s
units began trading on December 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 23, 2023, there were <span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20230323_zhuGc5uyylfk"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-03-23" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,034,200</ix:nonFraction></span> ordinary shares, par value $0.0001 issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report, including, without limitation, statements under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations,&#8221; includes forward-looking statements within the meaning of Section 27A of the Securities Act
and Section 21E of the Exchange Act. These forward-looking statements can be identified by the use of forward-looking terminology, including
the words &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221;
&#8220;may,&#8221; &#8220;will,&#8221; &#8220;potential,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;continue,&#8221;
or &#8220;should,&#8221; or, in each case, their negative or other variations or comparable terminology. There can be no assurance that
actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating
to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current
or historical facts. These statements are based on management&#8217;s current expectations, but actual results may differ materially
due to various factors, including, but not limited to our:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to complete our Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expectations around the performance of the prospective target business or businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    success in retaining or recruiting, or changes required in, our officers, key employees or directors following our Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or
    in approving our Business Combination, as a result of which they would then receive expense reimbursements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    potential ability to obtain additional financing to complete our Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of our officers and directors to generate a number of potential acquisition opportunities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    public securities&#8217; potential liquidity and trading;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    lack of a market for our securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    use of proceeds not held in the trust account or available to us from interest income on the trust account balance;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    trust account not being subject to claims of third parties; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    financial performance following our Initial Public Offering (as defined below).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements contained in this Form 10-K are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, those factors described in the section of this Form 10-K entitled &#8220;Risk
Factors.&#8221; Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual
results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update
or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required
under applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that
may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that
our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ
materially from those made in or suggested by the forward-looking statements contained in this annual report. In addition, even if our
results or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the
forward-looking statements contained in this annual report, those results or developments may not be indicative of results or developments
in subsequent periods.<br />
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
10-K</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#AR_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#AR_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#AR_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unresolved Staff Comments.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">68<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine Safety Disclosures.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART II</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved].</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements and Supplementary Data.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors, Executive Officers and Corporate Governance.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Compensation.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accounting Fees and Services.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART IV</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit and, Financial Statement Schedules.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">90</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    16.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#S1_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 10-K Summary.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="AR_001"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="AR_002"></span>ITEM
1. BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In
this Annual Report on Form 10-K (the &#8220;Form 10-K&#8221;), references to the &#8220;Company&#8221; and to &#8220;we,&#8221; &#8220;us,&#8221;
and &#8220;our&#8221; refer to AlphaTime Acquisition Corp.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AlphaTime
Acquisition Corp is a blank check company incorporated on September 15, 2021, as a Cayman Islands exempted company for the purpose of
effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses (a &#8220;Business Combination&#8221;). We may pursue an acquisition or a business combination with a target in any business
or industry that can benefit from the expertise and capabilities of our management team. Our efforts in identifying prospective target
businesses will not be limited to a particular geographic region, although we intend to primarily focus on businesses in Asia. We have
generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our Business
Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated
with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, our Sponsor acquired 1,437,500 founder shares for an aggregate purchase price of $25,000. On January 8, 2022, our
Sponsor acquired an additional 287,500 founder shares for no additional consideration, resulting in our Sponsor holding an aggregate
of 1,725,000 founder shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, and for the period from September 15, 2021 (inception) through December 31, 2022, the Company had not yet commenced
any operations. All activity for the period from September 15, 2021 (inception) through December 31, 2022, relates to the Company&#8217;s
formation and the initial public offering (the &#8220;Initial Public Offering&#8221; or &#8220;IPO&#8221;) and identifying a target for
a Business Combination. The Company will not generate any operating revenues until after the completion of its Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial
Public Offering. The Company has selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering was declared effective on December 30, 2022 (the &#8220;Registration
Statement&#8221;). On January 4, 2022 the Company consummated the Initial Public Offering of 6,000,000 units (the &#8220;Units&#8221;
and, with respect to the shares of ordinary shares included in the Units sold, the &#8220;Public Shares&#8221;), at $10.00 per Unit,
generating gross proceeds of $60,000,000. Unit consists of one ordinary share of the Company, par value $0.0001 per share (the &#8220;Ordinary
Shares&#8221;), one redeemable warrant (the &#8216;Warrants&#8221;) and one right (the &#8220;Rights&#8221;), with each Right entitling
the holder thereof to receive one-tenth of one Ordinary Share. Additionally, on January 6, 2023, the underwriters fully exercised the
over-allotment option and the closing of the issuance and sale of the additional Units occurred on January 9, 2023. The total aggregate
issuance by the Company of 900,000 Units at a price of $10.00 per Unit resulted in total gross proceeds of $9,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of private sale of 370,500 units (the &#8220;Private
Placement Units&#8221;) to Alphamade Holding LP (the &#8220;Sponsor&#8221;) at a purchase price of $10.00 per Private Placement Unit,
generating gross proceeds to the Company of $3,705,000. In connection with the underwriter&#8217;s exercise of their over-allotment option,
on January 9, 2023, the Company consummated the private sale of an additional 38,700 Private Units, generating additional gross proceeds
of $387,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, concurrent with the closing of the Initial Public Offering, our Sponsor also sold to Chardan Capital Markets, LLC 115,500 founder
shares at a purchase price of $2.00 per share for an aggregate purchase price of $231,000. In connection with the underwriter&#8217;s
exercise of their over-allotment option, on January 9, 2023, our Sponsor sold an additional 17, 325 founder shares at a purchase price
of $2.00 per share for an aggregate purchase price of $34,650.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the proceeds the Company received from the Initial Public Offering and the sale of the Private Placement Units, $70,242,000 ($10.18
per public share) was deposited into a U.S.-based trust account at Bank of America with American Stock Transfer &amp; Trust Company,
acting as trustee, with approximately $2,097,554 being used to pay fees and expenses in connection with the closing of the Initial
Public Offering, including underwriting commissions of $1,612,500, and $485,054 being available for working capital following the
Initial Public Offering. Except with respect to interest earned on the funds held in the trust account that may be released to the
Company to pay its tax obligations, the proceeds from the Initial Public Offering and the sale of the Private Placement Units that
are deposited in the trust account will not be released from the trust account until the earliest to occur of (a) the completion of
our initial business combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote
to amend our amended and restated articles of association (i) to modify the substance or timing of our obligation to allow
redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our
initial business combination within 9 months from the closing of this offering (or up to 18 months, if we extend the time to
complete a business combination) or (ii) with respect to any other provision relating to shareholders&#8217; rights or pre-initial
business combination activity and (c) the redemption of our public shares if we are unable to complete our business combination
within 9 months from the closing of this offering (or up to 18 months, if we extend the time to complete a business combination),
subject to applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. The outbreak of
the COVID-19 coronavirus has resulted in a widespread health crisis that has adversely affected the economies and financial markets worldwide,
and potential target companies may defer or end discussions for a potential business combination with us whether or not COVID-19 affects
their business operations. The extent to which COVID-19 impacts our search for a business combination will depend on future developments,
which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and
the actions to contain COVID-19 or treat its impact, among others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Management Team</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information on the experience and background of our management team, see the section entitled &#8220;Management.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will seek to capitalize on the strength of our management team. Our team consists of experienced financial services, accounting, and
legal professionals, and senior operating executives of companies operating in multiple jurisdictions. Collectively, our officers and
directors have decades of experience in mergers and acquisitions and operating companies. We believe that their accomplishments, and
specifically, their current activities, will be critical in identifying attractive acquisition opportunities. In turn, the businesses
that we identify, will be able to benefit from accessing the U.S. capital markets and the expertise and network of our management team.
However, there is no assurance that we will complete a business combination. Our officers and directors have no prior experience consummating
a business combination for a &#8220;blank check&#8221; company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no restrictions on the geographic location of targets we can pursue, although we intend to initially prioritize Asia. In particular,
we intend to focus our search for an Business Combination on private companies in Asia that have compelling economics and clear paths
to positive operating cash flow, significant assets, and successful management teams that are seeking access to the U.S. public capital
markets. However, we will not consummate our Business Combination with an entity or business with China operations consolidated through
a VIE structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an emerging market, Asia has experienced remarkable growth. Economies in Asia have experienced sustained expansion in recent years. We
believe that Asia is entering a new era of economic growth, which we expect will result in attractive Business Combination opportunities
for us. We believe that the growth will primarily be driven by private sector expansion, technological innovation, increasing consumption
by the middle class, structural economic and policy reforms and demographic changes in Asia.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
development of private equity and venture capital activities in Asia also provides us with opportunities. According to the Asia-Pacific
Private Equity Report 2022 issued by Bain &amp; Company, Asia-Pacific private equity investors closed a record number of deals in 2021.
Furthermore, the report states that investment and exit value set new highs for the region, and fund-raising rose slightly over 2020.
Deal value increased significantly to a record $296 billion, up 50% over 2020 and 82% over the previous five-year average.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acquisition
Criteria</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team intends to focus on creating shareholder value by leveraging its experience in the management, operation, and financing
of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions.
We have identified the following general criteria and guidelines, which we believe are important in evaluating prospective target businesses.
While we intend to use these criteria and guidelines in evaluating prospective businesses, we may deviate from these criteria and guidelines
should we see justification to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    Management Team that Can Create Significant Value for Target Business. We will seek to identify companies with strong and experienced
    management teams that will complement the operating and investment abilities of our management team. We believe that we can provide
    a platform for the existing management team to leverage the experience of our management team. We also believe that the operating
    expertise of our management team is well suited to complement many potential targets&#8217; management teams.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    and Earnings Growth Potential. We will seek to acquire one or more businesses that have the potential for significant revenue and
    earnings growth through a combination of both existing and new product development, increased production capacity, expense reduction
    and synergistic follow-on acquisitions resulting in increased operating leverage.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
    for Strong Free Cash Flow Generation. We will seek to acquire one or more businesses that have the potential to generate strong,
    stable, and increasing free cash flow, particularly businesses with predictable revenue streams and definable low working capital
    and capital expenditure requirements. We may also seek to prudently leverage this cash flow in order to enhance shareholder value.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benefit
    from Being a Public Company. We intend to only acquire a business or businesses that will benefit from being publicly traded and
    which can effectively utilize access to broader sources of capital and a public profile that are associated with being a publicly
    traded company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
criteria do not intend to be exhaustive. Any evaluation relating to the merits of a particular Business Combination may be based, to
the extent relevant, on these general guidelines as well as other considerations, factors, and criteria that our sponsor and management
team may deem relevant. In the event that we decide to enter into an Business Combination with a target business that does not meet the
above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our shareholder communications
related to our Business Combination, which, as discussed in our Registration Statement, would be in the form of proxy solicitation or
tender offer materials, as applicable, that we would file with the U.S. Securities and Exchange Commission, or the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will have up to 9 months from the closing of our Initial Public Offering to consummate an Business Combination. However, if we anticipate
that we may not be able to consummate our Business Combination within 9 months, we may, by resolution of our Board (the &#8220;Board&#8221;),
if requested by our sponsor, extend the period of time we will have to consummate an Business Combination up to three times, each by
an additional three months (for a total of up to 18 months from the closing of our Initial Public Offering), provided that, pursuant
to the terms of our amended and restated memorandum and articles of association and the trust agreement entered into between us and American
Stock Transfer &amp; Trust Company, in order for the time available for us to consummate our Business Combination to be extended, our
sponsor or their affiliates or designees, upon five days&#8217; advance notice prior to the applicable deadline, must deposit into the
trust account $600,000 (or $0.10 per share) for each extension, on or prior to the date of the applicable deadline. Our public shareholders
will not be entitled to vote or redeem their shares in connection with any such extension. In the event that our sponsor elects to extend
the time to complete a business combination, pay the additional amounts per each extension, and deposit the applicable amount of money
into trust, the sponsor will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit and payment
that will not be repaid in the event that we are unable to close a business combination unless there are funds available outside the
trust account to do so. In the event that we receive notice from our sponsor five days prior to the applicable deadline of their intent
to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the applicable deadline.
In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the funds had been timely
deposited. Our sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete
our Business Combination. To the extent that some, but not all, of our sponsor&#8217;s affiliates or designees, decide to extend the
period of time to consummate our Business Combination, such affiliates or designees may deposit the entire amount required. If we are
unable to consummate our Business Combination within such time period, we will, as promptly as possible but not more than 10 business
days thereafter, redeem 100% of our outstanding public shares for a pro rata portion of the funds held in the trust account, including
a pro rata portion of any interest earned on the funds held in the trust account and not previously released to us to pay our taxes,
and then seek to dissolve and liquidate. However, we may not be able to distribute such amounts as a result of claims of creditors which
may take priority over the claims of our public shareholders. In the event of our dissolution and liquidation, the private units will
expire and be worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80%
of the assets held in the trust account (excluding deferred underwriting commissions payable to our underwriters and taxes payable) at
the time of the agreement to enter into the Business Combination. If our board is not able to independently determine the fair market
value of the target business or businesses, we will obtain an opinion from an independent investment banking firm that is a member of
the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;), or an independent accounting firm with respect to the satisfaction
of such criteria. Our shareholders may not be provided with a copy of such opinion, nor will they be able to rely on such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds of our Initial Public Offering and the sale of the private units released to us from the trust account upon the closing
of our Business Combination may be used as consideration to pay the sellers of a target business with which we complete our Business
Combination. If our Business Combination is paid for using equity or debt securities, or not all of the funds released from the trust
account are used for payment of the consideration in connection with our Business Combination or used for redemption of our public shares,
we may use the balance of the cash released to us from the trust account following the closing for general corporate purposes, including
for maintenance or expansion of operations of the post-transaction businesses, the payment of principal or interest due on indebtedness
incurred in completing our Business Combination, to fund the purchase of other companies or for working capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may be required to obtain additional financing in connection with the closing of our Business Combination to be used following
the closing for general corporate purposes as described above. There is no limitation on our ability to raise funds through the issuance
of equity or equity-linked securities or through loans, advances or other indebtedness in connection with our Business Combination, including
pursuant to forward purchase agreements or backstop agreements we may enter into following consummation of our Initial Public Offering.
Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our
Business Combination. At this time, we are not a party to any arrangement or understanding with any third party with respect to raising
any additional funds through the sale of securities or otherwise. None of our founders is required to provide any financing to us in
connection with or after our Business Combination. We may also obtain financing prior to the closing of our Business Combination to fund
our working capital needs and transaction costs in connection with our search for and completion of our Business Combination. Our amended
and restated memorandum and articles of association provides that, following our Initial Public Offering and prior to the consummation
of our Business Combination, we will be prohibited from issuing additional securities that would entitle the holders thereof to (i) receive
funds from the trust account or (ii) vote as a class with our public shares (a) on any Business Combination or (b) to approve an amendment
to our amended and restated memorandum and articles of association to (x) extend the time we have to consummate a business combination
beyond 9 months from the closing of our Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination
as described in our Registration Statement) or (y) amend the foregoing provisions, unless (in connection with any such amendment to our
amended and restated memorandum and articles of association) we offer our public shareholders the opportunity to redeem their public
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Acquisition Process</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will utilize the diligence, rigor, and expertise of our managements&#8217; respective platforms to evaluate potential targets&#8217;
strengths, weaknesses, and opportunities to identify the relative risk and return profile of any potential target for our Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not have any specific business combination under consideration. Our officers and directors have not individually selected
a target business. Our management team is continuously made aware of potential business opportunities, one or more of which we may desire
to pursue for a business combination, but we have not (nor has anyone on our behalf) had any substantive discussions, directly or indirectly,
with any business combination target with respect to a Business Combination with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations
to other entities including other special purpose acquisition company, or SPAC pursuant to which such officer or director is or will
be required to present a business combination opportunity. Accordingly, if any of our officers or directors becomes aware of a business
combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he
or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. Our management team is
continuously made aware of potential investment opportunities, one or more of which we may desire to pursue for a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provides that we renounce our interest in any corporate opportunity offered
to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or
officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers may become an officer or director of any other special purpose acquisition company with a class of securities registered under
the Securities Exchange Act of 1934, as amended, or the Exchange Act, even before we enter into a definitive agreement regarding our
Business Combination or we have failed to complete our Business Combination within 9 months from the closing of our Initial Public Offering
(or up to 18 months, if we extend the time to complete a business combination as described in our Registration Statement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Competition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
identifying, evaluating and selecting a target business for our initial business combination, we may encounter intense competition from
other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged
buyout funds, and operating businesses seeking strategic acquisitions. Many of these entities are well established and have extensive
experience identifying and effecting business combinations directly or through affiliates. Moreover, many of these competitors possess
greater financial, technical, human and other resources than us. Our ability to acquire larger target businesses will be limited by our
available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a target business. Furthermore,
our obligation to pay cash in connection with our public shareholders who exercise their redemption rights may reduce the resources available
to us for our initial business combination and may not be viewed favorably by certain target businesses. This may place us at a competitive
disadvantage in successfully negotiating an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently maintain our executive offices at 500 Fifth Avenue, Suite 928, New York NY. The cost for our use of this space is included
in the $10,000 per month fee we will pay to our sponsor for office space, utilities and secretarial and administrative services. We consider
our current office space adequate for our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have two officers and do not intend to have any full-time employees prior to the completion of our initial business combination.
Members of our management team are not obligated to devote any specific number of hours to our matters, but they intend to devote as
much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time
that any such person will devote in any time period will vary based on whether a target business has been selected for our initial business
combination and the current stage of the business combination process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Periodic
Reporting and Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will register our units, Ordinary Shares, warrants and rights under the Exchange Act and have reporting obligations, including the requirement
that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual
reports will contain financial statements audited and reported on by our independent registered public auditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide shareholders with audited financial statements of the prospective target business as part of the tender offer materials
or proxy solicitation materials sent to shareholders to assist them in assessing the target business. These financial statements may
be required to be prepared in accordance with, or be reconciled to, U.S. GAAP or IFRS, depending on the circumstances and the historical
financial statements may be required to be audited in accordance with PCAOB standards. These financial statement requirements may limit
the pool of potential target businesses we may acquire because some targets may be unable to provide such financial statements in time
for us to disclose such financial statements in accordance with federal proxy rules and complete our initial business combination within
the prescribed time frame. While this may limit the pool of potential business combination candidates, we do not believe that this limitation
will be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to evaluate our internal control procedures for the fiscal year ending December 31, 2022 as required by the Sarbanes-Oxley
Act. Only in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth
company, will we be required to have our internal control procedures audited. A target business may not be in compliance with the provisions
of the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity
to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
filed a Registration Statement on Form 8-A with the SEC on December 29, 2022 to voluntarily register our securities under Section 12
of the Exchange Act. As a result, we will be subject to the rules and regulations promulgated under the Exchange Act. We have no current
intention of filing a Form 15 to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation
of our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such,
we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section 107 of the JOBS Act also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other
words, an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the benefits of this extended transition period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of
the completion of our Initial Public Offering, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which
we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held by non-affiliates
equals or exceeds $700,000,000 as of the prior June 30<sup>th</sup>, and (2) the date on which we have issued more than $1.0 billion
in non- convertible debt during the prior three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we are a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares
held by non-affiliates equals or exceeds $250 million as of the end of that year&#8217;s second fiscal quarter, and (2) our annual revenues
equaled or exceeded $100 million during such completed fiscal year or the market value of our ordinary shares held by non-affiliates
equals or exceeds $700,000,000 as of the end of that year&#8217;s second fiscal quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team
in their capacity as such.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Factors Summary<sup>1</sup></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a newly incorporated company that has conducted no operations and has generated no revenues. Until we complete our initial business
combination, we will have no operations and will generate no operating revenues. In making your decision whether to invest in our securities,
you should take into account not only the background of our management team, but also the special risks we face as a blank check company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we may initiate a business combination with target company operating in China, you may be subject to additional risk factors. These include
significant regulatory, liquidity, and enforcement risks. For example, we face risks arising from the legal system in China, including
risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance
notice. In addition, the Chinese government may intervene or influence our operations at any time or exert more control over offerings
conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations and/or
the value of our ordinary shares. Any actions by the Chinese government to exert more oversight and control over offerings that are conducted
overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue
to offer securities to investors and cause the value of such securities to significantly decline or be worthless. For a detailed description
of the risks relating to acquiring and operating a target business in China, see Please see &#8220;Risks Related to Our Possible Business
Combination in China&#8221; and &#8220;Risks Related to Acquiring and Operating a Business Outside of the United States&#8221; for more
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully consider these and the other risks set forth in the section entitled &#8220;Risk Factors&#8221; of this Form 10-K. Such
risks include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            public shareholders may not be afforded an opportunity to vote on our proposed business combination,
                                            which means we may complete our initial business combination even though a majority of our
                                            public shareholders do not support such a combination.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we seek shareholder approval of our initial business combination, our initial shareholders
                                            have agreed to vote their founder shares and private shares in favor of such initial business
                                            combination, regardless of how our public shareholders vote.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                            only opportunity to affect the investment decision regarding a potential business combination
                                            will be limited to the exercise of your right to redeem your shares from us for cash, unless
                                            we seek shareholder approval of the business combination.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            ability of our public shareholders to exercise redemption rights with respect to a large
                                            number of our shares may not allow us to complete the most desirable business combination
                                            or optimize our capital structure.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><sup>1
</sup>NTD: to be shortened to two pages</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            search for a business combination, and any target business with which we ultimately consummate
                                            a business combination, may be materially adversely affected by the coronavirus (COVID-19)
                                            and the status of debt and equity markets, as well as protectionist legislation in our target
                                            markets.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            requirement that we complete our initial business combination within 9 months from the closing
                                            of our IPO (or up to 18 months, if we extend the time to complete a business combination
                                            as described in this Form 10-K) may give potential target businesses leverage over us in
                                            negotiating a business combination and may decrease our ability to conduct due diligence
                                            on potential business combination targets as we approach our dissolution deadline.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may not be able to complete our initial business combination within the prescribed time frame,
                                            in which case we would cease all operations except for the purpose of winding up.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            will not have any rights or interests in funds from the trust account, except under certain
                                            limited circumstances. To liquidate your investment, therefore, you may be forced to sell
                                            your public shares, warrants or rights, potentially at a loss.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we seek shareholder approval of our initial business combination and we do not conduct redemptions
                                            pursuant to the tender offer rules, and if you or a &#8220;group&#8221; of shareholders are
                                            deemed to hold in excess of 15% of our ordinary shares, you will lose the ability to redeem
                                            all such shares in excess of 15% of our ordinary shares.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
                                            of our limited resources and the significant competition for business combination opportunities,
                                            it may be more difficult for us to complete our initial business combination and our warrants
                                            and rights will expire worthless.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are not registering the ordinary shares issuable upon exercise of the warrants under the
                                            Securities Act or any state securities laws at this time, and such registration may not be
                                            in place when an investor desires to exercise warrants.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may seek acquisition opportunities in industries or sectors which may or may not be outside
                                            of our management&#8217;s area of expertise.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            we have identified general criteria and guidelines that we believe are important in evaluating
                                            prospective target businesses, we may enter into our initial business combination with a
                                            target that does not meet such criteria and guidelines.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
                                            we are not limited to a particular industry, sector or any specific target businesses with
                                            which to pursue our initial business combination, you will be unable to ascertain the merits
                                            or risks of any particular target business&#8217;s operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            ability to complete a business combination may be impacted by the fact that a majority of
                                            our officers and directors are located in or have significant ties to the People&#8217;s
                                            Republic of China, including, Hong Kong, Taiwan and Macau. This may make us a less attractive
                                            partner to potential target companies outside the PRC, thereby limiting our pool of acquisition
                                            candidates and making it harder for us to complete an initial business combination with a
                                            non-China-based target company. For example, we may not be able to complete an initial business
                                            combination with a U.S. target company since such initial business combination may be subject
                                            to U.S. foreign investment regulations and review by a U.S. government entity, such as the
                                            Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are not registering the ordinary shares issuable upon exercise of the warrants under the
                                            Securities Act or any state securities laws at this time, and such registration may not be
                                            in place when an investor desires to exercise warrants, thus precluding such investor from
                                            being able to exercise its warrants except on a cashless basis and potentially causing such
                                            warrants to expire worthless.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may issue additional ordinary shares or preferred shares to complete our initial business
                                            combination or under an employee incentive plan after completion of our initial business
                                            combination, which would dilute the interest of our shareholders and likely present other
                                            risks.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            grant of registration rights to our founders may make it more difficult to complete our initial
                                            business combination, and the future exercise of such rights may adversely affect the market
                                            price of our ordinary shares.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            provision of our warrant agreement may make it more difficult for use to consummate an initial
                                            business combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            officers and directors may allocate their time to other businesses and may become officers
                                            or directors of any other special purpose acquisition companies, thereby causing conflicts
                                            of interest in their determination as to how much time to devote to our affairs and whether
                                            to present potential target to us instead of to our competitors. This conflict of interest
                                            could have a negative impact on our ability to complete our initial business combination.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            founders and their respective affiliates may have competitive pecuniary interests that conflict
                                            with our interests.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are an emerging growth company and a smaller reporting company within the meaning of the
                                            Securities Act, and if we take advantage of certain exemptions from disclosure requirements
                                            available to emerging growth companies and smaller reporting companies, this could make our
                                            securities less attractive to investors and may make it more difficult to compare our performance
                                            with other public companies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Acquiring and Operating a Business Outside of the United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
                                            of the costs and difficulties inherent in managing cross-border business operations, our
                                            results of operations may be negatively impacted.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
                                            countries have difficult and unpredictable legal systems and underdeveloped laws and regulations
                                            that are unclear and subject to corruption and inexperience, which may adversely impact our
                                            results of operations and financial condition.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may face additional and distinctive risks if we acquire a technology business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we effect our initial business combination with a business located in PRC, the laws applicable
                                            to such business will likely govern all of our material agreements and we may not be able
                                            to enforce our legal rights.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC
                                            regulations relating to offshore investment activities by PRC residents may limit our ability
                                            to inject capital in our Chinese subsidiaries and Chinese subsidiaries&#8217; ability to
                                            change their registered capital or distribute profits to us or otherwise expose us or our
                                            PRC resident beneficial owners to liability and penalties under PRC laws.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            existing or future U.S. laws and regulations may restrict or eliminate our ability to complete
                                            a business combination with certain companies, particularly those target companies in China.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            any dividend is declared in the future and paid in a foreign currency, you may be taxed on
                                            a larger amount in U.S.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we effect a business combination with a company located outside of the United States, the
                                            laws applicable to such company will likely govern all of our material agreements and we
                                            may not be able to enforce our legal rights.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in the policies, regulations, rules, and the enforcement of laws of the PRC government may
                                            be quick with little advance notice and could have a significant impact upon our ability
                                            to operate profitably in the PRC.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Chinese government may exert substantial interventions and influences over the manner in
                                            which our post-combination entity must conduct its business activities that we cannot expect
                                            when we enter into a definitive agreement with a target company with major operation in China.
                                            If the Chinese government establish some new policies, regulations, rules, or laws in the
                                            industries where our post-combination entity is in, our post-combination entity may subject
                                            to material change in its operations and the value of our ordinary shares.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
                                            government agencies may exert more oversight and control over offerings that are conducted
                                            overseas and foreign investment in China-based issuers. Additional compliance procedures
                                            may be required in connection with our Initial Public Offering and our business combination
                                            process, and, if required, we cannot predict whether we will be able to obtain such approval.
                                            As a result, both you and us face uncertainty about future actions by the PRC government
                                            that could significantly affect our ability to offer or continue to offer securities to investors
                                            and cause the value of our securities to significantly decline or be worthless.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            light of recent events indicating greater oversight by the Cyberspace Administration of China
                                            (&#8220;CAC&#8221;) over data security, particularly for companies seeking to list on a foreign
                                            exchange, companies with more than one million users&#8217; personal information in China,
                                            especially some internet and technology companies, may not be willing to list on a U.S. exchange
                                            or enter into a definitive business combination agreement with us. Further, we may also avoid
                                            conduct a business combination with a company with more than one million users&#8217; personal
                                            information in China due to the limited timeline for us to complete a business combination.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental
                                            control of currency conversion may affect the value of your investment.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            governing PRC laws and regulations are sometimes vague and uncertain, which may result in
                                            a material change in our operations and the value of our shares if we complete our business
                                            combination with a target in China.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="AR_003"></span>ITEM
1A. RISK FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider the following risks and other information in this Form 10-K in evaluating us and our capital stock. Any of
the following risks, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, could
materially and adversely affect our business, financial condition or results of operations, and could, in turn, impact the trading price
of our capital stock.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to our Search for, Consummation of, or Inability to Consummate, a Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are a newly incorporated company formed as a Cayman Islands exempted company with no operating history and no revenues, and you have
no basis on which to evaluate our ability to achieve our business objective.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a newly incorporated company formed as a Cayman Islands exempted company with no operating results, and we did not commence operations
until obtaining funding through our Initial Public Offering. Because we lack an operating history, you have no basis upon which to evaluate
our ability to achieve our business objective of completing our initial business combination with one or more target businesses. We have
no plans, arrangements or understandings with any prospective target business concerning a business combination and may be unable to
complete our business combination. If we fail to complete our business combination, we will never generate any operating revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
independent registered public accounting firm&#8217;s report contains an explanatory paragraph that expresses substantial doubt about
our ability to continue as a &#8220;going concern.&#8221;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we had a working capital of $15,198, including deferred offering costs. Further, we expect to incur significant costs in pursuit of our acquisition
plans. Management&#8217;s plans to address this need for capital through our Initial Public Offering are discussed in the section of
this Form 10-K titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; Our
plans to raise capital and to consummate our initial business combination may not be successful. These factors, among others, raise substantial
doubt about our ability to continue as a going concern. The financial statements contained elsewhere in this Form 10-K do not include
any adjustments that might result from our inability to consummate our Initial Public Offering or our inability to continue as a going
concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our
initial business combination even though a majority of our public shareholders do not support such a combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not hold a shareholder vote to approve our initial business combination unless the business combination would require shareholder
approval under applicable law or stock exchange listing requirements or if we decide to hold a shareholder vote for business or other
legal reasons. Except as required by law, the decision as to whether we will seek shareholder approval of a proposed business combination
or will allow shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based
on a variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us to
seek shareholder approval. Accordingly, we may complete our initial business combination even if holders of a majority of our public
shares do not approve of the business combination we complete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we seek shareholder approval of our initial business combination, our initial shareholders have agreed to vote in favor of such initial
business combination, regardless of how our public shareholders vote.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
many other blank check companies in which the initial shareholders agree to vote their founder shares in accordance with the majority
of the votes cast by the public shareholders in connection with an initial business combination, our initial shareholders have agreed
to vote their founder shares and private shares, as well as any public shares purchased during or after our Initial Public Offering,
in favor of our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, in addition to our initial shareholders&#8217; founder shares, we would need 2,515,726, or 36.5%, of the 6,900,000 public
shares sold in our Initial Public Offering to be voted in favor of an initial business combination in order to have our initial
business combination approved (assuming all outstanding shares are voted). Our founder shares and private shares will represent
22.2% of our outstanding ordinary shares immediately following the completion of our Initial Public Offering. Accordingly, if we
seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder approval will be
received than would be the case if our founders agreed to vote their founder shares and private shares in accordance with the
majority of the votes cast by our public shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Your
only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your
right to redeem your shares from us for cash, unless we seek shareholder approval of the business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
will not be provided with an opportunity to evaluate the specific merits or risks of one or more target businesses. Since our Board may
complete a business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote
on the business combination, unless we seek such shareholder vote. Accordingly, if we do not seek shareholder approval, your only opportunity
to affect the investment decision regarding a potential business combination may be limited to exercising your redemption rights within
the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders
in which we describe our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business
combination targets, which may make it difficult for us to enter into a business combination with a target.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that
we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not
be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, we
will only redeem our public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately
prior to or upon consummation of our initial business combination and after payment of underwriters&#8217; fees and commissions (so that
we are not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules) or any greater net tangible asset or cash requirement which may
be contained in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption
requests would cause our net tangible assets to be less than $5,000,001 upon completion of our initial business combination or such greater
amount necessary to satisfy a closing condition, each as described above, we would not proceed with such redemption and the related business
combination and may instead search for an alternate business combination. Prospective targets will be aware of these risks and, thus,
may be reluctant to enter into a business combination transaction with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete
the most desirable business combination or optimize our capital structure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time we enter into an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption
rights, and therefore will need to structure the transaction based on our expectations as to the number of shares that will be submitted
for redemption. If our business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase
price, or requires us to have a minimum amount of cash at closing, we will need to reserve a portion of the cash in the trust account
to meet such requirements, or arrange for third-party financing. In addition, if a larger number of shares are submitted for redemption
than we initially expected, we may need to restructure the transaction to reserve a greater portion of the cash in the trust account
or arrange for third-party financing. Raising additional third-party financing may involve dilutive equity issuances or the incurrence
of indebtedness at higher than desirable levels. The above considerations may limit our ability to complete the most desirable business
combination available to us or optimize our capital structure. The amount of deferred underwriting commissions payable to the underwriters
will not be adjusted for any shares that are redeemed in connection with a business combination. The per-share amount we will distribute
to shareholders who properly exercise their redemption rights will not be reduced by deferred underwriting commissions and after such
redemptions, the per-share value of shares held by non-redeeming shareholders will reflect our obligation to pay deferred underwriting
commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability
that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your share.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or requires
us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful is increased.
If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account until we liquidate
the trust account. If you are in need of immediate liquidity, you could attempt to sell your share in the open market; however, at such
time our share may trade at a discount to the pro rata amount per share in the trust account. In either situation, you may suffer a material
loss on your investment or lose the benefit of funds expected in connection with our redemption until we liquidate or you are able to
sell your share in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially
adversely affected by the coronavirus (COVID-19) and the status of debt and equity markets, as well as protectionist legislation in our
target markets.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COVID-19
has resulted in a widespread health crisis that has and may continue to adversely affect the economies and financial markets worldwide,
and the business of any potential target business with which we may consummate a business combination could be materially and adversely
affected. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 restrict travel,
limit the ability to have meetings with potential investors or the target company&#8217;s personnel, vendors and services providers are
unavailable to negotiate and consummate a transaction in a timely manner. In addition, countries or supranational organizations in our
target markets may develop and implement legislation that makes it more difficult or impossible for entities outside such countries or
target markets to acquire or otherwise invest in companies or businesses deemed essential or otherwise vital. The extent to which COVID-19
impacts our search for and ability to consummate a business combination will depend on future developments, which are highly uncertain
and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19
or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extensive
period of time, and result in protectionist sentiments and legislation in our target markets, our ability to consummate a business combination,
or the operations of a target business with which we ultimately consummate a business combination, may be materially adversely affected.
In addition, our ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be
impacted by COVID-19 and other events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may
be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in
our inability to find a target or to consummate an initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the number of special purpose acquisition companies that have been formed has increased substantially. Many potential targets
for special purpose acquisition companies have already entered into an initial business combination, and there are still many special
purpose acquisition companies seeking targets for their initial business combination, as well as many such companies currently in registration.
As a result, at times, fewer attractive targets may be available, and it may require more time, more effort and more resources to identify
a suitable target and to consummate an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because there are more special purpose acquisition companies seeking to enter into an initial business combination with available
targets, the competition for available targets with attractive fundamentals or business models may increase, which could cause targets
companies to demand improved financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry
sector downturns, geopolitical tensions, or increases in the cost of additional capital needed to close business combinations or operate
targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and
consummate an initial business combination, and may result in our inability to consummate an initial business combination on terms favorable
to our investors altogether.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and
complete an initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent months, the market for directors and officers liability insurance for special purpose acquisition companies has changed. Fewer
insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally
increased and the terms of such policies have generally become less favorable. There can be no assurance that these trends will not continue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive
for us to negotiate an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage
as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable
terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the
post-business combination&#8217;s ability to attract and retain qualified officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, even after we were to complete an initial business combination, our directors and officers could still be subject to potential
liability from claims arising from conduct alleged to have occurred prior to the initial business combination. As a result, in order
to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to
any such claims (&#8220;run-off insurance&#8221;). The need for run-off insurance would be an added expense for the post-business combination
entity, and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
sponsor has the right to extend the term we have to consummate our initial business combination up to 18 months from the closing of our
Initial Public Offering without providing our shareholders with a corresponding redemption right.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will have up to 9 months from the closing of our Initial Public Offering to consummate an initial business combination. However, if we
anticipate that we may not be able to consummate our initial business combination within 9 months, we may, by resolution of our Board,
if requested by our sponsor, extend the period of time we will have to consummate an initial business combination up to three times,
each by an additional three months (for a total of up to 18 months from the closing of our Initial Public Offering), provided that, pursuant
to the terms of our amended and restated memorandum and articles of association and the trust agreement to be entered into between us
and American Stock Transfer &amp; Trust Company on December 30, 2022 in order for the time available for us to consummate our initial
business combination to be extended, our sponsor or their affiliates or designees, upon five days&#8217; advance notice prior to the
applicable deadline, must deposit into the trust account $600,000 (or $0.10 per share) for each extension, on or prior to the date of
the applicable deadline. Our public shareholders will not be entitled to vote or redeem their shares in connection with any such extension.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that our sponsor elects to extend the time to complete a business combination, pay the additional amounts per each extension,
and deposit the applicable amount of money into trust, the sponsor will receive a non-interest bearing, unsecured promissory note equal
to the amount of any such deposit and payment that will not be repaid in the event that we are unable to close a business combination
unless there are funds available outside the trust account to do so. In the event that we receive notice from our sponsor five days prior
to the applicable deadline of their intent to effect an extension, we intend to issue a press release announcing such intention at least
three days prior to the applicable deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing
whether or not the funds had been timely deposited. Our sponsor and its affiliates or designees are not obligated to fund the trust account
to extend the time for us to complete our initial business combination. To the extent that some, but not all, of our sponsor&#8217;s
affiliates or designees, decide to extend the period of time to consummate our initial business combination, such affiliates or designees
may deposit the entire amount required. If we are unable to consummate our initial business combination within such time period, we will,
as promptly as possible but not more than 10 business days thereafter, redeem 100% of our outstanding public shares for a pro rata portion
of the funds held in the trust account, including a pro rata portion of any interest earned on the funds held in the trust account and
not previously released to us to pay our taxes, and then seek to dissolve and liquidate. However, we may not be able to distribute such
amounts as a result of claims of creditors which may take priority over the claims of our public shareholders. In the event of our dissolution
and liquidation, the private units and rights will expire and be worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage
over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination
targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination on terms that
would produce value for our shareholders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete
our initial business combination within 9 months from the closing of our Initial Public Offering, or if we decide to extend the period
of time to consummate our business combination, within 18 months from the closing of our Initial Public Offering (as further described
in our Registration Statement). Consequently, such target business may obtain leverage over us in negotiating a business combination,
knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete
our initial business combination with any target business. This risk will increase as we get closer to the timeframe described above.
In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would
have rejected upon a more comprehensive investigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations
except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may only
receive $10.18 per share, or less than such amount in certain circumstances, and our warrants and rights will expire worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provides that we must complete our initial business combination within 9
months from the closing of our Initial Public Offering, or we may, but are not obligated to, extend the period of time to consummate
our business combination up to three times by an additional three months each time, for a total of up to 18 months (as further described
in our Registration Statement). We may not be able to find a suitable target business and complete our initial business combination within
such time period. Our ability to complete our initial business combination may be negatively impacted by general market conditions, volatility
in the capital and debt markets and the other risks described herein. For example, COVID-19 in the U.S. and globally may grow or resurge
and while the extent of the impact of the outbreak on us will depend on future developments, it could limit our ability to complete our
initial business combination, including as a result of increased market volatility, decreased market liquidity and third-party financing
being unavailable on terms acceptable to us or at all. Furthermore, we may be unable to complete a business combination if continued
concerns relating to COVID-19 restrict travel, limit the ability to have meeting with potential investors or the target company&#8217;s
personnel, vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. Additionally,
COVID-19 may negatively impact businesses we may seek to acquire. If we have not completed our initial business combination within such
time period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not
more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount
then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to
us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
which redemption will completely extinguish public shareholders&#8217; rights as shareholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject in each case to our obligations
under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In such case, our public shareholders
may only receive $10.18 per share or less in certain circumstances, and our warrants and our rights will expire worthless. In certain
circumstances, our public shareholders may receive less than $10.18 per share on the redemption of their shares. See &#8220;&#8212; If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we seek shareholder approval of our initial business combination, our founders and their affiliates may elect to purchase ordinary shares,
warrants or rights from public shareholders, which may influence a vote on a proposed business combination and reduce the public &#8220;float&#8221;
of our ordinary shares, warrants or rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination
pursuant to the tender offer rules, our founders or their affiliates may purchase ordinary shares, warrants or rights, or a combination
thereof, in privately negotiated transactions or in the open market either prior to or following the completion of our initial business
combination, although they are under no obligation to do so. Such a purchase may include a contractual acknowledgement that such shareholder,
although still the record holder of our shares is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption
rights. In the event that our founders or their affiliates purchase shares in privately negotiated transactions from public shareholders
who have already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections
to redeem their shares. The purpose of such purchases could be to vote such shares in favor of the business combination and thereby increase
the likelihood of obtaining shareholder approval of the business combination, or to satisfy a closing condition in an agreement with
a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our business combination, where it
appears that such requirement would otherwise not be met. This may result in the completion of our business combination that may not
otherwise have been possible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if such purchases are made, the public &#8220;float&#8221; of our ordinary shares, warrants or rights and the number of beneficial
holders of our securities may be reduced, possibly making it difficult to obtain or maintain the quotation, listing or trading of our
securities on a national securities exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
a shareholder fails to receive notice of our offer to redeem our public shares in connection with our business combination, or fails
to comply with the procedures for tendering its shares, such shares may not be redeemed.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with our business combination.
Despite our compliance with these rules, if a shareholder fails to receive our tender offer or proxy materials, as applicable, such shareholder
may not become aware of the opportunity to redeem its shares. In addition, the tender offer documents or proxy materials, as applicable,
that we will furnish to holders of our public shares in connection with our initial business combination will describe the various procedures
that must be complied with in order to validly tender or redeem public shares. For example, we may require our public shareholders seeking
to exercise their redemption rights, whether they are record holders or hold their shares in &#8220;street name,&#8221; to either tender
their certificates to our transfer agent prior to the date set forth in the tender offer documents mailed to such holders, or up to two
business days prior to the vote on the proposal to approve the business combination in the event we distribute proxy materials, or to
deliver their shares to the transfer agent electronically. In the event that a shareholder fails to comply with these or any other procedures,
its shares may not be redeemed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your
investment, therefore, you may be forced to sell your public shares warrants or rights, potentially at a loss.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
public shareholders will be entitled to receive funds from the trust account only upon the earliest to occur of: (i) our completion of
an initial business combination, and then only in connection with those public shares that such shareholder properly elected to redeem,
subject to the limitations described in our Registration Statement, (ii) the redemption of any public shares properly submitted in connection
with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing
of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we
do not complete our initial business combination within 9 months from the closing of our Initial Public Offering, or if we decide to
extend the period of time to consummate our business combination, within 18 months from the closing of our Initial Public Offering (as
further described in our Registration Statement) or (B) with respect to any other provision relating to shareholders&#8217; rights or
pre-initial business combination activity and (iii) the redemption of our public shares if we are unable to complete an initial business
combination within 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, within 18 months from the closing of our Initial Public Offering (as further described in our Registration
Statement), subject to applicable law and as further described herein. In addition, if we are unable to complete an initial business
combination within 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, within 18 months from the closing of our Initial Public Offering (as further described in our Registration
Statement) for any reason, compliance with Cayman Islands law may require that we submit a plan of dissolution to our then-existing shareholders
for approval prior to the distribution of the proceeds held in our trust account. In that case, public shareholders may be forced to
wait beyond the 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, beyond the 18 months from the closing of our Initial Public Offering (as further described in our Registration
Statement) before they receive funds from our trust account. In no other circumstances will a public shareholder have any right or interest
of any kind in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your public shares, warrants or
rights, potentially at a loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
will not be entitled to protections normally afforded to investors of many other blank check companies.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the net proceeds of our Initial Public Offering and the sale of the private units are intended to be used to complete an initial business
combination with a target business that has not been selected, we may be deemed to be a &#8220;blank check&#8221; company under the United
States securities laws. However, because we will have net tangible assets in excess of $5,000,000 upon the successful completion of our
Initial Public Offering and the sale of the private units and will file a Current Report on Form 8-K, including an audited balance sheet
demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule
419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things, this means our units
will be immediately tradable and we will have a longer period of time to complete our business combination than do companies subject
to Rule 419. Moreover, if our Initial Public Offering were subject to Rule 419, that rule would prohibit the release of any interest
earned on funds held in the trust account to us unless and until the funds in the trust account were released to us in connection with
our completion of an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules,
and if you or a &#8220;group&#8221; of shareholders are deemed to hold in excess of 15% of our ordinary shares, you will lose the ability
to redeem all such shares in excess of 15% of our ordinary shares.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provides that a public
shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a &#8220;group&#8221; (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect
to more than an aggregate of 15% of the shares sold in our Initial Public Offering, which we refer to as the &#8220;Excess Shares.&#8221;
However, our amended and restated memorandum and articles of association does not restrict our shareholders&#8217; ability to vote all
of their shares (including Excess Shares) for or against our business combination. Your inability to redeem the Excess Shares will reduce
your influence over our ability to complete our business combination and you could suffer a material loss on your investment in us if
you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect to the Excess
Shares if we complete our business combination. As a result, you will continue to hold that number of shares exceeding 15% and, in order
to dispose of such shares, would be required to sell your share in open market transactions, potentially at a loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete
our initial business combination. If we are unable to complete our initial business combination, our public shareholders may receive
only approximately $10.18 per share on our redemption of our public shares, or less than such amount in certain circumstances, and our
warrants and rights will expire worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to encounter intense competition from other entities having a business objective similar to ours, including private investors
(which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing
for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have extensive experience
in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries.
Many of these competitors possess greater technical, human and other resources or more local industry knowledge than we do and our financial
resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target
businesses we could potentially acquire with the net proceeds of our Initial Public Offering and the sale of the private units, our ability
to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources.
This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
because we are obligated to pay cash for the ordinary shares which our public shareholders redeem in connection with our initial business
combination, target companies will be aware that this may reduce the resources available to us for our initial business combination.
This may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete our
initial business combination, our public shareholders may receive only approximately $10.18 per share, or less in certain circumstances,
on the liquidation of our trust account and our warrants and rights will expire worthless. In certain circumstances, our public shareholders
may receive less than $10.18 per share upon our liquidation. See &#8220;&#8212; If third parties bring claims against us, the proceeds
held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.18 per share&#8221;
and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
the net proceeds of our Initial Public Offering and the sale of the private units not being held in the trust account are insufficient
to allow us to operate for at least the next 9 months from the closing of our Initial Public Offering, or if we decide to extend the
period of time to consummate our business combination, the next 18 months from the closing of our Initial Public Offering (as further
described in our Registration Statement), we may be unable to complete our initial business combination, in which case our public shareholders
may only receive $10.18 per share, or less than such amount in certain circumstances, and our warrants and rights will expire worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
funds available to us outside of the trust account may not be sufficient to allow us to operate for at least the next 9 months from the
closing of our Initial Public Offering, or if we decide to extend the period of time to consummate our business combination, the next
18 months from the closing of our Initial Public Offering (as further described in our Registration Statement), assuming that our initial
business combination is not completed during that time. We believe that, upon the closing of our Initial Public Offering, the funds available
to us outside of the trust account will be sufficient to allow us to operate for at least the next 9 months from the closing of our Initial
Public Offering, or if we decide to extend the period of time to consummate our business combination, the next 18 months from the closing
of our Initial Public Offering (as further described in our Registration Statement); however, we cannot assure you that our estimate
is accurate. Of the funds available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us
with our search for a target business. We could also use a portion of the funds as a down payment or to fund a &#8220;no-shop&#8221;
provision (a provision in letters of intent or merger agreements designed to keep target businesses from &#8220;shopping&#8221; around
for transactions with other companies on terms more favorable to such target businesses) with respect to a particular proposed business
combination, although we do not have any current intention to do so. If we entered into a letter of intent or merger agreement where
we paid for the right to receive exclusivity from a target business and were subsequently required to forfeit such funds (whether as
a result of our breach or otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect
to, a target business. If we are unable to complete our initial business combination, our public shareholders may receive only approximately
$10.18 per share or less in certain circumstances on the liquidation of our trust account and our warrants and rights will expire worthless.
In certain circumstances, our public shareholders may receive less than $10.18 per share upon our liquidation. See &#8220;&#8212; If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
the net proceeds of our Initial Public Offering and the sale of the private units not being held in the trust account are insufficient,
it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination
and we will depend on loans from our founders or management team to fund our search for a business combination, to pay our taxes and
to complete our initial business combination. If we are unable to obtain these loans, we may be unable to complete our initial business
combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the net proceeds of our Initial Public Offering and the sale of the private units, only approximately $600,000 will be available to us
initially outside the trust account to fund our working capital requirements. In the event that our offering expenses exceed our estimate
of $525,000 (excluding deferred underwriting discount), we may fund such excess with funds not to be held in the trust account. In such
case, the amount of funds we intend to be held outside the trust account would decrease by a corresponding amount. Conversely, in the
event that the offering expenses are less than our estimate of $525,000 (excluding deferred underwriting discount), the amount of funds
we intend to be held outside the trust account would increase by a corresponding amount. If we are required to seek additional capital,
we would need to borrow funds from our founders or their affiliates to operate, or we may be forced to liquidate. None of our founders
nor any of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only
from funds held outside the trust account or from funds released to us upon completion of our initial business combination. We do not
expect to seek loans from parties other than our founders or an affiliate of our founders as we do not believe third parties will be
willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account but in the event
that we seek loans from any third parties, we will obtain a waiver against any and all rights to seek access to funds in our trust account.
If we are unable to obtain these loans, we may be unable to complete our initial business combination. If we are unable to complete our
initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate
the trust account. Consequently, our public shareholders may only receive approximately $10.18 per share on our redemption of our public
shares, and our warrants and rights will expire worthless. In certain circumstances, our public shareholders may receive less than $10.18
per share on the redemption of their shares. See &#8220;&#8212; If third parties bring claims against us, the proceeds held in the trust
account could be reduced and the per-share redemption amount received by shareholders may be less than $10.18 per share&#8221; and other
risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete
a business combination with which a substantial majority of our shareholders do not agree.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association does not provide a specified maximum redemption threshold, except that we
will only redeem our public shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately
prior to or upon consummation of our initial business combination and after payment of underwriters&#8217; fees and commissions (such
that we are not subject to the SEC&#8217;s &#8220;penny stock&#8221; rules). As a result, we may be able to complete our business combination
even though a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares or, if
we seek shareholder approval of our initial business combination and do not conduct redemptions in connection with our business combination
pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our founders, advisors
or their affiliates. In the event the aggregate cash consideration we would be required to pay for all ordinary shares that are validly
submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination
exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, all ordinary
shares submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.18 per share.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all
vendors, service providers, prospective target businesses or other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders,
such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims
against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims
to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter
into an agreement with a third party that has not executed a waiver if management believes that such third party&#8217;s engagement would
be significantly more beneficial to us than any alternative. Making such a request of potential target businesses may make our acquisition
proposal less attractive to them and, to the extent prospective target businesses refuse to execute such a waiver, it may limit the field
of potential target businesses that we might pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Examples
of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant
whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would
agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption
of our public shares, if we are unable to complete our business combination within the prescribed timeframe, or upon the exercise of
a redemption right in connection with our business combination, we will be required to provide for payment of claims of creditors that
were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount
received by public shareholders could be less than the $10.18 per share initially held in the trust account, due to claims of such creditors.
Our sponsor has agreed that it will be liable to us if and to the extent any claims by a vendor for services rendered or products sold
to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of funds
in the trust account to below (i) $10.18 per public share or (ii) such lesser amount per public share held in the trust account as of
the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest
which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver
of any and all rights to seek access to the trust account and except as to any claims under our indemnity of the underwriters of our
Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed
waiver is deemed to be unenforceable against a third party, then our sponsor will not be responsible to the extent of any liability for
such third-party claims. We have not independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations
and believe that our sponsor&#8217;s only assets are securities of our company. We have not asked our sponsor to reserve for such indemnification
obligations. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims
were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced
to less than $10.18 per public share. In such event, we may not be able to complete our initial business combination, and you would receive
such lesser amount per share in connection with any redemption of your public shares. None of our officers will indemnify us for claims
by third parties including, without limitation, claims by vendors and prospective target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
independent directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount
of funds in the trust account available for distribution to our public shareholders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that the proceeds in the trust account are reduced below the lesser of (i) $10.18 per public share or (ii) such lesser amount
per share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust
assets, in each case net of the interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its
obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether
to take legal action against our sponsor to enforce its indemnification obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification
obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so if, for
example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if
the independent directors determine that a favorable outcome is not likely. If our independent directors choose not to enforce these
indemnification obligations, the amount of funds in the trust account available for distribution to our public shareholders may be reduced
below $10.18 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If,
after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and we and our board may be
exposed to claims of punitive damages.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy
court could seek to recover all amounts received by our shareholders. In addition, our Board may be viewed as having breached its fiduciary
duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims of punitive damages, by paying public
shareholders from the trust account prior to addressing the claims of creditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If,
before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our
shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be
reduced.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy petition or an involuntary bankruptcy
petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy
law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders.
To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise be received by our shareholders
in connection with our liquidation may be reduced.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment
if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall
due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders.
Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad
faith, thereby exposing themselves and our company to claims, by paying public shareholders from the trust account prior to addressing
the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our directors and
officers who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were
unable to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable for a fine
of approximately $18,000 and imprisonment for five years in the Cayman Islands.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
we are not limited to a particular industry, sector or any specific target businesses with which to pursue our initial business combination,
you will be unable to ascertain the merits or risks of any particular target business&#8217; operations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek to complete a business combination with an operating company in any industry or sector. However, we will not, under our amended
and restated memorandum and articles of association, be permitted to complete our business combination with another blank check company
or similar company with nominal operations. Because we have not yet selected or approached any specific target business with respect
to a business combination, there is no basis to evaluate the possible merits or risks of any particular target business&#8217;s operations,
results of operations, cash flows, liquidity, financial condition or prospects. To the extent we complete our business combination, we
may be affected by numerous risks inherent in the business operations with which we combine. For example, if we combine with a financially
unstable business or an entity lacking an established record of revenues or earnings, we may be affected by the risks inherent in the
business and operations of a financially unstable or a development stage entity. Although our officers and directors will endeavor to
evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or assess all the significant
risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control
and leave us with no ability to control or reduce the chances that those risks will adversely impact a target business. We also cannot
assure you that an investment in our units will ultimately prove to be more favorable to investors than a direct investment, if such
opportunity were available, in a business combination target. Accordingly, any shareholders who choose to remain shareholders following
the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such
reduction in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Past
performance by our management team, our advisors and our founders may not be indicative of future performance of an investment in us.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
regarding performance by, or businesses associated with our management team and our founders and their affiliates is presented for informational
purposes only. Past performance by our management team and our founders is not a guarantee either (i) of success with respect to any
business combination we may consummate or (ii) that we will be able to locate a suitable candidate for our initial business combination.
Majority of our officers, directors and advisors have not had management experience with special purpose acquisition corporations in
the past. You should not rely on the historical record of our management team&#8217;s, our advisors&#8217; or our founders&#8217; respective
performance as indicative of our future performance of an investment in us or the returns we will, or are likely to, generate going forward.
Furthermore, an investment in us is not an investment in our founders or their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may seek acquisition opportunities in industries or sectors which may or may not be outside of our management&#8217;s area of expertise.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will consider a business combination outside of our management&#8217;s area of expertise if a business combination candidate is presented
to us and we determine that such candidate offers an attractive acquisition opportunity for our company. Although our management will
endeavor to evaluate the risks inherent in any particular business combination candidate, we cannot assure you that we will adequately
ascertain or assess all the significant risk factors. We also cannot assure you that an investment in our units will not ultimately prove
to be less favorable to investors in our Initial Public Offering than a direct investment, if an opportunity were available, in a business
combination candidate. In the event we elect to pursue an acquisition outside of the areas of our management&#8217;s expertise, our management&#8217;s
expertise may not be directly applicable to its evaluation or operation, and the information contained in this Form 10-K regarding the
areas of our management&#8217;s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result,
our management may not be able to adequately ascertain or assess all the significant risk factors. Accordingly, any shareholders who
choose to remain shareholders following our business combination could suffer a reduction in the value of their shares. Such shareholders
are unlikely to have a remedy for such reduction in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Although
we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may
enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target
business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria
and guidelines.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business
with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial
business combination with a target that does not meet some or all of these criteria and guidelines, such combination may not be as successful
as a combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective
business combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise
their redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to
have a minimum net worth or a certain amount of cash. In addition, if shareholder approval of the transaction is required by law, or
we decide to obtain shareholder approval for business or other legal reasons, it may be more difficult for us to attain shareholder approval
of our initial business combination if the target business does not meet our general criteria and guidelines. If we are unable to complete
our initial business combination, our public shareholders may receive only approximately $10.18 per share, or less in certain circumstances,
on the liquidation of our trust account and our warrants and rights will expire worthless. In certain circumstances, our public shareholders
may receive less than $10.18 per share on the redemption of their shares. See &#8220;&#8212; If third parties bring claims against us,
the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than
$10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may seek acquisition opportunities with an early stage company, a financially unstable business or an entity lacking an established record
of revenue or earnings, which could subject us to volatile revenues or earnings or difficulty in retaining key personnel.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we complete our initial business combination with an early stage company such as a pre-revenue entity with a limited operating
history, a financially unstable business, or an entity lacking an established record of revenues or earnings, we may be affected by numerous
risks inherent in the operations of the business with which we combine. These risks include investing in a business without a proven
business model and with limited historical financial data, a lack of revenues or earnings and difficulties in obtaining and retaining
key personnel. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we may
not be able to properly ascertain or assess all the significant risk factors and we may not have adequate time to complete due diligence.
Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those
risks will adversely impact a target business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently,
you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial
point of view.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we complete our business combination with an affiliated entity or our board cannot independently determine the fair market value of the
target business or businesses, we are not required to obtain an opinion from an independent investment banking firm that is a member
of FINRA or from an independent accounting firm that the price we are paying is fair to our company from a financial point of view. If
no opinion is obtained, our shareholders will be relying on the judgment of our Board, who will determine fair market value based on
standards generally accepted by the financial community. Such standards used will be disclosed in our proxy solicitation or tender offer
materials, as applicable, related to our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Resources
could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate
and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may
receive only approximately $10.18 per share, or less than such amount in certain circumstances, on the liquidation of our trust account
and our warrants and rights will expire worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements,
disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the
proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we
may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will
result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire
or merge with another business. If we are unable to complete our initial business combination, our public shareholders may receive only
approximately $10.18 per share on the liquidation of our trust account and our warrants and rights will expire worthless. In certain
circumstances, our public shareholders may receive less than $10.18 per share on the redemption of their shares. See &#8220;&#8212; If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete
our business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers
to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which may make
it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business combinations, we
could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence
investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations
and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks,
it could negatively impact our profitability and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may have a limited ability to assess the management of a prospective target business and, as a result, may complete our initial business
combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company,
which could, in turn, negatively impact the value of our shareholders&#8217; investment in us.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the
target business&#8217;s management may be limited due to a lack of time, resources or information. Our assessment of the capabilities
of the target&#8217;s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications or abilities
we suspected. Should the target&#8217;s management not possess the skills, qualifications or abilities necessary to manage a public company,
the operations and profitability of the post-combination business may be negatively impacted. Accordingly, any shareholders who choose
to remain shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are
unlikely to have a remedy for such reduction in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The departure of a
business combination target&#8217;s key personnel could negatively impact the operations and profitability of our post-combination business.
The role of an acquisition candidate&#8217;s key personnel upon the completion of our initial business combination cannot be ascertained
at this time. Although we contemplate that certain members of an acquisition candidate&#8217;s management team will remain associated
with the acquisition candidate following our initial business combination, it is possible that members of the management of an acquisition
candidate will not wish to remain in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may attempt to complete our initial business combination with a private company about which little information is available, which may
result in a business combination with a company that is not as profitable as we suspected, if at all.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuing our acquisition strategy, we may seek to complete our initial business combination with a privately held company. Very little
public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential
initial business combination on the basis of limited information, which may result in a business combination with a company that is not
as profitable as we suspected, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may only be able to complete one business combination with the proceeds of our Initial Public Offering and the sale of the private units,
which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of
diversification may negatively impact our operations and profitability.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the net proceeds from our Initial Public Offering and the sale of the private units, up to $70,242,000 will be available to complete
our business combination and pay related fees and expenses (which includes up to approximately $2,415,000 for the payment of deferred
underwriting commissions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may complete our business combination with a single target business or multiple target businesses simultaneously or within a short period
of time. However, we may not be able to complete our business combination with more than one target business because of various factors,
including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with
the SEC that present operating results and the financial condition of several target businesses as if they had been operated on a combined
basis. By completing our initial business combination with only a single entity, our lack of diversification may subject us to numerous
economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible
spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several business combinations
in different industries or different areas of a single industry. In addition, we intend to focus our search for an initial business combination
in a single industry. Accordingly, the prospects for our success may be:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">solely
    dependent upon the performance of a single business, property or asset, or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dependent
    upon the development or market acceptance of a single or limited number of products, processes or services.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
lack of diversification may subject us to numerous economic, competitive and regulatory developments, any or all of which may have a
substantial adverse impact upon the particular industry in which we may operate subsequent to our business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to complete a business combination may be impacted by the fact that a majority of our officers and directors are located in or
have significant ties to the People&#8217;s Republic of China, including, Hong Kong, Taiwan and Macau. This may make us a less attractive
partner to potential target companies outside the PRC, thereby limiting our pool of acquisition candidates and making it harder for us
to complete an initial business combination with a non-China-based target company. For example, we may not be able to complete an initial
business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations
and review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
majority of our directors and officers are located in, or have significant ties to, China, including Hong Kong, Taiwan and Macau. As
a result, we may be a less attractive partner to potential target companies outside the PRC, thereby limiting our pool of acquisition
candidates. This would impact our search for a target company and make it harder for us to complete an initial business combination with
a non-China-based target company. For example, we may not be able to complete an initial business combination with a U.S. target company
since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity.
Certain federally licensed businesses in the United States, such as broadcasters and airlines, may be subject to rules or regulations
that limit foreign ownership. In addition, CFIUS is an interagency committee authorized to review certain transactions involving foreign
investment in the United States by foreign persons in order to determine the effect of such transactions on the national security of
the United States. We may be considered a &#8220;foreign person&#8221; under such rules and regulations and any proposed business combination
between us and a U.S. business engaged in a regulated industry or which may affect national security could be subject to such foreign
ownership restrictions and/or CFIUS review.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
scope of CFIUS was expanded by the Foreign Investment Risk Review Modernization Act of 2018 (&#8220;FIRRMA&#8221;) to include certain
non-passive, non-controlling investments in sensitive U.S. businesses and certain acquisitions of real estate even with no underlying
U.S. business. FIRRMA and subsequent implementing regulations that are now in force also subject certain categories of investments to
mandatory filings. If our potential initial business combination with a U.S. business falls within the scope of foreign ownership restrictions,
we may be unable to consummate a business combination with such business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if our potential business combination falls within CFIUS&#8217;s jurisdiction, we may be required to make a mandatory filing,
determine to submit a voluntary notice to CFIUS, or proceed with the initial business combination without notifying CFIUS and then bear
the risk of CFIUS intervention, before or after closing the initial business combination. CFIUS may decide to block or delay our initial
business combination, impose conditions to mitigate national security concerns with respect to such initial business combination or order
us to divest all or a portion of a U.S. business of the combined company if we had proceeded without first obtaining CFIUS clearance.
The foreign ownership limitations, and the potential impact of CFIUS, may limit the attractiveness of a transaction with us or prevent
us from pursuing certain initial business combination opportunities that we believe would otherwise be beneficial to us and our stockholders.
As a result, the pool of potential targets with which we could complete an initial business combination may be limited and we may be
adversely affected in terms of competing with other special purpose acquisition companies which do not have similar foreign ownership
issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
the process of government review, whether by CFIUS or otherwise, could be lengthy. Because we only have 9 months (or 18 months if we
extend the period of time to consummate a business combination) to complete our initial business combination, our failure to obtain any
required approvals within the requisite time period may prevent us from completing the transaction and require us to liquidate. If we
liquidate, our public shareholders may only receive $10.18 per share initially, and our rights and warrants will expire worthless. Our
public shareholders may also lose the potential investment opportunity in a target company and the opportunity of realizing future gains
on such investments through any price appreciation in the combined company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NASDAQ
may delist our securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in our securities
and subject us to additional trading restrictions.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
units, ordinary shares, warrants and rights are listed on NASDAQ. Although we currently meet, on a pro forma basis, the minimum initial
listing standards set forth in the NASDAQ listing standards, we cannot assure you that our securities will continue to be listed on NASDAQ
in the future or prior to our initial business combination. In order to continue listing our securities on NASDAQ prior to our initial
business combination, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum
amount in shareholders&#8217; equity (generally $2,500,000) and a minimum number of holders of our securities (generally 300 public holders).
Additionally, in connection with our initial business combination, we will be required to demonstrate compliance with NASDAQ&#8217;s
initial listing requirements, which are more rigorous than NASDAQ&#8217;s continued listing requirements, in order to continue to maintain
the listing of our securities on NASDAQ. For instance, our share price would generally be required to be at least $4.00 per share and
our shareholders&#8217; equity would generally be required to be at least $5.0 million and we would be required to have a minimum of
300 round lot holders of our securities. We cannot assure you that we will be able to meet those initial listing requirements at that
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
NASDAQ delists our securities from trading on its exchange and we are not able to list our securities on another national securities
exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material
adverse consequences, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    limited availability of market quotations for our securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    liquidity for our securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    determination that our ordinary shares is a &#8220;penny stock&#8221; which will require brokers trading in our ordinary shares to
    adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our
    securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    limited amount of news and analyst coverage; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decreased ability to issue additional securities or obtain additional financing in the future.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the
sale of certain securities, which are referred to as &#8220;covered securities.&#8221; Because we expect that our units and eventually
our ordinary shares, warrants and rights will be listed on NASDAQ, our units, ordinary shares, warrants and rights will be covered securities.
Although the states are pre-empted from regulating the sale of our securities, the federal statute does allow the states to investigate
companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the
sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the
sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check
companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies
in their states. Further, if we were no longer listed on NASDAQ, our securities would not be covered securities and we would be subject
to regulation in each state in which we offer our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws
at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor
from being able to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not registering the ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws
at this time. However, under the terms of the warrant agreement, have agreed that as soon as practicable, but in no event later than
30 business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file, and
within 60 business days following our initial business combination to have declared effective, a registration statement under the Securities
Act covering such shares and maintain a current prospectus relating to the ordinary shares issuable upon exercise of the warrants, until
the expiration of the warrants in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able
to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration
statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC
issues a stop order. If the shares issuable upon exercise of the warrants are not registered under the Securities Act, we will be required
to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis,
and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon
such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration
is available. Notwithstanding the above, if our ordinary shares is at the time of any exercise of a warrant not listed on a national
securities exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities
Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221;
in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in
effect a registration statement, but we will be required to use our commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available. In no event will we be required to net cash settle any warrant.
If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification,
the holder of such warrant shall not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In
such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for
the ordinary shares included in the units. If and when the warrants become redeemable by us, we may exercise our redemption right even
if we are unable to register or qualify the underlying ordinary shares for sale under all applicable state securities laws. We will use
our commercially reasonable efforts to register or qualify such ordinary shares under the blue sky laws of the state of residence in
those states in which the warrants were offered by us in our Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may issue additional ordinary shares or preferred shares to complete our initial business combination or under an employee incentive
plan after completion of our initial business combination. Any such issuances would dilute the interest of our shareholders and likely
present other risks.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association authorizes the issuance of up to 200,000,000 ordinary shares, par value
$0.0001 per share and 1,000,000 preferred shares, par value $0.0001 per share. There are 9,034,200 ordinary shares issued and
outstanding as of March 23, 2023. There are 190,965,800 unissued ordinary shares, respectively, available for issuance, which amount does not take into
account the ordinary shares reserved for issuance upon exercise of any outstanding warrants or rights. There are no preferred shares
issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may issue a substantial number of additional ordinary shares or preferred shares to complete our initial business combination or under
an employee incentive plan after completion of our initial business combination (although our amended and restated memorandum and articles
of association provides that we may not issue securities that can vote with ordinary shareholders on matters related to our pre-initial
business combination activity). However, our amended and restated memorandum and articles of association provides, among other things,
that prior to our initial business combination, we may not issue additional shares of capital share that would entitle the holders thereof
to: (i) receive funds from the trust account; or (ii) vote as a class with our public shares (a) on any initial business combination
or (b) to approve an amendment to our amended and restated articles of association to (x) extend the time we have to consummate a business
combination beyond 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, beyond 18 months from the closing of our Initial Public Offering (as further described in our Registration
Statement), or (y) amend the foregoing provisions, unless (in connection with any such amendment to our amended and restated articles
of association) we offer our public shareholders the opportunity to redeem their public shares. These provisions of our amended and restated
memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of association, may be
amended with the approval of our shareholders. However, our executive officers and directors have agreed, pursuant to a written agreement
with us, that they will not propose any amendment to our amended and restated memorandum and articles of association to (A) modify the
substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination
or to redeem 100% of our public shares if we do not complete our initial business combination within 9 months from the closing of our
Initial Public Offering, or if we decide to extend the period of time to consummate our business combination, within 18 months from the
closing of our Initial Public Offering (as further described in our Registration Statement) or (B) with respect to any other material
provision relating to shareholders&#8217; rights or pre-initial business combination activity, unless we provide our public shareholders
with the opportunity to redeem their ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal
to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable), divided
by the number of then outstanding public shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of additional ordinary or preferred shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    significantly dilute the equity interest of investors in our Initial Public Offering;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    subordinate the rights of holders of ordinary shares if preferred shares are issued with rights senior to those afforded our ordinary
    shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">could
    cause a change of control if a substantial number of our ordinary shares are issued, which may affect, among other things, our ability
    to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and
    directors; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    adversely affect prevailing market prices for our units, ordinary shares, warrants and/or rights.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely
affect our leverage and financial condition and thus negatively impact the value of our shareholders&#8217; investment in us.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have no commitments as of the date of this Form 10-K, to issue any notes or other debt securities, or to otherwise incur outstanding
debt, we may choose to incur substantial debt to complete our business combination. We have agreed that we will not incur any indebtedness
unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust
account. As such, no issuance of debt will affect the per-share amount available for redemption from the trust account. Nevertheless,
the incurrence of debt could have a variety of negative effects, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">default
    and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt
    obligations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceleration
    of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants
    that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such
    financing while the debt security is outstanding;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to pay dividends on our ordinary shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
    a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends
    on our ordinary shares if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general
    corporate purposes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
    vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution
    of our strategy; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    disadvantages compared to our competitors who have less debt.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
grant of registration rights to our founders may make it more difficult to complete our initial business combination, and the future
exercise of such rights may adversely affect the market price of our ordinary shares.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an agreement to be entered into concurrently with the issuance and sale of the securities in our Initial Public Offering, our founders
and their permitted transferees can demand that we register their founder shares and private units, after those shares convert to our
ordinary shares at the closing of our initial business combination. In addition, holders of our private units and their permitted transferees
can demand that we register the private units and/or the underlying securities, and holders of units that may be issued upon conversion
of working capital loans may demand that we register such units and/or underlying securities. We will bear the cost of registering these
securities. The registration and availability of such a significant number of securities for trading in the public market may have an
adverse effect on the market price of our ordinary shares. In addition, the existence of the registration rights may make our initial
business combination more costly or difficult to conclude. This is because the shareholders of the target business may increase the equity
stake they seek in the combined entity or ask for more cash consideration to offset the negative impact on the market price of our ordinary
shares that is expected when the ordinary shares and private units owned by our founders or holders of our working capital units or their
respective permitted transferees are registered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
order to complete our initial business combination, we may seek to amend our amended and restated memorandum and articles of association
or other governing instruments, including our warrant agreement or rights agreement, in a manner that will make it easier for us to complete
our initial business combination but that our shareholders, warrant holders or rights holders may not support.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to complete a business combination, blank check companies have, in the recent past, amended various provisions of their charters
and governing instruments, including their warrant agreement and rights agreement. For example, blank check companies have amended the
definition of business combination, increased redemption thresholds, changed industry focus and, with respect to their warrants and rights,
amended their warrant agreements and rights agreements to require the warrants and rights, respectively, to be exchanged for cash and/or
other securities. We cannot assure you that we will not seek to amend our charter or other governing instruments or change our industry
focus in order to complete our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
founders paid an aggregate of $25,000 for the founder shares, or approximately $0.01 per founder share. As a result of this low initial
price, our founders stand to make a substantial profit even if an initial business combination subsequently declines in value or is unprofitable
for our public shareholders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the low acquisition cost of our founder shares, our founders could make a substantial profit even if we select and consummate
an initial business combination with an acquisition target that subsequently declines in value or is unprofitable for our public shareholders.
Thus, such parties may have more of an economic incentive for us to enter into an initial business combination with a riskier, weaker-performing
or financially unstable business, or an entity lacking an established record of revenues or earnings, than would be the case if such
parties had paid the full offering price for their founder shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of
at least 50% of the then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise
period could be shortened and the number of our ordinary shares purchasable upon exercise of a warrant could be decreased, all without
your approval.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
warrants are in a registered form under a warrant agreement and between American Stock Transfer &amp; Trust Company, as warrant agent,
and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity
or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public warrants
to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, we may amend the terms
of the public warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding public warrants approve of
such amendment. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then outstanding
public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of
the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of our ordinary shares purchasable upon
exercise of a warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of
$0.01 per warrant, provided that the last reported sales price of our ordinary shares equals or exceeds $16.50 per share (as adjusted
for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period
ending on the third trading day prior to the date on which we give proper notice of such redemption and provided certain other conditions
are met. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or
qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants could force
you (i) to exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii)
to sell your warrants at the then-current market price when you might otherwise wish to hold your warrants or (iii) to accept the nominal
redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market
value of your warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
private units and founder shares may have an adverse effect on the market price of our ordinary shares and make it more difficult to
complete our business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of our Initial Public Offering, we issued 409,200 private units to our sponsor, one of our founders. Our founders currently
own 1,725,000 founder shares. In addition, if our founders or their affiliates make any working capital loans, up to $300,000 of such
loans may be converted into working capital units, at the price of $10.00 per unit at the option of the lender. Such working capital
units would be identical to the private units sold in the private placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we issue ordinary shares to complete a business combination, the potential for the issuance of a substantial number of additional
ordinary shares upon exercise of these warrants and conversion rights of up to $500,000 working capital loans could make us a less attractive
acquisition vehicle to a target business. Any such issuance will increase the number of issued and outstanding ordinary shares and reduce
the value of the ordinary shares issued to complete the business combination. Therefore, our private units and founder shares may make
it more difficult to complete a business combination or increase the cost of acquiring the target business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A
provision of our warrant agreement may make it more difficult for use to consummate an initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
most blank check companies, if</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial
    business combination at a Newly Issued Price of less than $9.50 per share;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
    for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions),
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Market Value is below $9.50 per share,</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">then
the exercise price of the warrants will be adjusted to be equal to 115% of the greater of the Market Value and the Newly Issued Price,
and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the Market Value and
the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may amend the terms of the rights in a manner that may be adverse to holders of public rights with the approval by the holders of at
least 50% of the then outstanding public rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
rights will be issued in registered form under a rights agreement and between American Stock Transfer &amp; Trust Company, as rights
agent, and us. The rights agreement provides that the terms of the rights may be amended without the consent of any holder to cure any
ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public
rights to make any change that adversely affects the interests of the registered holders of public rights. Accordingly, we may amend
the terms of the public rights in a manner adverse to a holder if holders of at least 50% of the then outstanding public rights approve
of such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous
initial business combination with some prospective target businesses.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial significance
tests include target historical and/or pro forma financial statement disclosure. We will include the same financial statement disclosure
in connection with our tender offer documents, whether or not they are required under the tender offer rules. These financial statements
may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted in the United States
of America, or GAAP, or international financial reporting standards as issued by the International Accounting Standards Board, or IFRS,
depending on the circumstances and the historical financial statements may be required to be audited in accordance with the standards
of the Public Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool
of potential target businesses we may acquire because some targets may be unable to provide such financial statements in time for us
to disclose such financial statements in accordance with federal proxy rules and complete our initial business combination within the
prescribed time frame.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
ability to successfully complete our initial business combination and to be successful thereafter will be totally dependent upon the
efforts of members of our management team, some of whom may join us following our initial business combination. The loss of such people
could negatively impact the operations and profitability of our post-combination business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to successfully complete our business combination is dependent upon the efforts of members of our management team. The role of
members of our management team in the target business, however, cannot presently be ascertained. Although some members of our management
team may remain with the target business in senior management or advisory positions following our business combination, it is likely
that some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals
we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct.
These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause us to have to
expend time and resources helping them become familiar with such requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The
departure of a business combination target&#8217;s key personnel could negatively impact the operations and profitability of our post-combination
business. The role of an acquisition candidate&#8217;s key personnel upon the completion of our initial business combination cannot be
ascertained at this time. Although we contemplate that certain members of an acquisition candidate&#8217;s management team will remain
associated with the acquisition candidate following our initial business combination, it is possible that members of the management of
an acquisition candidate will not wish to remain in place. The loss of key personnel could negatively impact the operations and profitability
of our post-combination business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Members
of our management team may negotiate employment or consulting agreements with a target business in connection with a particular business
combination. These agreements may provide for them to receive compensation following our business combination and as a result, may cause
them to have conflicts of interest in determining whether a particular business combination is the most advantageous.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
of our management team may be able to remain with the Company after the completion of our business combination only if they are able
to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously
with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments
and/or our securities for services they would render to us after the completion of the business combination. The personal and financial
interests of such individuals may influence their motivation in identifying and selecting a target business. However, we believe the
ability of such individuals to remain with us after the completion of our business combination will not be the determining factor in
our decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any members
of our management team will remain with us after the completion of our business combination. We cannot assure you that any members of
our management team will remain in senior management or advisory positions with us. The determination as to whether any members of our
management team will remain with us will be made at the time of our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
officers and directors may allocate their time to other businesses and may become officers or directors of other special purpose acquisition
companies, thereby causing conflicts of interest in their determination as to how much time to devote to our affairs and whether to present
a target to us instead of our competitors. This conflict of interest could have a negative impact on our ability to complete our initial
business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers and directors have fiduciary responsibility to dedicate substantially all their business time to their respective affairs and
their respective portfolio companies. However, this responsibility does not require any of our officers or directors to commit his or
her full time to our affairs in particular, which may result in a conflict of interest in allocating their time between our operations
and our search for a business combination and their other businesses, including other business endeavors for which he or she may be entitled
to substantial compensation. Furthermore, our officer and directors may become an officer or director of another special purpose acquisition
company with a class of securities registered under the Securities Exchange Act of 1934, as amended, or the Exchange Act even before
we enter a definitive agreement regarding our initial business combination. We do not intend to have any full-time employees prior to
the completion of our initial business combination. In addition, each of our officers and certain of our directors are employed by or
affiliated with our founders, which makes investments in securities or other interests of or relating to companies in industries we may
target for our initial business combination. Our independent directors also serve as officers or board members for other entities. If
our officers&#8217; and directors&#8217; other business affairs require them to devote substantial amounts of time to such affairs in
excess of their current commitment levels, it could limit their ability to devote time to our affairs; or if they have fiduciary duty
to present a target company to our competitor instead of us, which may have a negative impact on our ability to complete our initial
business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities
similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining
to which entity a particular business opportunity should be presented.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of our Initial Public Offering and until we consummate our initial business combination, we intend to engage in the business
of identifying and combining with one or more businesses. Our officers and directors are, and may in the future become, affiliated with
entities (such as operating companies or investment vehicles) that are engaged in a similar business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the other
entities in the future to which they owe certain fiduciary or contractual duties, including our founders&#8217; affiliates. Accordingly,
they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts
may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us.
Our amended and restated memorandum and articles of association provides that we renounce our interest in any corporate opportunity offered
to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or
officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
founders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not adopted a policy that expressly prohibits our founders or their respective affiliates from having a direct or indirect pecuniary
or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an
interest. We do not have a policy that expressly prohibits any such persons from engaging for their own account in business activities
of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated
with our founders which may raise potential conflicts of interest.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the involvement of our officers and directors with other entities, we may decide to acquire one or more businesses affiliated
with our founders or their respective affiliates. Our officers and directors also serve as officers and board members for other entities.
Such entities may compete with us for business combination opportunities. Our founders are not currently aware of any specific opportunities
for us to complete our business combination with any entities with which they are affiliated, and there have been no preliminary discussions
concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any
transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria
for a business combination as set forth in our Registration Statement and such transaction was approved by a majority of our disinterested
directors. Despite our agreement to obtain an opinion from an independent investment banking firm that is a member of FINRA, or from
an independent accounting firm, regarding the fairness to our company from a financial point of view of a business combination with one
or more domestic or international businesses affiliated with our founders or their respective affiliates, potential conflicts of interest
still may exist and, as a result, the terms of the business combination may not be as advantageous to our public shareholders as they
would be absent any conflicts of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since
our founders will lose their entire investment in us if our business combination is not completed, a conflict of interest may arise in
determining whether a particular business combination target is appropriate for our initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, our sponsor acquired 1,437,500 founder shares for an aggregate purchase price of $25,000. On January 8, 2022, our
sponsor acquired an additional 287,500 founder shares for no additional consideration, resulting in our sponsor holding an aggregate
of 1,725,000 founder shares. Concurrent with the closing of our Initial Public Offering, our sponsor sold to Chardan or its designees
132,825 of these founder shares for a purchase price of $2.00 per share and an aggregate purchase price of $265,650. Prior to the initial
investment in the Company of $25,000 by our sponsor, the Company had no assets, tangible or intangible. The number of founder shares
issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares after our Initial
Public Offering (excluding the private shares and shares underlying the UPO). The founder shares will be worthless if we do not complete
an initial business combination. In addition, our sponsor purchased an aggregate of 409,200 private units, at $10.00 per unit, for a
purchase price of approximately $4,092,000. The founder shares and private units will be worthless if we do not complete an initial business
combination. Our initial shareholders have agreed (A) to vote any shares owned by them in favor of any proposed business combination
and (B) not to redeem any founder shares or private shares in connection with a shareholder vote to approve a proposed initial business
combination. In addition, we may obtain loans from our founders. The personal and financial interests of our founders may influence their
motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the
operation of the business following the initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
provisions of our amended and restated memorandum and articles of association that relate to our pre-business combination activity (and
corresponding provisions of the agreement governing the release of funds from our trust account) may be amended with the approval of
holders of two-thirds of our ordinary shares, which is a lower amendment threshold than that of some other blank check companies. It
may be easier for us, therefore, to amend our amended and restated memorandum and articles of association and the trust agreement to
facilitate the completion of an initial business combination that some of our shareholders may not support.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
other blank check companies have a provision in their charter which prohibits the amendment of certain of its provisions, including those
which relate to a company&#8217;s pre-business combination activity, without approval by a certain percentage of the company&#8217;s
shareholders. In those companies, amendment of these provisions requires approval by between 90% and 100% of the company&#8217;s public
shareholders. Our amended and restated memorandum and articles of association provides that any of its provisions related to pre-business
combination activity (including the requirement to deposit proceeds of our Initial Public Offering and the private placement of units
into the trust account and not release such amounts except in specified circumstances, and to provide redemption rights to public shareholders
as described herein) may be amended if approved by holders of two-thirds of our ordinary shares entitled to vote thereon, and corresponding
provisions of the trust agreement governing the release of funds from our trust account may be amended if approved by holders of two-thirds
of our ordinary shares entitled to vote thereon. In all other instances, our amended and restated memorandum and articles of association
may be amended by holders representing two-thirds of our outstanding ordinary shares entitled to vote thereon, subject to applicable
provisions of the Companies Act or applicable stock exchange rules. We may not issue additional securities that can vote on amendments
to our amended and restated memorandum and articles of association or in our initial business combination. Our founders, who will collectively
beneficially own up to 20% of our ordinary shares upon the closing of our Initial Public Offering will participate in any vote to amend
our amended and restated memorandum and articles of association and/or trust agreement and will have the discretion to vote in any manner
they choose. As a result, we may be able to amend the provisions of our amended and restated memorandum and articles of association which
govern our pre-business combination behavior more easily than some other blank check companies, and this may increase our ability to
complete a business combination with which you do not agree. Our shareholders may pursue remedies against us for any breach of our amended
and restated memorandum and articles of association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial shareholders have agreed, pursuant to a letter agreement with us, that they will not propose any amendment to our amended and
restated memorandum and articles of association (i) that would modify the substance or timing of our obligation to allow redemption in
connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination
within 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate our business
combination, within 18 months from the closing of our Initial Public Offering (as further described in our Registration Statement), or
(ii) with respect to any other material provision relating to shareholders&#8217; rights or pre-initial business combination activity,
unless we provide our public shareholders with the opportunity to redeem their ordinary shares upon approval of any such amendment at
a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest
shall be net of taxes payable), divided by the number of then outstanding public shares. These agreements are contained in a letter agreement
that we have entered into with our founders. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and,
as a result, will not have the ability to pursue remedies against our founders for any breach of these agreements. As a result, in the
event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target
business, which could compel us to restructure or abandon a particular business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the net proceeds of our Initial Public Offering and the sale of the private units will be sufficient to allow us to complete
our initial business combination, because we have not yet selected any prospective target business we cannot ascertain the capital requirements
for any particular transaction. If the net proceeds of our Initial Public Offering and the sale of the private units prove to be insufficient,
either because of the size of our initial business combination, the depletion of the available net proceeds in search of a target business,
the obligation to repurchase for cash a significant number of shares from shareholders who elect redemption in connection with our initial
business combination or the terms of negotiated transactions to purchase shares in connection with our initial business combination,
we may be required to seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing
will be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to complete
our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination
and seek an alternative target business candidate. If we are unable to complete our initial business combination, our public shareholders
may receive only approximately $10.18 per share plus any pro rata interest earned on the funds held in the trust account (and not previously
released to us to pay our taxes) on the liquidation of our trust account and our warrants and rights will expire worthless. In addition,
even if we do not need additional financing to complete our business combination, we may require such financing to fund the operations
or growth of the target business. The failure to secure additional financing could have a material adverse effect on the continued development
or growth of the target business. None of our officers, directors or shareholders is required to provide any financing to us in connection
with or after our initial business combination. If we are unable to complete our initial business combination, our public shareholders
may only receive approximately $10.18 per share on the liquidation of our trust account, and our warrants and rights will expire worthless.
In certain circumstances, our public shareholders may receive less than $10.18 per share on the redemption of their shares. See &#8220;&#8212;
If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by shareholders may be less than $10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
founders and other insiders may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you
do not support.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
founders own founder shares representing 20% of our issued and outstanding ordinary shares (excluding the private shares and shares underlying
the UPO). In connection with the closing of our Initial Public Offering, we issued 409,200 private units. In addition, if our founders
or their designated parties make any working capital loans, up to $300,000 of such loans may be converted into working capital units,
at the price of $10.00 per unit at the option of the lenders. Such working capital units would be identical to the private units sold
in the private placement. Accordingly, our founders along with any designated parties may exert a substantial influence on actions requiring
a shareholder vote, potentially in a manner that you do not support, including amendments to our amended and restated memorandum and
articles of association and approval of major corporate transactions. If our founders purchase any units in our Initial Public Offering
or if they purchase any additional ordinary shares in the aftermarket or in privately negotiated transactions, this would increase their
control. Factors that would be considered in making such additional purchases would include consideration of the current trading price
of our ordinary shares. In addition, our Board, whose members were elected by certain of our initial shareholders, is and will be divided
into three classes, each of which will generally serve for a term of three years with only one class of directors being elected in each
year. There is no requirement under the Companies Act for us to hold annual or general meetings to elect directors. We may not hold an
annual meeting of shareholders to elect new directors prior to the completion of our business combination, in which case all of the current
directors will continue in office until at least the completion of the business combination. If there is an annual meeting, as a consequence
of our &#8220;staggered&#8221; Board, only a minority of the Board will be considered for election and our initial shareholders, because
of their ownership position, will have considerable influence regarding the outcome. Accordingly, our initial shareholders will continue
to exert control at least until the completion of our business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Post
Business Combination Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance
that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably
operate such business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may structure a business combination so that the post-transaction company in which our public shareholders own shares will own less than
100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target
sufficient for the post-transaction company not to be required to register as an investment company under the Investment Company Act.
We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting
securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post business
combination company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could
pursue a transaction in which we issue a substantial number of new ordinary shares in exchange for all of the outstanding capital share
of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number
of new ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our outstanding ordinary
shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings resulting in
a single person or group obtaining a larger share of the company&#8217;s share than we initially acquired. Accordingly, this may make
it more likely that our management will not be able to maintain our control of the target business. We cannot provide assurance that,
upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably
operate such business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsequent
to the completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment
or other charges that could have a significant negative effect on our financial condition, results of operations and our share price,
which could cause you to lose some or all of your investment.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will surface
all material issues that may be present inside a particular target business, that it would be possible to uncover all material issues
through a customary amount of due diligence, or that factors outside of the target business and outside of our control will not later
arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment
or other charges that could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected
risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though
these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature
could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate
net worth or other covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue
of our obtaining post-combination debt financing. Accordingly, any shareholders who choose to remain shareholders following the business
combination could suffer a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction
in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may face general risks related to our business combination with any company.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
business combination with another company entails special considerations and risks. If we are successful in completing a business combination
with a target business, we may be subject to, and possibly adversely affected by, the following risks:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to compete effectively in a highly competitive environment with many incumbents having substantially greater resources;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to manage rapid change, increasing consumer expectations and growth;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to build strong brand identity and improve subscriber or customer satisfaction and loyalty;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    reliance on proprietary technology to provide services and to manage our operations, and the failure of this technology to operate
    effectively, or our failure to use such technology effectively;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to deal with our subscribers&#8217; or customers&#8217; privacy concerns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to attract and retain subscribers or customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to license or enforce intellectual property rights on which our business may depend;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    significant disruption in our computer systems or those of third parties that we would utilize in our operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability by us, or a refusal by third parties, to license content to us upon acceptable terms;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    liability for negligence, copyright, or trademark infringement or other claims based on the nature and content of materials that
    we may distribute;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
    for advertising revenue;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
    for the leisure and entertainment time and discretionary spending of subscribers or customers, which may intensify in part due to
    advances in technology and changes in consumer expectations and behavior;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption
    or failure of our networks, systems or technology as a result of computer viruses, &#8220;cyber-attacks,&#8221; misappropriation
    of data or other malfeasance, as well as outages, natural disasters, terrorist attacks, accidental releases of information or similar
    events;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    inability to obtain necessary hardware, software and operational support; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance
    on third-party vendors or service providers.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the foregoing could have an adverse impact on our operations following a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
success will ultimately depend upon market acceptance of our products and services, our ability to develop and commercialize existing
and new products and services and generate revenues, and our ability to identify new markets for its technology.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ultimately,
our success will depend on the acceptance of our products and services in the target markets. We are faced with the risk that the marketplace
will not be receptive to our products and services over competing products and that we will be unable to compete effectively. We will
face challenges of developing (or acquiring externally-developed) technology solutions that are adequate and competitive in meeting the
requirements of next-generation design challenges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure investors that the products and services of the company with which we conduct a business combination, or any future products
and services will gain broad market acceptance. If the market for our products and services fails to develop or develops more slowly
than expected, or if any of the services and standards supported by us do not achieve or sustain market acceptance, our business and
operating results would be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we fail to adapt and respond effectively to rapidly changing technology, evolving industry standards, changing regulations and payment
methods, demand for product enhancements, new product features, and changing business needs, requirements or preferences, our products
may become less competitive.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regardless
of our business combination target&#8217;s industry, it will likely be subject to ongoing technological change, evolving industry standards,
changing regulations, and changing customer needs, requirements and preferences. The success of our business will depend, in part, on
our ability to adapt and respond effectively to these changes on a timely basis, including launching new products and services. The success
of any new product and service, or any enhancements, features, or modifications to existing products and services, depends on several
factors, including the timely completion, introduction, and market acceptance of such products and services, enhancements, modifications
and new product features. If we are unable to enhance our products or develop new products that keep pace with technological and regulatory
change and changes in customer preferences and achieve market acceptance, or if new technologies emerge that are able to deliver competitive
products and services at lower prices, more efficiently, more conveniently, or more securely than our products, our business, operating
results and financial condition would be adversely affected. Furthermore, modifications to our existing platform, products, or technology
will increase our research and development expenses. Any failure of our products and services to operate effectively could reduce the
demand for our services, result in customer dissatisfaction and adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Technology
platforms may not operate properly or as we expect it to operate.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
platforms are expensive and complex, their continuous development, maintenance and operation may entail unforeseen difficulties including
material performance problems or undetected defects or errors. We may encounter technical obstacles, and it is possible that we may discover
additional problems that prevent our technology from operating properly. If our platform does not function reliably, we may not be able
to provide any products or services. Errors could also cause customer dissatisfaction with us, which could cause customers to stop purchasing
or working with us. Any of these eventualities could result in a material adverse effect on our business, results of operations and financial
condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
or changing technologies, could cause a disruption in our business model, which may materially impact our results of operations and financial
condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to anticipate the impact on our business of changing technology, our ability to successfully operate may be materially impaired.
Our business could also be affected by potential technological changes. Such changes could disrupt the demand for products from current
customers, create coverage issues or impact the frequency or severity of losses, or reduce the size of the ultimate market, causing our
business to decline. We may not be able to respond effectively to these changes, which could have a material effect on our results of
operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Claims
by others that we infringe or have infringed their proprietary technology or other intellectual property rights could harm our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in the technology industries are frequently subject to litigation based on allegations of infringement or other violations of intellectual
property rights. In addition, certain companies and rights holders seek to enforce and monetize patents or other intellectual property
rights they own, have purchased or have otherwise obtained. As we gain an increasingly high public profile, the possibility of intellectual
property rights claims against us grows. From time to time, third parties may assert claims of infringement of intellectual property
rights against us. Although we may have meritorious defenses, there can be no assurance that we will be successful in defending against
these allegations or in reaching a business resolution that is satisfactory to us. Our competitors and others may now and in the future
have significantly larger and more mature patent portfolios than us. In addition, future litigation may involve patent holding companies
or other adverse patent owners who have no relevant product or service revenue and against whom our own patents may therefore provide
little or no deterrence or protection. Many potential litigants, including competitors and patent-holding companies, have the ability
to dedicate substantial resources to the assertion of their intellectual property rights. Any claim of infringement by a third party,
even those without merit, could cause us to incur substantial costs defending against the claim, could distract our management from our
business and could require us to cease use of such intellectual property. Furthermore, because of the substantial amount of discovery
required in connection with intellectual property litigation, we risk compromising our confidential information during this type of litigation.
We may be required to pay substantial damages, royalties or other fees in connection with a claimant securing a judgment against us,
we may be subject to an injunction or other restrictions that prevent us from using or distributing our intellectual property, or from
operating under our brand, or we may agree to a settlement that prevents us from distributing our offerings or a portion thereof, which
could adversely affect our business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to any intellectual property rights claim, we may have to seek out a license to continue operations found or alleged to violate
such rights, which may not be available, or if available, may not be available on favorable or commercially reasonable terms and may
significantly increase our operating expenses. Some licenses may be non-exclusive, and therefore our competitors may have access to the
same technology licensed to us. If a third party does not offer us a license to its intellectual property on reasonable terms, or at
all, we may be required to develop alternative, non-infringing technology, which could require significant time (during which we would
be unable to continue to offer our affected offerings), effort and expense and may ultimately not be successful. Any of these events
could adversely affect our business, results of operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may seek acquisition opportunities with an early-stage company, a financially unstable business or an entity lacking an established record
of revenue or earnings.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we complete our initial business combination with an early-stage company, a financially unstable business or an entity lacking
an established record of sales or earnings, we may be affected by numerous risks inherent in the operations of the business with which
we combine. These risks include investing in a business without a proven business model and with limited historical financial data, volatile
revenues or earnings, intense competition and difficulties in obtaining and retaining key personnel. Although our officers and directors
will endeavor to evaluate the risks inherent in a particular target business, we may not be able to properly ascertain or assess all
of the significant risk factors and we may not have adequate time to complete due diligence. Furthermore, some of these risks may be
outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a target
business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Acquiring and Operating a Business Outside of the United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may effect a business combination with a company located outside of the United States and if we do, we would be subject to a variety
of additional risks that may negatively impact our business operations and financial results<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we consummate a business combination with a target business located outside of the United States, we would be subject to any special
considerations or risks associated with companies operating in the target business&#8217; governing jurisdiction, including any of the
following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rules
    and regulations or currency redemption or corporate withholding taxes on individuals;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tariffs
    and trade barriers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulations
    related to customs and import/export matters;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">longer
    payment cycles than in the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inflation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
    policies and market conditions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unexpected
    changes in regulatory requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in managing and staffing international operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax
    issues, such as tax law changes and variations in tax laws as compared to the United States;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency
    fluctuations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in collecting accounts receivable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cultural
    and language differences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">protection
    of intellectual property; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">employment
    regulations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that we would be able to adequately address these additional risks. If we were unable to do so, our operations might
suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
of the costs and difficulties inherent in managing cross-border business operations, our results of operations may be negatively impacted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
a business, operations, personnel or assets in another country is challenging and costly. Any management that we may have (whether based
abroad or in the U.S.) may be inexperienced in cross-border business practices and unaware of significant differences in accounting rules,
legal regimes and labor practices. Even with a seasoned and experienced management team, the costs and difficulties inherent in managing
cross-border business operations, personnel and assets can be significant (and much higher than in a purely domestic business) and may
negatively impact our financial and operational performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
social unrest, acts of terrorism, regime changes, changes in laws and regulations, political upheaval, or policy changes or enactments
occur in a country in which we may operate after we effect our initial business combination, it may result in a negative impact on our
business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Political
events in another country may significantly affect our business, assets or operations. Social unrest, acts of terrorism, regime changes,
changes in laws and regulations, political upheaval, and policy changes or enactments could negatively impact our business in a particular
country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Many
countries have difficult and unpredictable legal systems and underdeveloped laws and regulations that are unclear and subject to corruption
and inexperience, which may adversely impact our results of operations and financial condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to seek and enforce legal protections, including with respect to intellectual property and other property rights, or to defend
ourselves with regard to legal actions taken against us in a given country, may be difficult or impossible, which could adversely impact
our operations, assets or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules
and regulations in many countries are often ambiguous or open to differing interpretation by responsible individuals and agencies at
the municipal, state, regional and federal levels. The attitudes and actions of such individuals and agencies are often difficult to
predict and inconsistent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delay
with respect to the enforcement of particular rules and regulations, including those relating to customs, tax, environmental and labor,
could cause serious disruption to operations abroad and negatively impact our results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we effect a business combination with a company located outside of the United States, the laws applicable to such company will likely
govern all of our material agreements and we may not be able to enforce our legal rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we effect a business combination with a company located outside of the United States, the laws of the country in which such company operates
will govern almost all of the material agreements relating to its operations. We cannot assure you that the target business will be able
to enforce any of its material agreements or that remedies will be available in this new jurisdiction. The system of laws and the enforcement
of existing laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability
to enforce or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities
or capital. Additionally, if we acquire a company located outside of the United States, it is likely that substantially all of our assets
would be located outside of the United States and some of our officers and directors might reside outside of the United States. As a
result, it may not be possible for investors in the United States to enforce their legal rights, to effect service of process upon our
directors or officers, or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties of our
directors and officers under Federal securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
relations between the United States and foreign governments deteriorate, it could cause potential target businesses or their goods and
services to become less attractive.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relationship between the United States and foreign governments could be subject to sudden fluctuation and periodic tension. For instance,
the United States may announce its intention to impose quotas on certain imports. Such import quotas may adversely affect political relations
between the two countries and result in retaliatory countermeasures by the foreign government in industries that may affect our ultimate
target business. Changes in political conditions in foreign countries and changes in the state of U.S. relations with such countries
are difficult to predict and could adversely affect our operations or cause potential target businesses or their goods and services to
become less attractive. Because we are not limited to any specific industry, there is no basis for investors in our Initial Public Offering
to evaluate the possible extent of any impact on our ultimate operations if relations are strained between the United States and a foreign
country in which we acquire a target business or move our principal manufacturing or service operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
any dividend is declared in the future and paid in a foreign currency, you may be taxed on a larger amount in U.S.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a U.S. holder of our ordinary shares, you will be taxed on the U.S. dollar value of your dividends, if any, at the time you receive
them, even if you actually receive a smaller amount of U.S. dollars when the payment is in fact converted into U.S. dollars. Specifically,
if a dividend is declared and paid in a foreign currency, the amount of the dividend distribution that you must include in your income
as a U.S. holder will be the U.S. dollar value of the payments made in the foreign currency, determined at the spot rate of the foreign
currency to the U.S. dollar on the date the dividend distribution is includible in your income, regardless of whether the payment is
in fact converted into U.S. dollars. Thus, if the value of the foreign currency decreases before you actually convert the currency into
U.S. dollars, you will be taxed on a larger amount in U.S. dollars than the U.S. dollar amount that you will actually ultimately receive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time
and resources becoming familiar with such laws, which could lead to various regulatory issues.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
our initial business combination, certain members of our management team will likely resign from their positions as officers or directors
of the company and the management of the target business at the time of the business combination will remain in place. Management of
the target business may not be familiar with United States securities laws. If new management is unfamiliar with our laws, they may have
to expend time and resources becoming familiar with such laws. This could be expensive and time-consuming and could lead to various regulatory
issues, which may adversely affect our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
our initial business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue
may be derived from our operations in such country. Accordingly, our results of operations and prospects will be subject, to a significant
extent, to the economic, political and legal policies, developments and conditions in the country in which we operate.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
economic, political and social conditions, as well as government policies, of the country in which our operations are located could affect
our business. The economies of many countries in Asia where we would contemplate a business combination differ from the economies of
most developed countries in many respects. Such economic growth has been uneven, both geographically and among various sectors of the
economy and such growth may not be sustained in the future. If in the future such country&#8217;s economy experiences a downturn or grows
at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain
industries could materially and adversely affect our ability to find an attractive target business with which to consummate our initial
business combination and if we effect our initial business combination, the ability of that target business to become profitable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Currency
policies may cause a target business&#8217; ability to succeed in the international markets to be diminished.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we acquire a non-U.S. target, all revenues and income would likely be received in a foreign currency, the dollar equivalent
of our net assets and distributions, if any, could be adversely affected by reductions in the value of the local currency. The value
of the currencies in our target regions fluctuate and are affected by, among other things, changes in political and economic conditions.
Any change in the relative value of such currency against our reporting currency may affect the attractiveness of any target business
or, following consummation of our initial business combination, our financial condition and results of operations. Additionally, if a
currency appreciates in value against the dollar prior to the consummation of our initial business combination, the cost of a target
business as measured in dollars will increase, which may make it less likely that we are able to consummate such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Many
of the economies in Asia are experiencing substantial inflationary pressures which may prompt the governments to take action to control
the growth of the economy and inflation that could lead to a significant decrease in our profitability following our initial business
combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no restriction in the geographic location of targets that we can pursue, although we intend to initially prioritize geographic locations
in Asia. In the event that our target business is in Asia, while many of the economies in Asia have experienced rapid growth over the
last two decades, they currently are experiencing inflationary pressures. As governments take steps to address the current inflationary
pressures, there may be significant changes in the availability of bank credits, interest rates, limitations on loans, restrictions on
currency conversions and foreign investment. There also may be imposition of price controls. If prices for the products of our ultimate
target business rise at a rate that is insufficient to compensate for the rise in the costs of supplies, it may have an adverse effect
on our profitability. If these or other similar restrictions are imposed by a government to influence the economy, it may lead to a slowing
of economic growth. Because we are not limited to any specific industry, the ultimate industry that we operate in may be affected more
severely by such a slowing of economic growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Many
industries in Asia are subject to government regulations that limit or prohibit foreign investments in such industries, which may limit
the potential number of acquisition candidates.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governments
in many Asian countries have imposed regulations that limit foreign investors&#8217; equity ownership or prohibit foreign investments
altogether in companies that operate in certain industries. As a result, the number of potential acquisition candidates available to
us may be limited or our ability to grow and sustain the business, which we ultimately acquire will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
a country in Asia enacts regulations in industry segments that forbid or restrict foreign investment, our ability to consummate our initial
business combination could be severely impaired.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the rules and regulations that companies face concerning foreign ownership are not explicitly communicated. If new laws or regulations
forbid or limit foreign investment in industries in which we want to complete our initial business combination, they could severely impair
our candidate pool of potential target businesses. Additionally, if the relevant central and local authorities find us or the target
business with which we ultimately complete our initial business combination to be in violation of any existing or future laws or regulations,
they would have broad discretion in dealing with such a violation, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">levying
    fines;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revoking
    our business and other licenses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
    that we restructure our ownership or operations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
    that we discontinue any portion or all of our business.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the above could have an adverse effect on our company post-business combination and could materially reduce the value of your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
governance standards in Asia may not be as strict or developed as in the United States and such weakness may hide issues and operational
practices that are detrimental to a target business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
corporate governance standards in some countries are weak in that they do not prevent business practices that cause unfavorable related
party transactions, over-leveraging, improper accounting, family company interconnectivity and poor management. Local laws often do not
go far enough to prevent improper business practices. Therefore, shareholders may not be treated impartially and equally as a result
of poor management practices, asset shifting, conglomerate structures that result in preferential treatment to some parts of the overall
company, and cronyism. The lack of transparency and ambiguity in the regulatory process also may result in inadequate credit evaluation
and weakness that may precipitate or encourage financial crisis. In our evaluation of a business combination we will have to evaluate
the corporate governance of a target and the business environment, and in accordance with United States laws for reporting companies
take steps to implement practices that will cause compliance with all applicable rules and accounting practices. Notwithstanding these
intended efforts, there may be endemic practices and local laws that could add risk to an investment we ultimately make and that result
in an adverse effect on our operations and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may face additional and distinctive risks if we acquire a technology business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
combinations with technology businesses may involve special considerations and risks. If we complete our initial business combination
with a technology business, we will be subject to the following risks, any of which could be detrimental to us and the business we acquire:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are unable to keep pace with evolving technology and changes in the technology services industry, our revenues and future prospects
    may decline;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    business or company we acquire could be vulnerable to cyberattack or theft of individual identities or personal data;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulties
    with any products or services we provide could damage our reputation and business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    failure to comply with privacy regulations could adversely affect relations with customers and have a negative impact on business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to protect our intellectual property and we may be subject to infringement claims; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    and any business or company we acquire may not be able to adapt to the complex and evolving regulatory environment for financial
    technology services.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of the foregoing could have an adverse impact on our operations following a business combination. However, our efforts in identifying
prospective target businesses will not be limited to technology businesses. Accordingly, if we acquire a target business in another industry,
these risks will likely not affect us and we will be subject to other risks attendant with the specific industry in which we operate
or target business which we acquire, none of which can be presently ascertained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we effect our initial business combination with a business located in the in the PRC, the laws applicable to such business will likely
govern all of our material agreements and we may not be able to enforce our legal rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we effect our initial business combination with a business located in the PRC, the laws of the country in which such business operates
will govern almost all of the material agreements relating to its operations, including any contractual arrangements through which we
acquire control of target business as described above. We cannot assure you that we or the target business will be able to enforce any
of its material agreements or that remedies will be available in this jurisdiction. The system of laws and the enforcement of existing
laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. In addition, the judiciary
in the PRC is relatively inexperienced compared to others in enforcing corporate and commercial law, leading to a higher than usual degree
of uncertainty as to the outcome of any litigation. In addition, to the extent that our target business&#8217;s material agreements are
with governmental agencies in the PRC, we may not be able to enforce or obtain a remedy from such agencies due to sovereign immunity,
in which the government is deemed to be immune from civil lawsuit or criminal prosecution. The inability to enforce or obtain a remedy
under any of our future agreements could result in a significant loss of business, business opportunities or capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we effect our initial business combination with a business located in the PRC, we may be subject to certain risks associated with acquiring
and operating businesses in the PRC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to certain risks associated with acquiring and operating a business in the PRC in our search for a business combination
and operation of any target business with which we ultimately consummate a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
certain rules and regulations concerning mergers and acquisitions by foreign investors in the PRC may make merger and acquisition activities
by foreign investors more complex and time consuming, including, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    requirement that the Ministry of Commerce of the PRC (the &#8220;MOFCOM&#8221;) be notified in certain circumstances in advance of
    any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise or any concentration of
    undertaking if certain thresholds are triggered;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    authority of certain government agencies to have scrutiny over the economics of an acquisition transaction and requirement for consideration
    in a transaction to be paid within stated time limits; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    requirement for mergers and acquisitions by foreign investors that raise &#8220;national defense and security&#8221; concerns and
    mergers and acquisitions through which foreign investors may acquire de facto control over domestic enterprises that raise &#8220;national
    security&#8221; concerns to be subject to strict review by the MOFCOM.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complying
with these and other requirements could be time-consuming, and any required approval processes, including obtaining approval from the
MOFCOM or its local counterparts, may delay or inhibit our ability to complete such transactions, which could affect our ability to acquire
PRC-based businesses. A business combination we propose may not be able to be completed if the terms of the transaction do not satisfy
aspects of the approval process and may not be completed, even if approved, if they are not consummated within the time permitted by
the approvals granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the PRC currently prohibits and/or restricts foreign ownership in certain &#8220;important industries,&#8221; including telecommunications,
food production and heavy equipment. There are uncertainties under certain regulations whether obtaining a majority interest through
contractual arrangements will comply with regulations prohibiting or restricting foreign ownership in certain industries. There is no
assurance that the PRC government will not apply restrictions in other industries. In addition, there can be restrictions on the foreign
ownership of businesses that are determined from time to time to be in &#8220;important industries&#8221; that may affect the national
economic security or those having &#8220;famous brand names&#8221; or &#8220;well-established brand names.&#8221; Subject to the review
and approval requirements of the relevant agencies and the various percentage ownership limitations that exist from time to time, acquisitions
involving foreign investors and parties in the various restricted categories of assets and industries may nonetheless sometimes be consummated
using contractual arrangements with permitted local parties. If we choose to effect a business combination that employs the use of these
types of control arrangements, these contractual arrangements may not be as effective in providing us with the same economic benefits,
accounting consolidation or control over a target business as would direct ownership due to limited implementation guidance provided
with respect to such regulations. If the government of the PRC finds that the agreements we entered into to acquire control of a target
business through contractual arrangements with one or more operating businesses do not comply with local governmental restrictions on
foreign investment, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to
significant penalties or be forced to relinquish our interests in those operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we effect our initial business combination with a business located in the PRC, a substantial portion of our operations may be conducted
in the PRC, and a significant portion of our net revenues maybe derived from customers where the contracting entity is located in the
PRC. Accordingly, our business, financial condition, results of operations, prospects and certain transactions we may undertake may be
subject, to a significant extent, to economic, political and governmental and legal developments, laws and regulations in the PRC. For
instance, all or most of our material agreements may be governed by PRC law and we may have difficulty in enforcing our legal rights
because the system of laws and the enforcement of existing laws in PRC may not be as certain in implementation and interpretation as
in the United States. In addition, contractual arrangements we enter into with potential future subsidiaries and affiliated entities
or acquisitions of offshore entities that conduct operations through affiliates in the PRC may be subject to a high level of scrutiny
by the relevant PRC tax authorities. We may also be subject to restrictions on dividend payments after we consummate a business combination
and if we rely on dividends and other distributions from our operating company to provide us with cash flow and to meet our other obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
arrangements we enter into with potential future subsidiaries and affiliated entities or acquisitions of offshore entities that conduct
operations through affiliates in the PRC may be subject to a high level of scrutiny by the relevant tax authorities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the laws of the PRC, arrangements and transactions among related parties may be subject to audit or challenge by the relevant tax authorities.
If any of the transactions we enter into with potential future subsidiaries and affiliated entities are found not to be on an arm&#8217;s-length
basis, or to result in an unreasonable reduction in tax under local law, the relevant tax authorities may have the authority to disallow
any tax savings, adjust the profits and losses of such potential future local entities and assess late payment interest and penalties.
A finding by the relevant tax authorities that we are ineligible for any such tax savings, or that any of our possible future affiliated
entities are not eligible for tax exemptions, would substantially increase our possible future taxes and thus reduce our net income and
the value of a shareholder&#8217;s investment. In addition, in the event that in connection with an acquisition of an offshore entity
that conducted its operations through affiliates in the PRC, the sellers of such entities failed to pay any taxes required under local
law, the relevant tax authorities could require us to withhold and pay the tax, together with late-payment interest and penalties. The
occurrence of any of the foregoing could have a negative impact on our operating results and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
the government of the PRC finds that the agreements we entered into to acquire control of a target business do not comply with local
governmental restrictions on foreign investment, or if these regulations or the interpretation of existing regulations change in the
future, we could be subject to significant penalties or be forced to relinquish our interests in those operations or we could be unable
to assert our contractual control rights over the assets of the post-combination target company, which could cause the value of our ordinary
shares depreciate significantly or become worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC currently prohibits and/or restricts foreign ownership in certain &#8220;important industries,&#8221; including telecommunications,
food production and heavy equipment. There are uncertainties under certain regulations whether obtaining a majority interest through
contractual arrangements will comply with regulations prohibiting or restricting foreign ownership in certain industries. For example,
the PRC may apply restrictions in other industries in the future. In addition, there can be restrictions on the foreign ownership of
businesses that are determined from time to time to be in &#8220;important industries&#8221; that may affect the national economic security
or those having &#8220;famous brand names&#8221; or &#8220;well-established brand names.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we or any of our potential future target businesses are found to be in violation of any existing or future local laws or regulations
(for example, if we are deemed to be holding equity interests in certain of our affiliated entities in which direct foreign ownership
is prohibited), the relevant regulatory authorities might have the discretion to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revoke
    the business and operating licenses of the potential future target business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">confiscate
    relevant income and impose fines and other penalties;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discontinue
    or restrict the operations of the potential future target business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    us or the potential future target business to restructure the relevant ownership structure or operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrict
    or prohibit our use of the proceeds of our Initial Public Offering to finance our businesses and operations in the relevant jurisdiction;
    or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impose
    conditions or requirements with which we or the potential future target business may not be able to comply.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we acquire control of a target business through contractual arrangements with one or more operating businesses in the PRC, such contracts
may not be as effective in providing operational control as direct ownership of such business and may be difficult to enforce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will only acquire a business or businesses that, upon the consummation of our initial business combination, will be our majority-owned
subsidiaries and will be neither investment companies nor companies excluded from the definition of an investment company by Section
3(c)(1) or 3(c)(7) of the Investment Company Act. However, the PRC has restricted or limited foreign ownership of certain kinds of assets
and companies operating in certain industries. The industry groups that are restricted are wide-ranging, including, for example, certain
aspects of telecommunications, food production, and heavy equipment manufacturers. In addition, there can be restrictions on the foreign
ownership of businesses that are determined from time to time to be in &#8220;important industries&#8221; that may affect the national
economic security or having &#8220;famous brand names&#8221; or &#8220;well-established brand names.&#8221; Subject to the review and
approval requirements of the relevant agencies for acquisitions of assets and companies in the relevant jurisdictions and subject to
the various percentage ownership limitations that exist from time to time, acquisitions involving foreign investors and parties in the
various restricted categories of assets and industries may nonetheless sometimes be consummated using contractual arrangements with permitted
local parties. To the extent that such agreements are employed, they may be for control of specific assets such as intellectual property
or control of blocks of the equity ownership interests of a company which may provide exceptions to the merger and acquisition regulations
mentioned above since these types of arrangements typically do not involve a change of equity ownership in the operating company. The
agreements would be designed to provide our company with the economic benefits of, and control over, the subject assets or equity interests
similar to the rights of full ownership, while leaving the technical ownership in the hands of local parties who would be our nominees
and, therefore, may exempt the transaction from certain regulations, including the application process required thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
since there has been limited implementation guidance provided with respect to such regulations, the relevant government agency might
apply them to a business combination effected through contractual arrangements. If such an agency determines or interprets that such
an application should have been made or that our potential future target businesses are otherwise in violation of local laws or regulations,
consequences may include confiscating relevant income and levying fines and other penalties, revoking business and other licenses, requiring
restructure of ownership or operations, requiring discontinuation or restriction of the operations of any portion or all of the acquired
business, restricting or prohibiting our use of the proceeds of our Initial Public Offering to finance our businesses and operations
and imposing conditions or requirements with which we or potential future target businesses may not be able to comply, and we could be
unable to assert our contractual control rights over the assets of the post-combination target company, which could cause the value of
our ordinary shares may depreciate significantly or become worthless. These agreements likely also would provide for increased ownership
or full ownership and control by us when and if permitted under local laws and regulations. If we choose to effect a business combination
that employs the use of these types of control arrangements, we may have difficulty in enforcing our rights. Therefore, these contractual
arrangements may not be as effective in providing us with the same economic benefits, accounting consolidation or control over a target
business as would direct ownership. For example, if the target business or any other entity fails to perform its obligations under these
contractual arrangements, we may have to incur substantial costs and expend substantial resources to enforce such arrangements, and rely
on legal remedies under local law, including seeking specific performance or injunctive relief, and claiming damages, which we cannot
assure will be sufficient to offset the cost of enforcement and may adversely affect the benefits we expect to receive from the business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRC
regulations relating to offshore investment activities by PRC residents may limit our ability to inject capital in our Chinese subsidiaries
and Chinese subsidiaries&#8217; ability to change their registered capital or distribute profits to us or otherwise expose us or our
PRC resident beneficial owners to liability and penalties under PRC laws.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2014, the State Administration of Foreign Exchange of the PRC, or SAFE promulgated the Circular on Relevant Issues Concerning Foreign
Exchange Control on Domestic Residents&#8217; Offshore Investment and Financing and Roundtrip Investment Through Special Purpose Vehicles,
or SAFE Circular 37. SAFE Circular 37 requires PRC residents (including PRC individuals and PRC corporate entities as well as foreign
individuals that are deemed as PRC residents for foreign exchange administration purpose) to register with SAFE or its local branches
in connection with their direct or indirect offshore investment activities. SAFE Circular 37 is applicable to our shareholders who are
PRC residents and may be applicable to any offshore acquisitions that we make in the future. Under SAFE Circular 37, PRC residents who
make, or have prior to the implementation of SAFE Circular 37 made, direct or indirect investments in offshore special purpose vehicles,
or SPVs, will be required to register such investments with SAFE or its local branches. In addition, any PRC resident who is a direct
or indirect shareholder of an SPV, is required to update its filed registration with the local branch of SAFE with respect to that SPV,
to reflect any material change, including, among other things, any major change of a PRC resident shareholder, name or term of operation
of the SPVs, or any increase or reduction of the SPVs&#8217; registered capital, share transfer or swap, merger or division. Moreover,
any subsidiary of such SPV in China is required to urge the PRC resident shareholders to update their registration with the local branch
of SAFE. If any PRC shareholder of such SPV fails to make the required registration or to update the previously filed registration, the
subsidiary of such SPV in China may be prohibited from distributing its profits or the proceeds from any capital reduction, share transfer
or liquidation to the SPV, and the SPV may also be prohibited from making additional capital contributions into its subsidiary in China.
On February 13, 2015, SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration Policy on Direct
Investment, or SAFE Notice 13, which became effective on June 1, 2015. Under SAFE Notice 13, applications for foreign exchange registration
of inbound foreign direct investments and outbound overseas direct investments, including those required under SAFE Circular 37, will
be filed with qualified banks instead of SAFE or its branches. The qualified banks will directly examine the applications and accept
registrations under the supervision of SAFE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot provide assurance that our shareholders that are PRC residents comply with all of the requirements under SAFE Circular 37 or other
related rules. Failure or inability of our PRC resident shareholders to comply with the registration procedures set forth in these regulations
may subject us to fines and legal sanctions, restrict our cross-border investment activities, limit the ability of our wholly foreign-owned
subsidiary in China to distribute dividends and the proceeds from any reduction in capital, share transfer or liquidation to us, and
we may also be prohibited from injecting additional capital into the subsidiary. Moreover, failure to comply with the various foreign
exchange registration requirements described above could result in liability under PRC law for circumventing applicable foreign exchange
restrictions. As a result, our business operations and our ability to distribute profits to you could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
as these foreign exchange regulations are still relatively new and their interpretation and implementation has been constantly evolving,
it is unclear how these regulations, and any future regulation concerning offshore or cross-border transactions, will be interpreted,
amended and implemented by the relevant government authorities. For example, we may be subject to a more stringent review and approval
process with respect to our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings,
which may adversely affect our financial condition and results of operations. In addition, if we decide to acquire a PRC domestic company,
we cannot assure you that we or the owners of such company, as the case may be, will be able to obtain the necessary approvals or complete
the necessary filings and registrations required by the foreign exchange regulations. This may restrict our ability to implement our
acquisition strategy and could adversely affect our business and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compliance
with the PRC Antitrust Law may limit our ability to effect our initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC Antitrust Law became effective on August 1, 2008. The government authorities in charge of antitrust matters in China are the Antitrust
Commission and other antitrust authorities under the State Council. The PRC Antitrust Law regulates (1) monopoly agreements, including
decisions or actions in concert that preclude or impede competition, entered into by business operators; (2) abuse of dominant market
position by business operators; and (3) concentration of business operators that may have the effect of precluding or impeding competition.
To implement the Antitrust Law, in 2008, the State Council formulated the regulations that require filing of concentration of business
operators, pursuant to which concentration of business operators refers to (1) merger with other business operators; (2) gaining control
over other business operators through acquisition of equity interest or assets of other business operators; and (3) gaining control over
other business operators through exerting influence on other business operators through contracts or other means. In 2009, the Ministry
of Commerce, to which the Antitrust Commission is affiliated, promulgated the Measures for Filing of Concentration of Business Operators
(amended by the Guidelines for Filing of Concentration of Business Operators in 2014), which set forth the criteria of concentration
and the requirement of miscellaneous documents for the purpose of filing. The business combination we contemplate may be considered the
concentration of business operators, and to the extent required by the Antitrust Law and the criteria established by the State Council,
we must file with the antitrust authority under the PRC State Council prior to conducting the contemplated business combination. If the
antitrust authority decides not to further investigate whether the contemplated business combination has the effect of precluding or
impeding competition or fails to make a decision within 30 days from receipt of relevant materials, we may proceed to consummate the
contemplated business combination. If antitrust authority decides to prohibit the contemplated business combination after further investigation,
we must terminate such business combination and would then be forced to either attempt to complete a new business combination or we would
be required to return any amounts which were held in the trust account to our stockholders. When we evaluate a potential business combination,
we will consider the need to comply with the Antitrust Law and other relevant regulations which may limit our ability to effect an acquisition
or may result in our modifying or not pursuing a particular transaction. Since our business combination period is within 9 months from
the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate our business combination, within
18 months from the closing of our Initial Public Offering (as further described in this Form 10-K), and the approval process may take
a period longer than we expect before we enter into a definitive agreement with a target company, we may be unable to complete a business
combination within 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, within 18 months from the closing of our Initial Public Offering (as further described in this Form 10-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 49; Options: NewSection; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
controls that exist in the PRC may restrict or prevent us from using the proceeds of our Initial Public Offering to acquire a target
company in PRC and limit our ability to utilize our cash flow effectively following our initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE
promulgated the Notice of the State Administration of Foreign Exchange on Reforming the Administration of Foreign Exchange Settlement
of Capital of Foreign-invested Enterprises, or Circular 19, effective on June 1, 2015, in replacement of the Circular on the Relevant
Operating Issues Concerning the Improvement of the Administration of the Payment and Settlement of Foreign Currency Capital of Foreign-Invested
Enterprises, or SAFE Circular 142, the Notice from the State Administration of Foreign Exchange on Relevant Issues Concerning Strengthening
the Administration of Foreign Exchange Businesses, or Circular 59, and the Circular on Further Clarification and Regulation of the Issues
Concerning the Administration of Certain Capital Account Foreign Exchange Businesses, or Circular 45. According to Circular 19, the flow
and use of the RMB capital converted from foreign currency-denominated registered capital of a foreign-invested company is regulated
such that RMB capital may not be used for the issuance of RMB entrusted loans, the repayment of inter-enterprise loans or the repayment
of banks loans that have been transferred to a third party. Although Circular 19 allows RMB capital converted from foreign currency-denominated
registered capital of a foreign-invested enterprise to be used for equity investments within the PRC, it also reiterates the principle
that RMB converted from the foreign currency-denominated capital of a foreign-invested company may not be directly or indirectly used
for purposes beyond its business scope. Thus, it is unclear whether SAFE will permit such capital to be used for equity investments in
the PRC in actual practice. SAFE promulgated the Notice of the State Administration of Foreign Exchange on Reforming and Standardizing
the Foreign Exchange Settlement Management Policy of Capital Account, or Circular 16, effective on June 9, 2016, which reiterates some
of the rules set forth in Circular 19, but changes the prohibition against using RMB capital converted from foreign currency-denominated
registered capital of a foreign-invested company to issue RMB entrusted loans to a prohibition against using such capital to issue loans
to non-associated enterprises. Violations of SAFE Circular 19 and Circular 16 could result in administrative penalties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
such, Circular 19 and Circular 16 may significantly limit our ability to transfer the proceeds of our Initial Public Offering to a PRC
target company and the use of such proceeds by the PRC target company. In addition, following our initial business combination with a
PRC target company, we will be subject to the PRC&#8217;s rules and regulations on currency conversion. In the PRC, the SAFE regulates
the conversion of the Renminbi into foreign currencies. Currently, FIEs are required to apply to the SAFE for &#8220;Foreign Exchange
Registration Certificates for FIEs.&#8221; Following our initial business combination, we will likely be an FIE as a result of our ownership
structure. With such registration certificates, which need to be renewed annually, FIEs are allowed to open foreign currency accounts
including a &#8220;basic account&#8221; and &#8220;capital account.&#8221; Currency conversion within the scope of the &#8220;basic account,&#8221;
such as remittance of foreign currencies for payment of dividends, can be effected without requiring the approval of the SAFE. However,
conversion of currency in the &#8220;capital account,&#8221; including capital items such as direct investment, loans and securities,
still require approval of the SAFE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you the PRC regulatory authorities will not impose further restrictions on the convertibility of the Renminbi. Any future
restrictions on currency exchanges may limit our ability to use the proceeds of our Initial Public Offering in an initial business combination
with a PRC target company and the use our cash flow for the distribution of dividends to our stockholders or to fund operations we may
have outside of the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
initial business combination may be subject to national security review by the PRC government, and we may have to spend additional resources
and incur additional time delays to complete any such business combination or be prevented from pursuing certain investment opportunities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2011, the PRC government issued a Notice Concerning the Establishment of Security Review Procedure on Mergers and Acquisitions
of Domestic Enterprises by Foreign Investors, or Security Review Regulations, which became effective on March 5, 2011. The Security Review
Regulations cover acquisitions by foreign investors of a broad range of PRC enterprises if such acquisitions could result in de facto
control by foreign investors and the enterprises are relating to military, national defense, important agriculture products, important
energy and natural resources, important infrastructures, important transportation services, key technologies and important equipment
manufacturing. The scope of the review includes whether the acquisition will impact the national security, economic and social stability,
and the research and development capabilities on key national security related technologies. Foreign investors should submit a security
review application to the Department of Commerce for its initial review for contemplated acquisition. If the acquisition is considered
to be within the scope of the Security Review Regulations, the Department of Commerce will transfer the application to a joint security
review committee within five business days for further review. The joint security review committee, consisting of members from various
PRC government agencies, will conduct a general review and seek comments from relevant government agencies. The joint security review
committee may initiate a further special review and request the termination or restructuring of the contemplated acquisition if it determines
that the acquisition will result in significant national security issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security Review Regulations will potentially subject a large number of mergers and acquisitions transactions by foreign investors in
China to an additional layer of regulatory review. Currently, there is significant uncertainty as to the implication of the Security
Review Regulations. Neither the Department of Commerce nor other PRC government agencies have issued any detailed rules for the implementation
of the Security Review Regulations. If, for example, our potential initial business combination is with a target company operating in
the PRC in any of the sensitive sectors identified above, the transaction will be subject to the Security Review Regulations, and we
may have to spend additional resources and incur additional time delays to complete any such acquisition. There is no guarantee that
we can receive such approval in a timely manner, and we may also be prevented from pursuing certain investment opportunities if the PRC
government considers that the potential investments will result in a significant national security issue. If obtained, since our business
combination period is 9 months from the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate
our business combination, 18 months from the closing of our Initial Public Offering (as further described in our Registration Statement)
and the approval process may take a period longer than we expect before we enter into a definitive agreement with a target company, we
may be unable to complete a business combination within 9 months from the closing of our Initial Public Offering, or if we decide to
extend the period of time to consummate our business combination, within 18 months from the closing of our Initial Public Offering (as
further described in our Registration Statement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
initial business combination may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection,
and we may have to spend additional resources and incur additional time delays to complete any such business combination or be prevented
from pursuing certain investment opportunities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial business combination may be subject to PRC laws relating to the collection, use, sharing, retention, security, and transfer of
confidential and private information, such as personal information and other data. These laws continue to develop, and the PRC government
may adopt other rules and restrictions in the future. Non-compliance could result in penalties or other significant legal liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Cybersecurity Law, which was promulgated by the Standing Committee of the National People&#8217;s Congress on November 7,
2016 and took effect on June 1, 2017, personal information and important data collected and generated by a critical information infrastructure
operator in the course of its operations in China must be stored in China, and if a critical information infrastructure operator purchases
internet products and services that affects or may affect national security, it should be subject to cybersecurity review by the Cyberspace
Administration of China (&#8220;CAC&#8221;). Due to the lack of further interpretations, the exact scope of &#8220;critical information
infrastructure operator&#8221; remains unclear.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently,
the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued
the Opinions on Severe and Lawful Crackdown on Illegal Securities Activities, which was available to the public on July 6, 2021. These
opinions emphasized the need to strengthen the administration over illegal securities activities and the supervision on overseas listings
by China-based companies. These opinions proposed to take effective measures, such as promoting the construction of relevant regulatory
systems, to deal with the risks and incidents facing China-based overseas-listed companies and the demand for cybersecurity and data
privacy protection. Moreover, the State Internet Information Office issued the Measures of Cybersecurity Review (Revised Draft for Comments,
not yet effective) on July 10, 2021, which requires operators with personal information of more than 1 million users who want to list
abroad to file a cybersecurity review with the CAC. As these opinions and the draft measurers were recently issued, official guidance
and interpretation of these two remain unclear in several respects at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
for example, our potential initial business combination is with a target business operating in the PRC and if the enacted version of
the draft measures mandates clearance of cybersecurity review and other specific actions to be completed by the target business, we may
face uncertainties as to whether such clearance can be timely obtained, or at all, and incur additional time delays to complete any such
acquisition. Cybersecurity review could also result in negative publicity with respect to our initial business combination and diversion
of our managerial and financial resources. There is no guarantee that we can receive such approval in a timely manner, and we may also
be prevented from pursuing certain investment opportunities if the PRC government considers that the potential investments will result
in a significant national security issue. If obtained, since our business combination period is 9 months from the closing of our Initial
Public Offering, or if we decide to extend the period of time to consummate our business combination, 18 months from the closing of our
Initial Public Offering (as further described in this Form 10-K), and the approval process may take a period longer than we expect before
we enter into a definitive agreement with a target company, we may be unable to complete a business combination within 9 months from
the closing of our Initial Public Offering, or if we decide to extend the period of time to consummate our business combination, within
18 months from the closing of our Initial Public Offering (as further described in our Registration Statement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>In
light of recent events indicating greater oversight by the CAC over data security, particularly for companies seeking to list on a foreign
exchange, companies with more than one million users&#8217; personal information in China, especially some internet and technology companies,
may not be willing to list on a U.S. exchange or enter into a definitive business combination agreement with us. Further, we may also
avoid conduct a business combination with a company with more than one million users&#8217; personal information in China due to the
limited timeline for us to complete a business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in China are subject to various risks and costs associated with the collection, use, sharing, retention, security, and transfer of confidential
and private information, such as personal information and other data. This data is wide ranging and relates to our investors, employees,
contractors and other counterparties and third parties. If we decide to initiate a business combination with a company in China, our
compliance obligations include those relating to the Data Protection Act (As Revised) of the Cayman Islands and the relevant PRC laws
in this regard. These PRC laws apply not only to third-party transactions, but also to transfers of information between a holding company
and its subsidiaries. These laws continue to develop, and the PRC government may adopt other rules and restrictions in the future. Non-compliance
could result in penalties or other significant legal liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the PRC Cybersecurity Law, which was promulgated by the Standing Committee of the National People&#8217;s Congress on November 7,
2016 and took effect on June 1, 2017, personal information and important data collected and generated by a critical information infrastructure
operator in the course of its operations in China must be stored in China, and if a critical information infrastructure operator purchases
internet products and services that affects or may affect national security, it should be subject to cybersecurity review by the CAC.
Due to the lack of further interpretations, the exact scope of &#8220;critical information infrastructure operator&#8221; remains unclear.
On July 10, 2021, the CAC publicly issued the Measures for Cybersecurity Censorship (Revised Draft for Comments) aiming to, upon its
enactment, replace the existing Measures for Cybersecurity Censorship. The draft measures extend the scope of cybersecurity reviews to
data processing operators engaging in data processing activities that affect or may affect national security, including listing in a
foreign country. The draft measures require a company holding more than one million personal information to submit its IPO materials
prepared for submission for cybersecurity review before listing on a foreign exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is unclear whether the draft measures will apply to a company planning to list on a U.S. exchange by business combination with a special
purpose acquisition corporation like us. If cybersecurity review applies to our business combination with a company holding more than
one million personal information in China, we cannot guarantee that we will receive such approval in a timely manner. Further, due to
limited business combination period that we have, we may avoid searching for a target and completing an initial business combination
that will be subject to Chinese cybersecurity review. Therefore, we may avoid searching for a company with one million personal information
in China or a company operating critical information infrastructure in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if we were found to be in violation of applicable laws and regulations in China during such review, we could be subject to administrative
penalties, such as warnings, fines, or service suspension. Therefore, cybersecurity review could materially and adversely affect our
business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the PRC Data Security Law, which was promulgated by the Standing Committee of the National People&#8217;s Congress on June
10, 2021 and takes effect on September 1, 2021, requires data collection to be conducted in a legitimate and proper manner, and stipulates
that, for the purpose of data protection, data processing activities must be conducted based on data classification and hierarchical
protection system for data security. After the Data Security Law takes effect, if our post-combination entity&#8217;s data processing
activities were found to be not in compliance with this law, our post-combination entity could be ordered to make corrections, and under
certain serious circumstances, such as severe data divulgence, we and post-combination entity could be subject to penalties, including
the revocation of our business licenses or other permits. As a result, we and post-combination entity may be required to suspend our
relevant businesses, shut down our website, take down our operating applications, or face other penalties, which may materially and adversely
affect our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we make equity compensation grants to persons who are PRC citizens, they may be required to register with the State Administration of
Foreign Exchange of the PRC (&#8220;SAFE&#8221;). We may also face regulatory uncertainties that could restrict our ability to adopt
equity compensation plans for our directors and employees and other parties under PRC laws.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 6, 2007, SAFE issued the &#8220;Operating Procedures for Administration of Domestic Individuals Participating in the Employee Stock
Ownership Plan or Stock Option Plan of An Overseas Listed Company, also known as &#8220;Circular 78.&#8221; It is not clear whether Circular
78 covers all forms of equity compensation plans or only those which provide for the granting of shares options. For any plans which
are so covered and are adopted by a non-PRC listed company, such as our company, after April 6, 2007, Circular 78 requires all participants
who are PRC citizens to register with and obtain approvals from SAFE prior to their participation in the plan. In addition, Circular
78 also requires PRC citizens to register with SAFE and make the necessary applications and filings if they participated in an overseas
listed company&#8217;s covered equity compensation plan prior to April 6, 2007. We believe that the registration and approval requirements
contemplated in Circular 78 will be burdensome and time consuming.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of business combination with a target business with primary operations in PRC, we may adopt an equity incentive plan and
make shares option grants under the plan to our officers, directors and employees, whom may be PRC citizens and be required to register
with SAFE. If it is determined that any of our equity compensation plans are subject to Circular 78, failure to comply with such provisions
may subject us and participants of our equity incentive plan who are PRC citizens to fines and legal sanctions and prevent us from being
able to grant equity compensation to our PRC employees. In that case, our ability to compensate our employees and directors through equity
compensation would be hindered and our business operations may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Enhanced
scrutiny over acquisition transactions by the PRC tax authorities may have a negative impact on potential acquisitions we may pursue
in the future.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC tax authorities have enhanced their scrutiny over the direct or indirect transfer of certain taxable assets, including, in particular,
equity interests in a PRC resident enterprise, by a non-resident enterprise by promulgating and implementing SAT Circular 59 and Circular
698, which became effective in January 2008, and a Circular 7 in replacement of some of the existing rules in Circular 698, which became
effective in February 2015.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Circular 698, where a non-resident enterprise conducts an &#8220;indirect transfer&#8221; by transferring the equity interests of a PRC
&#8220;resident enterprise&#8221; indirectly by disposing of the equity interests of an overseas holding company, the non-resident enterprise,
being the transferor, may be subject to PRC corporate income tax, if the indirect transfer is considered to be an abusive use of company
structure without reasonable commercial purposes. As a result, gains derived from such indirect transfer may be subject to PRC tax at
a rate of up to 10%. Circular 698 also provides that, where a non-PRC resident enterprise transfers its equity interests in a PRC resident
enterprise to its related parties at a price lower than the fair market value, the relevant tax authority has the power to make a reasonable
adjustment to the taxable income of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2015, the SAT issued Circular 7 to replace the rules relating to indirect transfers in Circular 698. Circular 7 has introduced
a new tax regime that is significantly different from that under Circular 698. Circular 7 extends its tax jurisdiction to not only indirect
transfers set forth under Circular 698 but also transactions involving transfer of other taxable assets, through the offshore transfer
of a foreign intermediate holding company. In addition, Circular 7 provides clearer criteria than Circular 698 on how to assess reasonable
commercial purposes and has introduced safe harbors for internal group restructurings and the purchase and sale of equity through a public
securities market. Circular 7 also brings challenges to both the foreign transferor and transferee (or other person who is obligated
to pay for the transfer) of the taxable assets. Where a non-resident enterprise conducts an &#8220;indirect transfer&#8221; by transferring
the taxable assets indirectly by disposing of the equity interests of an overseas holding company, the non-resident enterprise being
the transferor, or the transferee, or the PRC entity which directly owned the taxable assets may report to the relevant tax authority
such indirect transfer. Using a &#8220;substance over form&#8221; principle, the PRC tax authority may disregard the existence of the
overseas holding company if it lacks a reasonable commercial purpose and was established for the purpose of reducing, avoiding or deferring
PRC tax. As a result, gains derived from such indirect transfer may be subject to PRC corporate income tax, and the transferee or other
person who is obligated to pay for the transfer is obligated to withhold the applicable taxes, currently at a rate of 10% for the transfer
of equity interests in a PRC resident enterprise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face uncertainties on the reporting and consequences on future private equity financing transactions, share exchange or other transactions
involving the transfer of shares in our company by investors that are non-PRC resident enterprises. The PRC tax authorities may pursue
such non-resident enterprises with respect to a filing or the transferees with respect to withholding obligation, and request our PRC
subsidiaries to assist in the filing. As a result, we and non-resident enterprises in such transactions may become at risk of being subject
to filing obligations or being taxed, under Circular 59 or Circular 698 and Circular 7, and may be required to expend valuable resources
to comply with Circular 59, Circular 698 and Circular 7 or to establish that we and our non-resident enterprises should not be taxed
under these circulars, which may have a material adverse effect on our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC tax authorities have the discretion under SAT Circular 59, Circular 698 and Circular 7 to make adjustments to the taxable capital
gains based on the difference between the fair value of the taxable assets transferred and the cost of investment. Although we currently
have no plans to pursue any acquisitions in China or elsewhere in the world, we may pursue acquisitions in the future that may involve
complex corporate structures. If we are considered a non-resident enterprise under the PRC corporate income tax law and if the PRC tax
authorities make adjustments to the taxable income of the transactions under SAT Circular 59 or Circular 698 and Circular 7, our income
tax costs associated with such potential acquisitions will be increased, which may have an adverse effect on our financial condition
and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Chinese government may exert substantial interventions and influences over the manner in which our post-combination entity must conduct
its business activities that we cannot expect when we enter into a definitive agreement with a target company with major operation in
China. If the Chinese government establishes some new policies, regulations, rules, or laws in the industries where our post-combination
entity is in, our post-combination entity may subject to material change in its operations and the value of our ordinary shares.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chinese government has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy through
regulation and state ownership. The Chinese government may intervene or influence the operations of a target business that we acquire
at any time, which could result in a material change in our operations and/or the value of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
post-combination entity&#8217;s ability to operate in China may also be harmed by changes in its laws and regulations, including those
relating to taxation, environmental regulations, land use rights, property and other matters. The central or local governments of these
jurisdictions may impose new, stricter regulations or interpretations of existing regulations that would require additional expenditures
and efforts on our part to ensure our compliance with such regulations or interpretations. Accordingly, government actions in the future,
including any decision not to continue to support recent economic reforms and to return to a more centrally planned economy or regional
or local variations in the implementation of economic policies, could have a significant effect on economic conditions in China or particular
regions thereof, and could require us to divest ourselves of any interest we then hold in Chinese properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, the Chinese cybersecurity regulator announced on July 2, 2021, that it had begun an investigation of Didi Global Inc. (NYSE:
DIDI) and two days later ordered that the company&#8217;s app be removed from smartphone app stores. On July 24, 2021, the General Office
of the Communist Party of China Central Committee and the General Office of the State Council jointly released the Guidelines for Further
Easing the Burden of Excessive Homework and Off-campus Tutoring for Students at the Stage of Compulsory Education, pursuant to which
foreign investment in such firms via mergers and acquisitions, franchise development, and variable interest entities are banned from
this sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
such, the post-combination entity&#8217;s business segments may be subject to various government and regulatory interference in the provinces
in which they operate. The post-combination entity could be subject to regulation by various political and regulatory entities, including
various local and municipal agencies and government sub-divisions. We and our post-combination entity may incur increased costs necessary
to comply with existing and newly adopted laws and regulations or penalties for any failure to comply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
recent statements by the Chinese government have indicated an intent to exert more oversight and control over offerings that are conducted
overseas and/or over foreign investment in China-based issuers. Any such action could significantly limit or completely hinder our ability
to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.
It is uncertain when and whether we and our post-combination entity will be required to obtain permission from the PRC government to
list on U.S. exchanges in the future, and even when such permission is obtained, whether it will be denied or rescinded. Although we
are currently not required to obtain permission from any of the PRC federal or local government and have not received any denial to list
on the U.S. exchange, our post-combination operations could be adversely affected, directly or indirectly, by existing or future laws
and regulations relating to our business or industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRC
laws and regulations governing our post-combination entity&#8217;s business operations are sometimes vague and uncertain, which may result
in a material change to our operations and the value of our shares if we complete our business combination with a target in China. Additionally,
any changes in such laws and regulations may impair our ability to operate profitably.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are substantial uncertainties regarding the interpretation and application of PRC laws and regulations including, but not limited to,
the laws and regulations governing our business and the enforcement and performance of our arrangements with customers in certain circumstances.
The laws and regulations are sometimes vague and may be subject to future changes, and their official interpretation and enforcement
may involve substantial uncertainty. The effectiveness and interpretation of newly enacted laws or regulations, including amendments
to existing laws and regulations, may be delayed, and our business may be affected if we rely on laws and regulations which are subsequently
adopted or interpreted in a manner different from our understanding of these laws and regulations. New laws and regulations that affect
existing and proposed future businesses may also be applied retroactively. We cannot predict what effect the interpretation of existing
or new PRC laws or regulations may have on our post-combination entity&#8217;s business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC legal system is a civil law system based on written statutes. Unlike the common law system, prior court decisions under the civil
law system may be cited for reference but have limited precedential value. Since these laws and regulations are relatively new and the
PRC legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform and the
enforcement of these laws, regulations and rules involves uncertainties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general. The
overall effect of legislation over the past three decades has significantly enhanced the protections afforded to various forms of foreign
investments in China. However, China has not developed a fully integrated legal system, and recently enacted laws and regulations may
not sufficiently cover all aspects of economic activities in China. In particular, the interpretation and enforcement of these laws and
regulations involve uncertainties. Since PRC administrative and court authorities have significant discretion in interpreting and implementing
statutory provisions and contractual terms, it may be difficult to evaluate the outcome of administrative and court proceedings and the
level of legal protection we enjoy. These uncertainties may affect our judgment on the relevance of legal requirements and our ability
to enforce our contractual rights or tort claims. In addition, the regulatory uncertainties may be exploited through unmerited or frivolous
legal actions or threats in attempts to extract payments or benefits from us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or
at all and may have retroactive effect. As a result, we may not be aware of our violation of any of these policies and rules until sometime
after the violation. In addition, any administrative and court proceedings in China may be protracted, resulting in substantial costs
and diversion of resources and management attention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, our post-combination entity may have to resort to administrative and court proceedings to enforce our legal rights. However,
since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual
terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection our
post-combination entity enjoys than in more developed legal systems. Furthermore, the PRC legal system is based in part on government
policies and internal rules (some of which are not published in a timely manner or at all) that may have retroactive effect. As a result,
we and our post-combination entity may not be aware of our violation of these policies and rules until sometime after the violation.
Such uncertainties, including uncertainty over the scope and effect of our contractual, property (including intellectual property) and
procedural rights, and any failure to respond to changes in the regulatory environment in China could materially and adversely affect
our business and impede our post-combination entity&#8217;s ability to continue its operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in the policies, regulations, rules, and the enforcement of laws of the PRC government may be quick with little advance notice and could
have a significant impact upon our ability to operate profitably in the PRC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
post-combination entity may conduct most of our operations and most of our revenue is generated in the PRC. Accordingly, economic, political
and legal developments in the PRC will significantly affect our post-combination entity&#8217;s business, financial condition, results
of operations and prospects. Policies, regulations, rules, and the enforcement of laws of the PRC government can have significant effects
on economic conditions in the PRC and the ability of businesses to operate profitably. Our post-combination entity&#8217;s ability to
operate profitably in the PRC may be adversely affected by changes in policies by the PRC government, including changes in laws, regulations
or their interpretation, particularly those dealing with the Internet, including censorship and other restriction on material which can
be transmitted over the Internet, security, intellectual property, money laundering, taxation and other laws that affect our post-combination
entity&#8217;s ability to operate its business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>China
Securities Regulatory Commission and other Chinese government agencies may exert more oversight and control over offerings that are conducted
overseas and foreign investment in China-based issuers. Additional compliance procedures may be required in connection with our Initial
Public Offering and our business combination process, and, if required, we cannot predict whether we will be able to obtain such approval.
As a result, both you and us face uncertainty about future actions by the PRC government that could significantly affect our ability
to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or be worthless.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2021, the General Office of the Communist Party of China Central Committee and the General Office of the State Council jointly
issued a document to crack down on illegal activities in the securities market and promote the high-quality development of the capital
market, which, among other things, requires the relevant governmental authorities to strengthen cross-border oversight of law-enforcement
and judicial cooperation, to enhance supervision over China-based companies listed overseas, and to establish and improve the system
of extraterritorial application of the PRC securities laws. Since this document is relatively new, uncertainties still exist in relation
to how soon legislative or administrative regulation making bodies will respond and what existing or new laws or regulations or detailed
implementations and interpretations will be modified or promulgated, if any, and the potential impact such modified or new laws and regulations
will have on our future business combination with a company with major operation in China. Therefore, China Securities Regulatory Commission
and other Chinese government agencies may exert more oversight and control over offerings that are conducted overseas and foreign investment
in China-based issuers. Additional compliance procedures may be required in connection with our Initial Public Offering and our business
combination process, and, if required, we cannot predict whether we will be able to obtain such approval. As a result, both you and us
face uncertainty about future actions by the PRC government that could significantly affect our ability to offer or continue to offer
securities to investors and cause the value of our securities to significantly decline or be worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 56; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
cash-flow structure of a post-acquisition company based in China or Hong Kong poses additional risks including, but not limited to, restrictions
on foreign exchange and restrictions on our ability to transfer cash between entities, across borders, and to U.S. investors.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government also has significant authority to exert restrictions on foreign exchange and our ability to transfer cash between entities,
across borders, and to U.S. investors that may apply if we acquire a company that is based in China or Hong Kong in an initial business
combination. We will be subject to restrictions on dividend payments as current regulations in China would permit our PRC subsidiary
to pay dividends to us only out of its accumulated distributable profits, if any, determined in accordance with Chinese accounting standards
and regulations. In addition, our PRC subsidiary will be required to set aside at least 10% (up to an aggregate amount equal to half
of its registered capital) of its accumulated profits each year. See &#8220;&#8212;If we successfully consummate a business combination
with a target business with primary operations in the PRC, we will be subject to restrictions on dividend payments following consummation
of our initial business combination.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may be subject to restrictions on currency exchange as the PRC government may limit or eliminate our ability to utilize
cash generated in Renminbi, or RMB to fund our business activities outside of the PRC or pay dividends in foreign currencies to our shareholders,
including holders of our securities, and may limit our ability to obtain foreign currency through debt or equity financing. Should we
choose to acquire a company in China, exchange controls that exist in the PRC may restrict or prevent us from using the proceeds of our
Initial Public Offering to acquire a target company in PRC and limit our ability to utilize our cash flow effectively following our initial
business combination. If we were to acquire a PRC company, the PRC regulation on loans to, and direct investment in, our PRC subsidiary
by offshore holding companies and governmental control in currency conversion may restrict our ability to make loans to or capital contributions
to our PRC subsidiary, which could materially and adversely affect our liquidity and our ability to fund and expand our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
restrictions will restrict our ability to distribute earnings from our businesses, including subsidiaries, to the parent company and
U.S. investors. In addition, fluctuations in exchange rates could result in foreign currency exchange losses to us and may reduce the
value of, and amount in U.S. Dollar of dividends payable on, our shares in foreign currency terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Form 10-K, we have not pursued an initial business combination and there have not been any capital contribution or
shareholder loans by us to any PRC entities, we do not yet have any subsidiaries, and (except as described in this Form 10-K), we have
not received, declared or made any dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following illustrative table shows the post-business combination funds flow of the Company to the extent that the Company will acquire
a company based in the PRC through direct equity investment. We will not consummate our initial business combination with an entity or
business with China operations consolidated through a VIE structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><img src="form10-k_001.jpg" alt="" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may transfer funds to the target (PRC-based operations company) through an increase in the registered capital of or a shareholder
    loan to the target (PRC-based operations company). The target (PRC-based operations company) may in turn make distributions or pay
    dividends to us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
PRC governmental authorities may take the view now or in the future that an approval from them is required for an overseas offering by
a company affiliated with Chinese businesses or persons or a business combination with a target business based in and primarily operating
in China.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
M&amp;A Rules include, among other things, provisions that purport to require that an offshore special purpose vehicle formed for the
purpose of an overseas listing of securities in a PRC company obtain the approval of the CSRC prior to the listing and trading of such
special purpose vehicle&#8217;s securities on an overseas stock exchange. On September 21, 2006, the CSRC published on its official website
procedures specifying documents and materials required to be submitted to it by special purpose vehicles seeking CSRC&#8217;s approval
of overseas listings. However, substantial uncertainty remains regarding the scope and applicability of the M&amp;A Rules and the CSRC
approval requirement to offshore special purpose vehicles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
except for emphasizing the need to strengthen the administration over illegal securities activities, and the need to strengthen the supervision
over overseas listings by Chinese companies, the Opinions, which was made available to the public on July 6, 2021, also provides that
the State Council will revise provisions regarding the overseas issuance and listing of shares by companies limited by shares and will
clarify the duties of domestic regulatory authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 24, 2021, the State Council published the draft Administrative Provisions on the Overseas Issuance and Listing of Securities
by Domestic Companies (Draft for Comments) (the &#8220;Administrative Provisions&#8221;), and the CSRC published the draft Measures for
Record-filings of the Overseas Issuance and Listing of Securities by Domestic Companies (Draft for Comments) (the &#8220;Administrative
Measures&#8221;), for public comment. Pursuant to Article 2 of the Administrative Provisions, domestic enterprises that (i) offer shares,
depository receipts, convertible notes or other equity securities overseas, or (ii) list securities on an overseas stock exchange, must
complete record-filing procedures and report the relevant information to the CSRC. The CSRC shall determine the record-filing method.
Pursuant to the Article 2 of the Administrative Measures, domestic enterprises that directly or indirectly offer or list securities on
an overseas stock exchange shall file with the CSRC within three business days after submitting their initial public offering and/or
listing application documents. The requested filing documents include but are not limited to: (1) a filing report and related undertakings;
(2) regulatory opinions, filing or approval documents issued by the relevant authorities (if applicable); (3) security review opinions
issued by the relevant authorities, if applicable; (4) a PRC legal opinion; and (5) a prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2021, the NDRC and the MOFCOM jointly promulgated the Special Administrative Measure (Negative List) for the Access of Foreign
Investment (2021 Version), or the Negative List, which became effective on January 1, 2022. According to Article 6 of the Negative List,
domestic enterprises engaging in businesses in which foreign investment is prohibited shall obtain approval from the relevant authorities
before offering and listing their shares on an overseas stock exchange. In addition, certain foreign investors shall not be involved
in the operation or management of the relevant enterprise, and shareholding percentage restrictions under relevant domestic securities
investment management regulations shall apply to such foreign investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our understanding of the current PRC laws and regulations in effect at the time of this Form 10-K, no prior permission is required
under the M&amp;A Rules, the Opinions or the Negative List from any PRC governmental authorities (including the CSRC) for consummating
our Initial Public Offering by our company, given that: (a) the CSRC currently has not issued any definitive rule or interpretation concerning
whether offerings like ours under this Form 10-K are subject to the M&amp;A Rules; and (b) our company is a blank check company newly
incorporated in Cayman Islands rather than China and currently the company conducts no business in China. However, there remains some
uncertainty as to how the M&amp;A Rules, the Opinions, or the Administrative Provisions and the Administrative Measures, if enacted,
will be interpreted or implemented in the context of an overseas offering or if we decide to consummate the business combination with
a target business based in and primarily operating in China. If the CSRC or another PRC governmental authority subsequently determines
that its approval is needed for our Initial Public Offering, or a business combination with a target business based in and primarily
operating in China, we may face approval delays, adverse actions or sanctions by the CSRC or other PRC governmental authorities. In any
such event, these governmental authorities may delay our Initial Public Offering or a potential business combination, impose fines and
penalties, limit our operations in China, or take other actions that could materially adversely affect our business, financial condition,
results of operations, reputation and prospects, as well as the trading price of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Form 10-K, we have not received any inquiry, notice, warning, sanctions or regulatory objection to our Initial Public
Offering from the CSRC or any other PRC governmental authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
company is a blank check company incorporated under the laws of the Cayman Islands. We currently do not hold any equity interest in any
PRC company or operate any business in China. Therefore, we are not required to obtain any permission from any PRC governmental authorities
to operate our business as currently conducted. If we decide to consummate our business combination with a target business based in and
primarily operating in China, the combined company&#8217;s business operations in China through its subsidiaries are subject to relevant
requirements to obtain applicable licenses from PRC governmental authorities under relevant PRC laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we select a business combination target that operates in the PRC, the approval of the China Securities Regulatory Commission (the &#8220;CSRC&#8221;),
the Cybersecurity Review Office (&#8220;CRO&#8221;), the Central Cyberspace Affairs Commission and/or other PRC authority may be required
for our initial business combination under PRC law.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Regulations on Mergers and Acquisitions of Domestic Companies by Foreign Investors (the &#8220;M&amp;A Rules&#8221;) requires overseas
special purpose vehicles that are controlled by PRC companies or individuals formed for the purpose of seeking a public listing on an
overseas stock exchange through acquisitions of PRC domestic companies using shares of such special purpose vehicles or held by their
shareholders as considerations to obtain the approval of the CSRC, prior to the listing and trading of such special purpose vehicle&#8217;s
securities on an overseas stock exchange. However, the application of the M&amp;A Rules remains unclear. If CSRC approval is required
for our initial business combination, it is uncertain whether it would be possible for us to obtain the approval. Any failure to obtain
or delay in obtaining CSRC approval for our initial business combination would subject us to sanctions imposed by the CSRC and other
PRC regulatory agencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
on July 10, 2021, the Cybersecurity Administration of China (&#8220;CAC&#8221;) released a draft of the revised Cybersecurity Review
Measures for public consultation until July 25, 2021 (the &#8220;2021 Measures&#8221;). The 2021 Measures apply to any business operator
that holds the personal information of more than one million users when it intends to seek a foreign listing. Upon receipt of an application,
if the CRO decides to conduct a review, the CRO will complete a preliminary review and send recommendations to a designated body of members
of the network security review mechanism and certain government departments for further consideration. The CSRC has been added in the
2021 Measures to the list of mainland Chinese authorities that are to be involved in formulating the national network security review
mechanism. This means that the CSRC can instruct the CRO to obtain approval from the Central Cyberspace Affairs Commission to conduct
a cybersecurity review of any proposed foreign public offering of a mainland Chinese operator where the capital markets regulator considers
the listing affects or is likely to affect China&#8217;s national security. The proposed rules might impact the timetable of our initial
business combination and the certainty of our initial business combination, if the target company we have identified is subject to the
2021 Measures or the final Cybersecurity Review Measures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Further
regulations or regulatory actions in the PRC could affect the timetable and closing certainty of our Initial Public Offering and/or our
initial business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
on July 6, 2021, the General Office of the Communist Party of China Central Committee and the General Office of the State Council of
the PRC jointly issued the &#8220;Opinion on Strictly Punishing Illegal Securities Activities according to Law&#8221; (&#12298;&#20851;&#20110;&#20381;&#27861;&#20174;&#20005;&#25171;&#20987;&#35777;&#21048;&#36829;&#27861;&#27963;&#21160;&#30340;&#24847;&#35265;&#12299;)
(the &#8220;Opinion&#8221;). The Opinion specifies the target of upgrading the securities law-enforcement and judicial systems by 2022
and 2025, including effectively curbing the frequent occurrence of major illegal and criminal cases, as well as making notable advances
in the transparency, standardization and credibility in the securities law-enforcement and judicial system. In particular, Clause 5 of
the Opinion is entitled &#8220;Further Enhancing Cross-Border Regulatory Oversight, Enforcement and Judicial Cooperation.&#8221; The
Opinion may require or facilitate further regulations or regulatory actions applicable to Chinese companies seeking to be listed overseas,
including in the U.S., which regulations could be applicable to our Initial Public Offering, our initial business combination or the
target company we identify and impact the timetable and closing certainty of our Initial Public Offering and/or our initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
M&amp;A Rules and certain other People&#8217;s Republic of China regulations establish complex procedures for some acquisitions of Chinese
companies by foreign investors, which could make it more difficult for us to pursue an acquisition in China.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
M&amp;A Rules and some other regulations and rules concerning mergers and acquisitions established additional procedures and requirements
that could make merger and acquisition activities by foreign investors more time-consuming and complex, including requirements in some
instances that MOFCOM be notified in advance of any change-of-control transaction in which a foreign investor takes control of a PRC
domestic enterprise. Moreover, the Anti-Monopoly Law requires that the MOFCOM shall be notified in advance of any concentration of undertaking
if certain thresholds are triggered. In addition, the security review rules issued by the MOFCOM that became effective in September 2011
specify that mergers and acquisitions by foreign investors that raise &#8220;national defense and security&#8221; concerns and mergers
and acquisitions through which foreign investors may acquire de facto control over domestic enterprises that raise &#8220;national security&#8221;
concerns are subject to strict review by the MOFCOM, and the rules prohibit any activities attempting to bypass a security review, including
by structuring the transaction through a proxy or contractual control arrangement. In the future, we may acquire a complementary business.
Complying with the requirements of the above-mentioned regulations and other relevant rules to complete such transactions could be time-consuming,
and any required approval processes, including obtaining approval from the MOFCOM or its local counterparts may delay or inhibit our
ability to complete such transactions, which could affect our ability to complete our initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial
uncertainties exist with respect to the interpretation and implementation of the Foreign Investment Law and how it may impact our ability
to pursue an acquisition in China.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2019, the PRC National People&#8217;s Congress approved the Foreign Investment Law, which came into effect on January 1, 2020
and replaces the trio of existing laws regulating foreign investment in the PRC, namely, the Sino-Foreign Equity Joint Venture Enterprise
Law, the Sino-Foreign Cooperative Joint Venture Enterprise Law and the Wholly Foreign-Invested Enterprise Law, together with their implementation
rules and ancillary regulations and become the legal foundation for foreign investment in the PRC. Meanwhile, the Implementation Regulation
of the Foreign Investment Law and the Measures for Reporting of Information on Foreign Investment came into effect as of January 1, 2020,
which clarified and elaborated the relevant provisions of the Foreign Investment Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Foreign Investment Law sets out the basic regulatory framework for foreign investments and proposes to implement a system of pre-entry
national treatment with a negative list for foreign investments, pursuant to which (i) foreign entities and individuals are prohibited
from investing in the areas that are not open to foreign investments, (ii) foreign investments in the restricted industries must satisfy
certain requirements under the law, and (iii) foreign investments in business sectors outside of the negative list will be treated equally
with domestic investments. The Foreign Investment Law also sets forth necessary mechanisms to facilitate, protect and manage foreign
investments and proposes to establish a foreign investment information reporting system, through which foreign investors or foreign-invested
enterprises are required to submit initial report, report of changes, report of deregistration and annual report relating to their investments
to the Ministry of Commerce, or MOFCOM, or its local branches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If,
after our initial business combination, substantially all of our assets will be located in China and substantially all of our revenue
will be derived from our operations there, our results of operations and prospects and trading prices of our securities will be subject,
to a significant extent, to the economic, political and legal policies, developments and conditions in China as well as litigation and
publicity surrounding China-based companies listed in the United States.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
economic, political and social conditions, as well as government policies, of China could affect our business. The economies in Asia
differ from the economies of most developed countries in many respects. For the most part, such economies have grown at a rate in excess
of the United States; however, (1) such economic growth has been uneven, both geographically and among various sectors of the economy
and (2) such growth may not be sustained in the future. If in the future such country&#8217;s economy experiences a downturn or grows
at a slower rate than expected, there may be less demand for spending in certain industries. A decrease in demand for spending in certain
industries could materially and adversely affect our ability to find an attractive target business with which to consummate our initial
business combination and if we effect our initial business combination, the ability of that target business to become profitable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that litigation and negative publicity surrounding companies with operations in China that are listed in the United States have
negatively impacted stock prices for these companies. Various equity-based research organizations have published reports on China-based
companies after examining their corporate governance practices, related party transactions, sales practices and financial statements,
and these reports have led to special investigations and listing suspensions on U.S. national exchanges. Any similar scrutiny of our
assets and operation, in China, if any, regardless of its lack of merit, could result in a diversion of management resources and energy,
potential costs to defend ourselves against rumors, decreases and volatility in the trading price of our securities, and increased directors
and officers insurance premiums and could have an adverse effect upon our business, including our results of operations, financial condition,
cash flows and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>China&#8217;s
economic, political and social conditions, as well as changes in any government policies, laws and regulations, could have a material
adverse effect on our business.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
substantial portion of our operations may be conducted in China, and a significant portion of our net revenues may be derived from customers
where the contracting entity is located in China. Accordingly, our business, financial condition, results of operations, prospects and
certain transactions we may undertake may be subject, to a significant extent, to economic, political and legal developments in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">China&#8217;s
economy differs from the economies of most developed countries in many respects, including the amount of government involvement, level
of development, growth rate, control of foreign exchange and allocation of resources. While the PRC economy has experienced significant
growth in the past two to three decades, growth has been uneven, both geographically and among various sectors of the economy. Demand
for target services and products depends, in large part, on economic conditions in China. Any slowdown in China&#8217;s economic growth
may cause our potential customers to delay or cancel their plans to purchase our services and products, which in turn could reduce our
net revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
China&#8217;s economy has been transitioning from a planned economy to a more market oriented economy since the late 1970s, the PRC government
continues to play a significant role in regulating industry development by imposing industrial policies. The PRC government also exercises
significant control over China&#8217;s economic growth through allocating resources, controlling the incurrence and payment of foreign
currency-denominated obligations, setting monetary policy and providing preferential treatment to particular industries or companies.
Changes in any of these policies, laws and regulations could adversely affect the economy in China and could have a material adverse
effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government has implemented various measures to encourage foreign investment and sustainable economic growth and to guide the allocation
of financial and other resources. However, we cannot assure you that the PRC government will not repeal or alter these measures or introduce
new measures that will have a negative effect on us. China&#8217;s social and political conditions may change and become unstable. Any
sudden changes to China&#8217;s political system or the occurrence of widespread social unrest could have a material adverse effect on
our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>After
we consummate a business combination in China, our operating company in China will be subject to restrictions on dividend payments.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
we consummate a business combination, we may rely on dividends and other distributions from our operating company to provide us with
cash flow and to meet our other obligations. Current regulations in China would permit our operating company in China to pay dividends
to us only out of its accumulated distributable profits, if any, determined in accordance with Chinese accounting standards and regulations.
In addition, our operating company in China will be required to set aside at least 10% (up to an aggregate amount equal to half of its
registered capital) of its accumulated profits each year. Such cash reserve may not be distributed as cash dividends. In addition, if
our operating company in China incurs debt on its own behalf in the future, the instruments governing the debt may restrict its ability
to pay dividends or make other payments to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we merge with a China-based operating company, then PRC regulation on loans to, and direct investment in, PRC entities by offshore holding
companies and governmental control in currency conversion may delay or prevent us from making loans to or making additional capital contributions
to our PRC entity, if any, which could materially and adversely affect our liquidity and our ability to fund and expand our business<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an exempted company incorporated in the Cayman Islands with limited liability structured as a blank check company and may conduct
our operations in China through a PRC entity. As permitted under PRC laws and regulations, we may make loans to our PRC entity subject
to the approval from governmental authorities and limitation of amount, or we may make additional capital contributions to our PRC entity.
Furthermore, loans by us to our PRC entity to finance its activities cannot exceed the difference between their respective total project
investment amount and registered capital or 2.5 times of their net worth and capital contributions to our PRC entity will be subject
to the requirement of making necessary filings in the Foreign Investment Comprehensive Management Information System and registration
with other governmental authorities in China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SAFE promulgated the Notice of the State Administration of Foreign Exchange on Reforming the Administration of Foreign Exchange Settlement
of Capital of Foreign-invested Enterprises, or Circular 19, effective on June 1, 2015, in replacement of the Circular on the Relevant
Operating Issues Concerning the Improvement of the Administration of the Payment and Settlement of Foreign Currency Capital of Foreign-Invested
Enterprises, the Notice from the State Administration of Foreign Exchange on Relevant Issues Concerning Strengthening the Administration
of Foreign Exchange Businesses, and the Circular on Further Clarification and Regulation of the Issues Concerning the Administration
of Certain Capital Account Foreign Exchange Businesses. According to SAFE Circular 19, the flow and use of the RMB capital converted
from foreign currency-denominated registered capital of a foreign-invested company is regulated such that RMB capital may not be used
for the issuance of RMB entrusted loans, the repayment of inter-enterprise loans or the repayment of bank loans that have been transferred
to a third party. Although SAFE Circular 19 allows RMB capital converted from foreign currency-denominated registered capital of a foreign-invested
enterprise to be used for equity investments within the PRC, it also reiterates the principle that RMB converted from the foreign currency-denominated
capital of a foreign-invested company may not be directly or indirectly used for purposes beyond its business scope. Thus, it is unclear
whether the SAFE will permit such capital to be used for equity investments in the PRC in actual practice. The SAFE promulgated the Notice
of the State Administration of Foreign Exchange on Reforming and Standardizing the Foreign Exchange Settlement Management Policy of Capital
Account, or SAFE Circular 16, effective on June 9, 2016, which reiterates some of the rules set forth in SAFE Circular 19, but changes
the prohibition against using RMB capital converted from foreign currency-denominated registered capital of a foreign-invested company
to issue RMB entrusted loans to a prohibition against using such capital to grant loans to non-associated enterprises. Violations of
SAFE Circular 19 and SAFE Circular 16 could result in administrative penalties. SAFE Circular 19 and SAFE Circular 16 may significantly
limit our ability to transfer any foreign currency we hold, including the net proceeds from our Initial Public Offering, to our PRC entity,
which may adversely affect our liquidity and our ability to fund and expand our business in the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the various requirements imposed by PRC regulations on loans to, and direct investment in, PRC entities by offshore holding
companies, and the fact that the PRC government may at its discretion restrict access to foreign currencies for current account transactions
in the future, we cannot assure you that we will be able to complete the necessary government registrations or obtain the necessary government
approvals on a timely basis, if at all, with respect to future loans by us to our PRC entity or with respect to future capital contributions
by us to our PRC entity. If we merge with a China-based operating company, and if we fail to complete such registrations or obtain such
approvals, our ability to use the proceeds from our Initial Public Offering and to capitalize or otherwise fund our PRC operations may
be negatively affected, which could materially and adversely affect our liquidity and our ability to fund and expand our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we successfully consummate a business combination with a target business with primary operations in the PRC, we will be subject to restrictions
on dividend payments following consummation of our initial business combination<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
we consummate our initial business combination, we may rely on dividends and other distributions from our operating company to provide
us with cash flow and to meet our other obligations. Current regulations in China would permit our operating company in China to pay
dividends to us only out of its accumulated distributable profits, if any, determined in accordance with Chinese accounting standards
and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our operating company in China will be required to set aside at least 10% (up to an aggregate amount equal to half of its registered
capital) of its accumulated profits each year. Each of our PRC subsidiaries as a foreign invested enterprise, is also required to further
set aside a portion of its after-tax profits to fund the employee welfare fund, although the amount to be set aside, if any, is determined
at its discretion. Such cash reserve may not be distributed as cash dividends. In addition, if our operating company in China incurs
debt on its own behalf in the future, the instruments governing the debt may restrict its ability to pay dividends or make other payments
to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Enterprise Income Tax Law and its implementation rules provide that a withholding tax rate of up to 10% will be applicable
to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties
or arrangements between the PRC central government and governments of other countries or regions where the non-PRC resident enterprises
are incorporated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental
control of currency conversion may limit our ability to utilize our net revenue effectively and affect the value of your investment<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
our initial business combination with a PRC target company, we will be subject to the PRC&#8217;s rules and regulations on currency conversion.
In the PRC, the SAFE regulates the conversion of the Renminbi into foreign currencies. The PRC government imposes controls on the convertibility
of the Renminbi into foreign currencies and, in certain cases, the remittance of currency out of China.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and
service-related foreign exchange transactions, can be made in foreign currencies without prior approval of SAFE by complying with certain
procedural requirements. Under existing exchange restrictions, without prior approval of SAFE, cash generated from PRC subsidiaries in
China may be used to pay dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency
and remitted out of China to pay capital expenses such as the repayment of loans denominated in foreign currencies. The PRC government
may at its discretion restrict access to foreign currencies for current account transactions in the future. If the foreign exchange control
system prevents us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not pay dividends in
foreign currencies to our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC
regulatory authorities could impose further restrictions on the convertibility of the Renminbi. Any future restrictions on currency exchanges
may limit our ability to use the proceeds of our Initial Public Offering in an initial business combination with a PRC target company
and the use our cash flow for the distribution of dividends to our shareholders or to fund operations we may have outside of the PRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we merge with a China-based operating company, then there are significant uncertainties under the PRC Enterprise Income Tax Law relating
to the withholding tax liabilities of the PRC entity, and dividends payable by the PRC entity to our offshore entity may not qualify
for certain treaty benefits<i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the PRC Enterprise Income Tax Law (&#8220;PRC EIT Law&#8221;) and its implementation rules, if following our initial business combination
we are a non-resident enterprise, that is, an enterprise lawfully incorporated pursuant to the laws of a foreign country (region) that
has an office or premises established in China with no actual management functions performed in China, or an enterprise that has income
derived from or accruing in China although it does not have an office or premises in China, will be subject to a withholding tax rate
of 10%. Under the Notice of the State Administration of Taxation on Issues regarding the Administration of the Dividend Provision in
Tax Treaties promulgated on February 20, 2009, the taxpayer needs to satisfy certain conditions to utilize the benefits under a tax treaty.
These conditions include: (1) the taxpayer must be the beneficial owner of the relevant dividends, and (2) the corporate shareholder
to receive dividends from the PRC entity must have continuously met the direct ownership thresholds during the 12 consecutive months
preceding the receipt of the dividends. Further, under Announcement of the State Administration of Taxation on Issues Relating to &#8220;Beneficial
Owner&#8221; in Tax Treaties, which took effect on April 1, 2018, a &#8220;Beneficial Owner&#8221; shall mean a person who has ownership
and control over the income and the rights and property from which the income is derived. To determine the &#8220;beneficial owner&#8221;
status of a resident of the treaty counterparty who needs to take advantage of the tax treaty benefits, a comprehensive analysis shall
be carried out, taking into account actual conditions of the specific case.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entitlement
to a lower tax rate on dividends according to tax treaties or arrangements between the PRC central government and governments of other
countries or regions is subject to Announcement of State Taxation Administration on Promulgation of the Administrative Measures on Non-resident
Taxpayers Enjoying Treaty Benefits, or Circular 35. Circular 35 provides that non-resident enterprises are not required to obtain pre-approval
from the relevant tax authority in order to enjoy the reduced withholding tax. Instead, non-resident enterprises and their withholding
agents may, by self-assessment and on confirmation that the prescribed criteria to enjoy the tax treaty benefits are met, directly apply
the reduced withholding tax rate, and file necessary forms and supporting documents when performing tax filings, which will be subject
to post-tax filing examinations by the relevant tax authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in response to the persistent capital outflow in China and the RMB&#8217;s depreciation against the U.S. dollar in the fourth
quarter of 2016, the People&#8217;s Bank of China and SAFE promulgated a series of capital control measures in early 2017, including
stricter vetting procedures for domestic companies to remit foreign currency for overseas investments, dividends payments and shareholder
loan repayments. The PRC government may continue to strengthen its capital controls, and more restrictions and substantial vetting process
may be put forward by SAFE for cross-border transactions falling under both the current account and the capital account. Any limitation
on the ability of us to pay dividends or make other kinds of payments to us following our initial business combination could materially
and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends, or
otherwise fund and conduct our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRC
regulations relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC resident beneficial
owners or any future PRC subsidiaries to liability or penalties, limit our ability to inject capital into any PRC subsidiaries, limit
any PRC subsidiary&#8217;s ability to increase its registered capital or distribute profits to us, or may otherwise adversely affect
us.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2014, SAFE promulgated the Circular on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents&#8217; Offshore
Investment and Financing and Roundtrip Investment Through Special Purpose Vehicles, or SAFE Circular 37, to replace the Notice on Relevant
Issues Concerning Foreign Exchange Administration for Domestic Residents&#8217; Financing and Roundtrip Investment Through Offshore Special
Purpose Vehicles, or SAFE Circular 75, which ceased to be effective upon the promulgation of SAFE Circular 37.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAFE
Circular 37 requires PRC residents (including PRC individuals and PRC corporate entities) to register with SAFE or its local branches
in connection with their direct or indirect offshore investment activities. SAFE Circular 37 applies to our shareholders who are PRC
residents and may apply to any offshore acquisitions that we make in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
SAFE Circular 37, PRC residents who make, or have prior to the implementation of SAFE Circular 37 made, direct or indirect investments
in offshore special purpose vehicles, or SPVs, must register such investments with SAFE or its local branches. In addition, any PRC resident
who is a direct or indirect shareholder of an SPV must update its filed registration with the local branch of SAFE with respect to that
SPV, to reflect any material change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our shareholders who are PRC residents or entities fail to make the required registration or to update the previously filed registration,
any PRC subsidiaries may be prohibited from distributing their profits and any proceeds from any reduction in capital, share transfer
or liquidation to us, and we may be restricted in our ability to contribute additional capital to any PRC subsidiaries. On February 13,
2015, SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration Policy on Direct Investment, or
SAFE Notice 13, which became effective on June 1, 2015.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
SAFE Notice 13, applications for foreign exchange registration of inbound foreign direct investments and outbound overseas direct investments,
including those required under SAFE Circular 37, will be filed with qualified banks instead of SAFE. The qualified banks will directly
examine the applications and accept registrations under the supervision of SAFE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have requested PRC residents who we know hold direct or indirect interests in us to make the necessary applications, filings and registrations
as required under SAFE Circular 37. We believe that most of these shareholders have completed the initial foreign exchange registrations
with relevant banks. However, these individuals may not continue to make required filings or updates in a timely manner, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not know the identities of all PRC residents holding direct or indirect interest in our company. Any failure or inability by such
individuals to comply with SAFE regulations may subject us to fines or legal sanctions, restrict our cross-border investment activities,
and limit any PRC subsidiary&#8217;s ability to distribute dividends to us. As a result, our business and our ability to make distributions
to you could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
as these foreign exchange regulations are still relatively new and their interpretation and implementation have been evolving, it is
unclear how these regulations, and any future regulation concerning offshore or cross-border transactions, will be interpreted, amended
and implemented by the relevant government authorities. For example, we may be subject to a more stringent review and approval process
with respect to our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings, which may
adversely affect our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we acquire a PRC domestic company, we or the owners of such company, as the case may be, may not obtain the necessary approvals or complete
the necessary filings and registrations required by the foreign exchange regulations. This may restrict our ability to implement our
acquisition strategy and could adversely affect our business and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
a majority of our executive officers and directors are located in or have significant ties to the PRC, you may face difficulties in protecting
your interests, and your ability to protect your rights through the U.S. Federal courts may be limited.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Chairwoman of the Board, Xinfeng Feng, and two of our directors, Li Wei and Wen He, are residents of mainland China. Our Chief Financial
Officer, Jichuan Yang, is a resident of Hong Kong. As a result, legal claims against us or our executive officers and directors may be
difficult or impossible for investors to pursue in U.S. courts. Moreover, even if an investor obtains a judgment in a U.S. court against
one of our directors or officers, the investor may be unable to enforce such judgment on these directors and officers. It will equally
be difficult to effect service of process upon us or those persons inside the PRC. PRC courts may only recognize and enforce foreign
judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between the PRC and the country
where the judgment is made or on principles of reciprocity between jurisdictions. This is reflected in a number of bilateral treaties
signed by the PRC, which provide that lack of jurisdiction of the judgment court can be a ground for refusal. Further, a foreign judgment
cannot be recognized and enforced in the PRC if a Chinese court has rendered a judgment on the same subject matter or recognized and
enforced another foreign judgment or arbitral award on the same subject matter. In addition, according to the PRC Civil Procedures Law,
the PRC courts will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates
the basic principles of PRC laws or national sovereignty, security, or public interest. The PRC has no treaties or other forms of written
arrangement with the United States that provide for the reciprocal recognition and enforcement of foreign judgments. As a result, it
may be difficult for investors to effect service of process within the United States upon us or our executive officers or directors who
are residents of the PRC, or to enforce judgments in the PRC (including Hong Kong and Macau) that are obtained in U.S. courts against
us or such individuals, including judgments predicated upon the civil liability provisions of the securities laws of the United States
or any state thereof. Even with proper service of process, the enforcement of judgments obtained in U.S. courts or foreign courts based
on the civil liability provisions of the U.S. federal securities laws would be extremely difficult given the PRC Civil Procedures Law
and the lack of a treaty or principles of reciprocity providing for the recognition and enforcement of U.S. judgments. Furthermore, there
would be added costs and issues with bringing an original action in foreign courts to enforce liabilities based on the U.S. federal securities
laws against us or our officers and directors, and they still may be fruitless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
recent joint statement by the SEC and PCAOB, proposed rule changes submitted by Nasdaq, and the HFCAA all call for additional and more
stringent criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S.
auditors who are not inspected by the PCAOB. These developments could add uncertainties to our offering.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2020, SEC Chairman Jay Clayton and PCAOB Chairman William D. Duhnke III, along with other senior SEC staff, released a joint
statement highlighting the risks associated with investing in companies based in or have substantial operations in emerging markets including
China. The joint statement emphasized the risks associated with lack of access for the PCAOB to inspect auditors and audit work papers
in emerging markets, including China, and higher risks of fraud in emerging markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 18, 2020, Nasdaq filed three proposals with the SEC to (i) apply minimum offering size requirement for companies primarily operating
in &#8220;Restrictive Market&#8221;, (ii) adopt a new requirement relating to the qualification of management or board of director for
Restrictive Market companies, and (iii) apply additional and more stringent criteria to an applicant or listed company based on the qualifications
of the company&#8217;s auditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2020, the U.S. Senate passed the Holding Foreign Companies Accountable Act (the &#8220;HFCAA&#8221;) requiring a foreign company
to certify it is not owned or controlled by a foreign government if the PCAOB is unable to audit specified reports because the company
uses a foreign auditor not subject to PCAOB inspection. If the PCAOB is unable to inspect the company&#8217;s auditors for three consecutive
years, the issuer&#8217;s securities are prohibited to trade on a national securities exchange or in the over the counter trading market
in the U.S. On December 2, 2020, the U.S. House of Representatives approved the HFCAA. On December 18, 2020, the HFCAA was signed into
law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2021, the SEC announced that it had adopted interim final amendments to implement congressionally mandated submission and disclosure
requirements of the Act. The interim final amendments will apply to registrants that the SEC identifies as having filed an annual report
on Forms 10-K, 20-F, 40-F or N-CSR with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction
and that the PCAOB has determined it is unable to inspect or investigate completely because of a position taken by an authority in that
jurisdiction. The SEC will implement a process for identifying such a registrant and any such identified registrant will be required
to submit documentation to the SEC establishing that it is not owned or controlled by a governmental entity in that foreign jurisdiction
and will also require disclosure in the registrant&#8217;s annual report regarding the audit arrangements of, and governmental influence
on, such a registrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if passed by the U.S. House
of Representatives and signed into law, would reduce the number of consecutive non-inspection years required for triggering the prohibitions
under the HFCAA from three years to two. If our auditor cannot be inspected by the PCAOB for two consecutive years, the trading of our
securities on any U.S. national securities exchanges, as well as any over-the-counter trading in the U.S., will be prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2021, the PCAOB adopted a final rule implementing the HFCAA, which provides a framework for the PCAOB to use when determining,
as contemplated under the HFCAA, whether the PCAOB is unable to inspect or investigate completely registered public accounting firms
located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the HFCAA. The
rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public
accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because of a
position taken by an authority in foreign jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 16, 2021, the SEC announced that the PCAOB designated China and Hong Kong as the jurisdictions where the PCAOB is not allowed
to conduct full and complete audit inspections as mandated under the HFCAA. The Company&#8217;s auditor is based in the United States
and therefore is not affected by this mandate by the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 26, 2022, the PCAOB signed a Statement of Protocol with the China Securities Regulatory Commission and the Ministry of Finance
of the PRC, taking the first step toward opening access for the PCAOB to inspect and investigate registered public accounting firms headquartered
in mainland China and Hong Kong completely, consistent with U.S. law. The Statement of Protocol gives the PCAOB sole discretion to select
the firms, audit engagements and potential violations it inspects and investigates and put in place procedures for PCAOB inspectors and
investigators to view complete audit work papers with all information included and for the PCAOB to retain information as needed. In
addition, the Statement of Protocol grants the PCAOB direct access to interview and take testimony from all personnel associated with
the audits the PCAOB inspects or investigates. While significant, uncertainties still exist as to how the Statement of Protocol will
be implemented and whether the applicable parties will comply with the framework.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lack of access to the PCAOB inspection in certain emerging markets prevents the PCAOB from fully evaluating audits and quality control
procedures of the auditors based in those emerging markets. As a result, the investors may be deprived of the benefits of such PCAOB
inspections. The inability of the PCAOB to conduct inspections of auditors in certain emerging markets makes it more difficult to evaluate
the effectiveness of these accounting firms&#8217; audit procedures or quality control procedures as compared to auditors outside of
those emerging markets that are subject to the PCAOB inspections, which could cause existing and potential investors in our shares to
lose confidence in our audit procedures and reported financial information and the quality of our financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
auditor, the independent registered public accounting firm that issues the audit report included elsewhere in this Form 10-K, as an auditor
of companies that are traded publicly in the United States and a firm registered with the PCAOB, is subject to laws in the United States
pursuant to which the PCAOB conducts regular inspections to assess our auditor&#8217;s compliance with the applicable professional standards.
Our auditor is subject to inspection by the PCAOB on a regular basis with the last inspection report dated June 28, 2021. As such, as
of the date of this Form 10-K, our auditor is not subject to the determinations announced by the PCAOB on December 16, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company&#8217;s auditor is based in the U.S. and is registered with the PCAOB and subject to PCAOB inspection, it may later be determined
that the PCAOB is unable to inspect or investigate completely the Company&#8217;s auditor because of a position taken by an authority
in a foreign jurisdiction. In addition, if we effect our initial business combination with a business located in the PRC and our new
auditor is located in the PRC, a jurisdiction where the PCAOB has been unable to conduct inspections without the approval of the Chinese
authorities, the work of our new auditor as it relates to those operations may not inspected by the PCAOB. In either case, such lack
of inspection could cause trading in the Company&#8217;s securities to be prohibited under the HFCAA, and ultimately result in a determination
by a securities exchange to delist the Company&#8217;s securities. Furthermore, the recent developments would add uncertainties to our
offering and we cannot assure you whether Nasdaq or regulatory authorities would apply additional and more stringent criteria to us after
considering the effectiveness of our auditor&#8217;s audit procedures and quality control procedures, adequacy of personnel and training,
or sufficiency of resources, geographic reach or experience as it relates to the audit of our financial statements. It remains unclear
what the SEC&#8217;s implementation process related to the above rules will entail or what further actions the SEC, the PCAOB or Nasdaq
will take to address these issues and what impact those actions will have on U.S. companies that have significant operations in certain
emerging markets and have securities listed on a U.S. stock exchange (including a national securities exchange or over-the-counter stock
market). In addition, the above amendments and any additional actions, proceedings, or new rules resulting from these efforts to increase
U.S. regulatory access to audit information could create some uncertainty for investors, the market price of our ordinary shares could
be adversely affected, and we could be delisted if we and our auditor are unable to meet the PCAOB inspection requirement or being required
to engage a new audit firm, which would require significant expense and management time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unanticipated
changes in our effective tax rate or challenges by tax authorities could harm our future results.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become subject to income taxes in various other jurisdictions in the future. Our effective tax rate could be adversely affected by
changes in the allocation of our pre-tax earnings and losses among countries with differing statutory tax rates, in certain non-deductible
expenses as a result of acquisitions, in the valuation of our deferred tax assets and liabilities, or in federal, state, local or non-U.S.
tax laws and accounting principles, including increased tax rates, new tax laws or revised interpretations of existing tax laws and precedents.
Increases in our effective tax rate would adversely affect our operating results. In addition, we may be subject to income tax audits
by various tax jurisdictions throughout the world. The application of tax laws in such jurisdictions may be subject to diverging and
sometimes conflicting interpretations by tax authorities in these jurisdictions. Although we believe our income tax liabilities are reasonably
estimated and accounted for in accordance with applicable laws and principles, an adverse resolution of one or more uncertain tax positions
in any period could have a material impact on the results of operations for that period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Because
we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to
protect your rights through the U.S. federal courts may be limited.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service
of process within the United States upon our directors or executive officers, or enforce judgments obtained in the U.S. courts against
our directors or officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate affairs are governed by our amended and restated memorandum and articles of association, the Companies Act (as the same may
be supplemented or amended from time to time) and the common law of the Cayman Islands. We will also be subject to the federal securities
laws of the United States. The rights of shareholders to take action against the directors, actions by minority shareholders and the
fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman
Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands
as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the
Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different
from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands
has a different body of securities laws as compared to the United States, and certain states, may have more fully developed and judicially
interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative
action in a federal court of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and results
of operations.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to comply
with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult,
time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and
those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to
comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, investments
and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of
certain exemptions from disclosure requirements available to emerging growth companies and smaller reporting companies, this could make
our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company&#8221; within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth
companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the
Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden
parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important.
We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including
if the market value of our ordinary shares held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case
we would no longer be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities
less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance
on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading
market for our securities and the trading prices of our securities may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accountant standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we are a &#8220;smaller reporting company&#8221; as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our ordinary shares
held by non-affiliates exceeds $250 million as of the end of the prior June 30<sup>th</sup>, or (2) our annual revenues exceeded $100
million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as
of the prior June 30<sup>th</sup>. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison
of our financial statements with other public companies difficult or impossible.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements
and our activities may be restricted, which may make it difficult for us to complete our business combination.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the nature of our investments; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the issuance of securities, each of which may make it difficult for us to complete our business combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may have imposed upon us burdensome requirements, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration
    as an investment company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption
    of a specific form of corporate structure; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting,
    record keeping, voting, proxy and disclosure requirements and other rules and regulations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must
ensure that we are engaged primarily in a business other than investing, reinvesting or trading of securities and that our activities
do not include investing, reinvesting, owning, holding or trading &#8220;investment securities&#8221; constituting more than 40% of our
total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business will be to identify and
complete a business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to
buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to
be a passive investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not believe that our anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held
in the trust account may only be invested in United States &#8220;government securities&#8221; within the meaning of Section 2(a)(16)
of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust
agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these
instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and
selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an &#8220;investment company&#8221;
within the meaning of the Investment Company Act. Our Initial Public Offering is not intended for persons who are seeking a return on
investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the
earliest to occur of: (i) the completion of our primary business objective, which is a business combination; (ii) the redemption of any
public shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles of association
to modify (A) the substance or timing of our obligation to allow redemption in connection with our initial business combination or to
redeem 100% of our public shares if we do not complete our initial business combination within 9 months from the closing of our Initial
Public Offering, or if we decide to extend the period of time to consummate our business combination, within 18 months from the closing
of our Initial Public Offering (as further described in this Form 10-K) or (B) with respect to any other provision relating to shareholders&#8217;
rights or pre-initial business combination activity; or (iii) absent a business combination, our return of the funds held in the trust
account to our public shareholders as part of our redemption of the public shares. If we do not invest the proceeds as discussed above,
we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance
with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability
to complete a business combination. If we are unable to complete our initial business combination, our public shareholders may receive
only approximately $10.18 per share on the liquidation of our trust account and our warrants and rights will expire worthless. In certain
circumstances, our public shareholders may receive less than $10.18 per share on the redemption of their shares. See &#8220;&#8212; If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.18 per share&#8221; and other risk factors in this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compliance
obligations under the Sarbanes-Oxley Act may make it more difficult for us to complete our initial business combination, require substantial
financial and management resources, and increase the time and costs of completing an acquisition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual Report
on Form 10-K for the year ending December 31, 2023. Only in the event we are deemed to be a large accelerated filer or an accelerated
filer will we be required to comply with the independent registered public accounting firm attestation requirement on our internal control
over financial reporting. Further, for as long as we remain an emerging growth company, we will not be required to comply with the independent
registered public accounting firm attestation requirement on our internal control over financial reporting. The fact that we are a blank
check company makes compliance with the requirements of the Sarbanes-Oxley Act particularly burdensome on us as compared to other public
companies because a target company with which we seek to complete our business combination may not be in compliance with the provisions
of the Sarbanes-Oxley Act regarding adequacy of its internal controls. The development of the internal control of any such entity to
achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provisions
in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors
might be willing to pay in the future for our ordinary shares and could entrench management.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association contains provisions that may discourage unsolicited takeover proposals that
shareholders may consider to be in their best interests. These provisions include a staggered Board and the ability of the Board to designate
the terms of and issue new series of preferred shares, which may make the removal of management more difficult and may discourage transactions
that otherwise could involve payment of a premium over prevailing market prices for our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may not hold an annual meeting of shareholders until after the consummation of our initial business combination, which could delay the
opportunity for our shareholders to elect directors.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with NASDAQ corporate governance requirements, we are not required to hold an annual meeting until no later than one year
after our first fiscal year end following our listing on NASDAQ. There is no requirement under the Companies Act for us to hold annual
or general meetings to appoint directors. Until we hold an annual general meeting, public shareholders may not be afforded the opportunity
to discuss company affairs with management. Our Board is divided into three classes with only one class of directors being appointed
in each year and each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term.
In addition, as holders of our ordinary shares, our public shareholders will not have the right to vote on the appointment of directors
until after the consummation of our initial business combination. Accordingly, you may not have any say in the management of our company
prior to the consummation of an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="S1_001"></span>ITEM
1B. UNRESOLVED STAFF COMMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="S1_002"></span>ITEM
2. PROPERTY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently maintain our executive offices at 500 5<sup>th</sup> Avenue, Suite 938, New York, NY 10110. The cost for our use of this space
is included in the $10,000 per month fee we will pay to our sponsor for office space, utilities and secretarial and administrative services.
We consider our current office space adequate for our current operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_003"></span><span style="font-size: 10pt"><b>ITEM
3. LEGAL PROCEEDINGS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_004"></span><b>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_005"></span><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="S1_006"></span>ITEM
5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
units, ordinary shares, rights and warrants are each traded on the Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the symbols &#8220;ATMCU,&#8221;
&#8220;ATMC,&#8221; &#8220;ATMCR&#8221; and &#8220;ATMCW,&#8221; respectively. Our units commenced public trading on December 30, 2022,
and our ordinary shares, rights, and warrants commenced separate trading on January 19, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 23, 2023, we had three holders of record of our ordinary shares, two holders of record of our units, one holder of record of
our rights and one holder of record of our warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends. The payment of cash dividends
in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition and will
be within the discretion of our board of directors. Further, if we incur any indebtedness, our ability to declare dividends may be limited
by restrictive covenants we may agree to in connection therewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Authorized for Issuance Under Equity Compensation Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
Sale of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, our Sponsor acquired 1,437,500 founder shares for an aggregate purchase price of $25,000. On January 8, 2022, our
Sponsor acquired an additional 287,500 founder shares for no additional consideration, resulting in our Sponsor holding an aggregate
of 1,725,000 founder shares. Concurrent with the closing of the Initial Public Offering, our Sponsor sold to Chardan or its designees
132,825 of these founder shares at a purchase price of $2.00 per share and an aggregate purchase price of $265,650.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, pursuant to the Private Placement Unit Purchase Agreement, the Company completed the private sale of 370,500
units (the &#8220;Private Placement Units&#8221;) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating
gross proceeds to the Company of $3,705,000. The Private Placement Units are identical to the Units sold in the IPO. No underwriting
discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption
from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. No underwriting discounts or commissions were
paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained
in Section 4(a)(2) of the Securities Act of 1933, as amended. On January 9, 2023, simultaneously with the sale of the over-allotment
Units, the Company consummated the private sale of an additional 38,700 Private Placement Units, generating additional gross proceeds
of $387,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company consummated the initial public offering of 6,000,000 Units (the &#8220;Units&#8221; and, with respect to
the Ordinary shares included in the Units sold, the &#8220;Public Shares&#8221;), including 900,000 Units that were issued pursuant to
the underwriters&#8217; exercise of their over-allotment option in full on January 9, 2023, at $10.00 per Unit, generating gross proceeds
of $69,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the initial public offering, we consummated the sale of 370,500 Private Placement Units at a price of $10.00 per
warrant, generating gross proceeds of $3,705,000. On January 9, 2023, simultaneously with the sale of the over-allotment Units, the Company
consummated the private sale of an additional 38,700 Private Units, generating additional gross proceeds of $387,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2021, we issued an unsecured promissory note to our Sponsor (the &#8220;Promissory Note&#8221;), pursuant to which we received
proceeds of $300,000 to cover expenses related to the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs related to the issuances described above amounted to $4,892,699 consisting of $1,612,500 of underwriting fees, $2,415,000 of deferred
underwriting fees and $865,199 of other offering costs. After deducting the underwriting discounts and commissions and offering expenses,
the total net proceeds from the initial public offering and the sale of the Private Placement Warrants $70,242,000 (or $10.18 per share
sold in the initial public offering) was placed in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_007"></span><b>ITEM
6. [RESERVED]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_008"></span><span style="font-size: 10pt"><b>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
to the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;we&#8221; refer to AlphaTime Acquisition Corp. The following
discussion and analysis of the Company&#8217;s financial condition and results of operations should be read in conjunction with the audited
financial statements and the notes related thereto which are included in &#8220;Item 8. Financial Statements and Supplementary Data&#8221;
of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.
Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results
may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth
under &#8220;Cautionary Note Regarding Forward-Looking Statements and Risk Factor Summary,&#8221; &#8220;Item 1A. Risk Factors&#8221;
and elsewhere in this Annual Report on Form 10-K.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company incorporated on September 15, 2021 (&#8220;inception&#8221;) as a Cayman Islands exempted company and formed
for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses. We have generated no revenues to date, and we do not expect that we will generate operating revenues at
the earliest until we consummate our initial business combination. We have not selected any specific business combination target and
we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination
target with respect to an initial business combination with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we may pursue an acquisition or a business combination target in any business or industry, we intend to focus our search on a rapidly-growing
and large-scaled target, including but not limited to, targets in the following space: fintech, alternative and clean energy, biotech,
logistics, industrial software, artificial intelligence (&#8220;AI&#8221;) and cloud industry, that can benefit from the expertise and
capabilities of our management team. Our efforts in identifying prospective target businesses will not be limited to a particular geographic
region, although we intend to focus on businesses in Asia. The issuance of additional shares in a business combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    significantly dilute the equity interest of investors in this offering;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    subordinate the rights of holders of our ordinary shares if preferred shares are issued with rights senior to those afforded our
    ordinary shares;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">could
    cause a change in control if a substantial number of our ordinary shares is issued, which may affect, among other things, our ability
    to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and
    directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking
to obtain control of us; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
    adversely affect prevailing market prices for our ordinary shares and/or warrants and/or rights.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similarly,
if we issue debt securities or otherwise incur significant debt to bank or other lenders or owners of a target, it could result in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">default
    and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt
    obligations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceleration
    of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants
    that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such
    financing while the debt security is outstanding;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to pay dividends on our ordinary shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">using
    a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends
    on our ordinary shares if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general
    corporate purposes;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
    vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution
    of our strategy; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    purposes and other disadvantages compared to our competitors who have less debt.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
indicated in the accompanying financial statements, as of December 31, 2022, we had deferred offering costs of $544,518. Further, we
expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete
our initial business combination will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have neither engaged in any operations nor generated any revenues to date. Our only activities since inception to December 31, 2022 have
been organizational activities and those necessary to consummate the Initial Public Offering (&#8220;IPO&#8221;), described below. Following
our IPO, we will not generate any operating revenues until the completion of our initial business combination. We will generate non-operating
income in the form of interest income after the IPO. We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2022, and for the period from inception to December 31, 2021, we had a net loss of $784 and $9,018, respectively,
which consists of operating and formation costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we had no cash and a working capital deficit of approximately $15,198. Until the consummation of our IPO, our liquidity
needs were satisfied through a capital contribution from our Sponsor of $25,000 to purchase the founder shares, and up to $300,000 in
loans available from our Sponsor under an unsecured promissory note. As of December 31, 2022, there were no borrowings outstanding under
the promissory note and the promissory note then expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, we consummated our IPO of 6,000,000 units (the &#8220;Units&#8221;), at $10.00 per Unit, generating gross proceeds of
$60,000,000. Simultaneously with the closing of our IPO, we consummated the sale of 370,500 Private Placement Units at a price of $10.00
per Private Placement Unit in a private placement to the Sponsor, generating total gross proceeds of $3,705,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, and effective January 9, 2023, the underwriters in our IPO purchased an additional 900,000 Units to exercise its over-allotment
option in full at a purchase price of $10.00 per Unit, generating gross proceeds of $9,000,000. Simultaneously with the closing of the
full exercise of the over-allotment option, we completed the private sale of an aggregate of 38,700 Private Placement Units, at a purchase
price of $10.00 per Private Placement Unit, generating gross proceeds of $387,000. Transaction costs amounted to $4,892,699 consisting
of $1,612,500 of underwriting discount, $2,415,000 of deferred underwriting commission and $865,199 of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of our IPO and the sale of over-allotment units, an aggregate of $70,242,000 ($10.18 per Unit) from the net proceeds and
the sale of the Private Placement Units was held in a Trust Account (&#8220;Trust Account&#8221;) and had approximately $525,554 held
in the Company&#8217;s bank account as of January 9, 2023, available for working capital needs as against estimated expenses of $600,000
for the period of 12 months from December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust
Account (less amounts released to us for taxes payable and deferred underwriting commissions) to complete our initial business combination.
We may withdraw interest to pay taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income
earned on the amounts held in the Trust Account. We expect the interest income earned on the amount in the Trust Account (if any) will
be sufficient to pay our taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our
initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations
of the target business or businesses, make other acquisitions and pursue our growth strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will use funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete a business combination. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees
for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a &#8220;no-shop&#8221;
provision (a provision designed to keep target businesses from &#8220;shopping&#8221; around for transactions with other companies or
investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we
do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a
target business, the amount that would be used as a down payment or to fund a &#8220;no-shop&#8221; provision would be determined based
on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether
as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due
diligence with respect to, prospective target businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination,
our founders or an affiliate of our founders may, but are not obligated to, loan us funds as may be required. If we complete our initial
business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use
a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would
be used for such repayment. Up to $300,000 of such loans may be convertible into working capital units, at a price of $10.00 per unit
at the option of the lender. The working capital units would be identical to the private units, each consisting of one ordinary share,
one private warrant and one right with the same exercise price, exercisability and exercise period, subject to similar limited restrictions
as compared to the units sold in our Initial Public Offering. The terms of such loans by our founders or their affiliates, if any, have not been determined
and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our founders or an
affiliate of our founders as we do not believe third parties will be willing to loan such funds and provide a waiver against any and
all rights to seek access to funds in our trust account, but in the event that we seek loans from any third parties, we will obtain a
waiver against any and all rights to seek access to funds in our trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, management believes that the Company lacks the financial resources it needs to sustain operations for a reasonable
period of time. Moreover, management&#8217;s plans to consummate the initial business combination may not be successful. These factors,
among others, raise substantial doubt about the Company&#8217;s ability to continue as a going concern (see note 1).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures About Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds of the IPO and the sale of the Private Placement Units held in the Trust Account will be invested in U.S. government treasury
bills with a maturity of 180 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions
under Rule 2a-7 under the Investment Company Act. Due to the short-term nature of these investments, we believe there will be no associated
material exposure to interest rate risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, our Sponsor received 1,437,500 of the Company&#8217;s Class B ordinary shares in exchange for $25,000 paid for deferred
offering costs borne by our Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the board of directors of the Company and our Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of the authorized but unissued 200,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001
    par value each;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of the 1,437,500 Class B ordinary shares in issue were repurchased in consideration for the issuance of 1,437,500 ordinary shares
    of $0.0001 par value each; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    completion of the above steps, the authorized but unissued 20,000,000 Class B ordinary shares were cancelled.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the Company issued an additional 287,500 ordinary shares to our Sponsor for no additional consideration, resulting in
our Sponsor holding an aggregate of 1,725,000 ordinary shares (the founder shares). The issuance was considered as a bonus share issuance,
in substance a recapitalization transaction, which was recorded and presented retroactively. The founder shares include an aggregate
of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters&#8217; over-allotment is not exercised in
full or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the initial investment in the Company of $25,000 by our Sponsor, the Company had no assets, tangible or intangible. The number of
founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares
upon completion of the IPO (excluding the private shares and shares underlying the UPO). The per share purchase price of the founder
shares was determined by dividing the amount of cash contributed to the Company by the aggregate number of founder shares issued. If
we increase or decrease the size of the IPO we will effect a share dividend or a share contribution back to capital or other appropriate
mechanism, as applicable, with respect to our ordinary shares immediately prior to the consummation of the offering in such amount as
to maintain the ownership of our initial shareholders at 20% of the issued and outstanding ordinary shares (excluding the private shares
and shares underlying the UPO) upon the consummation of the IPO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
founders and advisors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
Our audit committee will review on a quarterly basis all payments that were made to our founders, advisors or our or their affiliates
and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2021, our sponsor agreed to loan us up to $300,000 to be used for a portion of the expenses of the IPO. This loan is non-interest
bearing, unsecured and is due at the earlier of (1) December 31, 2022 and (2) the consummation of the IPO. At December 31, 2022, there
were no amounts outstanding and the Promissory Notes have then expired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in order to finance transaction costs in connection with an intended initial business combination, our founders or an affiliate
of our founders may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we
would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working
capital held outside the trust account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment.
Up to $300,000 of such loans may be convertible into working capital units, at a price of $10.00 per unit at the option of the lender.
Such working capital units would be identical to the private units sold in the private placement. The terms of such loans by our founders
or their affiliates, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to
seek loans from parties other than our founders or an affiliate of our founders as we do not believe third parties will be willing to
loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account, but in the event that we
seek loans from any third parties, we will obtain a waiver against any and all rights to seek access to funds in our trust account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Units</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, simultaneously with the closing of our IPO, we consummated the sale of 370,500 Private Placement Units at a price of
$10.00 per Private Placement Unit in a private placement to the Sponsor, generating total gross proceeds of $3,705,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 6, 2023, and effective January 9, 2023, the underwriters in our IPO purchased an additional 900,000 Units to exercise its over-allotment
option in full at a purchase price of $10.00 per Unit, generating gross proceeds of $9,000,000. Simultaneously with the closing of the
full exercise of the over-allotment option, we completed the private sale of an aggregate of 38,700 Private Placement Units, at a purchase
price of $10.00 per Private Placement Unit, generating gross proceeds of $387,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sponsor will be permitted to transfer the private units held by them to certain permitted transferees, including our officers and directors
and other persons or entities affiliated with or related to it or them, but the transferees receiving such securities will be subject
to the same agreements with respect to such securities as the founders. Otherwise, these private units (and underlying securities) will
be subject to certain transfer restrictions, subject to certain limited exceptions, as described under &#8220;Principal Shareholders
&#8212; Restrictions on Transfers of Founder Shares and Private Units.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement we will enter into with our founders on or prior to the closing of the IPO, we may be required to
register certain securities for sale under the Securities Act. Our founders and holders of private units issued upon conversion of working
capital loans, if any, are entitled under the registration rights agreement to make up to three demands that we register certain of our
securities held by them for sale under the Securities Act and to have the securities covered thereby registered for resale pursuant to
Rule 415 under the Securities Act. In addition, these holders have the right to include their securities in other registration statements
filed by us. We will bear the costs and expenses of filing any such registration statements. See the section of this Form 10-K entitled
&#8220;Certain Relationships and Related Party Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest
bearing. During the year ended December 31, 2022, and the period from September 15, 2021 (inception) through December 31, 2021, the Sponsor
paid $88,636 and $316,930 (includes $25,000 paid by the Sponsor to the Company for Founder Shares) on behalf of the Company. As of December
31, 2022 and 2021, the amount due to the related party was $380,566 and $291,930, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration
fee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effective date of the registration statement, an affiliate of the Sponsor shall be allowed to charge the Company an allocable
share of its overhead, up to $10,000 per month up to the close of the initial business combination, to compensate it for the Company&#8217;s
use of its offices, utilities and personnel. An administration fee of $667 was recorded for the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Contractual Obligations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
granted the underwriters a 45-day option from the date of IPO to purchase up to 900,000 additional Units to cover over-allotments, if
any, at the IPO price less the underwriting discounts and commissions. The underwriters exercised the over-allotment option in full effective
January 9, 2023. Simultaneously, on January 4, 2023, an amount of $352,350 due to related party was converted into over-allotment of
Private Placement, and the underwriter deposited additional $34,650 on behalf of Sponsor for 17,325 Founder Shares for $2 per share which
was sold by the Sponsor to underwriters. The Company paid a cash underwriting commission of $0.125 per Unit for 900,000 additional Units
and the underwriters will be entitled to a deferred commission of $0.35 per Unit, an aggregate of $2,415,000, which will be paid from
the funds held in the Trust Account upon completion of the initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the IPO, our Sponsor, at the option of the Company, sold to the underwriter or its designees 115,500 Founder Shares
for a purchase price of $2.00 per share and an aggregate purchase price of $231,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to sell to the underwriters, for $100.00, an option to purchase up to a total of 58,000 Units exercisable, in whole or in
part, at $11.50 per unit (or 115% of the Market Value), commencing on the consummation of our initial business combination, and expires
five years from the effective date of the IPO. The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants to
purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares upon
the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for
a period of 180 days immediately following the effective date of the registration statement or the commencement of sales in the IPO pursuant
to Rule 5110(e)(1) of FINRA&#8217;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated,
or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advisory
Services Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged TenX Global Capital LP (&#8220;TenX&#8221;), a related party to the Company, as an advisor in connection with the IPO
and the initial business combination, to assist in hiring consultants and other services providers in connection with the IPO and the
initial business combination, assist in the preparation of financial statements and other relevant services to commence trading including
filing the necessary documents as part of the transaction. Further, TenX will assist in preparing the Company for investor presentations,
conferences for due diligence, deal structuring and term negotiations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, and the period from September 15, 2021 (inception) through December 31, 2021, a cash fee of Nil and
$160,000, respectively, of deferred offering costs have been incurred for these services. As of December 31, 2022, total deferred offering
costs for these services amounted to an aggregate of $200,000, including the accrual for the remaining $40,000 which was due on listing
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements; Commitments and Contractual Obligations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not
have any commitments or contractual obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have
not identified any critical accounting policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Offering Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly
related to our IPO and that were charged to shareholder&#8217;s equity upon the completion of our IPO on January 4, 2023. As of December
31, 2022, offering costs aggregated to $584,518.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_009"></span><b>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_010"></span><span style="font-size: 10pt"><b>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information appears following Item 15 of this Report and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="S1_011"></span>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_012"></span><span style="font-size: 10pt"><b>ITEM
9A. CONTROLS AND PROCEDURES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Evaluation
of Disclosure Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently required to certify and report on our internal controls as defined by Section 404 of the Sarbanes-Oxley Act. We will
be required to comply with the internal control requirements of the Sarbanes-Oxley Act for the fiscal year ending December 31, 2022.
Only in the event that we are deemed to be a large accelerated filer or an accelerated filer would we be required to comply with the
independent registered public accounting firm attestation requirement. Further, for as long as we remain an emerging growth company as
defined in the JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to
other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent
registered public accounting firm attestation requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, we have not completed an assessment, nor have our auditors tested our systems, of internal controls. We expect
to assess the internal controls of our target business or businesses prior to the completion of our initial business combination and,
if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective
system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy
of internal controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Report on Internal Controls Over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K does not include a report of management&#8217;s assessment regarding internal control over financial reporting
or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the
SEC for newly public companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Internal Control over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_013"></span><b>ITEM
9B. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_014"></span><b>ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_015"></span><b>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_016"></span><b>ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
and Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current directors and executive officers are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif"><b>Age</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xinfeng
    Feng</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">41</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Chairwoman of the Board
    of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajiang
    Guo</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">54</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jichuan
    Yang</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">58</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Chief Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Li
    Wei</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">52</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Independent Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen
    He</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">55</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Independent Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    L Coyne</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">33</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Independent Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Xinfeng
Feng</b>, our Chairwoman of the Board of Directors, founded Guowangxin (Shenzhen) Investment Co., Ltd. in 2021 and has served as its
Chairman ever since. Mr. Feng founded Guoxing Supply China Management Co., Ltd. in 2020 and served as its Executive President. In 2017,
Ms. Feng founded Shenzhen Qianhai Zhongshang Wealth Management Co., Ltd and served as its Executive President. From 2015 to 2016, Ms.
Feng served as the Operation Manager of Zhongguang Yinrong Capital Management Co., Ltd. From 2012 to 2015, Ms. Feng served as the senior
Sales Director of FunDe Sino Life Insurance Co., Ltd. From 2003 to 2009, Ms. Feng served as the Financial Director of Shenzhen Shenxing
Technology Development Co., Ltd. Ms. Feng received her Associate Degree from Shenzhen University in 2003. Ms. Feng received her bachelor
degree in Finance from Xidian University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dajiang
Guo, </b>our Chief Executive Officer, serves as a Managing Director at Revere Securities LLC. Dr. Guo served as a Partner at Tiger Securities,
developing the institutional securities business of investment banking, sales and trading from 2019 to 2021. From 2017 to 2019, Dr. Guo
served as a Partner at China Bridge Capital in financial advisory and private equity. From 2016 to 2017, he served as the Chief Strategy
Officer at China Renaissance, where he was responsible for strategic planning, international expansion, and strategic investments. Dr.
Guo served as the CEO of CITIC Securities International USA, COO at CITICS Investment Banking Division, and Head of CITICS Strategy and
Planning, from 2011 to 2016. He has also held several executive positions at CICC HK/US from 2009 to 2011. Before venturing into cross
border financial services, Dr. Guo worked more than ten years for Citigroup Global Markets from 2004 to 2009, RBS Greenwich Capital Markets
from 2001 to 2004, and the Centre Re of Zurich Financial Services from 1996 to 2001, where he specialized in securitization and derivatives.
Dr. Guo also taught at the College of Insurance and the University of Guelph as an assistant professor and has published numerous academic
articles in peer-reviewed financial journals. Dr. Guo received his Ph.D. in Financial Economics from the University of Toronto. He is
a CFA Charterholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jichuan
Yang</b>, our Chief Financial Officer, serves as the Chairman Special Advisor at Sanya International Asset Exchange since 2021, as an
Advisory Board Member at Qinghua PBCSF China Finance Policy Study since 2020, as an independent director at Shanghai GuoSheng Industrial
Transformation Investment Fund since 2019, and as a board member at Cyan Bank Investments since 2017. From 2015 to 2020, Dr. Yang served
as the CEO of HFAX, a division of Sunshine Insurance Group with over $4 billion of assets under management and, from 2013 to 2015, the
Deputy General Manager and Chief Product Officer of LUFAX Holding Ltd (NYSE: LU) in the fintech and inclusive finance industry. From
2010 to 2013, Dr. Yang was the Head of Strategic Planning at Citic Securities. Dr. Yang received his Ph.D. in Applied Mathematics from
Brown University and his B.S. in Applied Mathematics from Tsinghua University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Li
Wei</b>, our director, is Professor of Practice at the Shanghai Advanced Institute of Finance (SAIF) of Shanghai Jiaotong University,
and the Assistant Director of the Shanghai Advanced Institute for Financial Research. Before SAIF, Dr. Wei has served many senior roles
in domestic and global financial institutions, including senior partner of Kunyuan Asset Management, Managing Director of Alternative
Investment at Citic Securities International, director of the Global Market at Deutsche Bank; director of Institutional Investment Group
at Citigroup, Officer &amp; Managing Director of the NYSE Group. In addition to her industry work, Dr. Wei also served as an adjunct
professor at Tsinghua PBCSF. Before industry practice, Dr. Wei had been a tenure track assistant professor of finance at Iowa State University,
the first senior financial advisor for the Shanghai Stock Exchange and the senior advisor for the Tel Aviv Stock Exchange. Dr. Wei received
her Ph.D in finance from the University of Utah, MS and BS from Tsinghua University Beijing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Wen
He</b>, our director, is an experienced professional who has 26 years of experience in Internets, Internet-of-Things, IT and software
industry. Mr. He also has over 10 years of experience in investment and M&amp;A, where he focuses on fund raising, investment management,
equity and bond financing and Fin-tech (e.g. Internets, Internet-of-Things, Blockchain). Mr. He has oversaw and participated in multiple
investment, listing and asset restructuring in renewable energy, new material, sustainability, healthcare and high-tech industries. Mr.
He now serves as the Vice Manager of Dr. Peng Cloud Computing Ltd. and the President of Haijuhuiren Holding Group. Mr. He served as the
Operation Director of Xunye Group, one of the earliest Internet companies in China. Mr. He served as the Vice President of Shenzhen Longmai
Information Co., Ltd. President and Technology Director of Naoku Technology Holding Group. In 2001, Mr. He co-founded OP.CN, the predecessor
company of Qvod Player, with Xin Wang and served as its Chairman. Mr. He served as the Executive Director of Guangdong Gaohe Financial
Leasing Co., Ltd. and the independent director of China Oil Gangran Energy Group Holdings Limited (08132.HK). Mr. He holds an MBA from
Columbia Southern University and a Bachelor Degree from Hunan Normal University. Mr. He holds a PMP and ICAA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
L. Coyne</b>, our director, has 7 years of extensive experience in capitals markets, business development, and deal origination. Since
2018, He has been serving as Head of Capital Markets at Ingalls &amp; Snyder, an investment advisory firm based in New York, and is currently
a Senior Director. At Ingalls &amp; Snyder, he built a capital markets investing and underwriting business, targeting listed IPOs, secondary
offerings, and block trades in technology, biotechnology, SPACs, and closed-end funds. He has participated in hundreds of SPAC transactions
through underwriting, merger advisory closing, PIPEs, risk capital sourcing, and selling groups. From August 2015 to February 2018, Mr.
Coyne served as Vice President and Head of Syndicate at Capital Integration Systems, an online financial services platform based in New
York, where he diversified revenue sources by orchestrating the firm&#8217;s first international pre-IPO private placement, increasing
client secondary equity trading, and developing relationships with investment banks. From February 2012 to July 2019, Mr. Coyne spent
7 years in the Army National Guard and the U.S. Army as 1st Lieutenant. His positions included Executive Officer, Task Force Officer-in-Charge,
Platoon Leader and Operations Officer, which he fulfilled both domestically and in Afghanistan. Mr. Coyne passed the Financial Industry
Regulatory Authority (FINRA) Series 7, 63, 24, 79 examinations and is a Securities Industry Essentials (SIE) license holder. Mr. Coyne
earned his Bachelor of Arts degree in Political Science and International Affairs from Northeastern University in 2011, and his MBA from
Leonard N. Stern School of Business, New York University in 2019. We believe that Mr. Coyne is qualified to serve on our board of directors
based on his extensive experience in capitals markets, business development, deal origination and SPACs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
and Terms of Office of Officers and Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have four directors as of December 31, 2022. Our board of directors is divided into three classes with only one class of directors being
elected in each year and each class (except for those directors appointed prior to our first annual meeting of shareholders) serving
a three-year term. The term of office of the first class of directors, consisting of Xinfeng Feng and Wen He, will expire at our first
annual meeting of shareholders. The term of office of the second class of directors, consisting of Dajiang Guo and Li Wei, will expire
at the second annual meeting of shareholders. The term of office of the third class of directors, consisting of Michael L. Coyne and
Jichuan Yang, will expire at the third annual meeting of shareholders. There is no requirement under the Companies Act for us to hold
annual or general meetings to elect directors. We may not hold an annual meeting of shareholders until after we consummate our initial
business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms
of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and
articles of association as it deems appropriate. Our amended and restated memorandum and articles of association provide that our officers
may consist of one or more Chairmen of the Board, one or more Chief Executive Officers, a President, a Chief Financial Officer, Vice
Presidents, Secretary, Treasurer, Assistant Secretary, and such other offices as may be determined by the board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ
listing standards require that a majority of our board of directors be independent. An &#8220;independent director&#8221; is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of independent judgment
in carrying out the responsibilities of a director. Our board of directors has determined that each of Li Wei, Wen He and Michael L.
Coyne are &#8220;independent directors&#8221; as defined in the NASDAQ listing standards and applicable SEC rules. Our audit committee
is entirely composed of independent directors meeting NASDAQ&#8217;s additional requirements applicable to members of the audit committee.
Our independent directors will have regularly scheduled meetings at which only independent directors are present.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officer
and Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our officers or directors has received any cash compensation for services rendered to us. Other than as described above and elsewhere
in this 10-K, no compensation of any kind, including finder&#8217;s and consulting fees, will be paid to our founders or any of their
respective affiliates, for services rendered prior to or in connection with the completion of our initial business combination although
we may consider cash or other compensation to officers or advisors we may hire to be paid either prior to or in connection with our initial
business combination. In addition, our officers, directors or any of their respective affiliates will be reimbursed for any out-of-pocket
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence
on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our founders or
their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting
or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in
the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination.
We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of
management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the
directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to
be paid to our officers will be determined, or recommended to the board of directors for determination, either by a compensation committee
constituted solely by independent directors or by a majority of the independent directors on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
a business combination, to the extent we deem it necessary, we may seek to recruit additional managers to supplement the incumbent management
team of the target business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers
will have the requisite skills, knowledge or experience necessary to enhance the incumbent management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has two standing committees: an audit committee and a compensation committee. Subject to phase-in rules and a limited
exception, the rules of NASDAQ and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely
of independent directors, and the rules of NASDAQ require that the compensation committee of a listed company be comprised solely of
independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established an audit committee of the board of directors. Li Wei, Wen He and Michael L. Coyne serve as members of our audit committee,
with Li Wei serving as the Chairwoman of the audit committee. Under the NASDAQ listing standards and applicable SEC rules, we are required
to have at least three members of the audit committee, all of whom must be independent, subject to certain phase-in provisions. Each
such person meets the independent director standard under NASDAQ listing standards and under Rule 10-A-3(b)(1) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
member of the audit committee is financially literate and our board of directors has determined that Li Wei qualifies as an &#8220;audit
committee financial expert&#8221; as defined in applicable SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopted an audit committee charter, which details the principal functions of the audit committee, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent
    registered public accounting firm engaged by us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
    all audit and permitted non-audit services to be provided by the independent auditors or any other registered public accounting firm
    engaged by us, and establishing pre-approval policies and procedures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
    clear hiring policies for employees or former employees of the independent auditors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
    clear policies for audit partner rotation in compliance with applicable laws and regulations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
    and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor&#8217;s internal
    quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review,
    of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years
    respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC
    prior to us entering into such transaction; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including
    any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues
    regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated
    by the Financial Accounting Standards Board, the SEC or other regulatory authorities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
established a compensation committee of the board of directors. Li Wei, Wen He, and Michael L. Coyne serve as members of our compensation
committee, with Wen He serving as the chairman of the compensation committee. Under the NASDAQ listing standards and applicable SEC rules,
we are required to have at least two members of the compensation committee, all of whom must be independent, subject to certain phase-in
provisions. Each such person meets the independent director standard under NASDAQ listing standards applicable to members of the compensation
committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 83; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopted a compensation committee charter, which details the principal functions of the compensation committee, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer&#8217;s compensation,
    evaluating our Chief Executive Officer&#8217;s performance in light of such goals and objectives and determining and approving the
    remuneration (if any) of our Chief Executive Officer based on such evaluation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving on an annual basis the compensation of all of our other officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    on an annual basis our executive compensation policies and plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
    and administering our incentive compensation equity-based remuneration plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
    management in complying with our proxy statement and annual report disclosure requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
    all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    required, producing a report on executive compensation to be included in our annual proxy statement; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    evaluating and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, as indicated above, other than reimbursement of expenses, no compensation of any kind, including finders, consulting or
other similar fees, will be paid to any of our existing shareholders, officers, directors or any of their respective affiliates, prior
to, or for any services they render in order to complete the consummation of a business combination although we may consider cash or
other compensation to officers or advisors we may hire to be paid either prior to or in connection with our initial business combination.
Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation committee will only be
responsible for the review and recommendation of any compensation arrangements to be entered into in connection with such initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such
adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the
compensation committee will consider the independence of each such adviser, including the factors required by NASDAQ and the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Nominations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a standing nominating committee. In accordance with Rule 5605(e)(2) of the NASDAQ Rules, a majority of the independent directors
may recommend a director nominee for selection by the board of directors. The board of directors believes that the independent directors
can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing
nominating committee. As there is no standing nominating committee, we do not have a nominating committee charter in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors will also consider director candidates recommended for nomination by our shareholders during such times as they are
seeking proposed nominees to stand for election at the next annual meeting of shareholders (or, if applicable, a special meeting of shareholders).
Our shareholders that wish to nominate a director for election to our board of directors should follow the procedures set forth in our
amended and restated memorandum and articles of association.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, our board of directors considers educational background, diversity of
professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent
the best interests of our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 84; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee Interlocks and Insider Participation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our officers currently serves, and in the past year have not served, as a member of the compensation committee of any entity that
has one or more officers serving on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopted a Code of Ethics applicable to our directors, officers and employees. We filed a copy of our Code of Ethics and our audit and
compensation committee charters as exhibits our Registration Statement. You will be able to review these documents by accessing our public
filings at the SEC&#8217;s web site at <i>www.sec.gov</i>. In addition, a copy of the Code of Ethics will be provided without charge
upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report
on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conflicts
of Interest</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as disclosed herein, we do not believe any conflict currently exists between us and our founders, and affiliates of our founders may
compete with us for acquisition opportunities. If such entities decide to pursue an opportunity, we may be precluded from procuring such
opportunity. In addition, investment ideas generated within our founders may be suitable for both us and for an affiliate of founders
and may be directed to such entity rather than to us. Neither our founders nor members of our management team who are also employed by
or affiliated with our founders will have any obligation to present us with any opportunity for a potential business combination of which
they become aware, unless presented to such member specifically in his or her capacity as an officer or director of the company. Our
founders and/or our management team, in their capacities as employees or affiliates of our founders or in their other endeavors, may
be required to present potential business combinations to future founders&#8217; affiliates or third parties, before they present such
opportunities to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations
to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to
such entity. Accordingly, in the future, if any of our officers or directors becomes aware of a business combination opportunity which
is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary
or contractual obligations to present such opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual
obligations of our officers arising in the future would materially undermine our ability to complete our business combination. Our amended
and restated memorandum and articles of association provides that we renounce our interest in any corporate opportunity offered to any
director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer
of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable
for us to pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officer or director may become an officer or director of any other special purpose acquisition company with a class of securities registered
under the Securities Exchange Act of 1934, as amended, or the Exchange Act, even before we enter into a definitive agreement regarding
our initial business combination or we have failed to complete our initial business combination within 9 months from the closing of our
Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
founders and management may also purchase public units or shares, including in the open market or through privately negotiated transactions.
During the offering, if any founders participates in the offering as an anchor investor, they may receive incentives which offer greater
economic benefits than those available to public investors in the offering. In addition, in order to incentivize the participation of
certain potential anchor investors, our sponsor may offer or share its economics in certain of our securities with such potential anchor
investors, the net effect of which could be to provide greater economic benefit to such potential anchor investors than that provided
to other investors in the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
investors should also be aware of the following other potential conflicts of interest:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
    of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest
    in allocating his or her time among various business activities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    officers may become an officer or director of any other SPACs even before we enter into a definitive agreement regarding our initial
    business combination or we have failed to complete our initial business combination within 9 months from the closing of our Initial
    Public Offering (or up to 18 months, if we extend the time to complete a business combination); as a result, our officers or directors
    may present a potential target to our competitor that would had been presented to us or devote time to our affairs which may have
    a negative impact on our ability to complete our initial business combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the course of their other business activities, our officers and directors may become aware of investment and business opportunities
    which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may
    have conflicts of interest in determining to which entity a particular business opportunity should be presented.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    initial shareholders have agreed to waive their redemption rights with respect to any founder shares, private shares and any public
    shares held by them in connection with the consummation of our initial business combination. Additionally, our initial shareholders
    have agreed to waive their redemption rights with respect to any founder shares and private shares held by them if we fail to consummate
    our initial business combination within 9 months from the closing of our Initial Public Offering (or up to 18 months, if we extend
    the time to complete a business combination). If we do not complete our initial business combination within such applicable time
    period, the proceeds of the sale of the private units held in the trust account will be used to fund the redemption of our public
    shares, and the private units and underlying securities will be worthless. With certain limited exceptions, 50% of the founder shares
    and private units (and underlying securities) will not be transferable, assignable by our founders until the earlier to occur of:
    (A) six months after the date of the consummation of our initial business combination, or (B) the date on which the closing price
    of our ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations)
    for any 20 trading days within any 30-trading day period commencing after our initial business combination and the remaining 50%
    of the founder shares and private units (and underlying securities) may not be transferred, assigned or sold until six months after
    the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business
    combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of
    our shareholders having the right to exchange their shares for cash, securities or other property. Since members of our management
    may directly or indirectly own ordinary shares, warrants and rights, our officers and directors may have a conflict of interest in
    determining whether a particular target business is an appropriate business with which to complete our initial business combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention
    or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect
    to our initial business combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    founders may have a conflict of interest with respect to evaluating a business combination and financing arrangements as we may obtain
    loans from our founders or an affiliate of our founders to finance transaction costs in connection with an intended initial business
    combination. Up to $500,000 of such loans may be convertible into working capital units at a price of $10.00 per unit at the option
    of the lender. Such working capital units would be identical to the private units sold in the private placement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conflicts described above may not be resolved in our favor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, officers and directors of a corporation incorporated under the laws of Cayman Islands are required to present business opportunities
to a corporation if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    corporation could financially undertake the opportunity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    opportunity is within the corporation&#8217;s line of business; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    would not be fair to our company and its shareholders for the opportunity not to be brought to the attention of the corporation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business
opportunities meeting the above-listed criteria to multiple entities. Furthermore, our amended and restated memorandum and articles of
association provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity
is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one
we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director
or officer is permitted to refer that opportunity to us without violating another legal obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not prohibited from pursuing an initial business combination with a company that is affiliated with our founders or any affiliate
of them, subject to certain approvals and consents. In the event we seek to complete our initial business combination with such a company,
we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm which is a member of
FINRA, or from an independent accounting firm, that such an initial business combination is fair to our company from a financial point
of view.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that we submit our initial business combination to our shareholders for a vote, our initial shareholders have agreed to vote
any founder shares and private shares held by them and any public shares purchased during or after the offering in favor of our initial
business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
on Liability and Indemnification of Officers and Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law does not limit the extent to which a company&#8217;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public
policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a
crime. Our amended and restated memorandum and articles of association provides for indemnification of our officers and directors to
the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual
fraud, willful default or willful neglect. We entered into agreements with our directors and officers to provide contractual indemnification
in addition to the indemnification provided for in our amended and restated memorandum and articles of association. We expect to purchase
a policy of directors&#8217; and officers&#8217; liability insurance that insures our officers and directors against the cost of defense,
settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account,
and have agreed to waive any right, title, interest or claim of any kind they may have in the future as a result of, or arising out of,
any services provided to us and will not seek recourse against the trust account for any reason whatsoever (except to the extent they
are entitled to funds from the trust account due to their ownership of public shares). Accordingly, any indemnification provided will
only be able to be satisfied by us if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced
officers and directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us
pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_017"></span><span style="font-size: 10pt"><b>ITEM
11. EXECUTIVE COMPENSATION</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our officers or directors have received or, prior to our initial business combination, will receive any cash compensation for services
rendered to us. Commencing on the date that our securities are first listed on the Nasdaq through the earlier of consummation of our
initial business combination and our liquidation, we will reimburse our sponsor for office space, utilities and secretarial and administrative
services provided to us in the amount of $10,000 per month. In addition, our sponsor, officers and directors, or any of their respective
affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying
potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly
basis all payments that were made to our sponsor, officers, directors or our or any of their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting,
management or other compensation from the combined company. Additionally, certain directors may receive additional compensation in the
form of equity interests of the Sponsor for their services. All compensation will be fully disclosed to shareholders, to the extent then
known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business
combination. It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination
business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our officers
after the completion of our initial business combination will be determined by a compensation committee constituted solely by independent
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. The
existence or terms of any such employment or consulting arrangements may influence our management&#8217;s motivation in identifying or
selecting a target business, and we do not believe that the ability of our management to remain with us after the completion of our initial
business combination should be a determining factor in our decision to proceed with any potential business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_018"></span><b>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary
shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement warrants
as these warrants are not exercisable within 60 days of the date of this Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is based on 9,034,200 ordinary shares outstanding at March 23 2023. Unless otherwise indicated, it is believed that
all persons named in the table below have sole voting and investment power with respect to all ordinary shares beneficially owned by
them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares Beneficially Owned</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Approximate
    Percentage of Outstanding Ordinary Share</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alphamade Holding
    LP <sup>(2)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,725,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xinfeng Feng<sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,725,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dajiang Guo</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jichuan Yang</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Li Wei</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Wen He</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael L. Coyne</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">All executive officers and directors as a group
    (6 individuals)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,725,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Glazer Capital, LLC (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">585,000</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">9.18</p></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">ATW SPAC MANAGEMENT LLC (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">438,093</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">5.57</p></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise noted, the business address of each of the following entities or individuals is c/o AlphaTime Acquisition Corp, 500 Fifth
    Avenue, Suite 938, New York, NY 10110.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    sponsor is the record holder of founder shares reported herein. Ms. Feng is the sole director and shareholder of Doreen International
    Limited, which owns 60% of the sponsor entity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">(3)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">According to a Schedule 13G filed with
the SEC on February 14, 2023, Glazer Capital, LLC beneficially owns 585,000 ordinary shares. Glazer Capital, LLC&#8217;s address is </span><span style="font-size: 11pt">250
West 55</span><span style="font-size: 12pt"><sup>th</sup></span><span style="font-size: 11pt">&#160;Street, Suite 30A, New York, New York
10019.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">(4)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to a Schedule 13G
filed with the SEC on February 14, 2023, the ordinary shares are held by (1) one or more private funds managed by ATW SPAC Management
LLC, a Delaware limited liability company (the &#8220;Adviser&#8221;), which has been delegated exclusive authority to vote and/or direct
the disposition of such Shares held by sub-accounts of one or more pooled investment vehicles managed by a Delaware limited liability
company and (2) a private fund that is managed by an affiliate of the Adviser. Antonio Ruiz-Gimenez and Kerry Propper are managing members
of the Adviser and its affiliate. The address is 17 State Street, Suite 2100 New York, New York 10004.</p>
</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 89; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_019"></span><span style="font-size: 10pt"><b>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Founder
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, our sponsor acquired 1,437,500 founder shares for an aggregate purchase price of $25,000. On January 8, 2022,
our sponsor acquired an additional 287,500 founder shares for no additional consideration, resulting in our sponsor holding an
aggregate of 1,725,000 founder shares. Prior to the initial investment in the company of $25,000 by our sponsor, the company had no
assets, tangible or intangible. The number of founder shares issued was determined based on the expectation that such founder shares
would represent approximately 20% of the outstanding shares upon completion of our Initial Public Offering (excluding the private
shares and shares underlying the UPO). Concurrent with the closing of the Initial Public Offering, our Sponsor sold to Chardan or
its designees 132,825 of these founder shares at a purchase price of $2.00 per share and an aggregate purchase price of
$265,650.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
Placement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, our sponsor purchased an aggregate of 370,500 private units for a purchase price of
$10.00 per unit in a private placement. On January 9, 2023, our Sponsor purchased 38,700 private units in connection with the exercise
of the over-allotment. Each private unit consists of one ordinary share, one private warrant and one right entitling the holder thereof
to receive one-tenth of one ordinary share upon the completion of an initial business combination. Each whole warrant is exercisable
to purchase one ordinary share at $11.50 per share, subject to adjustment as described in our Registration Statement. If the Company
does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants
will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants
will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Service
Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 30, 2022, we entered into an administrative services agreement with our Sponsor, pursuant to which the Sponsor agreed to make
available to the Company certain general and administrative services, including office space, utilities and administrative services,
as the Company may require from time to time. The Company has agreed to pay to the affiliate of the Sponsor $10,000 per month for such
administrative services. For the period from September 15, 2021 (inception) through December 31, 2022, the Company recorded an administration
fee of $667 for the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conflicts
of Interest</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations
to other entities pursuant to which such officer or director is or will be required to present business combination opportunities to
such entity. Accordingly, in the future, if any of our officers or directors becomes aware of a business combination opportunity which
is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary
or contractual obligations to present such opportunity to such entity. We do not believe, however, that any fiduciary duties or contractual
obligations of our officers arising in the future would materially undermine our ability to complete our Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note - Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 21, 2021, the Company issued an unsecured promissory note to the Sponsor (the &#8220;Promissory Note&#8221;), pursuant to which
the Company could borrow up to an aggregate of $300,000 to cover expenses related to the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of Founders Shares and Private Placement Units will be entitled to registration rights pursuant to a registration rights agreement
signed on December 30, 2022. The holders of these securities are entitled to make up to three demands, excluding short form demands,
that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect
to registration statements filed subsequent to our completion the Company&#8217;s initial business combination. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
compensation of any kind, including finder&#8217;s and consulting fees, will be paid by the company to our sponsor, executive officers
and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial
business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit
committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Sponsor, under which the sponsor may loan us funds up to $300,000 for a portion of the expenses of our initial public offering. As of
December 31, 2022, there were no borrowings outstanding under the promissory note. These loans would be non-interest bearing, unsecured
and are due at the earlier of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate
of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required on a non-interest
basis. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination
does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds
from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post
business combination entity at a price of&#8201; $1.00 per warrant at the option of the lender. The warrants would be identical to the
private placement warrants. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policy
for Approval of Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee of our board of directors adopted a policy setting forth the policies and procedures for its review and approval or ratification
of &#8220;related party transactions.&#8221; A &#8220;related party transaction&#8221; is any consummated or proposed transaction or
series of transactions: (i) in which the company was or is to be a participant; (ii) the amount of which exceeds (or is reasonably expected
to exceed) the lesser of $120,000 or 1% of the average of the company&#8217;s total assets at year-end for the prior two completed fiscal
years in the aggregate over the duration of the transaction (without regard to profit or loss); and (iii) in which a &#8220;related party&#8221;
had, has or will have a direct or indirect material interest. &#8220;Related parties&#8221; under this policy include: (i) our directors,
nominees for director or executive officers; (ii) any record or beneficial owner of more than 5% of any Class of our voting securities;
(iii) any immediate family member of any of the foregoing if the foregoing person is a natural person; and (iv) any other person who
maybe a &#8220;related person&#8221; pursuant to Item 404 of Regulation S-K under the Exchange Act. Pursuant to the policy, the audit
committee will consider (i) the relevant facts and circumstances of each related party transaction, including if the transaction is on
terms comparable to those that could be obtained in arm&#8217;s-length dealings with an unrelated third party, (ii) the extent of the
related party&#8217;s interest in the transaction, (iii) whether the transaction contravenes our code of ethics or other policies, (iv)
whether the audit committee believes the relationship underlying the transaction to be in the best interests of the company and its stockholders
and (v) the effect that the transaction may have on a director&#8217;s status as an independent member of the board and on his or her
eligibility to serve on the board&#8217;s committees. Management will present to the audit committee each proposed related party transaction,
including all relevant facts and circumstances relating thereto. Under the policy, we may consummate related party transactions only
if our audit committee approves or ratifies the transaction in accordance with the guidelines set forth in the policy. The policy does
not permit any director or executive officer to participate in the discussion of, or decision concerning, a related person transaction
in which he or she is the related party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
listing standards require that a majority of our board of directors be independent. An &#8220;independent director&#8221; is defined
generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship
which in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of independent judgment
in carrying out the responsibilities of a director. Our board of directors has determined that Li Wei, Wen He and Michael Coyne are &#8220;independent
directors&#8221; as defined in Nasdaq listing standards and applicable SEC rules. Our independent directors have regularly scheduled
meetings at which only independent directors are present.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="S1_020"></span><b>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,686</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,375</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit related fees<sup>(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>&#160;</sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)
</sup>&#8220;Audit fees&#8221; and &#8220;Audit related fees&#8221; are fees billed or billable by our external auditor for services
provided in auditing our Company&#8217;s financial statements for the respective periods and services related to the Company&#8217;s
registrations filings, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_021"></span><span style="font-size: 10pt"><b>ITEM
15. EXHIBITS, FINANCIAL STATEMENTS, AND SCHEDULES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    following documents are filed as part of this report:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Statements: See &#8220;Item 8. Financial Statements and Supplementary Data&#8221; herein and &#8220;Index to Financial Statements&#8221;
and financial statements incorporated by reference herein commencing below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex1-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Underwriting
    Agreement, dated December 30, 2022, by and between the Company and Chardan Capital Markets, LLC, as representative of the underwriters
    (incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Amended
    and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report
    on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Rights
    Agreement, dated December 30, 2022, by and between the Company and American Stock Transfer &amp; Trust Company, as rights agent (incorporated
    by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex4-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Warrant
    Agreement, dated December 30, 2022, by and between the Company and American Stock Transfer &amp; Trust Company, as warrant agent
    (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Specimen
    Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696),
    filed with the SEC on December 23, 2022).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex4-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Specimen
    Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Registration Statement on Form S-1 (No.
    333-268696), filed with the SEC on December 23, 2022).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex4-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Specimen
    Warrant Certificate. (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696),
    filed with the SEC on December 23, 2022).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex4-4.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Specimen
    Rights Certificate (incorporated by reference to Exhibit 4.4 to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696),
    filed with the SEC on December 23, 2022).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-7.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Letter
    Agreement, dated December 30, 2022, by and among the Company, its executive officers, its directors and Alphamade Holding LP (incorporated
    by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Investment
    Management Trust Agreement, dated December 30, 2022, by and between the Company and American Stock Transfer &amp; Trust Company,
    as trustee (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January
    5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Registration
    Rights Agreement, dated December 30, 2022, by and among the Company, Alphamade Holding, LP and Chardan Capital Markets, LLC (incorporated
    by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-4.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Private
    Placement Unit Purchase Agreement, dated December 30, 2022, by and between the Company and Alphamade Holding LP (incorporated by
    reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-5.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Units
    Purchase Option, dated December 30, 2022, by and between the Company and Chardan Capital Markets, LLC (incorporated by reference
    to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-6.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Securities
    Escrow Agreement, dated December 30, 2022, by and among the Company, American Stock Transfer &amp; Trust Company and the initial
    shareholders party thereto. (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K, filed with
    the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Administrative
    Services Agreement, dated December 30, 2022, by and between the Company and Alphamade Holding, LP (incorporated by reference to Exhibit
    10.7 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315223000610/ex10-7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Form
    of Indemnity Agreement (incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K, filed with the
    SEC on January 5, 2023).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Promissory
    Note, dated September 30, 2021, issued to Alphamade Holding LP (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
    Registration Statement on Form S-1 (No. 333-268696), filed with the SEC on December 23, 2022</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex10-9.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Amended
    and Restated Promissory Note, dated November 23, 2021, issued to Alphamade Holding LP (incorporated by reference to Exhibit 10.9
    to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696), filed with the SEC on December 23, 2022.</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex10-10.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Second
    Amended and Restated Promissory Note, dated January 26, 2022, issued to Alphamade Holding LP (incorporated by reference to Exhibit
    10.10 to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696), filed with the SEC on December 23, 2022</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1889106/000149315222034692/ex10-12.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Third
    Amended and Restated Promissory Note, dated October 20, 2022, issued to Alphamade Holding LP ((incorporated by reference to Exhibit
    10.12 to the Company&#8217;s Registration Statement on Form S-1 (No. 333-268696), filed with the SEC on December 23, 2022).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">32.2**</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex32-2.htm">Certificate of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within
    the inline XBRL document)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
                                            XBRL Taxonomy Extension Presentation Linkbase</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">104*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">**</td>
    <td style="font: 10pt Times New Roman, Times, Serif"> Furnished herewith</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="S1_022"></span><span style="font-size: 10pt"><b>Item
16. FORM 10-K SUMMARY</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 46 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Form 10-K to be signed on its behalf
by the undersigned, thereunto duly authorized, in the Cayman Islands, on the 23rd day of March, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
    ACQUISITION CORP</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Dajiang Guo</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajiang
    Guo</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this Annual Report has been signed below by the following persons in the
capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><i>/s/ <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajiang
    Guo</span></i></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Executive Officer and Director </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 23,
    2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Dajiang
    Guo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><i>(Principal
    Executive Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
                                            Jichuan Yang</i>&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
                                            Financial Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 23,
    2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jichuan
    Yang</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
    Financial Officer and Principal Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
                                            Xinfeng Feng</i>&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairwoman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 23,
    2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xinfeng
    Feng</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Section: Cover/ROC -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index
to Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_002">Balance Sheets as of December 31, 2022 and December 31, 2021</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><a href="#ak_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Operations for the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><a href="#ak_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Changes in Shareholder&#8217;s Equity for the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><a href="#ak_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Cash Flows for the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#ak_006">Notes to Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 95; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="form10-k_002.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Shareholder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
AlphaTime Acquisition Corp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of AlphaTime Acquisition Corp. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021,
and the related statements of operations, changes in shareholder&#8217;s equity, and cash flows for the year ended December
31, 2022 and for the period from September 15, 2021 (inception) to December 31, 2021, and the related notes (collectively referred to
as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position
of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31,
2022 and for the period from September 15, 2021 (inception) to December 31, 2021, in conformity with accounting principles generally
accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial
Doubt about the Company&#8217;s Ability to Continue as a Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared to assume the Company will continue as a going concern. As discussed in Note 1 to
the financial statements, the Company has no revenue. It expects to continue to incur significant professional costs to remain a publicly
traded company and significant transaction costs in pursuing the consummation of a Business Combination. The Company&#8217;s cash and
working capital as of December 31, 2022 are not sufficient to complete its planned activities for the upcoming year. These conditions
raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluation of the events
and conditions, and plans regarding these matters are also described in Note 1 to the financial statements. The financial statements
do not include any adjustments that might result from the outcome of this uncertainty, and our opinion is not modified with respect to
that matter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<span id="xdx_903_edei--AuditorName_c20220101__20221231_zxWn9cr9aPG9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorName">UHY LLP</ix:nonNumeric></span> (PCAOB ID # <span id="xdx_90F_edei--AuditorFirmId_c20220101__20221231_zigShkIhPWn1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorFirmId">1195</ix:nonNumeric></span>)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--AuditorLocation_c20220101__20221231_zxK63EGyYo25"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorLocation">New
York, New York</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
23, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_002"></span>BALANCE
SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zoW01c7zQoS9" summary="xdx: Statement - Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20221231_zV7BQZih1Zng" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_490_20211231_zwOD7zaOlbI4" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
                                            31, 2021</b></span></p></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsAbstract_iB_zMk7reHLUZg3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets:</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrentAbstract_i01B_zNFLQrfddnFj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--PrepaidExpenseCurrent_i02I_maACzvZA_zspXEnInT30f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid expenses</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1.5pt; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,052</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1.5pt; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0062">&#8212;</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredOfferingCosts_i02I_maACzvZA_z7231IFHvPkh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 0pt">Deferred offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,518</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrent_i02TI_mtACzvZA_maAzzlo_zgpIfpcpmBv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">592,570</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--Assets_i01TI_mtAzzlo_zQlHrpfyeX67" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">592,570</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,427</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities and Shareholder&#8217;s Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrentAbstract_i01B_zZ8Z49vgpjZ3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_i02I_maLCz46Z_z3NIBxQwLMO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">196,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DueToRelatedPartiesCurrent_i02I_maLCz46Z_zuCyXtZ4abJd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Due to related party</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">291,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_i02TI_mtLCz46Z_maLzymc_zN2ZHuAFOKm3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">577,372</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Liabilities_i01TI_mtLzymc_maLASEzRwm_ztVNaIHSJOp" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    liabilities</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">577,372</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">402,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzRwm_zQ9RL1pQ2PJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and Contingencies (See Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0091">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholder&#8217;s Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockValue_i02I_maSEzgJV_zpisMFSvTcw5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred shares, $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zN9s2SFeyQng" title="Preferred stock par or stated value per share"><span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211231_zq5MkEt2A7v7" title="Preferred stock par or stated value per share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zwW6BDoTKvb7" title="Preferred stock, shares authorized"><span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211231_zLvpL9U4oBo8" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pid_dn_c20221231_zNfJOo3E0dtk" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dn_c20221231_zhdXR6wnFBRg" title="Preferred stock, shares outstanding"><span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pid_dn_c20211231_zJlDYZDi9Kvb" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_dn_c20211231_zvIZob36CrDk" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0097">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0098">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i02I_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zm69q9HifgE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A
    ordinary shares, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zUkE0a1c9ga4"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value; <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zExpyFZaiDuk"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares authorized - cancelled and re-designated
    as Ordinary Shares <sup id="xdx_F4F_zhpUFSeKShS">(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0116">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommonStockValue_i02I_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXHpq9qongDk" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class B
    ordinary shares, $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpZ7cCQL4d23" title="Common stock, par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z4UX9uPTOhIg" title="Common stock par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zasESeLa0eEd" title="Common stock shares authorized"><span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zq3iwCGVRDd8" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized &#8211; cancelled <sup id="xdx_F44_z1P2wMgTne5c">(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0122">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommonStockValue_i02I_z6HmZzkojYo1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zNTHq8kMhqt3" title="Common stock par or stated value per share"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231_zlSXfPH6WQGd" title="Common stock par or stated value per share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zW9r5NW58AL" title="Common stock shares authorized"><span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231_znkJcntdKaL8" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zzqWTxwDCUP3" title="Common stock, shares issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zoXEvbX40fM4" title="Common stock, shares outstanding"><span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zeeaCnzNuHu4" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zgRpZX8KGSNl" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding on December 31, 2022 and 2021 <sup id="xdx_F4E_zDK2rhufr1d9">(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i02I_maSEzgJV_zyTyKa8R1Qol" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0pt; padding-left: 0pt">Common stock value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdditionalPaidInCapital_i02I_maSEzgJV_zUaaJn8plrj5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzgJV_zALmhsqsEXQg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,802</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtSEzgJV_maLASEzRwm_zO7vnZMJfFGa" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Shareholder&#8217;s Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,198</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,982</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzRwm_zTsWOeqyWdkk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Liabilities and Shareholder&#8217;s Equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">592,570</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">418,427</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F08_zelJi7VfiCTc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_F1A_zQzDyUJyJ0Uh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000165" xml:lang="en-US">See
                                            Note 7 for the changes in the structure of Ordinary Shares.</ix:footnote></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td id="xdx_F0A_zgLOBbfiLH7" style="font: 10pt Times New Roman, Times, Serif">(2)</td>
    <td id="xdx_F13_zBZV1IUy4rD3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote000166" xml:lang="en-US">Includes an aggregate of up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z39ZHBgJSMT8" title="Sharebased payment award options forfeitures"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on
    January 6, 2023 thus forfeiture condition has been removed (see Note 8).</ix:footnote></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_003"></span>STATEMENTS
OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_113_zHT7n3oWlbx3" summary="xdx: Statement - Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220101__20221231_zjBnTHKzJicj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20210915__20211231_znHjHwSHSHLh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the period from September 15,
    2021 (inception) through December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingCostsAndExpenses_maOEzDTg_zzzZ0PgCSC58" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt">Formation costs</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">784</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,018</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12pt; padding-left: 12pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_iT_mtOEzDTg_msNILz92U_zD3PFf1fmYUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt">Total Expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">784</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_mtNILz92U_z9SLiXMcbxti" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">784</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -12pt; padding-left: 12pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z498LRKRN2db" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    average ordinary shares outstanding, basic and diluted <sup id="xdx_F40_z67m7WO3mih">(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-12-31" id="Fact000179" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,500,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-09-152021-12-31" id="Fact000180" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,319,444</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_z3XLVc2x7oCh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Basic and diluted
    net loss per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0182">&#8212;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0C_zdQ5yhxTKNS5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zDrzKDPKS5h8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000184" xml:lang="en-US">This
    number excludes weighted average shares outstanding considered for <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVdveBXlyV21" title="Sharebased payment award options forfeitures"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> Ordinary Shares subject to forfeiture depending on the
    extent to which the over-allotment option is not exercised by the underwriters (see Notes 5 and 7). The underwriters subsequently
    exercised the over-allotment option in full on January 6, 2023 thus forfeiture condition has been removed (see Note 8).</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_004"></span>STATEMENTS
OF CHANGES IN SHAREHOLDER&#8217;S EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_114_zJktS8kxXDVj" summary="xdx: Statement - Statements of Changes in Shareholders&apos; Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_434_c20210915__20211231_eus-gaap--StockholdersEquity_iS_zMKgb8n1C3i4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zgY17EQ75G3h" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zBLEPwTIRuGl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zTrtFtJnKdtk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_zR44TK36FkB5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Additional paid-in capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total shareholder&#8217;s equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43B_c20210915__20211231_eus-gaap--StockholdersEquity_iS_zyRxiMDx9ngj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance as of September 15, 2021 (inception)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20210915__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOB1qyC0EAGc" title="Balance, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0194">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0191">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zXf5MWdNAzPa" style="vertical-align: bottom; background-color: White">
    <td style="width: 39%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of Ordinary
    Shares to Sponsor <sup id="xdx_F47_zwDB7iJx7Y4j">(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210915__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zduUoZOuc5J8" title="Issuance of Ordinary Shares to Sponsor, shares" style="width: 8%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember" id="Fact000196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0198">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-09-152021-12-31" id="Fact000199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueOther_znJDXVk7mfd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus issue allotment to the
    Sponsor <sup id="xdx_F45_z2BkT69T65q5">(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20210915__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7fNLi8McDg" title="Bonus issue allotment to the Sponsor, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">287,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember" id="Fact000203" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000204" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0205">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0206">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_z2lCqooEXY4h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0210">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0211">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220101__20221231_eus-gaap--StockholdersEquity_iS_zYpeDfylCil1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgBJghjzGv1l" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zMe0xrMYbSgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0222">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0223">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">784</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">784</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_439_c20220101__20221231_eus-gaap--StockholdersEquity_iE_zpXvrBfLfAqf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance as of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBuTfSxyuN07" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,802</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,198</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F06_zYrFAoAUOVPf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_z0HxLVv46WX8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000233" xml:lang="en-US">Includes
    an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79" title="Sharebased payment award options forfeitures"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-09-152021-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,500</ix:nonFraction></span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0F_zSOEd5SdAiwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zfIoUzUfCv6k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000236" xml:lang="en-US">Includes
    an aggregate of up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zeJ1C2au4wtj" title="Sharebased payment award options forfeitures"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">37,500</ix:nonFraction></span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_005"></span>STATEMENTS
OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the year ended December 31, 2022 and for the period from September 15, 2021 (inception) through December 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_112_z3PBF8X0LRfd" summary="xdx: Statement - Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20221231_zIAodowlvFX7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20210915__20211231_zJUvJPcTCLel" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the period from September 15,
    2021 (inception) through December 31, 2021</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_i01_maNCPBUzvRP_zVdRoZCkqsb1" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">784</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,018</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_i01B_zx01BsRWn8li" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in current assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_di_msNCPBUzvRP_zKQfJPVnHkej" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,466</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_i02_maNCPBUzvRP_zQCT3pgLiONi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued offering costs and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,552</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i02_maNCPBUzvRP_zmFrpowu8MFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Due to related party</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,802</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,018</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzvRP_maCCERCzQZa_z9jiz5Fq5rP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0259">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzQZa_zsuOdG1oxaq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net change in cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0261">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0262">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zKqfMRXqq1Ha" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Cash&#8212;beginning of the period</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0264">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zSsBGhG1XVI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Cash&#8212;end of the period</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0267">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z3Jbvjvi2QV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of noncash financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DeferredOfferingCostsIncludedInDueToRelatedParty_i01_z6tps72wGfLg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred offering costs included in due to related party</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,834</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">282,912</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredOfferingCostsIncludedInDueToAccruedLiabilities_i01_zTImSGAsYaD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred offering costs included in due to accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">117,843</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredOfferingCostsAdjustedFromPrepaidExpenses_i01_zKgnAC2hZPri" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Deferred offering costs adjusted from prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:DeferredOfferingCostsAdjustedFromPrepaidExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares_i01_zxPDjjM3FwM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of Ordinary Shares in consideration of re-purchase of Class B ordinary shares <sup id="xdx_F48_zWECfSJd2kD5">(1)</sup></span></td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" contextRef="From2021-09-152021-12-31" id="Fact000283" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--BonusIssueAllotmentToSponsor_i01_zbCFdBMPWPq8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Bonus issue allotment to the Sponsor</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0285">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ATMC:BonusIssueAllotmentToSponsor" contextRef="From2021-09-152021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F09_zpiIZZGPx3b2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zS8j5O2Btrr" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000287" xml:lang="en-US">See
    Note 7 for the changes in the structure of Ordinary Shares.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALPHATIME
ACQUISITION CORP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ak_006"></span>NOTES
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zUkR7KHWkmTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1 &#8211; <span id="xdx_829_zju43jbxuH5k">Description of Organization, Business Operations and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AlphaTime
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in Cayman Islands on <span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231_znzjOnlJRGI3" title="Date of incorporation"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayyearen" name="dei:EntityIncorporationDateOfIncorporation">September 15, 2021</ix:nonNumeric></span>. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had not commenced any operations. All activities for the year ended December 31, 2022, and for the
period from September 15, 2021 (inception) through December 31, 2021, relate to the Company&#8217;s formation and the Initial Public
Offering described below. The Company will not generate any operating revenues until the completion of its initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial
Public Offering (&#8220;IPO&#8221;). The Company has selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsor is Alphamade Holding LP, a Delaware limited partnership (the &#8220;Sponsor&#8221;). The registration statement
for the Company&#8217;s IPO was declared effective on December 30, 2022 (the &#8220;Effective Date&#8221;). On January 4, 2023, the Company
consummated the IPO of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zr5SsnIQAAKe" title="Issuance of ordinary share, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> units (the &#8220;Units&#8221;). Each Unit consists of one ordinary share of the Company, par value
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfra0tDUANI6" title="Ordinary share par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (the &#8220;Ordinary Shares&#8221;), one redeemable warrant (the &#8220;Warrants&#8221;) and one right (the &#8220;Rights&#8221;),
with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of an initial Business Combination,
subject to adjustment. The Units were sold at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0tuUGv13js4" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7G96pK3PAt9" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></span>. On
January 6, 2023, Chardan Capital Markets, LLC exercised its over-allotment option (the &#8220;Overallotment&#8221;), which subsequently
closed on January 9, 2023, to purchase an additional <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKHiaRtLlig5" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units at a public offering price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhy9pyYLfYh2" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating additional
gross proceeds to the Company of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3j4K7vANuhh" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, the Company completed the sale of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zJIU1hV6fcu7" title="Number of private units sold, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">370,500</ix:nonFraction></span> private units to the Sponsor (the &#8220;Private Units&#8221;)
at a purchase price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zDgedv021tI2" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Unit, generating gross proceeds to the Company of $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkAjP4fcvGA9" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,705,000</ix:nonFraction></span>. Simultaneously with the closing
of the Overallotment, the Company completed the private sale of an additional <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAXdF52StLv2" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,700</ix:nonFraction></span> Private Units, at a purchase price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJM4GoIiSjw1" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per
Private Unit, generating additional gross proceeds to the Company of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrazFFCTf5h3" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">387,000</ix:nonFraction></span>. Transaction costs amounted to $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeLj1JY04a6f" title="Transaction cost"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,892,699</ix:nonFraction></span> consisting of
$<span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgLwcMLZN9si" title="Payments for underwriting expense"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,612,500</ix:nonFraction></span> of underwriting discount, $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWH0QPZ5999e" title="Deferred underwriting commission"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span> of deferred underwriting commission and $<span id="xdx_902_eus-gaap--OtherDeferredCostsNet_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF999otopvCh" title="Other offering costs"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">865,199</ix:nonFraction></span> of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4NzIS9jYNwf" title="Sale of stock value issued"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,242,000</ix:nonFraction></span> of the proceeds from the IPO and the sale of
the Private Units (including the Overallotment of the Units and Private Units) were placed in a U.S.-based Trust Account at J.P. Morgan
Chase Bank, N.A. maintained by American Stock Transfer &amp; Trust Company, acting as trustee and will be invested only in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 180 days or less or
in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct
U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released
to the Company to pay income tax obligations, the proceeds from the IPO will not be released from the Trust Account until the earlier
of the completion of a Business Combination or the Company&#8217;s liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale
of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a
Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses
or assets with a fair market value equal to at least <span id="xdx_906_ecustom--PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zuq6JJdBEZC6" title="Percentage of fair market value of business acquisition"><ix:nonFraction name="ATMC:PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90</ix:nonFraction></span>% of the assets held in the Trust Account (as defined below) (excluding the amount
of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business
Combination if the post-Business Combination company owns or acquires <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20221231__us-gaap--BusinessAcquisitionAxis__custom--PostBusinessCombinationMember_zdMkaiU9Mo47" title="Percentage of voting interests acquired"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2022-12-31_custom_PostBusinessCombinationMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% or more of the issued and outstanding voting securities of
the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an
investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance
that the Company will be able to complete a Business Combination successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Shareholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvyNt7kIDMC3" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.18</ix:nonFraction></span> per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable). The Public Shares subject to redemption will be recorded
at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting
Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zLnE32xrnYK3" title="Business combination, net tangible assets"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2022-12-31_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span> (so that it does
not then become subject to the SEC&#8217;s &#8220;penny stock&#8221; rules) or any greater net tangible asset or cash requirement that
may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination,
the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving
a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does
not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum
and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the
&#8220;SEC&#8221;), and file tender offer documents containing substantially the same information as would be included in a proxy statement
with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial
Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public
Shares, without voting, and if they do vote, irrespective of whether they vote for or against an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant
to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder
is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public
Shares without the Company&#8217;s prior written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association
(i) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with the Company&#8217;s initial
business combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination
Period (as defined below) or (ii) with respect to any other provision relating to shareholder&#8217;s rights or pre-initial business
combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval
of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public
Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--BusinessCombinationInitialPublicOfferingDescription_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTXLobhMbHic" title="Business combination description"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_IPOMember" name="ATMC:BusinessCombinationInitialPublicOfferingDescription">The
Company will have until 9 months (or up to 18 months, if we extend the time to complete a Business Combination as described in our Registration Statement)
from the closing of the Initial Public Offering to consummate a Business Combination (the &#8220;Combination Period&#8221;). However,
if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to us to pay our taxes, if any (less up to $<span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_z0XKuhqmrRSf" title="Taxes payable and less interest to pay dissolution expenses"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_us-gaap_IPOMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> of interest to pay dissolution expenses),
divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public
Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company&#8217;s remaining Public Shareholders and its Board of Directors,
liquidate and dissolve, subject in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law.</ix:nonNumeric></span> The Sponsor has agreed to waive its rights to liquidating distributions from the Trust
Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination
Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating
distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters
have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company
does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other
funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering
price per Unit ($<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4qUCwMnDoH" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent
any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amount of funds in the Trust Account to below the lesser of (1) $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLERwIlLAFc4" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.18</ix:nonFraction></span> per Public Share and (2) the actual amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuLGvcKnVHVk" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.18</ix:nonFraction></span> per Public Share, due to reductions
in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any
claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the
Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will
seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers (other than the Company&#8217;s independent registered public accounting firm), prospective target
businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest
or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had <span id="xdx_900_eus-gaap--Cash_iI_do_c20221231_zDFzDbHzZLW6" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> cash and a working capital of $<span id="xdx_90C_ecustom--WorkingCapital_iI_c20221231_zG0LxahHb8Kf" title="Working capital"><ix:nonFraction name="ATMC:WorkingCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,198</ix:nonFraction></span>, included deferred offering costs. The Company has incurred and expects to continue
to incur significant costs in pursuit of its acquisition plans. On January 4, 2023, the Company consummated its IPO and private placement
which generated gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJQDdIwPIQ61" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUk6W0nVvCsf" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,092,000</ix:nonFraction></span>, respectively, and effective January 9, 2023, the underwriters exercised
their over-allotment option which generated gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z5izBWxW3kvk" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>. Following the closing of the IPO, including the over-allotment,
the private placement, and after deducting IPO transaction costs, the Company placed $<span id="xdx_909_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkCkMZ34SWqk" title="Cash in trust accouint"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,242,000</ix:nonFraction></span> into the Trust Account and had $<span id="xdx_90E_eus-gaap--Cash_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4t44Adx5PXe" title="Cash in bank account"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,554</ix:nonFraction></span>
held in the Company&#8217;s bank account as of January 9, 2023, available for working capital needs as against estimated expenses of
$<span id="xdx_902_eus-gaap--CostsAndExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2JAe5888cz2" title="Estimated expenses"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-01-012022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> for the period of 12 months from December 31, 2022. The Company lacks the financial resources it needs to sustain operations
for a reasonable period of time. Moreover, management&#8217;s plans to consummate the initial business combination may not be successful.
These factors, among others, raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations, close of the Initial Public Offering, and/or
search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zx922vZfC8pk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2 - <span><span id="xdx_823_zWYxsGlLlZA">Significant Accounting Policies</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbmngyE7Cjr7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z60VHDt2Lb93">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ATMC:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_84B_ecustom--EmergingGrowthCompanyPolicyTextBlock_zRrRTJQFo32b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zFpluZUDTtD3">Emerging
Growth Company Status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statement with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84B_eus-gaap--UseOfEstimates_zDqkBD5msYhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zYCsX0hDpxai">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statement and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly
from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zfHZ1AcQEcOl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zP8x6Q82sxcf">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_z4a4e3wmGFt2" title="cash equivalents"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z9cW93xcMMyf" title="cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents as of December 31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXoSRwyU0zN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zb6cXwvwWMFj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zJSIrn656xRb" title="Cash, FDIC insured amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. At December 31, 2022 and 2021, the Company had not
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_zsY5TrDcTvzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zs2axKg6Mk2a">Deferred
Offering Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 340-10-S99-1. Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through
the balance sheet date that are directly related to the IPO and that will be charged to shareholder&#8217;s deficit upon the completion
of the IPO. As of December 31, 2022 and 2021, deferred offering costs amounted to $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20221231_zLTHn2ZSCN7g" title="Deferred offering costs"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">584,518</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_c20211231_zG4Yh5BxJVLg" title="Deferred offering costs"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">418,427</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zZ2slRtZX3E" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z9moRdOLfXsi">Net
Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share is computed by dividing net loss by the weighted average number of shares of Ordinary Shares outstanding during the period,
excluding shares of Ordinary Shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_903_ecustom--WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_c20220101__20221231_zW2wor7igUe6" title="Shares subject to forfeiture"><ix:nonFraction name="ATMC:WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span>
Ordinary Shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Notes 5 and 7).
At December 31, 2022 and 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of Ordinary Shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z3vfFR8mnCV6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zSeDxucQiQxi">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_ziprP58uhsLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zeEvAsVwkBG">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z2qlYezAyrve" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zYzVsFNchwLc" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized tax benefits and <span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zPjR4fc2Nwac" title="Accrued for interest and penalties"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_z8yIVe1iAIsl" title="Accrued for interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts accrued for interest and penalties as of December 31, 2022
and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material
deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7RkTwEXNu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8uGfbXCKYT">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85F_zVKztYoEIKP3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ATMC:InitialPublicOfferingDisclosureTextBlock"><p id="xdx_80F_ecustom--InitialPublicOfferingDisclosureTextBlock_zDxcqjxty9G" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3 &#8211; <span id="xdx_823_z517F6ZWPZpf">Initial Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company sold <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQpEh6gwZt14" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> Units, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zw5Z1F0qkO1c" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. On January 9, 2023, the Company issued an
additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pdd" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Units, at a purchase price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per unit, in connection with the over-allotment option. Each Unit consists of
one Ordinary Share, one Warrant and one Right, with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share
upon the completion of an initial business combination, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants will become exercisable at $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLU8HfBw68Nh" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustment, on the later of 30 days after the completion of the initial
Business Combination or 12 months from the closing of our Initial Public Offering and will expire at 5:00 p.m., New York City time, five years after
the completion of the initial business combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0" title="Sale of stock value issued"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">70,242,000</ix:nonFraction></span> (at $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.18</ix:nonFraction></span> per Unit) from the net proceeds of
the sale of the Units in the IPO and the sale of the Private Placement Units was placed in a Trust Account, which may only be invested
in U.S. &#8220;government securities&#8221;, within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity
of 180 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act, which
invest only in direct U.S. government treasury obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="ATMC:PrivatePlacementDisclosureTextBlock"><p id="xdx_804_ecustom--PrivatePlacementDisclosureTextBlock_zs9Z6tHIeq98" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4 - <span id="xdx_82A_zzzaKaaC2Hll">Private Placement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkLIY4wdNieg" title="Number of private units sold, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">370,500</ix:nonFraction></span> Private Placement Units at a price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pp0p0_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zyLC0gU75eRe" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement
Unit, for an aggregate purchase price of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zBqs88z8uA0e" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,705,000</ix:nonFraction></span>, in a private placement (the &#8220;Private Placement&#8221;). Each whole Private
Placement Unit will consist of one ordinary share, one warrant (&#8220;Private Warrant&#8221;) and one right (&#8220;Private Right&#8221;)
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of an initial business combination. Each
Private Warrant entitles the holder to purchase one ordinary share at a price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1UKw2E71FD7" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustment. The proceeds
from the Private Placement Units were added to the proceeds from the IPO held in the Trust Account. Effective January 9, 2023, the underwriters
fully exercised the over-allotment option and the Company completed the private sale of an aggregate of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPGqLoRiJpA5" title="Number of private units sold, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,700</ix:nonFraction></span> Private Placement Units
at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrxgTCxAKhtk" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit, generating gross proceeds of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpY2tm0B3Z4b" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">387,000</ix:nonFraction></span>. If the Company does not complete a Business Combination
within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units will expire worthless.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z5dU2JDERFy" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5 - <span id="xdx_82B_z3n1QKYVvSA5">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Sponsor received <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znDAeg3Bxqwa" title="Number of shares issued, sale of transactions"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> of the Company&#8217;s Class B ordinary shares in exchange for $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8rN9t9xbJY1" title="Sale of stock, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for deferred
offering costs borne by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes (see Note 7):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of the authorized but unissued <span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zaUbkw3txeLi" title="Common stock shares subject to forfeited"><ix:nonFraction name="ATMC:CommonStockSharesSubjectToForfeiture" contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> Class A ordinary shares were cancelled and re-designated as the ordinary shares of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zSJOorZaOsvf" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
par value each;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the <span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zvd87faaG2xl" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> Class B ordinary shares in issue were repurchased in consideration for the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zWHbX8XQtNJk" title="Issuance of ordinary shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> ordinary shares
of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8MjWzIIZ5hg" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value each; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon completion of the above steps, the authorized but unissued <span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlgCdE82JAYi" title="Common stock shares cancelled"><ix:nonFraction name="ATMC:CommonStockSharesSubjectToForfeiture" contextRef="AsOf2022-01-08_us-gaap_CommonStockMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> Class B ordinary shares were cancelled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the Company issued an additional <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zrihGGQwk3n7" title="Number of additional shares issued to sponsor"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-072022-01-08_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">287,500</ix:nonFraction></span> ordinary shares to the Sponsor for no additional consideration, resulting in
the Sponsor holding an aggregate of <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztYfxIFmY8B9" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-01-08_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> ordinary shares (the &#8220;Founder Shares&#8221;). The issuance was considered as a bonus
share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include
an aggregate of up to <span id="xdx_909_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYGGRFA6656b" title="Common stock shares subject to forfeiture"><ix:nonFraction name="ATMC:CommonStockSharesSubjectToForfeiture" contextRef="AsOf2022-01-08_srt_MaximumMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction></span> ordinary shares subject to forfeiture to the extent that the underwriters&#8217; over-allotment is not
exercised in full or in part (refer Note 7). On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment
option with respect to the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdZzUUwxfsjg" title="Number of additional units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the
Company of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZREcAhOVrad" title="Number of additional units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>. Simultaneously, an amount of $<span id="xdx_90D_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zzTrIw4uTRpj" title="Due to related party amount converted"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,350</ix:nonFraction></span> due to related party was converted into over-allotment of Private Placement,
and the underwriter deposited additional $<span id="xdx_90A_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUorjUNeSAmi" title="Additional amount deposited by underwriter on behalf of related party"><ix:nonFraction name="ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,650</ix:nonFraction></span> on behalf of Sponsor for <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zqVQ0fnT8Vkb" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,325</ix:nonFraction></span> Founder Shares for $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zq1gPSUm4L6f" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2</ix:nonFraction></span> per share which was sold by the
Sponsor to underwriters. As a result, the Sponsor purchased additional <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zbtx9GQmNtNj" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,700</ix:nonFraction></span> Private Placement Units, an aggregate of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSoyuHZck8lc" title="Aggregate number of units issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">409,200</ix:nonFraction></span> units
at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7M3kMhWSsj1" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit (an aggregate of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaTzfua0yVqi" title="Aggregate value of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,092,000</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2023, the Founder Shares and Private Placement Units were placed into an escrow account maintained
by American Stock Transfer &amp; Trust Company acting as escrow agent. <span id="xdx_900_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230102__20230103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zX2fzeWfN07k" title="Description of sale of shares"><ix:nonNumeric contextRef="From2023-01-022023-01-03_us-gaap_SubsequentEventMember" name="us-gaap:SaleOfStockDescriptionOfTransaction">The Founder Shares and Private Placement Units (and underlying
securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of
the Founder Shares and Private Placement Units (and underlying securities) until the earlier to occur of: (A) six months after the date
of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or
exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days
within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and
Private Placement Units (and underlying securities) until six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities
or other property</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note&#8201;&#8212;&#8201;Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z9OmLcjoc6Kb" title="Loan amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-09-30_custom_PromissoryNoteMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>. <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20210929__20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z01MrAeg7wHg" title="Description of maturity date"><ix:nonNumeric contextRef="From2021-09-292021-09-30_custom_PromissoryNoteMember" name="us-gaap:DebtInstrumentMaturityDateDescription">The Promissory Note was amended and restated on November 23,
2021, to change the December 31, 2021 due date to March 31, 2022, amended and restated on January 26, 2022 to change the March 31, 2022
due date to May 31, 2022 and amended and restated again on October 20, 2022 to change the May 31, 2022 due date to December 31, 2022.
The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, or (ii) the consummation of the Initial
Public Offering. As of December 31, 2022 and 2021, there were no amounts outstanding under the Promissory Note and Promissory Note has
expired on December 31, 2022</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
to Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest
bearing. As of December 31, 2022 and 2021, due to related party amounted to $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_c20221231_zrZCTI1bK0Xj" title="Due to related party"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">380,566</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231_zNv299jOhxVg" title="Due to related party"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">291,930</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advisory
Services Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged TenX Global Capital LP (&#8220;TenX&#8221;), a related party to the Company, as an advisor in connection with the Initial
Public Offering and business combination, to assist in hiring consultants and other services providers in connection with our Initial Public Offering
and the business combination, assist in the preparation of financial statements and other relevant services to commence trading including
filing the necessary documents as part of the transaction. Further, TenX will assist in preparing the Company for investor presentations,
conferences for due diligence, deal structuring and term negotiations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period from September 15, 2021 (inception) through December 31, 2022, a cash fee of $<span id="xdx_908_ecustom--CashFee_c20210915__20221231_zxqU0XYU1me8" title="Cash Fee"><ix:nonFraction name="ATMC:CashFee" contextRef="From2021-09-152022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span> has been incurred as deferred offering
costs for these services of which $<span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_c20211231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zdSyUGgOIwYa"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2021-12-31_us-gaap_ServiceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,000</ix:nonFraction></span> has been paid by the Sponsor through December 31, 2021 and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20221231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zGt6r0SWw7vl"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2022-12-31_us-gaap_ServiceMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span> was recorded as accrued
offering costs as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administration
fee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effective date of the registration statement, an affiliate of the Sponsor shall be allowed to charge the Company an allocable
share of its overhead, up to $<span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zfU9b4k4sIUf" title="Sponsor fees"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2022-01-012022-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span> per month up to the close of the business combination, to compensate it for the Company&#8217;s
use of its offices, utilities and personnel. An administration fee of $<span id="xdx_901_eus-gaap--AdministrativeFeesExpense_c20220101__20221231_zllGKUOW3Vl4" title="Administration fee"><ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">667</ix:nonFraction></span> was recorded for the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcucOtTdAkWh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6 - <span id="xdx_827_zOV3NwJXR0N7">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (&#8220;UPO&#8221;), and Units
that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement
Units) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective
date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be
entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition,
the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion
of a business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities
Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or
cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriters
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters had a 45-day option beginning January 4, 2023, to purchase up to an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_za8E9225IMwj" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-022023-01-04_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> units to cover over-allotments, if
any, at the IPO price less the underwriting discounts and commissions. On January 6, 2023 and effective January 9, 2023, the underwriters
exercised their over-allotment option in full and purchased an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJLIYrEFti4j" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> units at $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zSKl8nFFJ3il" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company paid a fixed underwriting discount of $<span id="xdx_90E_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXZ3GSmT73yc" title="Underwriting discount"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-01-022023-01-04_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500,000</ix:nonFraction></span> and on January 9, 2023, it paid an additional $<span id="xdx_902_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1ORtPk35jN8" title="Underwriting discount"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2023-01-082023-01-09_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,500</ix:nonFraction></span>
of underwriting fees arising from the sale of the over-allotment units. The underwriters will be entitled to a deferred commission of
$<span id="xdx_902_eus-gaap--SharePrice_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zXPv2m7LoUHl" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span> per Unit, or $<span id="xdx_904_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zIoJIcb4TQre" title="Deferred underwriting commission"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span> in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the
Trust Account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unit
Purchase Option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2022, we sold to the underwriters, for $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zWwlAa2DTbJ3" title="Sale of price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2022-12-30_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">100.00</ix:nonFraction></span>, <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221229__20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_z7wyzrFQgawl" title="Number of stock exercisable, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-12-292022-12-30_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,000</ix:nonFraction></span> Units exercisable, in whole or in part, at $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zbhJFntbZw4j" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-30_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per unit (or
115% of the Market Value), commencing on the consummation of our initial business combination, and expires five years from the
effective date of our Initial Public Offering. <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20221229__20221230_zvnUFGeDQIpk" title="Option description"><ix:nonNumeric contextRef="From2022-12-292022-12-30" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">The option and the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20221229__20221230_z32hclBc0oGl" title="Number of units option exercised, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-12-292022-12-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,000</ix:nonFraction></span> Units, as well as the <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221229__20221230_zyyigFdZ2SZc" title="Number of ordinary shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-12-292022-12-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,000</ix:nonFraction> </span>ordinary shares, the warrants
to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20221230_zAFv1B5pvFw7" title="Warrants to purchase common shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2022-12-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,000</ix:nonFraction></span> ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares
upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a
lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule
5110(e)(1) of FINRA&#8217;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or
be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ztFxLxd9UZ76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7 - <span id="xdx_827_zK0FPKsTbAO1">Shareholder&#8217;s Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
shares </i></b>- The Company is authorized to issue <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zSI1It1Ygfej" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of preferred shares with a par value of $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zp32chfvoh9h" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
As of December 31, 2022, there were <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zg5apCfhuqmf" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zK43BmZypYzb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRIAX8Bl9TGf" title="Commo stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> Class A ordinary shares with a par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDcj2mBIgRDk" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share and <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zxd4grT4i6t7" title="Commo stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> Class B ordinary
shares with a par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8EnvECw90ic" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. <span id="xdx_904_eus-gaap--CommonStockVotingRights_c20220101__20221231_ziGgjSdHS4A6" title="Common stock voting rights"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="us-gaap:CommonStockVotingRights">Holders of Class A and Class B ordinary shares were entitled to one vote for each share</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Sponsor received <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXDTdn2Mqqbj" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> of the Company&#8217;s Class B ordinary shares in exchange for $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zePKbbTEnHdg" title="Number of shares issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> paid for deferred
offering costs borne by the Sponsor. Out of the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsAUs5PlN7Kg" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> Class B ordinary shares, an aggregate of up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210927__20210928__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVSUUk2vVn26" title="Number of shares forfeitured"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-09-272021-09-28_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,500</ix:nonFraction></span> Class B ordinary shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment option is not exercised in full or in part so that
the number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the Initial Public Offering
(excluding private placement shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of the authorized but unissued <span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z54daZiJ1312" title="Common stock shares subject to forfeited"><ix:nonFraction name="ATMC:CommonStockSharesSubjectToForfeiture" contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> Class A ordinary shares were cancelled and re-designated as the ordinary shares of $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqDsLlMrUfgd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
par value each;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziajJ0Evw8y8" title="Number of shares in issue were repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> Class B ordinary shares in issue were repurchased in consideration for the issuance of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8SQzHUvOpm2" title="Issuance of ordinary shares to sponsor"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,437,500</ix:nonFraction></span> ordinary shares
of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zkoQwTkp7nmc" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value each; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon completion of the above steps, the authorized but unissued <span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwJSIkSwwdTc" title="Common stock shares subject to forfeited"><ix:nonFraction name="ATMC:CommonStockSharesSubjectToForfeiture" contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> Class B ordinary shares were cancelled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an effect of the above, the Company is authorized to issue <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220108_ziBTI2ut9tta" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-01-08" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> ordinary shares with a par value of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108_zOtkqdo7FWgj" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-01-08" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20220107__20220108_zFNUkZgfWXgj" title="Common stock voting rights"><ix:nonNumeric contextRef="From2022-01-072022-01-08" name="us-gaap:CommonStockVotingRights">Holders
of ordinary shares are entitled to one vote for each share</ix:nonNumeric></span>. Further, the shareholder also approved the amendment and restatement of the
memorandum and articles of association filed with the Cayman Registrar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the Company issued an additional <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zpODIsKTgqJj" title="Number of additional shares issued to sponsor"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-072022-01-08_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">287,500</ix:nonFraction></span> ordinary shares to the Sponsor as fully paid bonus shares for no additional
consideration. The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded
and presented retroactively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and 2021, there were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zFEPk3iHf5sj" title="Common stock shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z8q4pMVvrsph" title="Common stock shares outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zngRiHJW3kid" title="Common stock shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziTi8CZO9ODf" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> ordinary shares issued and outstanding, Concurrent with the closing of this offering, our Sponsor, at the option of the Company,
sold to underwriter or its designees <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231_z9bu2SJFh566" title="Sale of stock shares issued"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">115,500</ix:nonFraction></span> Founder Shares for a purchase price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20221231_zbclwyN8msW9"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span> per share and an aggregate purchase price of
$<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220101__20221231_zAPID0AEMdaa" title="Sale of stock value issued"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">231,000</ix:nonFraction></span>, as part of the exercise of overallotment option by the underwriter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company converted an amount of $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zjiM7eQf7tT3" title="Due to related party amount converted"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,350</ix:nonFraction></span> into over-allotment of Private Placement Units (see note 8). The
Company had accounted for these proceeds received as of December 31, 2022, as Due to related party, pending final allotment to the
Sponsor. On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to
the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBJ7R99GQ7E2" title="Number of additional units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of
$<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKRIbeyAs4ki" title="Gross proceeds from exercise of option"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zGANXJEq1Aa2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8 - <span id="xdx_829_z0qEpeQFT2s1">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through March 23, 2023, which was the date these financial statements were available for issuance
and determined that there were no significant unrecognized events through that date other than those noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 4, 2023, the Company consummated the IPO of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxj0xmVw6ced" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> units at a price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpNUpB0eEu6" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
                                            per Unit, generating gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBYTgo6kMR5" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000,000</ix:nonFraction></span>. Simultaneously with the
                                            closing of the IPO, the Company completed the sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zZwSKZyZMYG6" title="Number of private units sold, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">370,500</ix:nonFraction></span> private units to the Sponsor
                                            at a purchase price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zw9Vdm5UOUT4" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Unit, generating gross proceeds to the Company
                                            of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zTLVUfOfaGYg" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,705,000</ix:nonFraction> </span>(See Notes 1, 3 and 4)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 5, 2023, from cash held in escrow account with amount of $<span id="xdx_904_eus-gaap--EscrowDeposit_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8Mds7xSxBUd" title="Cash held in escrow"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">779,034</ix:nonFraction></span>, $<span id="xdx_90B_ecustom--WorkingCapital_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy2nXe7VZCc5" title="Working capital"><ix:nonFraction name="ATMC:WorkingCapital" contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">485,054</ix:nonFraction></span> has been
                                            wired to the Company&#8217;s bank account for working capital purposes, within which $<span id="xdx_90C_ecustom--VendorsOutstandingBalances_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYrPn1ZNDs0b" title="Vendors outstanding balances"><ix:nonFraction name="ATMC:VendorsOutstandingBalances" contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,681</ix:nonFraction></span>
                                            was pending to distribute to vendors and $<span id="xdx_90B_ecustom--OutstandingBalancesTransferred_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUrBhgszZMrk" title="Outstanding balances transferred"><ix:nonFraction name="ATMC:OutstandingBalancesTransferred" contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293,980</ix:nonFraction></span> has been transferred to the vendors against
                                            their outstanding balances.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zn7TQcAs2FTh" title="Issuance of share to sponsor, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span>
    additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3YRVh5FGiPc" title="Proceeds from sale of units"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,000,000</ix:nonFraction></span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously,
an amount of $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z2Cm7xOIpZd3" title="Due to related party amount converted"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,350</ix:nonFraction></span> due to related party was converted into over-allotment of Private Placement, and the underwriter deposited additional
$<span id="xdx_900_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWkaBSgsTlN3" title="Additional amount deposited by underwriter on behalf of related party"><ix:nonFraction name="ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,650</ix:nonFraction></span> on behalf of Sponsor for <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziPB733MYWD5" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,325</ix:nonFraction></span> Founder Shares for $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zmtz6yNGg0X2" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2</ix:nonFraction></span> per share which was sold by the Sponsor to underwriters. As a result, the
Sponsor purchased additional <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztvtjjsB0655" title="Sale of stock number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,700</ix:nonFraction></span> Private Placement Units, an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zor0xLGNQ60i" title="Aggregate number of units issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">409,200</ix:nonFraction></span> units at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnHQWppSGS9" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement
Unit (an aggregate of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAuaRC8y7QI1" title="Aggregate value of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,092,000</ix:nonFraction></span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company paid a cash underwriting commission of $<span id="xdx_905_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPnJ8uHwIxdi" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.125</ix:nonFraction></span> per Unit for <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzdJBtgVOuC1" title="Number of additional units"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> additional Units and the underwriters will be entitled to
a deferred commission of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zHY9FJsKplMf" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span> per Unit, an aggregate of $<span id="xdx_906_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zDUwEEW32JL7" title="Deferred underwriting commission"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span>, which will be paid from the funds held in the Trust Account upon
completion of Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 9, 2023, an additional $<span id="xdx_90F_ecustom--WorkingCapital_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5sCopN0fG7l" title="Working capital"><ix:nonFraction name="ATMC:WorkingCapital" contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,500</ix:nonFraction></span> was wired to the Company&#8217;s bank account for
                                            working capital purposes.</span></td></tr></table>

</ix:nonNumeric><p id="xdx_811_z9KuFm8BUXNd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 109; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>2
<FILENAME>ex4-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.7</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our amended and restated memorandum and articles of association, our authorized share capital consists of 200,000,000 ordinary shares,
$0.0001 par value and 1,000,000 undesignated preferred shares, $0.0001 par value. The following description summarizes the material terms
of our shares. Because it is only a summary, it may not contain all the information that is important to you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Units
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
unit has an offering price of $10.00 and consists of one ordinary share, one redeemable warrant and one right entitling the holder thereof
to receive one-tenth of one ordinary share upon the completion of an initial business combination. We will not issue fractional shares
and only whole shares will trade, so unless you purchase units in multiple of tens, you will not be able to receive or trade the fractional
shares underlying the rights. Each whole warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per
share, subject to adjustment as described in this Form 10-K. Pursuant to the warrant agreement, a warrant holder may exercise its warrants
only for a whole number of ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ordinary shares, warrants and rights comprising the units will began separate trading on January 19, 2023. Holders have the option to
continue to hold units or separate their units into the component securities. Holders must have their brokers contact our transfer agent
in order to separate the units into ordinary shares, warrants and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
Units Sold in the Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
certain limited exceptions, the private units are subject to certain transfer restrictions. Otherwise, the private units have terms and
provisions that are identical to the units sold in our Initial Public Offering except as described under &ldquo;&mdash;Redeemable Warrants&mdash;Private
Warrants&rdquo; and &ldquo;&mdash;Rights&mdash;Private Rights&rdquo; below. The price of the private units was determined in negotiations
between our founders and the underwriter for our Initial Public Offering, with reference to the prices paid by initial shareholders for
such private units in special purpose acquisition companies, which have recently consummated their initial public offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of the ordinary
shares and holders of record of founder shares will vote together as a single class on all matters submitted to a vote of our shareholders.
Unless specified in our amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies
Act or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve
any such matter voted on by our shareholders. Approval of certain actions will require a special resolutions, which is passed by the
affirmative vote of two-thirds of our ordinary shares that are voted. Our board of directors will be divided into three classes, each
of which will generally serve for a term of three years with only one class of directors being elected in each year. There is no cumulative
voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election
of directors can elect all of the directors. Our shareholders are entitled to receive ratable dividends when, as and if declared by the
board of directors out of funds legally available therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our amended and restated memorandum and articles of association authorizes the issuance of up to 200,000,000 ordinary shares, if we were
to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number
of ordinary shares which we are authorized to issue at the same time as our shareholders vote on the business combination to the extent
we seek shareholder approval in connection with our business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with NASDAQ corporate governance requirements, we are not required to hold an annual meeting until no later than one year
after our first fiscal year end following our listing on NASDAQ. There is no requirement under the Companies Act for us to hold annual
general meetings to appoint directors. Until we hold an annual general meeting, public shareholders may not be afforded the opportunity
to discuss company affairs with management. Our board of directors is divided into three classes with only one class of directors being
appointed in each year and each class (except for those directors appointed prior to our first annual general meeting) serving a three-year
term. Accordingly, you may not have any say in the management of our company prior to the consummation of an initial business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our
initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account
as of two business days prior to the consummation of our initial business combination including interest earned on the funds held in
the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares, subject
to the limitations described herein. The amount in the trust account is initially anticipated to be approximately $10.18 per public share.
The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by deferred underwriting commissions
we will pay to the underwriters. Our initial shareholders have entered into a letter agreement with us, pursuant to which they have agreed
to waive their redemption rights with respect to any founder shares, private shares and any public shares held by them in connection
with the completion of our business combination. Unlike many blank check companies that hold shareholder votes and conduct proxy solicitations
in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon completion
of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by law and we do
not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our amended and restated memorandum and
articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with
the SEC prior to completing our initial business combination. Our amended and restated memorandum and articles of association will require
these tender offer documents to contain substantially the same financial and other information about the initial business combination
and the redemption rights as is required under the SEC&rsquo;s proxy rules. If, however, shareholder approval of the transaction is required
by law, or we decide to obtain shareholder approval for business or other legal reasons, we will, like many blank check companies, offer
to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If
we seek shareholder approval, we will complete our initial business combination only if a majority of the outstanding ordinary shares
voted are voted in favor of the business combination. A quorum for such meeting will consist of the holders present in person or by proxy
of outstanding share of the company representing a majority of the voting power of all outstanding shares of the company entitled to
vote at such meeting. However, the participation of our founders or their affiliates in privately-negotiated transactions (as described
in this Form 10-K), if any, could result in the approval of our business combination even if a majority of our public shareholders vote,
or indicate their intention to vote, against such business combination. For purposes of seeking approval of the majority of our outstanding
ordinary shares voted, non-votes will have no effect on the approval of our business combination once a quorum is obtained. We intend
to give approximately 30 days (but not less than 10 days nor more than 60 days) prior written notice of any such meeting, if required,
at which a vote shall be taken to approve our business combination. These quorum and voting thresholds, and the voting agreements of
our initial shareholders, may make it more likely that we will consummate our initial business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination
pursuant to the tender offer rules, our amended and restated memorandum and articles of association provides that a public shareholder,
together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &ldquo;group&rdquo;
(as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate
of 15% of the ordinary shares sold in our Initial Public Offering, which we refer to as the Excess Shares. However, we would not be restricting
our shareholders&rsquo; ability to vote all of their shares (including Excess Shares) for or against our business combination. Our shareholders&rsquo;
inability to redeem the Excess Shares will reduce their influence over our ability to complete our business combination, and such shareholders
could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such shareholders
will not receive redemption distributions with respect to the Excess Shares if we complete the business combination. And, as a result,
such shareholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to
sell their share in open market transactions, potentially at a loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we seek shareholder approval in connection with our business combination, our initial shareholders have agreed to vote their founder
shares and private shares as well as any public shares purchased during or after our Initial Public Offering in favor of our initial
business combination. As a result, in addition to our initial shareholders&rsquo; founder shares, we would need 2,515,726, or 36.5%,
of the 6,900,000 public shares sold in our Initial Public Offering to be voted in favor of an initial business combination in order to
have our initial business combination approved (assuming all outstanding shares are voted). Additionally, each public shareholder may
elect to redeem its public shares irrespective of whether it votes for or against the proposed transaction (subject to the limitation
described in the preceding paragraph).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our amended and restated memorandum and articles of association, if we are unable to complete our business combination within 9 months
(or up to 18 months at our sponsor&rsquo;s option, as described herein) from the closing of our Initial Public Offering, we will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days
thereafter subject to lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously
released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
public shares, which redemption will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to
receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of our remaining shareholders and our board of directors, dissolve and liquidate, subject in
each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Our initial shareholders have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder
shares and private shares held by them if we fail to complete our business combination within 9 months from the closing of our Initial
Public Offering (or up to 18 months at our sponsor&rsquo;s option).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we anticipate that we may not be able to consummate our initial business combination within 9 months, we may, by resolution of our Board
of Directors, if requested by our sponsor, extend the period of time we will have to consummate an initial business combination up to
three times, each by an additional three months (for a total of up to 18 months from the closing of our Initial Public Offering), provided
that, pursuant to the terms of our amended and restated memorandum and articles of association and the trust agreement to be entered
into between us and American Stock Transfer &amp; Trust Company on December 30, 2022, in order for the time available for us to consummate
our initial business combination to be extended, our sponsor or their affiliates or designees, upon five days&rsquo; advance notice prior
to the applicable deadline, must deposit into the trust account $690,000 (or $0.10 per share) for each extension, on or prior to the
date of the applicable deadline. Our public shareholders will not be entitled to vote or redeem their shares in connection with any such
extension.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that our sponsor elects to extend the time to complete a business combination, pay the additional amounts per each extension,
and deposit the applicable amount of money into trust, the sponsor will receive a non-interest bearing, unsecured promissory note equal
to the amount of any such deposit and payment that will not be repaid in the event that we are unable to close a business combination
unless there are funds available outside the trust account to do so. In the event that we receive notice from our sponsor five days prior
to the applicable deadline of their intent to effect an extension, we intend to issue a press release announcing such intention at least
three days prior to the applicable deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing
whether or not the funds had been timely deposited. Our sponsor and its affiliates or designees are not obligated to fund the trust account
to extend the time for us to complete our initial business combination. To the extent that some, but not all, of our sponsor&rsquo;s
affiliates or designees, decide to extend the period of time to consummate our initial business combination, such affiliates or designees
may deposit the entire amount required. If we are unable to consummate our initial business combination within such time period, we will,
as promptly as possible but not more than 10 business days thereafter, redeem 100% of our outstanding public shares for a pro rata portion
of the funds held in the trust account, including a pro rata portion of any interest earned on the funds held in the trust account and
not previously released to us to pay our taxes, and then seek to dissolve and liquidate. However, we may not be able to distribute such
amounts as a result of claims of creditors which may take priority over the claims of our public shareholders. In the event of our dissolution
and liquidation, the private units will expire and be worthless.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our founders acquire public shares in or after our Initial Public Offering, they will be entitled to liquidating distributions from the
trust account with respect to such public shares if we fail to complete our business combination within the prescribed time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a liquidation, dissolution or winding up of the company after a business combination, our shareholders are entitled to share
ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each
class of share, if any, having preference over the ordinary shares. Our shareholders have no pre-emptive or other subscription rights.
There are no sinking fund provisions applicable to the ordinary shares, except that we will provide our public shareholders with the
opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust
account, upon the completion of our initial business combination, subject to the limitations described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Founder
Shares and Private Shares underlying the Private Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below, the founder shares and private shares are identical to the ordinary shares included in the units being sold in our
Initial Public Offering, and holders of founder shares have the same shareholder rights as public shareholders, except that (i) the founder
shares and private shares are subject to certain transfer restrictions, as described under &ldquo;&mdash;Transfer Restrictions on Founder
Shares and Private Units&rdquo; below; (ii) our initial shareholders have entered into a letter agreement with us, pursuant to which
they have agreed (A) to waive their redemption rights with respect to any founder shares, private shares and any public shares held by
them in connection with the completion of our initial business combination, (B) to waive their redemption rights with respect to their
founder shares, private shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated
memorandum and articles of association to (a) modify the substance or timing of our obligation to provide for the redemption of our public
shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business
combination within 9 months from the closing of our Initial Public Offering (or up to 18 months, if we extend the time to complete a
business combination as described in our Registration Statement) or (b) with respect to any other material provisions relating to shareholders&rsquo;
rights or pre-initial business combination activity, and (C) to waive their rights to liquidating distributions from the trust account
with respect to any founder shares held by them if we fail to complete our initial business combination within 9 months from the closing
of our Initial Public Offering (or up to 18 months, if we extend the time to complete a business combination as described in our Registration
Statement), although they will be entitled to liquidating distributions from the trust account with respect to any public shares they
hold if we fail to complete our initial business combination within such time period; and (iii) are entitled to registration rights.
If we submit our initial business combination to our public shareholders for a vote, our initial shareholders have agreed (and their
permitted transferees will agree) pursuant to the letter agreement to vote any founder shares and private shares held by them and any
public shares purchased during or after tour Initial Public Offering (including in open market and privately-negotiated transactions)
in favor of our initial business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Restrictions on Founder Shares and Private Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2023, the founder shares and private units were placed into an escrow account maintained by American Stock Transfer &amp;
Trust Company acting as escrow agent. The founder shares and private units (and underlying securities) will not, subject to certain exceptions,
be transferred, assigned, sold or released from escrow in the case of (i) 50% of the founder shares and private units (and underlying
securities) until the earlier to occur of: (A) six months after the date of the consummation of our initial business combination, or
(B) the date on which the closing price of our ordinary shares equals or exceeds $12.50 per share (as adjusted for share splits, share
dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after our initial
business combination and (ii) the remaining 50% of the founder shares and private units (and underlying securities) until six months
after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business
combination, we consummate a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of our
shareholders having the right to exchange their shares for cash, securities or other property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Register
of Members</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, we must keep a register of members and there will be entered therein:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    names and addresses of the members, a statement of the shares held by each member (which shall distinguish each share by its number
    (so long as the share has a number); confirm the amount paid or agreed to be considered as paid, confirm the number and category
    of each member and the voting rights of such shares (and whether such voting rights are conditional);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which the name of any person was entered on the register as a member; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date on which any person ceased to be a member.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, the register of members of our company is prima facie evidence of the matters set out therein (i.e., the register
of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register
of members will be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register
of members. Upon the closing of this public offering, the register of members will be immediately updated to reflect the issue of shares
by us. Once our register of members has been updated, the shareholders recorded in the register of members will be deemed to have legal
title to the shares set against their name. However, there are certain limited circumstances where an application may be made to a Cayman
Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands
court has the power to order that the register of members maintained by a company should be rectified where it considers that the register
of members does not reflect the correct legal position. If an application for an order for rectification of the register of members were
made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated memorandum and articles of association provides that preferred shares may be issued from time to time in one or
more series. Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative,
participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares
of each series. Our board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights
that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects.
The ability of our board of directors to issue preferred shares without shareholder approval could have the effect of delaying, deferring
or preventing a change of control of us or the removal of existing management. We have no preferred shares outstanding at the date hereof.
Although we do not currently intend to issue any preferred shares, we cannot assure you that we will not do so in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redeemable
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Public
Shareholders&rsquo; Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
whole warrant entitles the registered holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as
discussed below, at any time commencing 30 days after the completion of our initial business combination. Pursuant to the warrant agreement,
a warrant holder may exercise its warrants only for a whole number of ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
warrants will be exercisable for cash unless we have an effective and current registration statement covering the ordinary shares issuable
upon exercise of the warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration
statement covering the ordinary shares issuable upon exercise of the public warrants is not effective within a specified period following
the consummation of our initial business combination, warrant holders may, until such time as there is an effective registration statement
and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis
pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption,
or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. In the event of such
cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of ordinary shares equal to
the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference
between the exercise price of the warrants and the &ldquo;fair market value&rdquo; (defined below) by (y) the fair market value. The
&ldquo;fair market value&rdquo; for this purpose will mean the average reported last sale price of the ordinary shares for the 10 trading
days ending on the third trading day prior to the date on which the notice of exercise is sent to the warrant agent. The warrants will
expire on the fifth anniversary of our completion of an initial business combination, at 5:00 p.m., New York City time, or earlier upon
redemption or liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    any time after the warrants become exercisable,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    not less than 30 days&rsquo; prior written notice of redemption to each warrant holder,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share (as adjusted for share splits,
    share dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any
    time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
    and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and
after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder&rsquo;s
warrant upon surrender of such warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium
to the initial exercise price and provide a sufficient differential between the then- prevailing share price and the warrant exercise
price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below
the exercise price of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we call the warrants for redemption as described above, our management will have the option to require all holders that wish to exercise
warrants to do so on a &ldquo;cashless basis.&rdquo; In such event, each holder would pay the exercise price by surrendering the warrants
for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying
the warrants, multiplied by the difference between the exercise price of the warrants and the &ldquo;fair market value&rdquo; (defined
below) by (y) the fair market value. The &ldquo;fair market value&rdquo; for this purpose shall mean the average reported last sale price
of the shares of ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to
the holders of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants will be issued in registered form under a warrant agreement between American Stock Transfer &amp; Trust Company, as warrant
agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder (i) to
cure any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms
of the warrants and the warrant agreement set forth in this Form 10-K, or to cure, correct or supplement any defective provision, or
(ii) to add or change any other provisions with respect to matters or questions arising under the warrant agreement as the parties to
the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the interests of the registered
holders of the warrants. The warrant agreement requires the approval, by written consent or vote, of the holders of at least a majority
of the then outstanding public warrants in order to make any change that adversely affects the interests of the registered holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances as described
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the number of outstanding ordinary shares is increased by a share dividend payable in ordinary shares, or by a split-up of ordinary shares
or other similar event, then, on the effective date of such capitalization or share dividend, split-up or similar event, the number of
ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares.
If the number of outstanding ordinary shares is decreased by a consolidation, combination, reverse share subdivision or reclassification
of ordinary shares or other similar event, then, on the effective date of such consolidation, combination, reverse share sub-division,
reclassification or similar event, the number of ordinary shares issuable on exercise of each warrant will be decreased in proportion
to such decrease in outstanding ordinary shares. Whenever the number of ordinary shares purchasable upon the exercise of the warrants
is adjusted as described in this paragraph, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately
prior to such adjustment by a fraction (x) the numerator of which will be the number of ordinary shares purchasable upon the exercise
of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of ordinary shares so purchasable
immediately thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities
or other assets to all or substantially all of the holders of the ordinary shares or other securities into which the warrants are convertible,
then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash
and/or the fair market value of any securities or other assets in respect of such event divided by all outstanding shares of the company
at such time (whether or not any shareholders waived their right to receive such dividend). The foregoing adjustment shall not apply
to any of the following: (a) any adjustment described in the <U>preceding paragraph</U>, (b) any cash dividends or cash distributions
which, when combined on a per share basis with all other cash dividends and cash distributions paid on the ordinary shares during the
365- day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (taking into account
all of the outstanding shares of the company at such time (whether or not any shareholders waived their right to receive such dividend)
and as adjusted to appropriately reflect any of the other events requiring adjustment to the exercise price of the warrant pursuant to
the warrant agreement and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price of the
warrant or to the number ordinary shares issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash
dividends or cash distributions equal to or less than $0.50, (c) any payment to satisfy the conversion rights of the holders of the ordinary
shares in connection with a proposed initial business combination or certain amendments to the company&rsquo;s Amended and Restated Certificate
of Incorporation (as described in the Registration Statement) or (d) any payment in connection with the company&rsquo;s liquidation and
the distribution of its assets upon its failure to consummate a business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case of any reclassification or reorganization of the outstanding ordinary shares (other than those described above or that solely affects
the par value of such ordinary shares), or in the case of any merger or consolidation of us with or into another corporation (other than
a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization
of our outstanding ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other
property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants
will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and
in lieu of the ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby,
the kind and amount of ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received
if such holder had exercised their warrants immediately prior to such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the
closing of our initial business combination at a Newly Issued Price of less than $9.50 per ordinary share (with such issue price or effective
issue price to be determined in good faith by our board of directors, and in the case of any such issuance to our sponsor, initial shareholders
or their affiliates, without taking into account any founder shares held by them prior to such issuance), (y) the aggregate gross proceeds
from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial
business combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the Market Value
is below $9.50 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater
of (i) the Market Value or (ii) the Newly Issued Price, and the $16.50 per share redemption trigger price of the warrants will be adjusted
(to the nearest cent) to be equal to 165% of (i) the Market Value or (ii) the Newly Issued Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant
agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full
payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised. The warrant
holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and
receive ordinary shares. After the issuance of ordinary shares upon exercise of the warrants, each holder will be entitled to one vote
for each share held of record on all matters to be voted on by shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
holders may elect to be subject to a restriction on the exercise of their warrants such that an electing warrant holder would not be
able to exercise their warrants to the extent that, after giving effect to such exercise, such holder would beneficially own in excess
of 9.8% of the ordinary shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive
a fractional interest in a share, we will, upon exercise, round up to the nearest whole number the number of ordinary shares to be issued
to the warrant holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the
warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will
be the exclusive forum for any such action, proceeding or claim. This exclusive forum provision shall not apply to suits brought to enforce
a duty or liability created by the Exchange Act, any other claim for which the federal district courts of the United States of America
are the sole and exclusive forum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Private
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
private warrants included in the private units have terms and provisions that are identical to those of the warrants sold as part of
the units in our Initial Public Offering except the warrants included in the private units will be non-redeemable and may be exercised
on a cashless basis, in each case so long as they continue to be held by the sponsor its permitted transferees. If the private warrants
included in the private units are held by holders other than our sponsor or its permitted transferees, the private warrants will be redeemable
by us and exercisable by the holders on the same basis as the warrants included in the units sold in our Initial Public Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
private warrants included in the private units (including the ordinary shares issuable upon exercise of the private warrants) are subject
to certain transfer restrictions, as described in more detail under &ldquo;&mdash;Transfer Restrictions on Founder Shares and Private
Units&rdquo; above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Public
Rights </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in cases where we are not the surviving company in a business combination, each holder of a right will automatically receive one-tenth
(1/10) of one ordinary share upon consummation of our initial business combination, even if the holder of a public right converted all
ordinary shares held by him, her or it in connection with the initial business combination or an amendment to our amended and restated
memorandum and articles of association with respect to our pre-initial business combination activities. In the event we will not be the
surviving company upon completion of our initial business combination, each holder of a right will be required to affirmatively convert
his, her or its rights in order to receive the one-tenth (1/10) of one ordinary share underlying each right upon consummation of the
business combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its
additional ordinary shares upon consummation of an initial business combination. The ordinary shares issuable upon conversion of the
rights will be freely tradable (except to the extent held by affiliates of ours). If we enter into a definitive agreement for a business
combination in which we will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive
the same consideration per ordinary share the holders of the ordinary shares will receive in the transaction on an as-converted into
ordinary shares basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not issue fractional ordinary shares in connection with an exchange of rights. Fractional shares will either be rounded down to
the nearest whole share. As a result, you must hold rights in multiples of ten in order to receive ordinary shares for all of your rights
upon closing of a business combination. If we are unable to complete an initial business combination within the required time period
and we liquidate the funds held in the trust account, holders of rights will not receive any of such funds with respect to their rights,
nor will they receive any distribution from our assets held outside of the trust account with respect to such rights, and the rights
will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon
consummation of an initial business combination. Additionally, in no event will we be required to net cash settle the rights. Accordingly,
the rights may expire worthless.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Private
Rights </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
private rights have terms and provisions that are identical to those of the rights sold as part of the units in our Initial Public Offering,
except that the private rights (including the ordinary shares issuable upon conversion of the rights) will not be transferable, assignable,
or salable until the completion of our initial business combination (except as described herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of a
business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements
and general financial conditions subsequent to completion of a business combination. The payment of any cash dividends subsequent to
a business combination will be within the discretion of our board of directors at such time. If we increase the size of the offering,
we will effect a share capitalization with respect to our ordinary shares immediately prior to the consummation of the offering in such
amount as to maintain the ownership of founder shares by our initial shareholders prior to our Initial Public Offering at 20% of the
issued and outstanding ordinary shares upon the consummation of our Initial Public Offering (excluding the private shares and shares
underlying the UPO). Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants
we may agree to in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are unable to complete our initial business combination within 9 months from the closing of our Initial Public Offering (or up
    to 18 months, if we extend the time to complete a business combination as described in our Registration Statement), we will (i) cease
    all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
    thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash,
    equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account
    and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the
    number of then outstanding public shares, which redemption will completely extinguish public shareholders&rsquo; rights as shareholders
    (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
    possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, dissolve and
    liquidate, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements
    of other applicable law;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
    to our initial business combination, we may not issue additional shares that would entitle the holders thereof to: (i) receive funds
    from the trust account; (ii) vote on any initial business combination; or (iii) vote on matters related to our pre-initial business
    combination activity;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
    we do not intend to enter into a business combination with a target business that is affiliated with our founders, our directors
    or our officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent
    directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting
    firm that such a business combination is fair to our company from a financial point of view;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    a shareholder vote on our initial business combination is not required by law and we do not decide to hold a shareholder vote for
    business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E under the Exchange
    Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially
    the same financial and other information about our initial business combination and the redemption rights as is required under Regulation
    14A under the Exchange Act;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at
    least 80% of our assets held in the trust account (excluding deferred underwriting commissions and interest income earned on the
    trust account that is released to us to pay taxes) at the time of the agreement to enter into the initial business combination;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our shareholders approve an amendment to our amended and restated memorandum and articles of association (i) to modify the substance
    or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public
    shares if we do not complete our initial business combination within 9 months from the closing of our Initial Public Offering (or
    up to 18 months, if we extend the time to complete a business combination as described in our Registration Statement) or (ii) with
    respect to any other provision relating to shareholders&rsquo; rights or pre-initial business combination activity, we will provide
    our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon such approval at a per-share
    price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds
    held in the trust account and not previously released to us to pay our taxes, divided by the number of then outstanding public shares;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not complete our initial business combination with another blank check company or a similar company with nominal operations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our amended and restated memorandum and articles of association provides that we will only redeem our public shares so long
as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our
initial business combination and after payment of underwriters&rsquo; fees and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Dajiang Guo, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Annual Report on Form 10-K of AlphaTime Acquisition Corp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles; </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions): </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 23, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dajiang Guo</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajiang
    Guo</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CERTIFICATION
OF PRINCIPAL Financial OFFICER PURSUANT TO </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECTION
302 OF THE SARBANES-OXLEY ACT OF 2002 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jichuan Yang, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Annual Report on Form
    10-K of AlphaTime Acquisition Corp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does
    not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
    of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements,
    and other financial information included in this report, fairly present in all material respects the financial condition, results
    of operations and cash flows of the registrant as of, and for, the periods presented in this report; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying
    officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
    13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
    for the registrant and have: </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed such disclosure controls and procedures, or
    caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
    to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
    the period in which this report is being prepared; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed such internal control over financial reporting,
    or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
    the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
    accepted accounting principles; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated the effectiveness of the registrant&rsquo;s
    disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
    and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed in this report any change in the registrant&rsquo;s
    internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
    fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
    the registrant&rsquo;s internal control over financial reporting; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant&rsquo;s other certifying
    officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
    auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions): </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all significant deficiencies and material weaknesses
    in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
    ability to record, process, summarize and report financial information; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any fraud, whether or not material, that involves management
    or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
March 23, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jichuan Yang</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jichuan
    Yang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CERTIFICATIONS
PURSUANT TO 18 U.S.C. SECTION 1350, </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>AS
ADOPTED PURSUANT TO SECTION 906 OF </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>THE
SARBANES-OXLEY ACT OF 2002 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of AlphaTime Acquisition Corp (the &ldquo;Company&rdquo;) for the fiscal year ending December
31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, Dajiang
Guo, Chief Executive Officer of the Company, certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: white 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dajiang Guo</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dajiang
    Guo</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal
    Executive Officer)</I></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CERTIFICATIONS
PURSUANT TO 18 U.S.C. SECTION 1350, </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>AS
ADOPTED PURSUANT TO SECTION 906 OF </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>THE
SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Annual Report on Form 10-K of AlphaTime Acquisition Corp (the &ldquo;Company&rdquo;) for the fiscal year ending December
31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, Jichuan
Yang, Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jichuan Yang</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jichuan
    Yang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Principal
    Financial Officer)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>form10-k_001.jpg
<TEXT>
begin 644 form10-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #4 G # 2(  A$! Q$!_\0
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M/F#,3GKDYYY/:O;O^%8?#K_HGO@K_P )+1/_ (U0!U?]M:5_T$]/_P# Q?\
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M&+_\57*?\*P^'7_1/?!7_A):)_\ &J/^%8?#K_HGO@K_ ,)+1/\ XU0!U?\
M;6E?]!/3_P#P,7_XJC^VM*_Z">G_ /@8O_Q5<I_PK#X=?]$]\%?^$EHG_P :
MH_X5A\.O^B>^"O\ PDM$_P#C5 '5_P!M:5_T$]/_ / Q?_BJ/[:TK_H)Z?\
M^!B__%5RG_"L/AU_T3WP5_X26B?_ !JC_A6'PZ_Z)[X*_P#"2T3_ .-4 =7_
M &UI7_03T_\ \#%_^*H_MK2O^@GI_P#X&+_\57*?\*P^'7_1/?!7_A):)_\
M&J/^%8?#K_HGO@K_ ,)+1/\ XU0!U7]O:+_T%;#_ ,#$_P#BJ/[>T7_H*V'_
M (&)_P#%5RO_  K#X=?]$]\%?^$EHG_QJD_X59\._+\G_A /!&W_ +%+1L8S
M_P!<\_KT[4 =9_;6E?\ 03T__P #%_\ BJ/[:TK_ *">G_\ @8O_ ,57*?\
M"L/AU_T3WP5_X26B?_&J/^%8?#K_ *)[X*_\)+1/_C5 '5_VUI7_ $$]/_\
M Q?_ (JC^VM*_P"@GI__ (&+_P#%5RG_  K#X=?]$]\%?^$EHG_QJC_A6'PZ
M_P"B>^"O_"2T3_XU0!U?]M:5_P!!/3__  ,7_P"*H_MK2O\ H)Z?_P"!B_\
MQ5<I_P *P^'7_1/?!7_A):)_\:H_X5A\.O\ HGO@K_PDM$_^-4 =7_;6E?\
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M&45N<<M!<T;7M_P+(Z3]ZZ\O^''Q!\#_ !*\.#QC\.?%&B>-?#S:SXG\+?\
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M62M]WY_EOY"Q'^RK=/T_'K_GMZ,_;;7O$GAWPY=^'K36[^TT^X\3ZR^B:/\
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MXC^"GP-^'_PR\5:_J7C/7_!NE-HMUK]W=ZQJK?V9_;<W]A:3_;>O;O$6M?\
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MZ$K6_P#PZGQC_P#GCT ?7-%?(W_##_[-O_0E:W_X=3XQ_P#SQZ/^&'_V;?\
MH2M;_P##J?&/_P">/0!]&ZGX;T36#IYU32M/U(Z9>"^T@W5FNH_8M4^8C5AN
M(VMGJ3CGHPR,=97R-_PP_P#LV_\ 0E:W_P"'4^,?_P \>C_AA_\ 9M_Z$K6_
M_#J?&/\ ^>/0!]<T5\C?\,/_ +-O_0E:W_X=3XQ__/'H_P"&'_V;?^A*UO\
M\.I\8_\ YX] 'US17R-_PP_^S;_T)6M_^'4^,?\ \\>C_AA_]FW_ *$K6_\
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MJ*K^'QY3A5+*C,4;>%( /J:BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***^ _'/QP\8-^V;X)_9#\'#3-#MM4_9\\4?M&>(_B#=6BZGJ-]
MI6@?$_P_X!;P5H.B Y7Q"6\:CQ,WB8$ [ &0,6! /ORBOSO^)/[4M_\ LZ:A
M\// _P 4--O/%6O>*?'GA/P9_P )MX5L]+TK3FU+XK:[XZ;0R_@D>)_%-PLG
MA1/#^B1>-29,#_A(BW@F.=,QUP.F_MV77BJP@M[[X9?$KX7:AJM]^QIXS\-W
M,]]X/\9CQ9\+_P!JGXT:#\*4UE@GB8+X=/A3Q%_;7A7QUX7;;XQ\(QA/&G@4
M>,XRJ$ _4ZBORU^&'[?7_";>"OA?XS\5_"?4/#Q^)OCS5/!.BKI7C#1_$*V7
M_&3FL?LUZ$T\<;#Q"]PK01^*?&%QY"^#;>,E(O&P#.9,#P-^U_\ $5/^"?FG
M_M*^.M/T3Q;\3[OXC>*OAHIL[)O#7AM-5_X:R\0? 'P/KNMZ2C@P:!X7671/
M$OC+8JOMAN2&.3L /UIHKY1U+7/B9\,KC0;[QMXY\->,[#Q2WA?X>Z3X?L_"
M#>"M3U+XFZ[K*K_;AU\>)/%3?V 85UK;X:'A$F)@N&=4(;Y'\/\ _!3/P1XI
MU_POI?A7X3>/[O3M5\->&_$WC'5KR\\(Z<_A+^W_ -IO7/V2=:T5-%:1CKGB
M'PE\0_#X$H0#S?!^)08V#!P#]9J*_*+X<?\ !0CQ'\5/ OA_Q+!\"?$VB7_C
M#X<_M0^/3<:-XM\(>)=,\)>&?V<_B?K?PE5C_;X\)'Q#XC\5>)#HA/AI=L:+
M(Q<@1LU>;:'_ ,%#/%/A;Q??S?$;PKXF\;?"'7[W]F+1_!OC?PY:^$/#FH^$
M?$WQR^ <?CW1-%\<Z0/$).O-XK\1A3_PD/A5E3P>-?\ #<922-"R@'[345^5
M-W_P40TB^^.G[/OP8\*?!_7-0U'XVV?P)\2WOB+5O$6B:5IGA/PM\=OAE\?O
M'FC9)0/KWB+PNWP/UKPT_A>,KO;6T<$+PU'PC_P4:\%V'P-3XE^(_#?Q"\1_
M\(/\+M,^,WQ3NX]#\'V'B30? NN_$WXA?"O1-:ET/P[XB>/6_$+CX4>._$[>
M&_#&P-X.T)8Q)YTL2L ?K)17PE\#?VO_  O\:OB7J_PRB\(>(?"6LV^C^/?$
MOAB\U2ZT:_T_Q;X7^%'QEUWX2Z]K8.ANXT)AXC31G(()V:\JD'RBTGT7\/O%
M4WC:V\1>(K?5M.U/PQ=^(]5L?"'V2U8!=-T(?V'K@)!SKK-XCT;6RI5=VW&.
M%44 5_$$./BQ\-[W['X0G^R^$?B<#>:O=?\ %<6.7\ #&A9(_P") QROC4Y)
M60^%CM;[I]JKQ/7YK%?BG\.(;G^S3J-SX;^)WV$7/AAM2U$ R> 3K(T/QN!(
M?#N,J)/#0!'C$ R,(U\(87VR@ KX/_9U_P"3PO\ @HA_V.'[./\ ZS_H%?>%
M?!_[.O\ R>%_P40_['#]G'_UG_0* /O"BBB@ HHHH **** "BBB@ HHHH **
M** /G'Q1ITTWQK^#&JCPKXCU2#2?#GQDCO/%]GK+6/AGPH=:?P%&NB:]HWEG
M_A(&\5L#_P (: I,+Z"^3@%S]'5\T^++31)?CQ\(//@T?^W[/PO\8?\ A&UN
M_$NLZ?J*Z8&\"_V__8.AG&@>)&&-"+M(,>$%V-&"S2"O$OVEOB%\3?#G[1O[
M#/PP\$>/KKP3X8^-GQ)^,7AGXD?V1HWA#4=1U#2_ O[/OCWQ[H(T-_$'AOQ:
M-#QXCT++8SP=C9)((!^@=%?CK\,/VLOC1J?Q3^*_PCUZVM?B?_PJ7]J?Q-\"
M? GQ6\.WNC>"M*^+!'[,8^/*^"O&VA_\(UXM \1>$?$G_%K_ !L?"(\&G_A-
M?#_MXQ\%#UK7/VV/"^H^$/@=\;?#&H7FN_!?X@>.I;6S\5^"=3.-<TOP]^S]
M\5_BMKFS2=;\-[/'?APGP1KWAN.+PS)X2N7\:Z&61PMO(J 'Z845^3>F?MD^
M*&\3VWBJ;0[76_#OQN^$?[)OBC]G[X>2:MI.GL?%7QRTCX_>(%T76M=?PX-O
MB'Q3H/@?0O#49 9%0*(@J["O4V7[=OB+2%&N?$WX+'X?Z!I?C#Q1X+\96EE\
M2-(\9>)="U;0/V25_:S8[?#_ (<_X1CQ"#X<36_"X_X17QBP/C#"@M&QW 'Z
M=T5^+7A+]OOQAH7Q$_:/\8?$BV=?@CI7@/\ 8D\9>#K6W$>I>&_A-X6_:,\'
M?%W7=;\<>.-=\->&V\1CPW)XCT'0?#GC3Q/_ ,5>?!:M_P )R\<?@4/&OZ7_
M  UU[5?%6O>/]:.K7=SX0/B1_#GA"S?2A86"_P#"$L=#\0:NNN*Q_P"$@_X2
M;Q))K"AL%$CT)$5B#F@#W:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *^3OCA\"OA!\6M5\&^(_'M[J7A/QAX0&J6W@+XA>"_'FM_"3XE:$
MFO2(?$.B:-X[\,Z_X5\1#0/$\&C*OB_PJ)C]H(8$X1I%^L:_(_\ ;J\':A)X
MCT[XB>'CJFJ?$#PK\%_'WAGPS\/?B;\"-:^/G[-7Q6CUW7-&UV+P;XAT+P%H
M<OBGP'\0G\0:#H*CQ3X5))\'G>8O%N/+@ /;_B-^QO\ LV?%#Q??>,]12ZUC
MXBZ%#\/K*[NV^)/B^./_ (2?X7:SKWC7X2>,/'6BZ%X@!\0^)/"T^OZT(_$?
MBAGN&\)^(?$*;A%*463P!^Q?X0TSX(_#WX7?$/5?$WB;Q+X7T;X$+XD\5^'?
M'GQ(\.:CJ6K? S6D\0> O["UUO$J>)O#_A[PKXB#>)8O#'FK&'D&]7)&S\\O
M"_C/]H3X1?'/X@>./#OP<^)'A&V^*'[1_P"R=HGQ5^'WAWX6ZWXTTT>%V_85
M\/CQSK6A>.%\-_\ %0-\)_B+X'T7PL/%@\8KX-3IX[X8X]M\$?'?]KOQ/XL\
M >$9U^(&B3Z_XQ_:@^QZQJ?[/NN^'M.\0^&_!/@[P!XY^!Q\0:QKWAH^%OA^
M/%']M:OX665CX1_X2Z,/'^Y\;1DL ?35C^PK^REX6\1>%=5T_P /7.BWXO?%
M%CI-L_Q&\9Z;INIZGKGQG;]I3^QAH8\2(->/A3XDZ'K7BOP/X8"LG@U!XGV*
M ZNOJGA?]F7X(> O@%J_[.;^&+;6/@OJ;>./^$D\*^-M9U;QGIFHZ;X[U[7/
M'7C==:UGQ&)!ME\1Z_KGB-R[!E.WR]KD2+^2GQ]\=?&CXO\ PZ_9O^+FDZ3\
M;-1^)'@/]J@^)K32=5_9,\::9XF^!'CS0OV2/VF- \=:,0/#>WQ%\/1\1M9T
M'PLOBQ@?!BC7B!XY\9 FO>OAQ\>OVM/B)>PZ9\1/ 6M^'-0UO_AF+Q/I7A"Y
M^%VN?\(5X[_9W\>?"WX>ZY^T?J_C9M?T%$\-?$+PG\0=<^*?AD^$"B^,6DT/
MPIX._P"$'\7OXLWN ?96C?LX_!^T^']KX,;QM\2/%F@^(-7\+:[X1\5>+/C5
MXS\:^)-"U/0=7CUSP2GPP\=:_P"(Y?$?AU@='#)'X3E5I IV,T:2,>>U;]@7
M]G#4M:M]<;PYXJT6_MO!_@3X>V?_  B'Q'^)OAS[#X8\!_&H?'G0F7_A'_$@
MSXAD^,I'BOQOXF)W^,2K?\)TUQ'M=?SY^$WC7XJWG@G]FGX+:A\+/B5X<TSP
M)X _8Z\:? G2;GX+>-=+\-ZWJFAB/0?BLOQ0UG7/AH&^$'B'X4^(@_AG_A&?
M%LG@Z6/P=CQO'_PF8D^3UKPC^T#^TCX]T#X,:A!JGQK\%^(?B-\:_ ?PE^,&
MC^(?V6=;TW4/@5XI_P"%7^/AXYT71=:U[PVR^(OAV/B+H6A ?%,HW@L #'C<
MGQ:HH ^L[']CC]F[P/J$]CX=L?$OAA==\"?&7X?6GA32OBEXRT[3++PO\<_&
MD?CSXJ_\(_HJ^))%T MXF<>(1XC\+B*;PB2[PX$8W])X=_9"^ 7@ZZ\/:II/
MA75-3;PSX=\!^%;*SU?Q%K?B32KYOA1H!\#>!/&>O:-KOB%AKGQ"\)^&A_PB
M_P#PEKY\8[B(P=[HI\ _:;\5:'\-OVS?V./B-XI\)_$'4M%\&_"W]K+1=6\;
M^%/@I\2_B2NA:EKJ_!\:$=9UOX??#CQ?_P (\GBO^P]< !"DE6(4A@S<9X\_
M: _;!C^(OBBV\(?"WQ=>:=I7Q,\!ZYX#\#GPB-1TSQU^R=KOPQ/B'XI^,=<U
MK70@\/?&7P=\1!K7AB+PK_PE^Y=GA3P8?!!E\6B6@#Z!\-_\$^_V7?!^O^#_
M !%H?A'Q'_PE/@&\\ 7WA'Q5JWQ(^)6J>)]#3X6?\)^O@+2%UO7?$S.GASPM
MX?\ BEXY\*Q^%V!#^#-<= "2&$^C_L%_LSZ-H_A+0M/\'ZX+#P9X=U'P79V=
M]XY\:ZF/%O@+7/&>N^/Y?!/Q177O$2?\+#\.'XAZ[K?B9?#?BIY5$SE#N,9B
M/Q!_PT_^UI?Z7XP.G6?QLM["Z\'^./'WPUU6X_9D\8CQ+>H/V9/#_CG0=$UH
M'X<JBZ]'\:#KOAIE3P>" O\ P@Z(SX5OUM^$WB/5/''PO^'_ (O\16-UI^O^
M)_ _AC7/$=M>Z-K/AO4-.U;7=&T5];T?^P== \2:%Y<OR^6^UU=%D)WA'8 \
MI^'/[(WP;^$_CVX^)_A;1_%A\92:3X]TB.[UCXB^,O$NG+IGQ6^);_%GQSI"
MZ'K_ (C?PTH?XAF3Q%E8Q(0TB+G.#]-:/IECH.F:=HFAP+;:?IEIIME9V8X-
MEIR_*HZ\D*I!'J!V6NDHH \C\0R3?\+4^'\,)\8FW/A+XF?;/['/_%#J1)X!
MV_\ ";@=-?);_BBSU,?_  DX/ (KURO"_$5B;CXN_#F]']FC[+X.^)P%K>>)
M/[.U$L6\ X&BZ$&C/B%0>9/$^5_X0Y"44D^+B*]TH *^#_V=?^3PO^"B'_8X
M?LX_^L_Z!7WA7P?^SK_R>%_P40_['#]G'_UG_0* /O"BBB@ HHHH **** "B
MBB@ HHHH **** /G+Q;>V,7QU^#ME/JFC6US>>&_B^UG9W?@\W^JWVY?A\?^
M)+XU<K_PC17.7B!)\: $[6;PGM.9\3],^ 6H:M\-]2^+L_@&UU_P_K7B>]^%
M-YXZ\2:/X?\ $MAJ9T<G7SX(9G25IG\.!Q*WAES(/";%Y P)+=!XI.LGXP?#
M(62>,6TI?#?Q*;6O[,U;2+#P."P\/#0/^$VT79_;^O/F/6V\%I;G9&W_  DL
MT@ <$_./[4/@GQOK7[4'[ _Q%\.^ M;\:>$O@]\2?CKK7CS5M)L])OV\*Z7X
MW_9]\?>!-$(C8AEW>(]:T53C<2@&YG"@  ]V\*>&?V>X;'X8OX)T'X;_ -A:
M;XP\3ZO\([KPG_89TMO$FLCQ(?'&K^"/[!;!UXM)K[>,V4)(0WB(3*0L@KK+
M+X.?"JST?P1X5L?ASX3MO#WPPUC_ (2GP)X>LM$TG3M+\*>)]FN?\3G0=' V
MZ#QKNM$$#D:\1@E6*_F-\(_@U^TS\+_B)\6/&GAS0/$WPM^''[17[6'C?XG6
M?PB\*#P;XE7X4^ _^&9)? 8\8ZWHS,WAO0?$OQ4^-.@:+\4W\*^%<X\9>)%;
MQZ[,WC4#!\8>%_V^;?3/^$WM[GXB#XP-^RWXI^'GAQ?A[XE&I>!]0\?Z%\?]
M!\0Z'XR'@?X@'_B0>)?%GPW!D8>+ 3L4^!SXWQR #[3UOX'?L2:!X>N/AIK7
M@+X*Z)I&NZQ\,?!A\#:NFA:<6U,ZWKGB+X4>"]!T-Y(=K+X@&O\ B'P)X7\+
M; KMXFD\$(RHV?>X?@A\'(;BWU6W\!>$X-0MO&!\9V=X-)B#KXJ_X0S_ (0#
M^V>,1[S\/ WA4 Y7_A$#L/R@E?S'_:8^!'[1_C75-0\#Z5JWQA\5_#?P)\=_
MV$?B9X.\67FM>#1\2+'3?!?CCQYKOQRUKP3K'_"/*K^)/"^@?\(-L/BQ2S%F
M".#(0^%X<LO^"F?AOQ;X?T3QA<>/_%FGW7CK]A'6;SQ#I7_"M3I=AX#.M>/=
M"_:NT;70"%/B+_A&QX&_X3?_ (109_X3,_\ "<^ 2 QR ?H=X4_9U_9:\!Z]
M-X'\)_"SX7^'-7U[PWIEZV@:79QZ=J6H^%? AU[0-!;^Q$*[= \+?\)QKGAI
M"JE,>('5E7<@7ZBTS3+'1K6#2],LK?3M/M1_HEK:CY0!G.%[#GN2>.2>,?AM
M\'?"O_!0?X2_#_X<^%K?2_BOXE@T/X<?&%_B5::]XD\&^)/$^O>*6_;/\/:X
MC:-XYU_EO$3?LY:SXX'@9C@%%"\^.U(JU\6M"_X*2'4/BBOPX\5_%DZ!I?P%
M_:SUOX$65F?AH?$]_P#$[1/B?\)!^S;HWCD:_P ^(/$!\.+\5L'&#X+7PT/'
MA/CS. #]V:*_/GX+2?M/R_'CX@?\+*&I3_!G5=*\2:AX1O-?M-'\->*?"GBE
M?&F%\%R:)X>\4>*O#/B/PXWAM/\ A)/ _BGPNWA'QD?!@ ^("OXY!K]!J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN<U;4=+\/Z?
M/JFMWVGZ;I]F!=7EY>7@T[3[(*!ABQ)&203EN2>?XB* .CHKBM"\5^'/$EB-
M3\.:YHVM:?\ :1:&\\/:KI6I:;_:' *"5"!YF[L'+D D*0-U=K0 45PVI:_I
M&FWOA^QOM3T_39=?O?[&T>SN[G!U[5/[(_MYM+T7<$76W&@:/KDQ!^;$995+
M JL%EXKT'4=4UC0K'7-,U#6-";3#K&D66KZ9J&JZ$VLY&C_V[HN%;1"P&Z,%
M1YJJ9%,B_,H!Z!117GNA>+/#GB9]2@\-ZUI'B)O#^KZEX:UAO#^IZ7J7]B>)
M]$##6-'UORMIT37T8NLEN^'0'?((U:)Y0#T*BBO.='^(?@+Q)=7]CHWC;PIK
M5QI5L+O6+72/$.CZI]BTXH%\S61&\K1)]X$OM*@DL5R2P!Z-17 :%XU\&^)1
M/!X=\8^'/$D]M:_;+FUT#Q#I.JM'8?,!)G1"2H)^5. #N'S$.,Q1?$#P1-K5
MQX<M_&'ANYUZVNS8-X>7Q)I UC^T]O&CG1]ZN&  &<&0,>O4@ ]$HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BOGKXG:SXHA\8_##PMX2\1CPH
M?&.K^)X]7U7^R-(U._\ [-T#P>=;"[=>#JI6089PI,8^_@)MKI?^$.^*?_18
MM0_\(/P7_A0![!17C_\ PAWQ3_Z+%J'_ (0?@O\ PH_X0[XI_P#18M0_\(/P
M7_A0![!17C__  AWQ3_Z+%J'_A!^"_\ "C_A#OBG_P!%BU#_ ,(/P7_A0!\-
M:U^WA\ O^'C_ ,/?V&[ZX\>V?Q^M?A?XY\96F@7OPAUS4/"^O>!?$&C:#K?_
M  F6A?%0;/#.@^'_  PW@C7?"OC+<0&\;,/!:JS*%;]1:^0KS]FJ#4?BUH/Q
MWO\ Q1IUS\:/"O@/Q1\)=&^(8^'/A ^);'P!XXUKP_KVN^#0P'_(O_\ "2:%
MH?B<QY.2#N)5LGUW_A#OBG_T6+4/_"#\%_X4 >P5^"7[!O\ P4%_9\_:(_X*
M,?\ !0OX&?#1/B<GQ(T/Q)X!O/$=MXL^'/BWP]IWA9/A)X.T'X2Z_'K^L:^B
MHC3?$&*0>#$\N-O&$;M+&HC\N0?L;_PAWQ3_ .BQ:A_X0?@O_"O#/!7[*^E_
M#'XH?&#XT>!_$-KX<^)W[05]X$O?C#XMLO G@\ZIX[U'P+H/_""^!6UK"_,?
M"GATA %)!4E@VX%* /M.BO'_ /A#OBG_ -%BU#_P@_!?^%'_  AWQ3_Z+%J'
M_A!^"_\ "@#V"BO'_P#A#OBG_P!%BU#_ ,(/P7_A1_PAWQ3_ .BQ:A_X0?@O
M_"@#V"BO'_\ A#OBG_T6+4/_  @_!?\ A1_PAWQ3_P"BQ:A_X0?@O_"@#V"B
MO'_^$.^*?_18M0_\(/P7_A1_PAWQ3_Z+%J'_ (0?@O\ PH ]@HKQ_P#X0[XI
M_P#18M0_\(/P7_A1_P (=\4_^BQ:A_X0?@O_  H ]@HKQ_\ X0[XI_\ 18M0
M_P#"#\%_X4?\(=\4_P#HL6H?^$'X+_PH X_Q39M<?''X)23Z%X0O)[?PW\9
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M/X/\5^+=.^&W[/OQM\,ZS^TYX)TF[?\ X1SQU^S'X[+^ _'NMZWHK,3K^O\
MPI&NZ)\3X_NA%\/^)@K.LB!*]Y^TOXBT/QIJ'B'X8^#O$G[1NH?$Z\_MKX4_
M#WP1XQWZ9'\"_A1XT\!?"?QQ\3=%UKQ!_P 4N?$7B?Q)XZUKQ5%'DKXQ\&:
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M.^ O@8+32?$J>(_#7C?X8_'3QF/ ?@;XF:$5!);_ (27^Q/%G@L^%MY;P8[
ML\9"A-1_89TGP5X*M_#7[.GBG4_AAXBTCP)X6^#'AV^\:C6OBSX#TWX#:'K4
MH_X4S_PA+^)/""^(/#WA+P]K.OQ^"D\4/*Z'Q I<>,%8E?1[W]B7P#>>'/@1
MX 'BGXD6OP]_9TTKP*?ASX7M/$<>G)'XF\ ;?^$'\:2G^P@Q\2>%U5_+<#Y
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MAM<UA]:-GK^L/J:Z$&&1I&AKL T/00$!$8SMW<MDJ2 =]1110 4444 %%%%
M!1110!\H_&KQ=HW@+QK\$?&'BNXN;?0=+\2>.+.\UBS\.:WXB6R;6_!&N#1/
M^0!X?G95)0 CL"<M(Q+MI_\ #7'P _Z'C4?_  A/B3_\S5?3=% 'S)_PUQ\
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MB3_\S5>/^(_B[X&^)OQ5_9RL/AS>ZYXEO]#^*?B;6-66U\'^,=.33])'PO\
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MXE?#GQ?+]@\'^/\ PEXNN!9_;A:^'_$>CZHRZ<!C>IT)WVCJ%4YQWR#SZ90
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MX5:J=8TC_A6W_"L]>_86\1>!'^9_$S>&=!^(?_"Z-<USPMXT3Q6H5/&.N_\
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MX:_X)Q_$3PG8?#7P/H7Q1\*ZGX/^'/P5\=_#*UN_$&C:JWB6[U;XJ_#+X@^
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M2;'Q0!]X45\A?\,D:)_T6O\ :I_\2-^)/_QVC_ADC1/^BU_M4_\ B1OQ)_\
MCM 'U[17R%_PR1HG_1:_VJ?_ !(WXD__ !VC_ADC1/\ HM?[5/\ XD;\2?\
MX[0!]>T5\A?\,D:)_P!%K_:I_P#$C?B3_P#':/\ ADC1/^BU_M4_^)&_$G_X
M[0!]>T5\A?\ #)&B?]%K_:I_\2-^)/\ \=H_X9(T3_HM?[5/_B1OQ)_^.T ?
M7M%?(7_#)&B?]%K_ &J?_$C?B3_\=H_X9(T3_HM?[5/_ (D;\2?_ ([0!]>T
M5\A?\,D:)_T6O]JG_P 2-^)/_P =H_X9(T3_ *+7^U3_ .)&_$G_ ..T >G?
M&J#[7\(/BM;RV5Q?K<_#;QS9W=C::JVE7]^&\&^( VC#7!M&@,X*JOB3=^[)
M1F5LKFO\#H8+3X,_!V&"P;3X+3X6> 1::3=>(G\;:AIRGP=HH71CXX!V^)'4
MJJ-XH8D^+6)F*QJV6\:UG]C/P1XET?6?#FN?%G]J#6=(UW2-6T;5]*OOV@OB
M2VFWNFZZ&36]+.V0?(R@J%&)"#@E!N 9H7[&7@;PSHVC>'/#_P 6_P!J#0M
MT#2-+T+1]*TK]H3XD+IEEI6@QKHVC:2NZ4D1@9W*<R*REOF0!B ?;]%?(7_#
M)&B?]%K_ &J?_$C?B3_\=H_X9(T3_HM?[5/_ (D;\2?_ ([0!]>T5\A?\,D:
M)_T6O]JG_P 2-^)/_P =H_X9(T3_ *+7^U3_ .)&_$G_ ..T ?7M%?(7_#)&
MB?\ 1:_VJ?\ Q(WXD_\ QVO.M0^$T_PA^+/[/^HZ'\6_C[KEMXJ^(WB;PUXB
M\/>-_B_XQ\;^&K_2O^%8>/M? .BZ^Q5L>)-$T,Y4D>A(^8@'Z!4444 %%%%
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M/V'[.W\&_!#X5?L]Z!X4\+?#'X2>)_'6M6?A/4OB+\?OAIJ6@:AX_E.MC7/
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MGQE_PD/B4O@.F?VZ_P"%_P#P6_Z*S\,/_"\T3_XNO"M-/[*5E:^*=+U'Q?\
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M7\?ZWKD9<@>&M"'BSP[X&,A\UWE\%2.Q9O&*E /NF[\5?LAZQJ?@[7=3UO\
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M_P#"RK_P-^U9X)^$WB#1->\%Z+&@\,CQ'X5_X6J6;PQ(PC\:>$/#GB(QA)6
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M\-_^"33O_D>C_A#?!_\ T*?AO_P2:=_\CT44 '_"&^#_ /H4_#?_ ()-._\
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>form10-k_002.jpg
<TEXT>
begin 644 form10-k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ IX# 2(  A$! Q$!_\0
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M64J&"PU.G&7E356O4YE)63<K:IL_U/?^";OPMMO@W^PM^R]X @M3:S:5\&_
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MR$QE5(/[P_\ !UL<?\$Z_!9< H/VA/!98#K@:'XE+#\L]_2OQ?\ V&_V+O\
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MU.XN+6_LM3M--@46UI<&."Y6W2..1I"@:O[>_P!LC]A?]ES]O+P':^ /VCO
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MK_S\0_\ ?Q/\:/M=K_S\0_\ ?Q/\:.;RE_X#/_Y6&OE]R_\ DRQ15?[7:_\
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MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
M_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNO
MVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\
MV\/_ !)[QY_\ET?\.2/@]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO
M_P#G:']CY=_T#O\ \'XK_P":C\6?^')'P>_Z.O\ V\/_ !)[QY_\ET?\.2/@
M]_T=?^WA_P")/>//_DNOVFHH_P!;.(O^AG4_\)LO_P#G:']CY=_T#O\ \'XK
&_P":C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>atmc-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGDGbP9z5Z8WekhvWBwbemqLyIn/M7cLCN9esTG4XwP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ATMC="http://alphatimeacquisitioncorp.com/20221231" elementFormDefault="qualified" targetNamespace="http://alphatimeacquisitioncorp.com/20221231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
	  <link:definition>00000005 - Statement - Statements of Operations (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
	  <link:definition>00000006 - Statement - Statements of Changes in Shareholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" id="StatementsOfChangesInShareholdersEquityParenthetical">
	  <link:definition>00000007 - Statement - Statements of Changes in Shareholders' Equity (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000008 - Statement - Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" id="DescriptionOfOrganizationBusinessOperationsAndGoingConcern">
	  <link:definition>00000009 - Disclosure - Description of Organization, Business Operations and Going Concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000010 - Disclosure - Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" id="InitialPublicOffering">
	  <link:definition>00000011 - Disclosure - Initial Public Offering</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" id="PrivatePlacement">
	  <link:definition>00000012 - Disclosure - Private Placement</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000013 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000015 - Disclosure - Shareholder&#8217;s Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000016 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000017 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" id="DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative">
	  <link:definition>00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000019 - Disclosure - Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" id="InitialPublicOfferingDetailsNarrative">
	  <link:definition>00000020 - Disclosure - Initial Public Offering (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" id="PrivatePlacementDetailsNarrative">
	  <link:definition>00000021 - Disclosure - Private Placement (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000022 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
	  <link:definition>00000024 - Disclosure - Shareholder&#8217;s Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000025 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="atmc-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="atmc-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="atmc-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="atmc-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" name="UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_OrdinarySharesParValue0.0001PerShareMember" name="OrdinarySharesParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" name="WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" name="RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_SponsorMember" name="SponsorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_PostBusinessCombinationMember" name="PostBusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_UnderwritersMember" name="UnderwritersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" name="DeferredOfferingCostsIncludedInDueToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" name="DeferredOfferingCostsIncludedInDueToAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" name="DeferredOfferingCostsAdjustedFromPrepaidExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" name="IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_BonusIssueAllotmentToSponsor" name="BonusIssueAllotmentToSponsor" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_DisclosureInitialPublicOfferingAbstract" name="DisclosureInitialPublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_InitialPublicOfferingDisclosureTextBlock" name="InitialPublicOfferingDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_DisclosurePrivatePlacementAbstract" name="DisclosurePrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_PrivatePlacementDisclosureTextBlock" name="PrivatePlacementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" name="PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_BusinessCombinationInitialPublicOfferingDescription" name="BusinessCombinationInitialPublicOfferingDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" name="WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_CommonStockSharesSubjectToForfeiture" name="CommonStockSharesSubjectToForfeiture" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" name="AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_CashFee" name="CashFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_VendorsOutstandingBalances" name="VendorsOutstandingBalances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ATMC_OutstandingBalancesTransferred" name="OutstandingBalancesTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>atmc-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/Cover" xlink:href="atmc-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:href="atmc-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:href="atmc-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:href="atmc-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:href="atmc-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:href="atmc-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:href="atmc-20221231.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:href="atmc-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:href="atmc-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:href="atmc-20221231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:href="atmc-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atmc-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:href="atmc-20221231.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atmc-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atmc-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:href="atmc-20221231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="atmc-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Statements of Changes in Shareholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Shareholders&apos; Equity (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - Description of Organization, Business Operations and Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - Initial Public Offering" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - Private Placement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholder&#8217;s Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000019 - Disclosure - Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000020 - Disclosure - Initial Public Offering (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000021 - Disclosure - Private Placement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000022 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000024 - Disclosure - Shareholder&#8217;s Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000025 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>atmc-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/Cover" xlink:href="atmc-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:href="atmc-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:href="atmc-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:href="atmc-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:href="atmc-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:href="atmc-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:href="atmc-20221231.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:href="atmc-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:href="atmc-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:href="atmc-20221231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:href="atmc-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atmc-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:href="atmc-20221231.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atmc-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atmc-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:href="atmc-20221231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="atmc-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" xlink:label="loc_ATMCUnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCUnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_ATMCOrdinarySharesParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCOrdinarySharesParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_ATMCWarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCWarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" xlink:label="loc_ATMCRightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCRightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_80" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_80" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_80" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_80" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_80" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_80" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_80" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_80" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_80" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_80" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_80" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_80" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_80" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_80" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_80" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_80" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_80" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_80" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_80" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_80" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_80" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_80" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_80" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_80" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_80" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_80" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_80" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_80" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_80" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_80" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_80" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_80" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_80" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_80" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_80" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_80" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_80" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_80" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_80" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_80" xlink:type="arc" order="61" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseCurrent_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapDeferredOfferingCosts_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Shareholders&apos; Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - Description of Organization, Business Operations and Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - Initial Public Offering" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - Private Placement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholder&#8217;s Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PostBusinessCombinationMember" xlink:label="loc_ATMCPostBusinessCombinationMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ATMCPostBusinessCombinationMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaapOtherDeferredCostsNet_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDeferredCostsNet_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="loc_ATMCPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_200" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_200" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_200" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_BusinessCombinationInitialPublicOfferingDescription" xlink:label="loc_ATMCBusinessCombinationInitialPublicOfferingDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCBusinessCombinationInitialPublicOfferingDescription_200" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent_200" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash_200" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WorkingCapital" xlink:label="loc_ATMCWorkingCapital_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCWorkingCapital_200" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_200" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCostsAndExpenses_200" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000019 - Disclosure - Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000020 - Disclosure - Initial Public Offering (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000021 - Disclosure - Private Placement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000022 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PromissoryNoteMember" xlink:label="loc_ATMCPromissoryNoteMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATMCPromissoryNoteMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CommonStockSharesSubjectToForfeiture" xlink:label="loc_ATMCCommonStockSharesSubjectToForfeiture_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCCommonStockSharesSubjectToForfeiture_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_240" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_240" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_240" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_240" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_240" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_240" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_240" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:label="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_240" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_240" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_240" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_240" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_240" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_240" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription_240" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_240" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CashFee" xlink:label="loc_ATMCCashFee_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCCashFee_240" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_240" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSponsorFees_240" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense_240" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnderwritersMember" xlink:label="loc_ATMCUnderwritersMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ATMCUnderwritersMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_110" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000024 - Disclosure - Shareholder&#8217;s Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CommonStockSharesSubjectToForfeiture" xlink:label="loc_ATMCCommonStockSharesSubjectToForfeiture_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ATMCCommonStockSharesSubjectToForfeiture_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_170" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_170" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000025 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnderwritersMember" xlink:label="loc_ATMCUnderwritersMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ATMCUnderwritersMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEscrowDeposit_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WorkingCapital" xlink:label="loc_ATMCWorkingCapital_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCWorkingCapital_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_VendorsOutstandingBalances" xlink:label="loc_ATMCVendorsOutstandingBalances_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCVendorsOutstandingBalances_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OutstandingBalancesTransferred" xlink:label="loc_ATMCOutstandingBalancesTransferred_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCOutstandingBalancesTransferred_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:label="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_150" xlink:type="arc" order="14" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>atmc-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" xlink:label="ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" xlink:to="ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember_lbl" xml:lang="en-US">Units, each consisting of one ordinary share, one redeemable warrant and one right</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OrdinarySharesParValue0.0001PerShareMember" xlink:label="ATMC_OrdinarySharesParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_OrdinarySharesParValue0.0001PerShareMember" xlink:to="ATMC_OrdinarySharesParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_OrdinarySharesParValue0.0001PerShareMember_lbl" xml:lang="en-US">Ordinary Shares, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:to="ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xml:lang="en-US">Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" xlink:label="ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" xlink:to="ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember_lbl" xml:lang="en-US">Rights, each right entitling the holder thereof to one-tenth of one ordinary share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="ATMC_SponsorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_SponsorMember" xlink:to="ATMC_SponsorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PostBusinessCombinationMember" xlink:label="ATMC_PostBusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PostBusinessCombinationMember" xlink:to="ATMC_PostBusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_PostBusinessCombinationMember_lbl" xml:lang="en-US">Post-business Combination [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PromissoryNoteMember" xlink:label="ATMC_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PromissoryNoteMember" xlink:to="ATMC_PromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceMember" xlink:to="us-gaap_ServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServiceMember_lbl" xml:lang="en-US">Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnderwritersMember" xlink:label="ATMC_UnderwritersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_UnderwritersMember" xlink:to="ATMC_UnderwritersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_UnderwritersMember_lbl" xml:lang="en-US">Underwriters [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholder&#8217;s Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued offering costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (See Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholder&#8217;s Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholder&#8217;s Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholder&#8217;s Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par or stated value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par or stated value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Sharebased payment award options forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Formation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average ordinary shares outstanding, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Ordinary Shares to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Ordinary Shares to Sponsor, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Bonus issue allotment to the Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Bonus issue allotment to the Sponsor, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in current assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Accrued offering costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash&#8212;beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash&#8212;end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of noncash financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" xlink:to="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty_lbl" xml:lang="en-US">Deferred offering costs included in due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" xlink:to="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities_lbl" xml:lang="en-US">Deferred offering costs included in due to accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" xlink:to="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses_lbl" xml:lang="en-US">Deferred offering costs adjusted from prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" xlink:label="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" xlink:to="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares_lbl" xml:lang="en-US">Issuance of Ordinary Shares in consideration of re-purchase of Class B ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_BonusIssueAllotmentToSponsor" xlink:label="ATMC_BonusIssueAllotmentToSponsor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_BonusIssueAllotmentToSponsor" xlink:to="ATMC_BonusIssueAllotmentToSponsor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATMC_BonusIssueAllotmentToSponsor_lbl" xml:lang="en-US">Bonus issue allotment to the Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Description of Organization, Business Operations and Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosureInitialPublicOfferingAbstract" xlink:label="ATMC_DisclosureInitialPublicOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DisclosureInitialPublicOfferingAbstract" xlink:to="ATMC_DisclosureInitialPublicOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_DisclosureInitialPublicOfferingAbstract_lbl" xml:lang="en-US">Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_InitialPublicOfferingDisclosureTextBlock" xlink:label="ATMC_InitialPublicOfferingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_InitialPublicOfferingDisclosureTextBlock" xlink:to="ATMC_InitialPublicOfferingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATMC_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US">Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosurePrivatePlacementAbstract" xlink:label="ATMC_DisclosurePrivatePlacementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DisclosurePrivatePlacementAbstract" xlink:to="ATMC_DisclosurePrivatePlacementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_DisclosurePrivatePlacementAbstract_lbl" xml:lang="en-US">Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PrivatePlacementDisclosureTextBlock" xlink:label="ATMC_PrivatePlacementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PrivatePlacementDisclosureTextBlock" xlink:to="ATMC_PrivatePlacementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATMC_PrivatePlacementDisclosureTextBlock_lbl" xml:lang="en-US">Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Shareholder&#8217;s Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_EmergingGrowthCompanyPolicyTextBlock" xlink:label="ATMC_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ATMC_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US">Date of incorporation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Issuance of share to sponsor, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Ordinary share par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock, price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from sale of units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock number of shares issued in transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Proceeds from sale of units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Transaction cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US">Payments for underwriting expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredOfferingCosts_2_lbl" xml:lang="en-US">Deferred underwriting commission</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="us-gaap_OtherDeferredCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCostsNet" xlink:to="us-gaap_OtherDeferredCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCostsNet_lbl" xml:lang="en-US">Other offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Sale of stock value issued</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:to="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_lbl" xml:lang="en-US">Percentage of fair market value of business acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of voting interests acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Business combination, net tangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_BusinessCombinationInitialPublicOfferingDescription" xlink:label="ATMC_BusinessCombinationInitialPublicOfferingDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_BusinessCombinationInitialPublicOfferingDescription" xlink:to="ATMC_BusinessCombinationInitialPublicOfferingDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_BusinessCombinationInitialPublicOfferingDescription_lbl" xml:lang="en-US">Business combination description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Taxes payable and less interest to pay dissolution expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash in bank account</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WorkingCapital" xlink:label="ATMC_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_WorkingCapital" xlink:to="ATMC_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Cash in trust accouint</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Estimated expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC insured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" xlink:label="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" xlink:to="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_lbl" xml:lang="en-US">Shares subject to forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Accrued for interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Number of private units sold, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2_lbl" xml:lang="en-US">Sale of stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CommonStockSharesSubjectToForfeiture" xlink:label="ATMC_CommonStockSharesSubjectToForfeiture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_CommonStockSharesSubjectToForfeiture" xlink:to="ATMC_CommonStockSharesSubjectToForfeiture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_CommonStockSharesSubjectToForfeiture_lbl" xml:lang="en-US">Common stock shares subject to forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Aggregate number of units issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Number of additional shares issued to sponsor</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Common stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Number of additional units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to related party amount converted</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:label="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:to="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_lbl" xml:lang="en-US">Additional amount deposited by underwriter on behalf of related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Sale of stock price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Share issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Aggregate value of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Description of sale of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Loan amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xml:lang="en-US">Description of maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CashFee" xlink:label="ATMC_CashFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_CashFee" xlink:to="ATMC_CashFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_CashFee_lbl" xml:lang="en-US">Cash Fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_3_lbl" xml:lang="en-US">Deferred Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="us-gaap_SponsorFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SponsorFees_lbl" xml:lang="en-US">Sponsor fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdministrativeFeesExpense" xlink:to="us-gaap_AdministrativeFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdministrativeFeesExpense_lbl" xml:lang="en-US">Administration fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_3_lbl" xml:lang="en-US">Sale of price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsForUnderwritingExpense_2_lbl" xml:lang="en-US">Underwriting discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3_lbl" xml:lang="en-US">Number of stock exercisable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Option description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Number of units option exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrants to purchase common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock voting rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Number of shares issued, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Number of shares forfeitured</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_CommonStockSharesSubjectToForfeiture" xlink:to="ATMC_CommonStockSharesSubjectToForfeiture_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ATMC_CommonStockSharesSubjectToForfeiture_2_lbl" xml:lang="en-US">Common stock shares subject to forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Number of shares in issue were repurchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Gross proceeds from exercise of option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDeposit_lbl" xml:lang="en-US">Cash held in escrow</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_VendorsOutstandingBalances" xlink:label="ATMC_VendorsOutstandingBalances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_VendorsOutstandingBalances" xlink:to="ATMC_VendorsOutstandingBalances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_VendorsOutstandingBalances_lbl" xml:lang="en-US">Vendors outstanding balances</link:label>
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OutstandingBalancesTransferred" xlink:label="ATMC_OutstandingBalancesTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_OutstandingBalancesTransferred" xlink:to="ATMC_OutstandingBalancesTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_OutstandingBalancesTransferred_lbl" xml:lang="en-US">Outstanding balances transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_SponsorMember" xlink:to="ATMC_SponsorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_SponsorMember_doc" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_CommonStockSharesSubjectToForfeiture" xlink:to="ATMC_CommonStockSharesSubjectToForfeiture_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_CommonStockSharesSubjectToForfeiture_doc" xml:lang="en-US">Common stock shares subject to forfeiture.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_WorkingCapital" xlink:to="ATMC_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_WorkingCapital_doc" xml:lang="en-US">Working capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:to="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_doc" xml:lang="en-US">Additional Amount Deposited By Underwriter On Behalf Of Related Party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ATMC_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging Growth Company [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" xlink:to="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_doc" xml:lang="en-US">Weighted average number of shares common stock subject to forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_CashFee" xlink:to="ATMC_CashFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_CashFee_doc" xml:lang="en-US">Cash Fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" xlink:to="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty_doc" xml:lang="en-US">Deferred Offering Costs Included In Due To Related Party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" xlink:to="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities_doc" xml:lang="en-US">Deferred Offering Costs Included In Due To Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" xlink:to="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses_doc" xml:lang="en-US">Deferred Offering Costs Adjusted From Prepaid Expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" xlink:to="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares_doc" xml:lang="en-US">Issuance Of Ordinary Shares In Consideration Of Repurchase Of Class B Ordinary Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_BonusIssueAllotmentToSponsor" xlink:to="ATMC_BonusIssueAllotmentToSponsor_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_BonusIssueAllotmentToSponsor_doc" xml:lang="en-US">Bonus Issue Allotment To Sponsor.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_InitialPublicOfferingDisclosureTextBlock" xlink:to="ATMC_InitialPublicOfferingDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_InitialPublicOfferingDisclosureTextBlock_doc" xml:lang="en-US">Initial Public Offering [Disclosure Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PrivatePlacementDisclosureTextBlock" xlink:to="ATMC_PrivatePlacementDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_PrivatePlacementDisclosureTextBlock_doc" xml:lang="en-US">Private Placement [Disclosure Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PromissoryNoteMember" xlink:to="ATMC_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_UnderwritersMember" xlink:to="ATMC_UnderwritersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_UnderwritersMember_doc" xml:lang="en-US">Underwriters [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_VendorsOutstandingBalances" xlink:to="ATMC_VendorsOutstandingBalances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_VendorsOutstandingBalances_doc" xml:lang="en-US">Vendors Outstanding Balances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:to="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_doc" xml:lang="en-US">Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PostBusinessCombinationMember" xlink:to="ATMC_PostBusinessCombinationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_PostBusinessCombinationMember_doc" xml:lang="en-US">Post-business Combination [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_BusinessCombinationInitialPublicOfferingDescription" xlink:to="ATMC_BusinessCombinationInitialPublicOfferingDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_BusinessCombinationInitialPublicOfferingDescription_doc" xml:lang="en-US">Business Combination Initial Public Offering Description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_OutstandingBalancesTransferred" xlink:to="ATMC_OutstandingBalancesTransferred_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ATMC_OutstandingBalancesTransferred_doc" xml:lang="en-US">Outstanding Balances Transferred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Due to Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_BonusIssueAllotmentToSponsor" xlink:to="ATMC_BonusIssueAllotmentToSponsor_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_BonusIssueAllotmentToSponsor_3_lbl" xml:lang="en-US">BonusIssueAllotmentToSponsor</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_InitialPublicOfferingDisclosureTextBlock" xlink:to="ATMC_InitialPublicOfferingDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_InitialPublicOfferingDisclosureTextBlock_3_lbl" xml:lang="en-US">InitialPublicOfferingDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATMC_PrivatePlacementDisclosureTextBlock" xlink:to="ATMC_PrivatePlacementDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATMC_PrivatePlacementDisclosureTextBlock_3_lbl" xml:lang="en-US">PrivatePlacementDisclosureTextBlock</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>atmc-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/Cover" xlink:href="atmc-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:href="atmc-20221231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:href="atmc-20221231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:href="atmc-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:href="atmc-20221231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:href="atmc-20221231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:href="atmc-20221231.xsd#InitialPublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:href="atmc-20221231.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:href="atmc-20221231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:href="atmc-20221231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:href="atmc-20221231.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:href="atmc-20221231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:href="atmc-20221231.xsd#DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="atmc-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:href="atmc-20221231.xsd#InitialPublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:href="atmc-20221231.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="atmc-20221231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="atmc-20221231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:href="atmc-20221231.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:href="atmc-20221231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" xlink:label="loc_ATMCUnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCUnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_ATMCOrdinarySharesParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCOrdinarySharesParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_ATMCWarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCWarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" xlink:label="loc_ATMCRightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATMCRightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000006 - Statement - Statements of Changes in Shareholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical" xlink:title="00000007 - Statement - Statements of Changes in Shareholders&apos; Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty" xlink:label="loc_ATMCDeferredOfferingCostsIncludedInDueToRelatedParty" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ATMCDeferredOfferingCostsIncludedInDueToRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities" xlink:label="loc_ATMCDeferredOfferingCostsIncludedInDueToAccruedLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ATMCDeferredOfferingCostsIncludedInDueToAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses" xlink:label="loc_ATMCDeferredOfferingCostsAdjustedFromPrepaidExpenses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ATMCDeferredOfferingCostsAdjustedFromPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" xlink:label="loc_ATMCIssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ATMCIssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_BonusIssueAllotmentToSponsor" xlink:label="loc_ATMCBonusIssueAllotmentToSponsor" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ATMCBonusIssueAllotmentToSponsor" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern" xlink:title="00000009 - Disclosure - Description of Organization, Business Operations and Going Concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOffering" xlink:title="00000011 - Disclosure - Initial Public Offering">
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_ATMCDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_InitialPublicOfferingDisclosureTextBlock" xlink:label="loc_ATMCInitialPublicOfferingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATMCDisclosureInitialPublicOfferingAbstract" xlink:to="loc_ATMCInitialPublicOfferingDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacement" xlink:title="00000012 - Disclosure - Private Placement">
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosurePrivatePlacementAbstract" xlink:label="loc_ATMCDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PrivatePlacementDisclosureTextBlock" xlink:label="loc_ATMCPrivatePlacementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATMCDisclosurePrivatePlacementAbstract" xlink:to="loc_ATMCPrivatePlacementDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions" xlink:title="00000013 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquity" xlink:title="00000015 - Disclosure - Shareholder&#8217;s Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ATMCEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATMCEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="loc_us-gaapDeferredChargesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredChargesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative" xlink:title="00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PostBusinessCombinationMember" xlink:label="loc_ATMCPostBusinessCombinationMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ATMCPostBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="loc_deiEntityIncorporationDateOfIncorporation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_deiEntityIncorporationDateOfIncorporation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaapOtherDeferredCostsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDeferredCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="loc_ATMCPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_BusinessCombinationInitialPublicOfferingDescription" xlink:label="loc_ATMCBusinessCombinationInitialPublicOfferingDescription" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCBusinessCombinationInitialPublicOfferingDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WorkingCapital" xlink:label="loc_ATMCWorkingCapital" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_ATMCWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000019 - Disclosure - Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" xlink:label="loc_ATMCWeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ATMCWeightedAverageNumberOfSharesCommonStockSubjectToForfeiture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="00000020 - Disclosure - Initial Public Offering (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosureInitialPublicOfferingAbstract" xlink:label="loc_ATMCDisclosureInitialPublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATMCDisclosureInitialPublicOfferingAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000021 - Disclosure - Private Placement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_DisclosurePrivatePlacementAbstract" xlink:label="loc_ATMCDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ATMCDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000022 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_PromissoryNoteMember" xlink:label="loc_ATMCPromissoryNoteMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ATMCPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtProductOrServiceAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CommonStockSharesSubjectToForfeiture" xlink:label="loc_ATMCCommonStockSharesSubjectToForfeiture" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCCommonStockSharesSubjectToForfeiture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:label="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CashFee" xlink:label="loc_ATMCCashFee" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ATMCCashFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="loc_us-gaapAdministrativeFeesExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAdministrativeFeesExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnderwritersMember" xlink:label="loc_ATMCUnderwritersMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ATMCUnderwritersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="loc_us-gaapPaymentsForUnderwritingExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsForUnderwritingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000024 - Disclosure - Shareholder&#8217;s Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_CommonStockSharesSubjectToForfeiture" xlink:label="loc_ATMCCommonStockSharesSubjectToForfeiture" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ATMCCommonStockSharesSubjectToForfeiture" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000025 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_UnderwritersMember" xlink:label="loc_ATMCUnderwritersMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ATMCUnderwritersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ATMCSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_SponsorMember" xlink:label="loc_ATMCSponsorMember_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ATMCSponsorMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_WorkingCapital" xlink:label="loc_ATMCWorkingCapital" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_VendorsOutstandingBalances" xlink:label="loc_ATMCVendorsOutstandingBalances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCVendorsOutstandingBalances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_OutstandingBalancesTransferred" xlink:label="loc_ATMCOutstandingBalancesTransferred" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCOutstandingBalancesTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atmc-20221231.xsd#ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:label="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ATMCAdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649322592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALPHATIME
ACQUISITION CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001889106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500
                                            5th Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
                                            938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New
    York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(347)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">627-0058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,034,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">UHY LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New
York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember', window );">Units, each consisting of one ordinary share, one redeemable warrant and one right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units,
    each consisting of one ordinary share, one redeemable warrant and one right<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATMCU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATMC_OrdinarySharesParValue0.0001PerShareMember', window );">Ordinary Shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
    Shares, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATMC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember', window );">Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATMCW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember', window );">Rights, each right entitling the holder thereof to one-tenth of one ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Rights,
    each right entitling the holder thereof to one-tenth of one ordinary share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATMCR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATMC_OrdinarySharesParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATMC_OrdinarySharesParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710648381568">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,052<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">584,518<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">592,570<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">592,570<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued offering costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">196,806<span></span>
</td>
<td class="nump">110,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">380,566<span></span>
</td>
<td class="nump">291,930<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">577,372<span></span>
</td>
<td class="nump">402,445<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">577,372<span></span>
</td>
<td class="nump">402,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (See Note 6)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholder&#8217;s Equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">173<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,827<span></span>
</td>
<td class="nump">24,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,802)<span></span>
</td>
<td class="num">(9,018)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholder&#8217;s Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,198<span></span>
</td>
<td class="nump">15,982<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholder&#8217;s Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">592,570<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholder&#8217;s Equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholder&#8217;s Equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes an aggregate of up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z39ZHBgJSMT8" title="Sharebased payment award options forfeitures">225,000</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on
    January 6, 2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See
                                            Note 7 for the changes in the structure of Ordinary Shares.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649228592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Sharebased payment award options forfeitures</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649244000">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Formation costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,018<span></span>
</td>
<td class="nump">$ 784<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,018<span></span>
</td>
<td class="nump">784<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (9,018)<span></span>
</td>
<td class="num">$ (784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average ordinary shares outstanding, basic and diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,319,444<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">This
    number excludes weighted average shares outstanding considered for <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVdveBXlyV21" title="Sharebased payment award options forfeitures">225,000</span> Ordinary Shares subject to forfeiture depending on the
    extent to which the over-allotment option is not exercised by the underwriters (see Notes 5 and 7). The underwriters subsequently
    exercised the over-allotment option in full on January 6, 2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650548192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Sharebased payment award options forfeitures</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710645645760">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statements of Changes in Shareholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Sep. 14, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 14, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Ordinary Shares to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">24,856<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Bonus issue allotment to the Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 29<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Bonus issue allotment to the Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">287,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,018)<span></span>
</td>
<td class="num">(9,018)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">24,827<span></span>
</td>
<td class="num">(9,018)<span></span>
</td>
<td class="nump">15,982<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(784)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 24,827<span></span>
</td>
<td class="num">$ (9,802)<span></span>
</td>
<td class="nump">$ 15,198<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79" title="Sharebased payment award options forfeitures">187,500</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zeJ1C2au4wtj" title="Sharebased payment award options forfeitures">37,500</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710648971552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Changes in Shareholders' Equity (Parenthetical) - Over-Allotment Option [Member] - shares<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Sharebased payment award options forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Sharebased payment award options forfeitures</a></td>
<td class="nump">187,500<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649641872">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (9,018)<span></span>
</td>
<td class="num">$ (784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in current assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,466)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued offering costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,018<span></span>
</td>
<td class="nump">40,802<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash&#8212;beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash&#8212;end of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty', window );">Deferred offering costs included in due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">282,912<span></span>
</td>
<td class="nump">47,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities', window );">Deferred offering costs included in due to accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,515<span></span>
</td>
<td class="nump">117,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses', window );">Deferred offering costs adjusted from prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares', window );">Issuance of Ordinary Shares in consideration of re-purchase of Class B ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_BonusIssueAllotmentToSponsor', window );">Bonus issue allotment to the Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See
    Note 7 for the changes in the structure of Ordinary Shares.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_BonusIssueAllotmentToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bonus Issue Allotment To Sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_BonusIssueAllotmentToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs Adjusted From Prepaid Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs Included In Due To Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs Included In Due To Related Party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Ordinary Shares In Consideration Of Repurchase Of Class B Ordinary Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650931072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization, Business Operations and Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Organization, Business Operations and Going Concern</a></td>
<td class="text"><p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zUkR7KHWkmTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1 &#8211; <span id="xdx_829_zju43jbxuH5k">Description of Organization, Business Operations and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AlphaTime
Acquisition Corp (the &#8220;Company&#8221;) was incorporated in Cayman Islands on <span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231_znzjOnlJRGI3" title="Date of incorporation">September 15, 2021</span>. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had not commenced any operations. All activities for the year ended December 31, 2022, and for the
period from September 15, 2021 (inception) through December 31, 2021, relate to the Company&#8217;s formation and the Initial Public
Offering described below. The Company will not generate any operating revenues until the completion of its initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial
Public Offering (&#8220;IPO&#8221;). The Company has selected December 31 as its fiscal year end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s sponsor is Alphamade Holding LP, a Delaware limited partnership (the &#8220;Sponsor&#8221;). The registration statement
for the Company&#8217;s IPO was declared effective on December 30, 2022 (the &#8220;Effective Date&#8221;). On January 4, 2023, the Company
consummated the IPO of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zr5SsnIQAAKe" title="Issuance of ordinary share, shares">6,000,000</span> units (the &#8220;Units&#8221;). Each Unit consists of one ordinary share of the Company, par value
$<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfra0tDUANI6" title="Ordinary share par value">0.0001</span> per share (the &#8220;Ordinary Shares&#8221;), one redeemable warrant (the &#8220;Warrants&#8221;) and one right (the &#8220;Rights&#8221;),
with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of an initial Business Combination,
subject to adjustment. The Units were sold at a price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0tuUGv13js4" title="Sale of stock, price per share">10.00</span> per Unit, generating gross proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7G96pK3PAt9" title="Proceeds from sale of units">60,000,000</span>. On
January 6, 2023, Chardan Capital Markets, LLC exercised its over-allotment option (the &#8220;Overallotment&#8221;), which subsequently
closed on January 9, 2023, to purchase an additional <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKHiaRtLlig5" title="Issuance of share to sponsor, shares">900,000</span> Units at a public offering price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhy9pyYLfYh2" title="Sale of stock, price per share">10.00</span> per Unit, generating additional
gross proceeds to the Company of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3j4K7vANuhh" title="Proceeds from sale of units">9,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, the Company completed the sale of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zJIU1hV6fcu7" title="Number of private units sold, shares">370,500</span> private units to the Sponsor (the &#8220;Private Units&#8221;)
at a purchase price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zDgedv021tI2" title="Sale of stock, price per share">10.00</span> per Private Unit, generating gross proceeds to the Company of $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkAjP4fcvGA9" title="Proceeds from sale of units">3,705,000</span>. Simultaneously with the closing
of the Overallotment, the Company completed the private sale of an additional <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAXdF52StLv2" title="Sale of stock number of shares issued in transaction">38,700</span> Private Units, at a purchase price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJM4GoIiSjw1" title="Sale of stock, price per share">10.00</span> per
Private Unit, generating additional gross proceeds to the Company of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrazFFCTf5h3" title="Proceeds from sale of units">387,000</span>. Transaction costs amounted to $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeLj1JY04a6f" title="Transaction cost">4,892,699</span> consisting of
$<span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgLwcMLZN9si" title="Payments for underwriting expense">1,612,500</span> of underwriting discount, $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWH0QPZ5999e" title="Deferred underwriting commission">2,415,000</span> of deferred underwriting commission and $<span id="xdx_902_eus-gaap--OtherDeferredCostsNet_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF999otopvCh" title="Other offering costs">865,199</span> of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4NzIS9jYNwf" title="Sale of stock value issued">70,242,000</span> of the proceeds from the IPO and the sale of
the Private Units (including the Overallotment of the Units and Private Units) were placed in a U.S.-based Trust Account at J.P. Morgan
Chase Bank, N.A. maintained by American Stock Transfer &amp; Trust Company, acting as trustee and will be invested only in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 180 days or less or
in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct
U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released
to the Company to pay income tax obligations, the proceeds from the IPO will not be released from the Trust Account until the earlier
of the completion of a Business Combination or the Company&#8217;s liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale
of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a
Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses
or assets with a fair market value equal to at least <span id="xdx_906_ecustom--PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zuq6JJdBEZC6" title="Percentage of fair market value of business acquisition">90</span>% of the assets held in the Trust Account (as defined below) (excluding the amount
of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business
Combination if the post-Business Combination company owns or acquires <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20221231__us-gaap--BusinessAcquisitionAxis__custom--PostBusinessCombinationMember_zdMkaiU9Mo47" title="Percentage of voting interests acquired">50</span>% or more of the issued and outstanding voting securities of
the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an
investment company under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). There is no assurance
that the Company will be able to complete a Business Combination successfully.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Shareholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvyNt7kIDMC3" title="Shares issued price per share">10.18</span> per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable). The Public Shares subject to redemption will be recorded
at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting
Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zLnE32xrnYK3" title="Business combination, net tangible assets">5,000,001</span> (so that it does
not then become subject to the SEC&#8217;s &#8220;penny stock&#8221; rules) or any greater net tangible asset or cash requirement that
may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination,
the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving
a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does
not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum
and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the
&#8220;SEC&#8221;), and file tender offer documents containing substantially the same information as would be included in a proxy statement
with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial
Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public
Shares, without voting, and if they do vote, irrespective of whether they vote for or against an initial business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant
to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder
is acting in concert or as a &#8220;group&#8221; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public
Shares without the Company&#8217;s prior written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association
(i) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with the Company&#8217;s initial
business combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination
Period (as defined below) or (ii) with respect to any other provision relating to shareholder&#8217;s rights or pre-initial business
combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval
of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public
Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--BusinessCombinationInitialPublicOfferingDescription_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTXLobhMbHic" title="Business combination description">The
Company will have until 9 months (or up to 18 months, if we extend the time to complete a Business Combination as described in our Registration Statement)
from the closing of the Initial Public Offering to consummate a Business Combination (the &#8220;Combination Period&#8221;). However,
if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to us to pay our taxes, if any (less up to $<span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_z0XKuhqmrRSf" title="Taxes payable and less interest to pay dissolution expenses">100,000</span> of interest to pay dissolution expenses),
divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public
Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company&#8217;s remaining Public Shareholders and its Board of Directors,
liquidate and dissolve, subject in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law.</span> The Sponsor has agreed to waive its rights to liquidating distributions from the Trust
Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination
Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating
distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters
have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company
does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other
funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering
price per Unit ($<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4qUCwMnDoH" title="Sale of stock, price per share">10.00</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent
any claims by a third party (other than the Company&#8217;s independent registered public accounting firm) for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amount of funds in the Trust Account to below the lesser of (1) $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLERwIlLAFc4" title="Shares issued price per share">10.18</span> per Public Share and (2) the actual amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuLGvcKnVHVk" title="Shares issued price per share">10.18</span> per Public Share, due to reductions
in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any
claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the
Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will
seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers (other than the Company&#8217;s independent registered public accounting firm), prospective target
businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest
or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the Company had <span id="xdx_900_eus-gaap--Cash_iI_do_c20221231_zDFzDbHzZLW6" title="Cash">no</span> cash and a working capital of $<span id="xdx_90C_ecustom--WorkingCapital_iI_c20221231_zG0LxahHb8Kf" title="Working capital">15,198</span>, included deferred offering costs. The Company has incurred and expects to continue
to incur significant costs in pursuit of its acquisition plans. On January 4, 2023, the Company consummated its IPO and private placement
which generated gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJQDdIwPIQ61" title="Proceeds from sale of units">60,000,000</span> and $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUk6W0nVvCsf" title="Proceeds from sale of units">4,092,000</span>, respectively, and effective January 9, 2023, the underwriters exercised
their over-allotment option which generated gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z5izBWxW3kvk" title="Proceeds from sale of units">9,000,000</span>. Following the closing of the IPO, including the over-allotment,
the private placement, and after deducting IPO transaction costs, the Company placed $<span id="xdx_909_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkCkMZ34SWqk" title="Cash in trust accouint">70,242,000</span> into the Trust Account and had $<span id="xdx_90E_eus-gaap--Cash_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4t44Adx5PXe" title="Cash in bank account">525,554</span>
held in the Company&#8217;s bank account as of January 9, 2023, available for working capital needs as against estimated expenses of
$<span id="xdx_902_eus-gaap--CostsAndExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2JAe5888cz2" title="Estimated expenses">600,000</span> for the period of 12 months from December 31, 2022. The Company lacks the financial resources it needs to sustain operations
for a reasonable period of time. Moreover, management&#8217;s plans to consummate the initial business combination may not be successful.
These factors, among others, raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#8217;s financial position, results of its operations, close of the Initial Public Offering, and/or
search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650750800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zx922vZfC8pk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2 - <span><span id="xdx_823_zWYxsGlLlZA">Significant Accounting Policies</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbmngyE7Cjr7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z60VHDt2Lb93">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecustom--EmergingGrowthCompanyPolicyTextBlock_zRrRTJQFo32b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zFpluZUDTtD3">Emerging
Growth Company Status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statement with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--UseOfEstimates_zDqkBD5msYhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zYCsX0hDpxai">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statement and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly
from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zfHZ1AcQEcOl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zP8x6Q82sxcf">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_z4a4e3wmGFt2" title="cash equivalents"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z9cW93xcMMyf" title="cash equivalents">no</span></span> cash equivalents as of December 31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXoSRwyU0zN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zb6cXwvwWMFj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zJSIrn656xRb" title="Cash, FDIC insured amount">250,000</span>. At December 31, 2022 and 2021, the Company had not
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_zsY5TrDcTvzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zs2axKg6Mk2a">Deferred
Offering Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 340-10-S99-1. Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through
the balance sheet date that are directly related to the IPO and that will be charged to shareholder&#8217;s deficit upon the completion
of the IPO. As of December 31, 2022 and 2021, deferred offering costs amounted to $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20221231_zLTHn2ZSCN7g" title="Deferred offering costs">584,518</span> and $<span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_c20211231_zG4Yh5BxJVLg" title="Deferred offering costs">418,427</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zZ2slRtZX3E" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z9moRdOLfXsi">Net
Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share is computed by dividing net loss by the weighted average number of shares of Ordinary Shares outstanding during the period,
excluding shares of Ordinary Shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_903_ecustom--WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_c20220101__20221231_zW2wor7igUe6" title="Shares subject to forfeiture">225,000</span>
Ordinary Shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Notes 5 and 7).
At December 31, 2022 and 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of Ordinary Shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z3vfFR8mnCV6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zSeDxucQiQxi">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_ziprP58uhsLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zeEvAsVwkBG">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z2qlYezAyrve" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zYzVsFNchwLc" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zPjR4fc2Nwac" title="Accrued for interest and penalties"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_z8yIVe1iAIsl" title="Accrued for interest and penalties">no</span></span> amounts accrued for interest and penalties as of December 31, 2022
and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material
deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7RkTwEXNu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8uGfbXCKYT">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s financial statements.</span></p>

<p id="xdx_85F_zVKztYoEIKP3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650917648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_DisclosureInitialPublicOfferingAbstract', window );"><strong>Initial Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_InitialPublicOfferingDisclosureTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><p id="xdx_80F_ecustom--InitialPublicOfferingDisclosureTextBlock_zDxcqjxty9G" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3 &#8211; <span id="xdx_823_z517F6ZWPZpf">Initial Public Offering</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company sold <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQpEh6gwZt14" title="Issuance of share to sponsor, shares">6,000,000</span> Units, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zw5Z1F0qkO1c" title="Sale of stock, price per share">10.00</span> per Unit. On January 9, 2023, the Company issued an
additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pdd" title="Issuance of share to sponsor, shares">900,000</span> Units, at a purchase price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Sale of stock, price per share">10.00</span> per unit, in connection with the over-allotment option. Each Unit consists of
one Ordinary Share, one Warrant and one Right, with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share
upon the completion of an initial business combination, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants will become exercisable at $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLU8HfBw68Nh" title="Warrant exercise price">11.50</span> per share, subject to adjustment, on the later of 30 days after the completion of the initial
Business Combination or 12 months from the closing of our Initial Public Offering and will expire at 5:00 p.m., New York City time, five years after
the completion of the initial business combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0" title="Sale of stock value issued">70,242,000</span> (at $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Shares issued price per share">10.18</span> per Unit) from the net proceeds of
the sale of the Units in the IPO and the sale of the Private Placement Units was placed in a Trust Account, which may only be invested
in U.S. &#8220;government securities&#8221;, within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity
of 180 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act, which
invest only in direct U.S. government treasury obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_DisclosureInitialPublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_DisclosureInitialPublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering [Disclosure Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710651988768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_DisclosurePrivatePlacementAbstract', window );"><strong>Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_PrivatePlacementDisclosureTextBlock', window );">Private Placement</a></td>
<td class="text"><p id="xdx_804_ecustom--PrivatePlacementDisclosureTextBlock_zs9Z6tHIeq98" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4 - <span id="xdx_82A_zzzaKaaC2Hll">Private Placement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkLIY4wdNieg" title="Number of private units sold, shares">370,500</span> Private Placement Units at a price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pp0p0_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zyLC0gU75eRe" title="Sale of stock, price per share">10.00</span> per Private Placement
Unit, for an aggregate purchase price of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zBqs88z8uA0e" title="Proceeds from sale of units">3,705,000</span>, in a private placement (the &#8220;Private Placement&#8221;). Each whole Private
Placement Unit will consist of one ordinary share, one warrant (&#8220;Private Warrant&#8221;) and one right (&#8220;Private Right&#8221;)
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of an initial business combination. Each
Private Warrant entitles the holder to purchase one ordinary share at a price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1UKw2E71FD7" title="Sale of stock, price per share">11.50</span> per share, subject to adjustment. The proceeds
from the Private Placement Units were added to the proceeds from the IPO held in the Trust Account. Effective January 9, 2023, the underwriters
fully exercised the over-allotment option and the Company completed the private sale of an aggregate of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPGqLoRiJpA5" title="Number of private units sold, shares">38,700</span> Private Placement Units
at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrxgTCxAKhtk" title="Sale of stock, price per share">10.00</span> per Private Placement Unit, generating gross proceeds of $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpY2tm0B3Z4b" title="Proceeds from sale of units">387,000</span>. If the Company does not complete a Business Combination
within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_DisclosurePrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_DisclosurePrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_PrivatePlacementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private Placement [Disclosure Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_PrivatePlacementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650943584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z5dU2JDERFy" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5 - <span id="xdx_82B_z3n1QKYVvSA5">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Sponsor received <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znDAeg3Bxqwa" title="Number of shares issued, sale of transactions">1,437,500</span> of the Company&#8217;s Class B ordinary shares in exchange for $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8rN9t9xbJY1" title="Sale of stock, value">25,000</span> paid for deferred
offering costs borne by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes (see Note 7):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of the authorized but unissued <span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zaUbkw3txeLi" title="Common stock shares subject to forfeited">200,000,000</span> Class A ordinary shares were cancelled and re-designated as the ordinary shares of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zSJOorZaOsvf" title="Common stock, par value">0.0001</span>
par value each;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the <span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zvd87faaG2xl" title="Number of shares repurchased">1,437,500</span> Class B ordinary shares in issue were repurchased in consideration for the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zWHbX8XQtNJk" title="Issuance of ordinary shares issued">1,437,500</span> ordinary shares
of $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8MjWzIIZ5hg" title="Common stock, par value">0.0001</span> par value each; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon completion of the above steps, the authorized but unissued <span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlgCdE82JAYi" title="Common stock shares cancelled">20,000,000</span> Class B ordinary shares were cancelled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the Company issued an additional <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zrihGGQwk3n7" title="Number of additional shares issued to sponsor">287,500</span> ordinary shares to the Sponsor for no additional consideration, resulting in
the Sponsor holding an aggregate of <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztYfxIFmY8B9" title="Common stock shares outstanding">1,725,000</span> ordinary shares (the &#8220;Founder Shares&#8221;). The issuance was considered as a bonus
share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include
an aggregate of up to <span id="xdx_909_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYGGRFA6656b" title="Common stock shares subject to forfeiture">225,000</span> ordinary shares subject to forfeiture to the extent that the underwriters&#8217; over-allotment is not
exercised in full or in part (refer Note 7). On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment
option with respect to the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdZzUUwxfsjg" title="Number of additional units">900,000</span> additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the
Company of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZREcAhOVrad" title="Number of additional units">9,000,000</span>. Simultaneously, an amount of $<span id="xdx_90D_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zzTrIw4uTRpj" title="Due to related party amount converted">352,350</span> due to related party was converted into over-allotment of Private Placement,
and the underwriter deposited additional $<span id="xdx_90A_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUorjUNeSAmi" title="Additional amount deposited by underwriter on behalf of related party">34,650</span> on behalf of Sponsor for <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zqVQ0fnT8Vkb" title="Sale of stock number of shares issued in transaction">17,325</span> Founder Shares for $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zq1gPSUm4L6f" title="Sale of stock price per share">2</span> per share which was sold by the
Sponsor to underwriters. As a result, the Sponsor purchased additional <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zbtx9GQmNtNj" title="Sale of stock number of shares issued in transaction">38,700</span> Private Placement Units, an aggregate of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSoyuHZck8lc" title="Aggregate number of units issued">409,200</span> units
at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7M3kMhWSsj1" title="Share issued price per share">10.00</span> per Private Placement Unit (an aggregate of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaTzfua0yVqi" title="Aggregate value of shares issued">4,092,000</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2023, the Founder Shares and Private Placement Units were placed into an escrow account maintained
by American Stock Transfer &amp; Trust Company acting as escrow agent. <span id="xdx_900_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230102__20230103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zX2fzeWfN07k" title="Description of sale of shares">The Founder Shares and Private Placement Units (and underlying
securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of
the Founder Shares and Private Placement Units (and underlying securities) until the earlier to occur of: (A) six months after the date
of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or
exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days
within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and
Private Placement Units (and underlying securities) until six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities
or other property</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note&#8201;&#8212;&#8201;Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#8220;Promissory Note&#8221;), pursuant to which
the Company may borrow up to an aggregate principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z9OmLcjoc6Kb" title="Loan amount">300,000</span>. <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20210929__20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z01MrAeg7wHg" title="Description of maturity date">The Promissory Note was amended and restated on November 23,
2021, to change the December 31, 2021 due date to March 31, 2022, amended and restated on January 26, 2022 to change the March 31, 2022
due date to May 31, 2022 and amended and restated again on October 20, 2022 to change the May 31, 2022 due date to December 31, 2022.
The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, or (ii) the consummation of the Initial
Public Offering. As of December 31, 2022 and 2021, there were no amounts outstanding under the Promissory Note and Promissory Note has
expired on December 31, 2022</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Due
to Related Party</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest
bearing. As of December 31, 2022 and 2021, due to related party amounted to $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_c20221231_zrZCTI1bK0Xj" title="Due to related party">380,566</span> and $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231_zNv299jOhxVg" title="Due to related party">291,930</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advisory
Services Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged TenX Global Capital LP (&#8220;TenX&#8221;), a related party to the Company, as an advisor in connection with the Initial
Public Offering and business combination, to assist in hiring consultants and other services providers in connection with our Initial Public Offering
and the business combination, assist in the preparation of financial statements and other relevant services to commence trading including
filing the necessary documents as part of the transaction. Further, TenX will assist in preparing the Company for investor presentations,
conferences for due diligence, deal structuring and term negotiations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period from September 15, 2021 (inception) through December 31, 2022, a cash fee of $<span id="xdx_908_ecustom--CashFee_c20210915__20221231_zxqU0XYU1me8" title="Cash Fee">200,000</span> has been incurred as deferred offering
costs for these services of which $<span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_c20211231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zdSyUGgOIwYa">160,000</span> has been paid by the Sponsor through December 31, 2021 and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20221231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zGt6r0SWw7vl">40,000</span> was recorded as accrued
offering costs as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administration
fee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on the effective date of the registration statement, an affiliate of the Sponsor shall be allowed to charge the Company an allocable
share of its overhead, up to $<span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zfU9b4k4sIUf" title="Sponsor fees">10,000</span> per month up to the close of the business combination, to compensate it for the Company&#8217;s
use of its offices, utilities and personnel. An administration fee of $<span id="xdx_901_eus-gaap--AdministrativeFeesExpense_c20220101__20221231_zllGKUOW3Vl4" title="Administration fee">667</span> was recorded for the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650716416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcucOtTdAkWh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6 - <span id="xdx_827_zOV3NwJXR0N7">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (&#8220;UPO&#8221;), and Units
that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement
Units) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective
date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be
entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition,
the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to completion
of a business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities
Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or
cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriters
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters had a 45-day option beginning January 4, 2023, to purchase up to an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_za8E9225IMwj" title="Issuance of share to sponsor, shares">900,000</span> units to cover over-allotments, if
any, at the IPO price less the underwriting discounts and commissions. On January 6, 2023 and effective January 9, 2023, the underwriters
exercised their over-allotment option in full and purchased an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJLIYrEFti4j" title="Issuance of share to sponsor, shares">900,000</span> units at $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zSKl8nFFJ3il" title="Sale of stock, price per share">10.00</span> per unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company paid a fixed underwriting discount of $<span id="xdx_90E_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXZ3GSmT73yc" title="Underwriting discount">1,500,000</span> and on January 9, 2023, it paid an additional $<span id="xdx_902_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1ORtPk35jN8" title="Underwriting discount">112,500</span>
of underwriting fees arising from the sale of the over-allotment units. The underwriters will be entitled to a deferred commission of
$<span id="xdx_902_eus-gaap--SharePrice_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zXPv2m7LoUHl" title="Share price">0.35</span> per Unit, or $<span id="xdx_904_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zIoJIcb4TQre" title="Deferred underwriting commission">2,415,000</span> in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the
Trust Account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unit
Purchase Option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2022, we sold to the underwriters, for $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zWwlAa2DTbJ3" title="Sale of price per share">100.00</span>, <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221229__20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_z7wyzrFQgawl" title="Number of stock exercisable, shares">58,000</span> Units exercisable, in whole or in part, at $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zbhJFntbZw4j" title="Share issued price per share">11.50</span> per unit (or
115% of the Market Value), commencing on the consummation of our initial business combination, and expires five years from the
effective date of our Initial Public Offering. <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20221229__20221230_zvnUFGeDQIpk" title="Option description">The option and the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20221229__20221230_z32hclBc0oGl" title="Number of units option exercised, shares">58,000</span> Units, as well as the <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221229__20221230_zyyigFdZ2SZc" title="Number of ordinary shares">58,000 </span>ordinary shares, the warrants
to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20221230_zAFv1B5pvFw7" title="Warrants to purchase common shares">58,000</span> ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares
upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a
lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule
5110(e)(1) of FINRA&#8217;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or
be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710652021120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholder&#8217;s Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholder&#8217;s Equity</a></td>
<td class="text"><p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ztFxLxd9UZ76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7 - <span id="xdx_827_zK0FPKsTbAO1">Shareholder&#8217;s Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
shares </i></b>- The Company is authorized to issue <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zSI1It1Ygfej" title="Preferred stock, shares authorized">1,000,000</span> shares of preferred shares with a par value of $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zp32chfvoh9h" title="Preferred stock, par value">0.0001</span> per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
As of December 31, 2022, there were <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zg5apCfhuqmf" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zK43BmZypYzb" title="Preferred stock, shares outstanding">no</span></span> preferred shares issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRIAX8Bl9TGf" title="Commo stock, shares authorized">200,000,000</span> Class A ordinary shares with a par value of $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDcj2mBIgRDk" title="Common stock, par value">0.0001</span> per share and <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zxd4grT4i6t7" title="Commo stock, shares authorized">20,000,000</span> Class B ordinary
shares with a par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8EnvECw90ic" title="Common stock, par value">0.0001</span> per share. <span id="xdx_904_eus-gaap--CommonStockVotingRights_c20220101__20221231_ziGgjSdHS4A6" title="Common stock voting rights">Holders of Class A and Class B ordinary shares were entitled to one vote for each share</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Sponsor received <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXDTdn2Mqqbj" title="Number of shares issued">1,437,500</span> of the Company&#8217;s Class B ordinary shares in exchange for $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zePKbbTEnHdg" title="Number of shares issued, value">25,000</span> paid for deferred
offering costs borne by the Sponsor. Out of the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsAUs5PlN7Kg" title="Number of shares issued">1,437,500</span> Class B ordinary shares, an aggregate of up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210927__20210928__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVSUUk2vVn26" title="Number of shares forfeitured">187,500</span> Class B ordinary shares
were subject to forfeiture to the extent that the underwriters&#8217; over-allotment option is not exercised in full or in part so that
the number of Founder Shares will equal 20% of the Company&#8217;s issued and outstanding ordinary shares after the Initial Public Offering
(excluding private placement shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of the authorized but unissued <span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z54daZiJ1312" title="Common stock shares subject to forfeited">200,000,000</span> Class A ordinary shares were cancelled and re-designated as the ordinary shares of $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqDsLlMrUfgd" title="Common stock, par value">0.0001</span>
par value each;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each of the <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziajJ0Evw8y8" title="Number of shares in issue were repurchased">1,437,500</span> Class B ordinary shares in issue were repurchased in consideration for the issuance of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8SQzHUvOpm2" title="Issuance of ordinary shares to sponsor">1,437,500</span> ordinary shares
of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zkoQwTkp7nmc" title="Common stock, par value">0.0001</span> par value each; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon completion of the above steps, the authorized but unissued <span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwJSIkSwwdTc" title="Common stock shares subject to forfeited">20,000,000</span> Class B ordinary shares were cancelled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an effect of the above, the Company is authorized to issue <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220108_ziBTI2ut9tta" title="Common stock shares authorized">200,000,000</span> ordinary shares with a par value of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108_zOtkqdo7FWgj" title="Common stock, par value">0.0001</span> per share. <span id="xdx_906_eus-gaap--CommonStockVotingRights_c20220107__20220108_zFNUkZgfWXgj" title="Common stock voting rights">Holders
of ordinary shares are entitled to one vote for each share</span>. Further, the shareholder also approved the amendment and restatement of the
memorandum and articles of association filed with the Cayman Registrar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2022, the Company issued an additional <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zpODIsKTgqJj" title="Number of additional shares issued to sponsor">287,500</span> ordinary shares to the Sponsor as fully paid bonus shares for no additional
consideration. The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded
and presented retroactively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 and 2021, there were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zFEPk3iHf5sj" title="Common stock shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z8q4pMVvrsph" title="Common stock shares outstanding"><span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zngRiHJW3kid" title="Common stock shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziTi8CZO9ODf" title="Common stock shares outstanding">1,725,000</span></span></span></span> ordinary shares issued and outstanding, Concurrent with the closing of this offering, our Sponsor, at the option of the Company,
sold to underwriter or its designees <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231_z9bu2SJFh566" title="Sale of stock shares issued">115,500</span> Founder Shares for a purchase price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20221231_zbclwyN8msW9">2.00</span> per share and an aggregate purchase price of
$<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220101__20221231_zAPID0AEMdaa" title="Sale of stock value issued">231,000</span>, as part of the exercise of overallotment option by the underwriter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2023, the Company converted an amount of $<span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zjiM7eQf7tT3" title="Due to related party amount converted">352,350</span> into over-allotment of Private Placement Units (see note 8). The
Company had accounted for these proceeds received as of December 31, 2022, as Due to related party, pending final allotment to the
Sponsor. On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to
the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBJ7R99GQ7E2" title="Number of additional units">900,000</span> additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of
$<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKRIbeyAs4ki" title="Gross proceeds from exercise of option">9,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710656295744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zGANXJEq1Aa2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8 - <span id="xdx_829_z0qEpeQFT2s1">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through March 23, 2023, which was the date these financial statements were available for issuance
and determined that there were no significant unrecognized events through that date other than those noted below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 4, 2023, the Company consummated the IPO of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxj0xmVw6ced" title="Issuance of share to sponsor, shares">6,000,000</span> units at a price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpNUpB0eEu6" title="Sale of stock, price per share">10.00</span>
                                            per Unit, generating gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBYTgo6kMR5" title="Proceeds from sale of units">60,000,000</span>. Simultaneously with the
                                            closing of the IPO, the Company completed the sale of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zZwSKZyZMYG6" title="Number of private units sold, shares">370,500</span> private units to the Sponsor
                                            at a purchase price of $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zw9Vdm5UOUT4" title="Sale of stock, price per share">10.00</span> per Private Unit, generating gross proceeds to the Company
                                            of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zTLVUfOfaGYg" title="Proceeds from sale of units">3,705,000 </span>(See Notes 1, 3 and 4)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 5, 2023, from cash held in escrow account with amount of $<span id="xdx_904_eus-gaap--EscrowDeposit_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8Mds7xSxBUd" title="Cash held in escrow">779,034</span>, $<span id="xdx_90B_ecustom--WorkingCapital_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy2nXe7VZCc5" title="Working capital">485,054</span> has been
                                            wired to the Company&#8217;s bank account for working capital purposes, within which $<span id="xdx_90C_ecustom--VendorsOutstandingBalances_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYrPn1ZNDs0b" title="Vendors outstanding balances">61,681</span>
                                            was pending to distribute to vendors and $<span id="xdx_90B_ecustom--OutstandingBalancesTransferred_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUrBhgszZMrk" title="Outstanding balances transferred">293,980</span> has been transferred to the vendors against
                                            their outstanding balances.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to the <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zn7TQcAs2FTh" title="Issuance of share to sponsor, shares">900,000</span>
    additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3YRVh5FGiPc" title="Proceeds from sale of units">9,000,000</span>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously,
an amount of $<span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z2Cm7xOIpZd3" title="Due to related party amount converted">352,350</span> due to related party was converted into over-allotment of Private Placement, and the underwriter deposited additional
$<span id="xdx_900_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWkaBSgsTlN3" title="Additional amount deposited by underwriter on behalf of related party">34,650</span> on behalf of Sponsor for <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziPB733MYWD5" title="Sale of stock number of shares issued in transaction">17,325</span> Founder Shares for $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zmtz6yNGg0X2" title="Sale of stock price per share">2</span> per share which was sold by the Sponsor to underwriters. As a result, the
Sponsor purchased additional <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztvtjjsB0655" title="Sale of stock number of shares issued in transaction">38,700</span> Private Placement Units, an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zor0xLGNQ60i" title="Aggregate number of units issued">409,200</span> units at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnHQWppSGS9" title="Share issued price per share">10.00</span> per Private Placement
Unit (an aggregate of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAuaRC8y7QI1" title="Aggregate value of shares issued">4,092,000</span>).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company paid a cash underwriting commission of $<span id="xdx_905_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPnJ8uHwIxdi" title="Share issued price per share">0.125</span> per Unit for <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzdJBtgVOuC1" title="Number of additional units">900,000</span> additional Units and the underwriters will be entitled to
a deferred commission of $<span id="xdx_903_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zHY9FJsKplMf" title="Share price">0.35</span> per Unit, an aggregate of $<span id="xdx_906_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zDUwEEW32JL7" title="Deferred underwriting commission">2,415,000</span>, which will be paid from the funds held in the Trust Account upon
completion of Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 9, 2023, an additional $<span id="xdx_90F_ecustom--WorkingCapital_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5sCopN0fG7l" title="Working capital">40,500</span> was wired to the Company&#8217;s bank account for
                                            working capital purposes.</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649280128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbmngyE7Cjr7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z60VHDt2Lb93">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#8220;US GAAP&#8221;) and pursuant to the rules and regulations of the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><p id="xdx_84B_ecustom--EmergingGrowthCompanyPolicyTextBlock_zRrRTJQFo32b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zFpluZUDTtD3">Emerging
Growth Company Status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statement with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--UseOfEstimates_zDqkBD5msYhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zYCsX0hDpxai">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statement in conformity with US GAAP requires the Company&#8217;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statement and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly
from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zfHZ1AcQEcOl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zP8x6Q82sxcf">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_z4a4e3wmGFt2" title="cash equivalents"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z9cW93xcMMyf" title="cash equivalents">no</span></span> cash equivalents as of December 31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXoSRwyU0zN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zb6cXwvwWMFj">Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zJSIrn656xRb" title="Cash, FDIC insured amount">250,000</span>. At December 31, 2022 and 2021, the Company had not
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_zsY5TrDcTvzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zs2axKg6Mk2a">Deferred
Offering Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with the requirements of the Financial Accounting Standards Board (the &#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 340-10-S99-1. Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through
the balance sheet date that are directly related to the IPO and that will be charged to shareholder&#8217;s deficit upon the completion
of the IPO. As of December 31, 2022 and 2021, deferred offering costs amounted to $<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20221231_zLTHn2ZSCN7g" title="Deferred offering costs">584,518</span> and $<span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_c20211231_zG4Yh5BxJVLg" title="Deferred offering costs">418,427</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zZ2slRtZX3E" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z9moRdOLfXsi">Net
Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share is computed by dividing net loss by the weighted average number of shares of Ordinary Shares outstanding during the period,
excluding shares of Ordinary Shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of <span id="xdx_903_ecustom--WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_c20220101__20221231_zW2wor7igUe6" title="Shares subject to forfeiture">225,000</span>
Ordinary Shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Notes 5 and 7).
At December 31, 2022 and 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of Ordinary Shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z3vfFR8mnCV6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zSeDxucQiQxi">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC 820, &#8220;<i>Fair Value
Measurement</i>,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_ziprP58uhsLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zeEvAsVwkBG">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#8220;<i>Income Taxes</i>.&#8221; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were <span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z2qlYezAyrve" title="Unrecognized tax benefits"><span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zYzVsFNchwLc" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zPjR4fc2Nwac" title="Accrued for interest and penalties"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_z8yIVe1iAIsl" title="Accrued for interest and penalties">no</span></span> amounts accrued for interest and penalties as of December 31, 2022
and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material
deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#8217;s financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7RkTwEXNu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z8uGfbXCKYT">Recent
Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#8217;s financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710643653072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization, Business Operations and Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 05, 2023</div></th>
<th class="th"><div>Jan. 08, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in bank account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ATMC_PostBusinessCombinationMember', window );">Post-business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance', window );">Percentage of fair market value of business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business combination, net tangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="nump">$ 112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_WorkingCapital', window );">Working capital</a></td>
<td class="nump">40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 485,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_BusinessCombinationInitialPublicOfferingDescription', window );">Business combination description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company will have until 9 months (or up to 18 months, if we extend the time to complete a Business Combination as described in our Registration Statement)
from the closing of the Initial Public Offering to consummate a Business Combination (the &#8220;Combination Period&#8221;). However,
if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses),
divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public
Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company&#8217;s remaining Public Shareholders and its Board of Directors,
liquidate and dissolve, subject in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Estimated expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes payable and less interest to pay dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,892,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,612,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash in bank account</a></td>
<td class="nump">525,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash in trust accouint</a></td>
<td class="nump">$ 70,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from sale of units</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="nump">$ 387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_BusinessCombinationInitialPublicOfferingDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Initial Public Offering Description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_BusinessCombinationInitialPublicOfferingDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ATMC_PostBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ATMC_PostBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649246368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 584,518<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture', window );">Shares subject to forfeiture</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued for interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of shares common stock subject to forfeiture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650286064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of share to sponsor, shares</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649071744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of private units sold, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of private units sold, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of private units sold, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of private units sold, shares</a></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="nump">$ 387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710641627728">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">16 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Jan. 03, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 28, 2022</div></th>
<th class="th"><div>Jan. 08, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291,930<span></span>
</td>
<td class="nump">$ 380,566<span></span>
</td>
<td class="nump">$ 380,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CashFee', window );">Cash Fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,427<span></span>
</td>
<td class="nump">584,518<span></span>
</td>
<td class="nump">584,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Administration fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ATMC_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Description of maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Promissory Note was amended and restated on November 23,
2021, to change the December 31, 2021 due date to March 31, 2022, amended and restated on January 26, 2022 to change the March 31, 2022
due date to May 31, 2022 and amended and restated again on October 20, 2022 to change the May 31, 2022 due date to December 31, 2022.
The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, or (ii) the consummation of the Initial
Public Offering. As of December 31, 2022 and 2021, there were no amounts outstanding under the Promissory Note and Promissory Note has
expired on December 31, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Description of sale of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Founder Shares and Private Placement Units (and underlying
securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of
the Founder Shares and Private Placement Units (and underlying securities) until the earlier to occur of: (A) six months after the date
of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or
exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days
within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and
Private Placement Units (and underlying securities) until six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities
or other property<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Number of additional units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeiture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeiture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of additional shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeiture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeiture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of additional shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Sponsor fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party amount converted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty', window );">Additional amount deposited by underwriter on behalf of related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member] | Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member] | Common Class B [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79" title="Sharebased payment award options forfeitures">187,500</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Amount Deposited By Underwriter On Behalf Of Related Party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_CashFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_CashFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_CommonStockSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_CommonStockSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ATMC_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ATMC_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710650328512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584,518<span></span>
</td>
<td class="nump">$ 418,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of stock exercisable, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Option description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants
to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares
upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a
lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule
5110(e)(1) of FINRA&#8217;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or
be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Number of units option exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember', window );">Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of stock exercisable, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Underwriting discount</a></td>
<td class="nump">$ 112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of stock exercisable, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of stock exercisable, shares</a></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710649347360">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Shareholder&#8217;s Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 28, 2022</div></th>
<th class="th"><div>Jan. 08, 2022</div></th>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holders
of ordinary shares are entitled to one vote for each share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holders of Class A and Class B ordinary shares were entitled to one vote for each share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock value issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of additional shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
<td class="nump">1,725,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember', window );">Sponsor [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party amount converted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares forfeitured</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from exercise of option</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Ordinary Shares to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued, value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_CommonStockSharesSubjectToForfeiture', window );">Common stock shares subject to forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares in issue were repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of additional shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79" title="Sharebased payment award options forfeitures">187,500</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_CommonStockSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_CommonStockSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140710645274800">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_WorkingCapital', window );">Working capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418,427<span></span>
</td>
<td class="nump">$ 584,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Cash held in escrow</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 779,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_WorkingCapital', window );">Working capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_VendorsOutstandingBalances', window );">Vendors outstanding balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_OutstandingBalancesTransferred', window );">Outstanding balances transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party amount converted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="nump">$ 352,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty', window );">Additional amount deposited by underwriter on behalf of related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from sale of units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate value of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Subsequent Event [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Aggregate number of units issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from sale of units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,700<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from sale of units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember', window );">Underwriters [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember', window );">Underwriters [Member] | Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred underwriting commission</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    an aggregate of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79" title="Sharebased payment award options forfeitures">187,500</span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Amount Deposited By Underwriter On Behalf Of Related Party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_OutstandingBalancesTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding Balances Transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_OutstandingBalancesTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_VendorsOutstandingBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendors Outstanding Balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_VendorsOutstandingBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ATMC_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ATMC_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ATMC_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ATMC_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ATMC_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ATMC_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ATMC="http://alphatimeacquisitioncorp.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="atmc-20221231.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATMC:RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2023-03-23</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-09-152021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-14_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="AsOf2021-09-14_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="AsOf2021-09-14_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="AsOf2021-09-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2021-09-14</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-09-152021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2021-09-152021-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-05</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-05</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-09</instant>
        </period>
    </context>
    <context id="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-08</startDate>
            <endDate>2023-01-09</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PostBusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ATMC:PostBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_IPOMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-09</instant>
        </period>
    </context>
    <context id="AsOf2023-01-04_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-08_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="From2022-01-072022-01-08_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-07</startDate>
            <endDate>2022-01-08</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-08_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="AsOf2022-01-08_us-gaap_CommonStockMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="From2022-01-072022-01-08_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-07</startDate>
            <endDate>2022-01-08</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-08_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="AsOf2022-01-08_srt_MaximumMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-05</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="From2023-01-022023-01-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATMC:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-09-292021-09-30_custom_PromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ATMC:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-29</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-09-152022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <startDate>2021-09-15</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_ServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-022023-01-04_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="From2023-01-022023-01-04_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-02</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="From2023-01-082023-01-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-08</startDate>
            <endDate>2023-01-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="AsOf2022-12-30_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="From2022-12-292022-12-30_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="From2022-12-292022-12-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="From2022-09-272022-09-28_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-27</startDate>
            <endDate>2022-09-28</endDate>
        </period>
    </context>
    <context id="From2021-09-272021-09-28_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <instant>2022-01-08</instant>
        </period>
    </context>
    <context id="From2022-01-072022-01-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
        </entity>
        <period>
            <startDate>2022-01-07</startDate>
            <endDate>2022-01-08</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ATMC:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="AsOf2023-01-05_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-05</instant>
        </period>
    </context>
    <context id="From2023-01-052023-01-06_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-05</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ATMC:UnderwritersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="AsOf2023-01-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001889106</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-09</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31">0001889106</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-12-31">false</dei:DocumentTransitionReport>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0091"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0182"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-14_us-gaap_CommonStockMember"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-14_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-14_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-14"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-14_us-gaap_CommonStockMember"
      id="xdx2ixbrl0194"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0198"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-09-152021-12-31"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0210"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0222"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-09-152021-12-31"
      id="xdx2ixbrl0259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-09-152021-12-31"
      id="xdx2ixbrl0262"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-09-14"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <ATMC:DeferredOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2021-09-152021-12-31"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <ATMC:IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <ATMC:BonusIssueAllotmentToSponsor
      contextRef="From2022-01-01to2022-12-31"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2022-01-01to2022-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-12-31">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-12-31">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-12-31">001-41584</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31">ALPHATIME ACQUISITION CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-12-31">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-12-31">500                                             5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-12-31">Suite                                             938</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-12-31">New     York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-12-31">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-12-31">10110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-12-31">(347)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-12-31">627-0058</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">Units,     each consisting of one ordinary share, one redeemable warrant and one right</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">ATMCU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-12-31_custom_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember">Ordinary     Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember">ATMC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-12-31_custom_OrdinarySharesParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">Warrants,     each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">ATMCW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-12-31_custom_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">Rights,     each right entitling the holder thereof to one-tenth of one ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">ATMCR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-12-31_custom_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-01-01to2022-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-01-01to2022-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-12-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-01-01to2022-12-31">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2022-01-01to2022-12-31">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-12-31">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">0.00</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-03-23" decimals="INF" unitRef="Shares">9034200</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2022-01-01to2022-12-31">UHY LLP</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2022-01-01to2022-12-31">1195</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="From2022-01-01to2022-12-31">New York, New York</dei:AuditorLocation>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">8052</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">584518</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">418427</us-gaap:DeferredOfferingCosts>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">592570</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">418427</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">592570</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">418427</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">196806</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">110515</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">380566</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">291930</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">577372</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">402445</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">577372</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">402445</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1725000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1725000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1725000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1725000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000132"
      unitRef="USD">173</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">173</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">173</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">173</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">24827</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24827</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-9802</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-9018</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">15198</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15982</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">592570</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">418427</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">784</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">9018</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">784</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">9018</us-gaap:OperatingExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-784</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">-9018</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      id="Fact000179"
      unitRef="Shares">1500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-09-152021-12-31"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">1319444</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-09-152021-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000196"
      unitRef="USD">144</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000197"
      unitRef="USD">24856</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      id="Fact000199"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">287500</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-09-152021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000203"
      unitRef="USD">29</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000204"
      unitRef="USD">-29</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9018</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">-9018</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">173</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24827</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9018</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">15982</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-784</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-784</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">173</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24827</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-9802</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">15198</us-gaap:StockholdersEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-09-152021-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Shares">187500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Shares">37500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-784</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">-9018</us-gaap:NetIncomeLoss>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">8466</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">-31552</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">40802</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">9018</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">47834</ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty>
    <ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">282912</ATMC:DeferredOfferingCostsIncludedInDueToRelatedParty>
    <ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">117843</ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities>
    <ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">110515</ATMC:DeferredOfferingCostsIncludedInDueToAccruedLiabilities>
    <ATMC:DeferredOfferingCostsAdjustedFromPrepaidExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">414</ATMC:DeferredOfferingCostsAdjustedFromPrepaidExpenses>
    <ATMC:IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      id="Fact000283"
      unitRef="USD">25000</ATMC:IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares>
    <ATMC:BonusIssueAllotmentToSponsor
      contextRef="From2021-09-152021-12-31"
      decimals="0"
      unitRef="USD">29</ATMC:BonusIssueAllotmentToSponsor>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zUkR7KHWkmTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1 &#x2013; &lt;span id="xdx_829_zju43jbxuH5k"&gt;Description of Organization, Business Operations and Going Concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;AlphaTime
Acquisition Corp (the &#x201c;Company&#x201d;) was incorporated in Cayman Islands on &lt;span id="xdx_907_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231_znzjOnlJRGI3" title="Date of incorporation"&gt;September 15, 2021&lt;/span&gt;. The Company was formed for the
purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination
with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had not commenced any operations. All activities for the year ended December 31, 2022, and for the
period from September 15, 2021 (inception) through December 31, 2021, relate to the Company&#x2019;s formation and the Initial Public
Offering described below. The Company will not generate any operating revenues until the completion of its initial Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial
Public Offering (&#x201c;IPO&#x201d;). The Company has selected December 31 as its fiscal year end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s sponsor is Alphamade Holding LP, a Delaware limited partnership (the &#x201c;Sponsor&#x201d;). The registration statement
for the Company&#x2019;s IPO was declared effective on December 30, 2022 (the &#x201c;Effective Date&#x201d;). On January 4, 2023, the Company
consummated the IPO of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zr5SsnIQAAKe" title="Issuance of ordinary share, shares"&gt;6,000,000&lt;/span&gt; units (the &#x201c;Units&#x201d;). Each Unit consists of one ordinary share of the Company, par value
$&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfra0tDUANI6" title="Ordinary share par value"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Ordinary Shares&#x201d;), one redeemable warrant (the &#x201c;Warrants&#x201d;) and one right (the &#x201c;Rights&#x201d;),
with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share upon the completion of an initial Business Combination,
subject to adjustment. The Units were sold at a price of $&lt;span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0tuUGv13js4" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds to the Company of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7G96pK3PAt9" title="Proceeds from sale of units"&gt;60,000,000&lt;/span&gt;. On
January 6, 2023, Chardan Capital Markets, LLC exercised its over-allotment option (the &#x201c;Overallotment&#x201d;), which subsequently
closed on January 9, 2023, to purchase an additional &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKHiaRtLlig5" title="Issuance of share to sponsor, shares"&gt;900,000&lt;/span&gt; Units at a public offering price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhy9pyYLfYh2" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Unit, generating additional
gross proceeds to the Company of $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3j4K7vANuhh" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the IPO, the Company completed the sale of &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zJIU1hV6fcu7" title="Number of private units sold, shares"&gt;370,500&lt;/span&gt; private units to the Sponsor (the &#x201c;Private Units&#x201d;)
at a purchase price of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zDgedv021tI2" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Private Unit, generating gross proceeds to the Company of $&lt;span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkAjP4fcvGA9" title="Proceeds from sale of units"&gt;3,705,000&lt;/span&gt;. Simultaneously with the closing
of the Overallotment, the Company completed the private sale of an additional &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAXdF52StLv2" title="Sale of stock number of shares issued in transaction"&gt;38,700&lt;/span&gt; Private Units, at a purchase price of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJM4GoIiSjw1" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per
Private Unit, generating additional gross proceeds to the Company of $&lt;span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrazFFCTf5h3" title="Proceeds from sale of units"&gt;387,000&lt;/span&gt;. Transaction costs amounted to $&lt;span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zeLj1JY04a6f" title="Transaction cost"&gt;4,892,699&lt;/span&gt; consisting of
$&lt;span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgLwcMLZN9si" title="Payments for underwriting expense"&gt;1,612,500&lt;/span&gt; of underwriting discount, $&lt;span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWH0QPZ5999e" title="Deferred underwriting commission"&gt;2,415,000&lt;/span&gt; of deferred underwriting commission and $&lt;span id="xdx_902_eus-gaap--OtherDeferredCostsNet_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zF999otopvCh" title="Other offering costs"&gt;865,199&lt;/span&gt; of other offering costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4NzIS9jYNwf" title="Sale of stock value issued"&gt;70,242,000&lt;/span&gt; of the proceeds from the IPO and the sale of
the Private Units (including the Overallotment of the Units and Private Units) were placed in a U.S.-based Trust Account at J.P. Morgan
Chase Bank, N.A. maintained by American Stock Transfer &amp;amp; Trust Company, acting as trustee and will be invested only in U.S. government
securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 180 days or less or
in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct
U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released
to the Company to pay income tax obligations, the proceeds from the IPO will not be released from the Trust Account until the earlier
of the completion of a Business Combination or the Company&#x2019;s liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale
of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a
Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses
or assets with a fair market value equal to at least &lt;span id="xdx_906_ecustom--PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zuq6JJdBEZC6" title="Percentage of fair market value of business acquisition"&gt;90&lt;/span&gt;% of the assets held in the Trust Account (as defined below) (excluding the amount
of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business
Combination if the post-Business Combination company owns or acquires &lt;span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20221231__us-gaap--BusinessAcquisitionAxis__custom--PostBusinessCombinationMember_zdMkaiU9Mo47" title="Percentage of voting interests acquired"&gt;50&lt;/span&gt;% or more of the issued and outstanding voting securities of
the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an
investment company under the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance
that the Company will be able to complete a Business Combination successfully.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem
all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination
or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $&lt;span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvyNt7kIDMC3" title="Shares issued price per share"&gt;10.18&lt;/span&gt; per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable). The Public Shares subject to redemption will be recorded
at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting
Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $&lt;span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zLnE32xrnYK3" title="Business combination, net tangible assets"&gt;5,000,001&lt;/span&gt; (so that it does
not then become subject to the SEC&#x2019;s &#x201c;penny stock&#x201d; rules) or any greater net tangible asset or cash requirement that
may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination,
the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving
a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting
of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does
not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum
and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the
&#x201c;SEC&#x201d;), and file tender offer documents containing substantially the same information as would be included in a proxy statement
with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial
Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public
Shares, without voting, and if they do vote, irrespective of whether they vote for or against an initial business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant
to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder
is acting in concert or as a &#x201c;group&#x201d; (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the
&#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public
Shares without the Company&#x2019;s prior written consent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association
(i) to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the Company&#x2019;s initial
business combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination
Period (as defined below) or (ii) with respect to any other provision relating to shareholder&#x2019;s rights or pre-initial business
combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval
of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public
Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--BusinessCombinationInitialPublicOfferingDescription_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTXLobhMbHic" title="Business combination description"&gt;The
Company will have until 9 months (or up to 18 months, if we extend the time to complete a Business Combination as described in our Registration Statement)
from the closing of the Initial Public Offering to consummate a Business Combination (the &#x201c;Combination Period&#x201d;). However,
if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to us to pay our taxes, if any (less up to $&lt;span id="xdx_909_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--RangeAxis__srt--MaximumMember_z0XKuhqmrRSf" title="Taxes payable and less interest to pay dissolution expenses"&gt;100,000&lt;/span&gt; of interest to pay dissolution expenses),
divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public
Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company&#x2019;s remaining Public Shareholders and its Board of Directors,
liquidate and dissolve, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law.&lt;/span&gt; The Sponsor has agreed to waive its rights to liquidating distributions from the Trust
Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination
Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating
distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters
have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company
does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other
funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering
price per Unit ($&lt;span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4qUCwMnDoH" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent
any claims by a third party (other than the Company&#x2019;s independent registered public accounting firm) for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amount of funds in the Trust Account to below the lesser of (1) $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLERwIlLAFc4" title="Shares issued price per share"&gt;10.18&lt;/span&gt; per Public Share and (2) the actual amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zuLGvcKnVHVk" title="Shares issued price per share"&gt;10.18&lt;/span&gt; per Public Share, due to reductions
in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any
claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the
Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). In the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will
seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers (other than the Company&#x2019;s independent registered public accounting firm), prospective target
businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest
or claim of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the Company had &lt;span id="xdx_900_eus-gaap--Cash_iI_do_c20221231_zDFzDbHzZLW6" title="Cash"&gt;no&lt;/span&gt; cash and a working capital of $&lt;span id="xdx_90C_ecustom--WorkingCapital_iI_c20221231_zG0LxahHb8Kf" title="Working capital"&gt;15,198&lt;/span&gt;, included deferred offering costs. The Company has incurred and expects to continue
to incur significant costs in pursuit of its acquisition plans. On January 4, 2023, the Company consummated its IPO and private placement
which generated gross proceeds of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJQDdIwPIQ61" title="Proceeds from sale of units"&gt;60,000,000&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUk6W0nVvCsf" title="Proceeds from sale of units"&gt;4,092,000&lt;/span&gt;, respectively, and effective January 9, 2023, the underwriters exercised
their over-allotment option which generated gross proceeds of $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z5izBWxW3kvk" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;. Following the closing of the IPO, including the over-allotment,
the private placement, and after deducting IPO transaction costs, the Company placed $&lt;span id="xdx_909_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkCkMZ34SWqk" title="Cash in trust accouint"&gt;70,242,000&lt;/span&gt; into the Trust Account and had $&lt;span id="xdx_90E_eus-gaap--Cash_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4t44Adx5PXe" title="Cash in bank account"&gt;525,554&lt;/span&gt;
held in the Company&#x2019;s bank account as of January 9, 2023, available for working capital needs as against estimated expenses of
$&lt;span id="xdx_902_eus-gaap--CostsAndExpenses_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2JAe5888cz2" title="Estimated expenses"&gt;600,000&lt;/span&gt; for the period of 12 months from December 31, 2022. The Company lacks the financial resources it needs to sustain operations
for a reasonable period of time. Moreover, management&#x2019;s plans to consummate the initial business combination may not be successful.
These factors, among others, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company&#x2019;s financial position, results of its operations, close of the Initial Public Offering, and/or
search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2022-01-01to2022-12-31">2021-09-15</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">370500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">3705000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">38700</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">387000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">4892699</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">1612500</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">2415000</us-gaap:DeferredOfferingCosts>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">865199</us-gaap:OtherDeferredCostsNet>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">70242000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <ATMC:PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.90</ATMC:PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2022-12-31_custom_PostBusinessCombinationMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.18</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_srt_MinimumMember"
      decimals="0"
      unitRef="USD">5000001</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <ATMC:BusinessCombinationInitialPublicOfferingDescription contextRef="From2022-01-012022-12-31_us-gaap_IPOMember">The
Company will have until 9 months (or up to 18 months, if we extend the time to complete a Business Combination as described in our Registration Statement)
from the closing of the Initial Public Offering to consummate a Business Combination (the &#x201c;Combination Period&#x201d;). However,
if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of
the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses),
divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public
Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company&#x2019;s remaining Public Shareholders and its Board of Directors,
liquidate and dissolve, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors
and the requirements of other applicable law.</ATMC:BusinessCombinationInitialPublicOfferingDescription>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_IPOMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.18</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.18</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:Cash contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:Cash>
    <ATMC:WorkingCapital contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">15198</ATMC:WorkingCapital>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">4092000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">70242000</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Cash
      contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">525554</us-gaap:Cash>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-01-012022-12-31_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:CostsAndExpenses>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zx922vZfC8pk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2 - &lt;span&gt;&lt;span id="xdx_823_zWYxsGlLlZA"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbmngyE7Cjr7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z60VHDt2Lb93"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#x201c;US GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--EmergingGrowthCompanyPolicyTextBlock_zRrRTJQFo32b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zFpluZUDTtD3"&gt;Emerging
Growth Company Status&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statement with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zDqkBD5msYhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zYCsX0hDpxai"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statement and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zfHZ1AcQEcOl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zP8x6Q82sxcf"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had &lt;span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_z4a4e3wmGFt2" title="cash equivalents"&gt;&lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z9cW93xcMMyf" title="cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXoSRwyU0zN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zb6cXwvwWMFj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $&lt;span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zJSIrn656xRb" title="Cash, FDIC insured amount"&gt;250,000&lt;/span&gt;. At December 31, 2022 and 2021, the Company had not
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_zsY5TrDcTvzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zs2axKg6Mk2a"&gt;Deferred
Offering Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) 340-10-S99-1. Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through
the balance sheet date that are directly related to the IPO and that will be charged to shareholder&#x2019;s deficit upon the completion
of the IPO. As of December 31, 2022 and 2021, deferred offering costs amounted to $&lt;span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20221231_zLTHn2ZSCN7g" title="Deferred offering costs"&gt;584,518&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_c20211231_zG4Yh5BxJVLg" title="Deferred offering costs"&gt;418,427&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zZ2slRtZX3E" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_z9moRdOLfXsi"&gt;Net
Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss per share is computed by dividing net loss by the weighted average number of shares of Ordinary Shares outstanding during the period,
excluding shares of Ordinary Shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of &lt;span id="xdx_903_ecustom--WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_c20220101__20221231_zW2wor7igUe6" title="Shares subject to forfeiture"&gt;225,000&lt;/span&gt;
Ordinary Shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Notes 5 and 7).
At December 31, 2022 and 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of Ordinary Shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z3vfFR8mnCV6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zSeDxucQiQxi"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_ziprP58uhsLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zeEvAsVwkBG"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z2qlYezAyrve" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zYzVsFNchwLc" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zPjR4fc2Nwac" title="Accrued for interest and penalties"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_z8yIVe1iAIsl" title="Accrued for interest and penalties"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2022
and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material
deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7RkTwEXNu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z8uGfbXCKYT"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zVKztYoEIKP3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zbmngyE7Cjr7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z60VHDt2Lb93"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America
(&#x201c;US GAAP&#x201d;) and pursuant to the rules and regulations of the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ATMC:EmergingGrowthCompanyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84B_ecustom--EmergingGrowthCompanyPolicyTextBlock_zRrRTJQFo32b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zFpluZUDTtD3"&gt;Emerging
Growth Company Status&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), and it may take
advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statement with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATMC:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zDqkBD5msYhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zYCsX0hDpxai"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statement in conformity with US GAAP requires the Company&#x2019;s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statement and the reported amounts of expenses during the reporting period. Accordingly, the actual results could differ significantly
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zfHZ1AcQEcOl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zP8x6Q82sxcf"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had &lt;span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_z4a4e3wmGFt2" title="cash equivalents"&gt;&lt;span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_z9cW93xcMMyf" title="cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXoSRwyU0zN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zb6cXwvwWMFj"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $&lt;span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zJSIrn656xRb" title="Cash, FDIC insured amount"&gt;250,000&lt;/span&gt;. At December 31, 2022 and 2021, the Company had not
experienced losses on this account and management believes the Company is not exposed to significant risks on such account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_zsY5TrDcTvzb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zs2axKg6Mk2a"&gt;Deferred
Offering Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) 340-10-S99-1. Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through
the balance sheet date that are directly related to the IPO and that will be charged to shareholder&#x2019;s deficit upon the completion
of the IPO. As of December 31, 2022 and 2021, deferred offering costs amounted to $&lt;span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20221231_zLTHn2ZSCN7g" title="Deferred offering costs"&gt;584,518&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DeferredOfferingCosts_iI_c20211231_zG4Yh5BxJVLg" title="Deferred offering costs"&gt;418,427&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">584518</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">418427</us-gaap:DeferredOfferingCosts>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zZ2slRtZX3E" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_z9moRdOLfXsi"&gt;Net
Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
loss per share is computed by dividing net loss by the weighted average number of shares of Ordinary Shares outstanding during the period,
excluding shares of Ordinary Shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of &lt;span id="xdx_903_ecustom--WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture_c20220101__20221231_zW2wor7igUe6" title="Shares subject to forfeiture"&gt;225,000&lt;/span&gt;
Ordinary Shares that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Notes 5 and 7).
At December 31, 2022 and 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised
or converted into shares of Ordinary Shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <ATMC:WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">225000</ATMC:WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z3vfFR8mnCV6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zSeDxucQiQxi"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under ASC 820, &#x201c;&lt;i&gt;Fair Value
Measurement&lt;/i&gt;,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_ziprP58uhsLj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zeEvAsVwkBG"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the asset and liability method of accounting for income taxes under ASC 740, &#x201c;&lt;i&gt;Income Taxes&lt;/i&gt;.&#x201d; Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period
that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected
to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were &lt;span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z2qlYezAyrve" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_900_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zYzVsFNchwLc" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zPjR4fc2Nwac" title="Accrued for interest and penalties"&gt;&lt;span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20211231_z8yIVe1iAIsl" title="Accrued for interest and penalties"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2022
and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material
deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zJ7RkTwEXNu" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z8uGfbXCKYT"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ATMC:InitialPublicOfferingDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80F_ecustom--InitialPublicOfferingDisclosureTextBlock_zDxcqjxty9G" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3 &#x2013; &lt;span id="xdx_823_z517F6ZWPZpf"&gt;Initial Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2023, the Company sold &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQpEh6gwZt14" title="Issuance of share to sponsor, shares"&gt;6,000,000&lt;/span&gt; Units, at a purchase price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zw5Z1F0qkO1c" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Unit. On January 9, 2023, the Company issued an
additional &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pdd" title="Issuance of share to sponsor, shares"&gt;900,000&lt;/span&gt; Units, at a purchase price of $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per unit, in connection with the over-allotment option. Each Unit consists of
one Ordinary Share, one Warrant and one Right, with each Right entitling the holder thereof to receive one-tenth of one Ordinary Share
upon the completion of an initial business combination, subject to adjustment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants will become exercisable at $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLU8HfBw68Nh" title="Warrant exercise price"&gt;11.50&lt;/span&gt; per share, subject to adjustment, on the later of 30 days after the completion of the initial
Business Combination or 12 months from the closing of our Initial Public Offering and will expire at 5:00 p.m., New York City time, five years after
the completion of the initial business combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the IPO and the sale of over-allotment units, an aggregate of $&lt;span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0" title="Sale of stock value issued"&gt;70,242,000&lt;/span&gt; (at $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Shares issued price per share"&gt;10.18&lt;/span&gt; per Unit) from the net proceeds of
the sale of the Units in the IPO and the sale of the Private Placement Units was placed in a Trust Account, which may only be invested
in U.S. &#x201c;government securities&#x201d;, within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity
of 180 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act, which
invest only in direct U.S. government treasury obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATMC:InitialPublicOfferingDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">70242000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.18</us-gaap:SharesIssuedPricePerShare>
    <ATMC:PrivatePlacementDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_804_ecustom--PrivatePlacementDisclosureTextBlock_zs9Z6tHIeq98" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4 - &lt;span id="xdx_82A_zzzaKaaC2Hll"&gt;Private Placement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zkLIY4wdNieg" title="Number of private units sold, shares"&gt;370,500&lt;/span&gt; Private Placement Units at a price of $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pp0p0_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zyLC0gU75eRe" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Private Placement
Unit, for an aggregate purchase price of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zBqs88z8uA0e" title="Proceeds from sale of units"&gt;3,705,000&lt;/span&gt;, in a private placement (the &#x201c;Private Placement&#x201d;). Each whole Private
Placement Unit will consist of one ordinary share, one warrant (&#x201c;Private Warrant&#x201d;) and one right (&#x201c;Private Right&#x201d;)
entitling the holder thereof to receive one-tenth of one ordinary share upon the completion of an initial business combination. Each
Private Warrant entitles the holder to purchase one ordinary share at a price of $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1UKw2E71FD7" title="Sale of stock, price per share"&gt;11.50&lt;/span&gt; per share, subject to adjustment. The proceeds
from the Private Placement Units were added to the proceeds from the IPO held in the Trust Account. Effective January 9, 2023, the underwriters
fully exercised the over-allotment option and the Company completed the private sale of an aggregate of &lt;span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPGqLoRiJpA5" title="Number of private units sold, shares"&gt;38,700&lt;/span&gt; Private Placement Units
at a price of $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrxgTCxAKhtk" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Private Placement Unit, generating gross proceeds of $&lt;span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20230108__20230109__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpY2tm0B3Z4b" title="Proceeds from sale of units"&gt;387,000&lt;/span&gt;. If the Company does not complete a Business Combination
within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund
the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Units will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ATMC:PrivatePlacementDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="Shares">370500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="0"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">3705000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">38700</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-082023-01-09_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">387000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z5dU2JDERFy" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5 - &lt;span id="xdx_82B_z3n1QKYVvSA5"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2021, the Sponsor received &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_znDAeg3Bxqwa" title="Number of shares issued, sale of transactions"&gt;1,437,500&lt;/span&gt; of the Company&#x2019;s Class B ordinary shares in exchange for $&lt;span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210927__20210928__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8rN9t9xbJY1" title="Sale of stock, value"&gt;25,000&lt;/span&gt; paid for deferred
offering costs borne by the Sponsor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes (see Note 7):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)
Each of the authorized but unissued &lt;span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zaUbkw3txeLi" title="Common stock shares subject to forfeited"&gt;200,000,000&lt;/span&gt; Class A ordinary shares were cancelled and re-designated as the ordinary shares of $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zSJOorZaOsvf" title="Common stock, par value"&gt;0.0001&lt;/span&gt;
par value each;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)
Each of the &lt;span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zvd87faaG2xl" title="Number of shares repurchased"&gt;1,437,500&lt;/span&gt; Class B ordinary shares in issue were repurchased in consideration for the issuance of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zWHbX8XQtNJk" title="Issuance of ordinary shares issued"&gt;1,437,500&lt;/span&gt; ordinary shares
of $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8MjWzIIZ5hg" title="Common stock, par value"&gt;0.0001&lt;/span&gt; par value each; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)
Upon completion of the above steps, the authorized but unissued &lt;span id="xdx_90A_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlgCdE82JAYi" title="Common stock shares cancelled"&gt;20,000,000&lt;/span&gt; Class B ordinary shares were cancelled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 8, 2022, the Company issued an additional &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zrihGGQwk3n7" title="Number of additional shares issued to sponsor"&gt;287,500&lt;/span&gt; ordinary shares to the Sponsor for no additional consideration, resulting in
the Sponsor holding an aggregate of &lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztYfxIFmY8B9" title="Common stock shares outstanding"&gt;1,725,000&lt;/span&gt; ordinary shares (the &#x201c;Founder Shares&#x201d;). The issuance was considered as a bonus
share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include
an aggregate of up to &lt;span id="xdx_909_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYGGRFA6656b" title="Common stock shares subject to forfeiture"&gt;225,000&lt;/span&gt; ordinary shares subject to forfeiture to the extent that the underwriters&#x2019; over-allotment is not
exercised in full or in part (refer Note 7). On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment
option with respect to the &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdZzUUwxfsjg" title="Number of additional units"&gt;900,000&lt;/span&gt; additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the
Company of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZREcAhOVrad" title="Number of additional units"&gt;9,000,000&lt;/span&gt;. Simultaneously, an amount of $&lt;span id="xdx_90D_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zzTrIw4uTRpj" title="Due to related party amount converted"&gt;352,350&lt;/span&gt; due to related party was converted into over-allotment of Private Placement,
and the underwriter deposited additional $&lt;span id="xdx_90A_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUorjUNeSAmi" title="Additional amount deposited by underwriter on behalf of related party"&gt;34,650&lt;/span&gt; on behalf of Sponsor for &lt;span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zqVQ0fnT8Vkb" title="Sale of stock number of shares issued in transaction"&gt;17,325&lt;/span&gt; Founder Shares for $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zq1gPSUm4L6f" title="Sale of stock price per share"&gt;2&lt;/span&gt; per share which was sold by the
Sponsor to underwriters. As a result, the Sponsor purchased additional &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zbtx9GQmNtNj" title="Sale of stock number of shares issued in transaction"&gt;38,700&lt;/span&gt; Private Placement Units, an aggregate of &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zSoyuHZck8lc" title="Aggregate number of units issued"&gt;409,200&lt;/span&gt; units
at a price of $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7M3kMhWSsj1" title="Share issued price per share"&gt;10.00&lt;/span&gt; per Private Placement Unit (an aggregate of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zaTzfua0yVqi" title="Aggregate value of shares issued"&gt;4,092,000&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2023, the Founder Shares and Private Placement Units were placed into an escrow account maintained
by American Stock Transfer &amp;amp; Trust Company acting as escrow agent. &lt;span id="xdx_900_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230102__20230103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zX2fzeWfN07k" title="Description of sale of shares"&gt;The Founder Shares and Private Placement Units (and underlying
securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of
the Founder Shares and Private Placement Units (and underlying securities) until the earlier to occur of: (A) six months after the date
of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or
exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days
within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and
Private Placement Units (and underlying securities) until six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities
or other property&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note&#x2009;&#x2014;&#x2009;Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 30, 2021, the Sponsor issued an unsecured promissory note to the Company (the &#x201c;Promissory Note&#x201d;), pursuant to which
the Company may borrow up to an aggregate principal amount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z9OmLcjoc6Kb" title="Loan amount"&gt;300,000&lt;/span&gt;. &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20210929__20210930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z01MrAeg7wHg" title="Description of maturity date"&gt;The Promissory Note was amended and restated on November 23,
2021, to change the December 31, 2021 due date to March 31, 2022, amended and restated on January 26, 2022 to change the March 31, 2022
due date to May 31, 2022 and amended and restated again on October 20, 2022 to change the May 31, 2022 due date to December 31, 2022.
The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, or (ii) the consummation of the Initial
Public Offering. As of December 31, 2022 and 2021, there were no amounts outstanding under the Promissory Note and Promissory Note has
expired on December 31, 2022&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Due
to Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor paid certain formation, operating or deferred offering costs on behalf of the Company. These amounts are due on demand and non-interest
bearing. As of December 31, 2022 and 2021, due to related party amounted to $&lt;span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrent_iI_c20221231_zrZCTI1bK0Xj" title="Due to related party"&gt;380,566&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231_zNv299jOhxVg" title="Due to related party"&gt;291,930&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Advisory
Services Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company engaged TenX Global Capital LP (&#x201c;TenX&#x201d;), a related party to the Company, as an advisor in connection with the Initial
Public Offering and business combination, to assist in hiring consultants and other services providers in connection with our Initial Public Offering
and the business combination, assist in the preparation of financial statements and other relevant services to commence trading including
filing the necessary documents as part of the transaction. Further, TenX will assist in preparing the Company for investor presentations,
conferences for due diligence, deal structuring and term negotiations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period from September 15, 2021 (inception) through December 31, 2022, a cash fee of $&lt;span id="xdx_908_ecustom--CashFee_c20210915__20221231_zxqU0XYU1me8" title="Cash Fee"&gt;200,000&lt;/span&gt; has been incurred as deferred offering
costs for these services of which $&lt;span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_c20211231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zdSyUGgOIwYa"&gt;160,000&lt;/span&gt; has been paid by the Sponsor through December 31, 2021 and $&lt;span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20221231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zGt6r0SWw7vl"&gt;40,000&lt;/span&gt; was recorded as accrued
offering costs as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Administration
fee&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commencing
on the effective date of the registration statement, an affiliate of the Sponsor shall be allowed to charge the Company an allocable
share of its overhead, up to $&lt;span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zfU9b4k4sIUf" title="Sponsor fees"&gt;10,000&lt;/span&gt; per month up to the close of the business combination, to compensate it for the Company&#x2019;s
use of its offices, utilities and personnel. An administration fee of $&lt;span id="xdx_901_eus-gaap--AdministrativeFeesExpense_c20220101__20221231_zllGKUOW3Vl4" title="Administration fee"&gt;667&lt;/span&gt; was recorded for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2021-09-272021-09-28_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ATMC:CommonStockSharesSubjectToForfeiture
      contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">200000000</ATMC:CommonStockSharesSubjectToForfeiture>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ATMC:CommonStockSharesSubjectToForfeiture
      contextRef="AsOf2022-01-08_us-gaap_CommonStockMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</ATMC:CommonStockSharesSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-072022-01-08_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">287500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-01-08_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:CommonStockSharesOutstanding>
    <ATMC:CommonStockSharesSubjectToForfeiture
      contextRef="AsOf2022-01-08_srt_MaximumMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">225000</ATMC:CommonStockSharesSubjectToForfeiture>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">352350</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty
      contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">34650</ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">17325</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">38700</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">409200</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">4092000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockDescriptionOfTransaction contextRef="From2023-01-022023-01-03_us-gaap_SubsequentEventMember">The Founder Shares and Private Placement Units (and underlying
securities) will not, subject to certain exceptions, be transferred, assigned, sold or released from escrow in the case of (i) 50% of
the Founder Shares and Private Placement Units (and underlying securities) until the earlier to occur of: (A) six months after the date
of the consummation of our initial business combination, or (B) the date on which the closing price of our ordinary shares equals or
exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days
within any 30-trading day period commencing after our initial business combination and (ii) the remaining 50% of the Founder Shares and
Private Placement Units (and underlying securities) until six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a subsequent liquidation, merger, stock
exchange or other similar transaction which results in all of our shareholders having the right to exchange their shares for cash, securities
or other property</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-09-30_custom_PromissoryNoteMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2021-09-292021-09-30_custom_PromissoryNoteMember">The Promissory Note was amended and restated on November 23,
2021, to change the December 31, 2021 due date to March 31, 2022, amended and restated on January 26, 2022 to change the March 31, 2022
due date to May 31, 2022 and amended and restated again on October 20, 2022 to change the May 31, 2022 due date to December 31, 2022.
The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2022, or (ii) the consummation of the Initial
Public Offering. As of December 31, 2022 and 2021, there were no amounts outstanding under the Promissory Note and Promissory Note has
expired on December 31, 2022</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">380566</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">291930</us-gaap:DueToRelatedPartiesCurrent>
    <ATMC:CashFee
      contextRef="From2021-09-152022-12-31"
      decimals="0"
      unitRef="USD">200000</ATMC:CashFee>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2021-12-31_us-gaap_ServiceMember"
      decimals="0"
      unitRef="USD">160000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2022-12-31_us-gaap_ServiceMember"
      decimals="0"
      unitRef="USD">40000</us-gaap:DeferredOfferingCosts>
    <us-gaap:SponsorFees
      contextRef="From2022-01-012022-12-31_custom_SponsorMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:SponsorFees>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">667</us-gaap:AdministrativeFeesExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcucOtTdAkWh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6 - &lt;span id="xdx_827_zOV3NwJXR0N7"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of the Founder Shares, Private Placement Units, securities underlying the unit purchase option (&#x201c;UPO&#x201d;), and Units
that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement
Units) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective
date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be
entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition,
the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to completion
of a business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities
Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or
cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriters
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters had a 45-day option beginning January 4, 2023, to purchase up to an additional &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_za8E9225IMwj" title="Issuance of share to sponsor, shares"&gt;900,000&lt;/span&gt; units to cover over-allotments, if
any, at the IPO price less the underwriting discounts and commissions. On January 6, 2023 and effective January 9, 2023, the underwriters
exercised their over-allotment option in full and purchased an additional &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJLIYrEFti4j" title="Issuance of share to sponsor, shares"&gt;900,000&lt;/span&gt; units at $&lt;span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zSKl8nFFJ3il" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2023, the Company paid a fixed underwriting discount of $&lt;span id="xdx_90E_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXZ3GSmT73yc" title="Underwriting discount"&gt;1,500,000&lt;/span&gt; and on January 9, 2023, it paid an additional $&lt;span id="xdx_902_eus-gaap--PaymentsForUnderwritingExpense_pp0p0_c20230108__20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1ORtPk35jN8" title="Underwriting discount"&gt;112,500&lt;/span&gt;
of underwriting fees arising from the sale of the over-allotment units. The underwriters will be entitled to a deferred commission of
$&lt;span id="xdx_902_eus-gaap--SharePrice_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zXPv2m7LoUHl" title="Share price"&gt;0.35&lt;/span&gt; per Unit, or $&lt;span id="xdx_904_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zIoJIcb4TQre" title="Deferred underwriting commission"&gt;2,415,000&lt;/span&gt; in the aggregate. The deferred commission will be paid to the underwriters from the amounts held in the
Trust Account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unit
Purchase Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 30, 2022, we sold to the underwriters, for $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zWwlAa2DTbJ3" title="Sale of price per share"&gt;100.00&lt;/span&gt;, &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221229__20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_z7wyzrFQgawl" title="Number of stock exercisable, shares"&gt;58,000&lt;/span&gt; Units exercisable, in whole or in part, at $&lt;span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20221230__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zbhJFntbZw4j" title="Share issued price per share"&gt;11.50&lt;/span&gt; per unit (or
115% of the Market Value), commencing on the consummation of our initial business combination, and expires five years from the
effective date of our Initial Public Offering. &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20221229__20221230_zvnUFGeDQIpk" title="Option description"&gt;The option and the &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20221229__20221230_z32hclBc0oGl" title="Number of units option exercised, shares"&gt;58,000&lt;/span&gt; Units, as well as the &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221229__20221230_zyyigFdZ2SZc" title="Number of ordinary shares"&gt;58,000 &lt;/span&gt;ordinary shares, the warrants
to purchase &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20221230_zAFv1B5pvFw7" title="Warrants to purchase common shares"&gt;58,000&lt;/span&gt; ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares
upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a
lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule
5110(e)(1) of FINRA&#x2019;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or
be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-022023-01-04_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-01-022023-01-04_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">1500000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="From2023-01-082023-01-09_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">112500</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:SharePrice
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember"
      decimals="INF"
      unitRef="USDPShares">0.35</us-gaap:SharePrice>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember"
      decimals="0"
      unitRef="USD">2415000</us-gaap:DeferredOfferingCosts>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2022-12-30_custom_UnderwritersMember"
      decimals="INF"
      unitRef="USDPShares">100.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-12-292022-12-30_custom_UnderwritersMember"
      decimals="INF"
      unitRef="Shares">58000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-30_custom_UnderwritersMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2022-12-292022-12-30">The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants
to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares
upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a
lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule
5110(e)(1) of FINRA&#x2019;s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or
be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the
securities, except as permitted under FINRA Rule 5110(e)(2).</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-12-292022-12-30"
      decimals="0"
      unitRef="USD">58000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-12-292022-12-30"
      decimals="INF"
      unitRef="Shares">58000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2022-12-30" decimals="INF" unitRef="Shares">58000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_803_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ztFxLxd9UZ76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7 - &lt;span id="xdx_827_zK0FPKsTbAO1"&gt;Shareholder&#x2019;s Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
shares &lt;/i&gt;&lt;/b&gt;- The Company is authorized to issue &lt;span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zSI1It1Ygfej" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; shares of preferred shares with a par value of $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zp32chfvoh9h" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share with such
designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.
As of December 31, 2022, there were &lt;span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zg5apCfhuqmf" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zK43BmZypYzb" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; preferred shares issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company was authorized to issue &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRIAX8Bl9TGf" title="Commo stock, shares authorized"&gt;200,000,000&lt;/span&gt; Class A ordinary shares with a par value of $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDcj2mBIgRDk" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share and &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zxd4grT4i6t7" title="Commo stock, shares authorized"&gt;20,000,000&lt;/span&gt; Class B ordinary
shares with a par value of $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8EnvECw90ic" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. &lt;span id="xdx_904_eus-gaap--CommonStockVotingRights_c20220101__20221231_ziGgjSdHS4A6" title="Common stock voting rights"&gt;Holders of Class A and Class B ordinary shares were entitled to one vote for each share&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2021, the Sponsor received &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zXDTdn2Mqqbj" title="Number of shares issued"&gt;1,437,500&lt;/span&gt; of the Company&#x2019;s Class B ordinary shares in exchange for $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zePKbbTEnHdg" title="Number of shares issued, value"&gt;25,000&lt;/span&gt; paid for deferred
offering costs borne by the Sponsor. Out of the &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220927__20220928__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsAUs5PlN7Kg" title="Number of shares issued"&gt;1,437,500&lt;/span&gt; Class B ordinary shares, an aggregate of up to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210927__20210928__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVSUUk2vVn26" title="Number of shares forfeitured"&gt;187,500&lt;/span&gt; Class B ordinary shares
were subject to forfeiture to the extent that the underwriters&#x2019; over-allotment option is not exercised in full or in part so that
the number of Founder Shares will equal 20% of the Company&#x2019;s issued and outstanding ordinary shares after the Initial Public Offering
(excluding private placement shares).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 8, 2022, the board of directors of the Company and the Sponsor, as sole shareholder of the Company, approved, through a special
resolution, the following share capital changes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)
Each of the authorized but unissued &lt;span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z54daZiJ1312" title="Common stock shares subject to forfeited"&gt;200,000,000&lt;/span&gt; Class A ordinary shares were cancelled and re-designated as the ordinary shares of $&lt;span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqDsLlMrUfgd" title="Common stock, par value"&gt;0.0001&lt;/span&gt;
par value each;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)
Each of the &lt;span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziajJ0Evw8y8" title="Number of shares in issue were repurchased"&gt;1,437,500&lt;/span&gt; Class B ordinary shares in issue were repurchased in consideration for the issuance of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z8SQzHUvOpm2" title="Issuance of ordinary shares to sponsor"&gt;1,437,500&lt;/span&gt; ordinary shares
of $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zkoQwTkp7nmc" title="Common stock, par value"&gt;0.0001&lt;/span&gt; par value each; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)
Upon completion of the above steps, the authorized but unissued &lt;span id="xdx_90D_ecustom--CommonStockSharesSubjectToForfeiture_iI_pid_c20220108__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zwJSIkSwwdTc" title="Common stock shares subject to forfeited"&gt;20,000,000&lt;/span&gt; Class B ordinary shares were cancelled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
an effect of the above, the Company is authorized to issue &lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220108_ziBTI2ut9tta" title="Common stock shares authorized"&gt;200,000,000&lt;/span&gt; ordinary shares with a par value of $&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220108_zOtkqdo7FWgj" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. &lt;span id="xdx_906_eus-gaap--CommonStockVotingRights_c20220107__20220108_zFNUkZgfWXgj" title="Common stock voting rights"&gt;Holders
of ordinary shares are entitled to one vote for each share&lt;/span&gt;. Further, the shareholder also approved the amendment and restatement of the
memorandum and articles of association filed with the Cayman Registrar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 8, 2022, the Company issued an additional &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220107__20220108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zpODIsKTgqJj" title="Number of additional shares issued to sponsor"&gt;287,500&lt;/span&gt; ordinary shares to the Sponsor as fully paid bonus shares for no additional
consideration. The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded
and presented retroactively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 and 2021, there were &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zFEPk3iHf5sj" title="Common stock shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z8q4pMVvrsph" title="Common stock shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zngRiHJW3kid" title="Common stock shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziTi8CZO9ODf" title="Common stock shares outstanding"&gt;1,725,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; ordinary shares issued and outstanding, Concurrent with the closing of this offering, our Sponsor, at the option of the Company,
sold to underwriter or its designees &lt;span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231_z9bu2SJFh566" title="Sale of stock shares issued"&gt;115,500&lt;/span&gt; Founder Shares for a purchase price of $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20221231_zbclwyN8msW9"&gt;2.00&lt;/span&gt; per share and an aggregate purchase price of
$&lt;span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20220101__20221231_zAPID0AEMdaa" title="Sale of stock value issued"&gt;231,000&lt;/span&gt;, as part of the exercise of overallotment option by the underwriter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2023, the Company converted an amount of $&lt;span id="xdx_90E_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zjiM7eQf7tT3" title="Due to related party amount converted"&gt;352,350&lt;/span&gt; into over-allotment of Private Placement Units (see note 8). The
Company had accounted for these proceeds received as of December 31, 2022, as Due to related party, pending final allotment to the
Sponsor. On January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to
the &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBJ7R99GQ7E2" title="Number of additional units"&gt;900,000&lt;/span&gt; additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of
$&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zKRIbeyAs4ki" title="Gross proceeds from exercise of option"&gt;9,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2022-01-01to2022-12-31">Holders of Class A and Class B ordinary shares were entitled to one vote for each share</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-09-272022-09-28_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-09-272021-09-28_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">187500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <ATMC:CommonStockSharesSubjectToForfeiture
      contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">200000000</ATMC:CommonStockSharesSubjectToForfeiture>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-01-08_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-072022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">1437500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ATMC:CommonStockSharesSubjectToForfeiture
      contextRef="AsOf2022-01-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</ATMC:CommonStockSharesSubjectToForfeiture>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-01-08" decimals="INF" unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-01-08"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2022-01-072022-01-08">Holders
of ordinary shares are entitled to one vote for each share</us-gaap:CommonStockVotingRights>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-072022-01-08_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">287500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">1725000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">115500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">2.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">231000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">352350</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zGANXJEq1Aa2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8 - &lt;span id="xdx_829_z0qEpeQFT2s1"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has evaluated subsequent events through March 23, 2023, which was the date these financial statements were available for issuance
and determined that there were no significant unrecognized events through that date other than those noted below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 4, 2023, the Company consummated the IPO of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxj0xmVw6ced" title="Issuance of share to sponsor, shares"&gt;6,000,000&lt;/span&gt; units at a price of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpNUpB0eEu6" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt;
                                            per Unit, generating gross proceeds to the Company of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230102__20230104__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBYTgo6kMR5" title="Proceeds from sale of units"&gt;60,000,000&lt;/span&gt;. Simultaneously with the
                                            closing of the IPO, the Company completed the sale of &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zZwSKZyZMYG6" title="Number of private units sold, shares"&gt;370,500&lt;/span&gt; private units to the Sponsor
                                            at a purchase price of $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zw9Vdm5UOUT4" title="Sale of stock, price per share"&gt;10.00&lt;/span&gt; per Private Unit, generating gross proceeds to the Company
                                            of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pid_c20230102__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zTLVUfOfaGYg" title="Proceeds from sale of units"&gt;3,705,000 &lt;/span&gt;(See Notes 1, 3 and 4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 5, 2023, from cash held in escrow account with amount of $&lt;span id="xdx_904_eus-gaap--EscrowDeposit_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8Mds7xSxBUd" title="Cash held in escrow"&gt;779,034&lt;/span&gt;, $&lt;span id="xdx_90B_ecustom--WorkingCapital_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zy2nXe7VZCc5" title="Working capital"&gt;485,054&lt;/span&gt; has been
                                            wired to the Company&#x2019;s bank account for working capital purposes, within which $&lt;span id="xdx_90C_ecustom--VendorsOutstandingBalances_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYrPn1ZNDs0b" title="Vendors outstanding balances"&gt;61,681&lt;/span&gt;
                                            was pending to distribute to vendors and $&lt;span id="xdx_90B_ecustom--OutstandingBalancesTransferred_iI_c20230105__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUrBhgszZMrk" title="Outstanding balances transferred"&gt;293,980&lt;/span&gt; has been transferred to the vendors against
                                            their outstanding balances.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
    January 6, 2023, the underwriters notified the Company that it is exercising the over-allotment option with respect to the &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zn7TQcAs2FTh" title="Issuance of share to sponsor, shares"&gt;900,000&lt;/span&gt;
    additional Units, which was subsequently closed on January 9, 2023, generating gross proceeds to the Company of $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3YRVh5FGiPc" title="Proceeds from sale of units"&gt;9,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously,
an amount of $&lt;span id="xdx_90B_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z2Cm7xOIpZd3" title="Due to related party amount converted"&gt;352,350&lt;/span&gt; due to related party was converted into over-allotment of Private Placement, and the underwriter deposited additional
$&lt;span id="xdx_900_ecustom--AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty_c20230105__20230106__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWkaBSgsTlN3" title="Additional amount deposited by underwriter on behalf of related party"&gt;34,650&lt;/span&gt; on behalf of Sponsor for &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ziPB733MYWD5" title="Sale of stock number of shares issued in transaction"&gt;17,325&lt;/span&gt; Founder Shares for $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zmtz6yNGg0X2" title="Sale of stock price per share"&gt;2&lt;/span&gt; per share which was sold by the Sponsor to underwriters. As a result, the
Sponsor purchased additional &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_ztvtjjsB0655" title="Sale of stock number of shares issued in transaction"&gt;38,700&lt;/span&gt; Private Placement Units, an aggregate of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zor0xLGNQ60i" title="Aggregate number of units issued"&gt;409,200&lt;/span&gt; units at a price of $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZnHQWppSGS9" title="Share issued price per share"&gt;10.00&lt;/span&gt; per Private Placement
Unit (an aggregate of $&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAuaRC8y7QI1" title="Aggregate value of shares issued"&gt;4,092,000&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company paid a cash underwriting commission of $&lt;span id="xdx_905_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPnJ8uHwIxdi" title="Share issued price per share"&gt;0.125&lt;/span&gt; per Unit for &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230105__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzdJBtgVOuC1" title="Number of additional units"&gt;900,000&lt;/span&gt; additional Units and the underwriters will be entitled to
a deferred commission of $&lt;span id="xdx_903_eus-gaap--SharePrice_iI_c20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zHY9FJsKplMf" title="Share price"&gt;0.35&lt;/span&gt; per Unit, an aggregate of $&lt;span id="xdx_906_eus-gaap--DeferredOfferingCosts_iI_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwritersMember_zDUwEEW32JL7" title="Deferred underwriting commission"&gt;2,415,000&lt;/span&gt;, which will be paid from the funds held in the Trust Account upon
completion of Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 9, 2023, an additional $&lt;span id="xdx_90F_ecustom--WorkingCapital_iI_c20230109__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5sCopN0fG7l" title="Working capital"&gt;40,500&lt;/span&gt; was wired to the Company&#x2019;s bank account for
                                            working capital purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-022023-01-04_us-gaap_IPOMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">60000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">370500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-01-022023-01-04_us-gaap_PrivatePlacementMember_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">3705000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">779034</us-gaap:EscrowDeposit>
    <ATMC:WorkingCapital
      contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">485054</ATMC:WorkingCapital>
    <ATMC:VendorsOutstandingBalances
      contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">61681</ATMC:VendorsOutstandingBalances>
    <ATMC:OutstandingBalancesTransferred
      contextRef="AsOf2023-01-05_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">293980</ATMC:OutstandingBalancesTransferred>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-01-052023-01-06_us-gaap_OverAllotmentOptionMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">352350</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty
      contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">34650</ATMC:AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_custom_SponsorMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">17325</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember"
      decimals="INF"
      unitRef="USDPShares">2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">38700</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">409200</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">4092000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">0.125</us-gaap:SharePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-01-052023-01-06_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharePrice
      contextRef="AsOf2023-01-06_us-gaap_SubsequentEventMember_custom_UnderwritersMember"
      decimals="INF"
      unitRef="USDPShares">0.35</us-gaap:SharePrice>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2023-01-04_us-gaap_SubsequentEventMember_custom_UnderwritersMember"
      decimals="0"
      unitRef="USD">2415000</us-gaap:DeferredOfferingCosts>
    <ATMC:WorkingCapital
      contextRef="AsOf2023-01-09_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">40500</ATMC:WorkingCapital>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0116"
          xlink:label="xdx2ixbrl0116"
          xlink:type="locator"/>
        <link:footnote id="Footnote000165" xlink:label="Footnote000165" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See
                                            Note 7 for the changes in the structure of Ordinary Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0116"
          xlink:to="Footnote000165"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0117"
          xlink:label="xdx2ixbrl0117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0117"
          xlink:to="Footnote000165"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0121"
          xlink:label="xdx2ixbrl0121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0121"
          xlink:to="Footnote000165"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0122"
          xlink:label="xdx2ixbrl0122"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0122"
          xlink:to="Footnote000165"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000132"
          xlink:label="Fact000132"
          xlink:type="locator"/>
        <link:footnote id="Footnote000166" xlink:label="Footnote000166" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes an aggregate of up to <xhtml:span
  id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z39ZHBgJSMT8"
  title="Sharebased payment award options forfeitures">225,000</xhtml:span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full
    or in part by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on
    January 6, 2023 thus forfeiture condition has been removed (see Note 8).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000132"
          xlink:to="Footnote000166"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000133"
          xlink:label="Fact000133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000133"
          xlink:to="Footnote000166"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000179"
          xlink:label="Fact000179"
          xlink:type="locator"/>
        <link:footnote id="Footnote000184" xlink:label="Footnote000184" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This
    number excludes weighted average shares outstanding considered for <xhtml:span
  id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVdveBXlyV21"
  title="Sharebased payment award options forfeitures">225,000</xhtml:span> Ordinary Shares subject to forfeiture depending on the
    extent to which the over-allotment option is not exercised by the underwriters (see Notes 5 and 7). The underwriters subsequently
    exercised the over-allotment option in full on January 6, 2023 thus forfeiture condition has been removed (see Note 8).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000179"
          xlink:to="Footnote000184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000180"
          xlink:label="Fact000180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000180"
          xlink:to="Footnote000184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000196"
          xlink:label="Fact000196"
          xlink:type="locator"/>
        <link:footnote id="Footnote000233" xlink:label="Footnote000233" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    an aggregate of up to <xhtml:span
  id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210915__20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zM5r2SLFqK79"
  title="Sharebased payment award options forfeitures">187,500</xhtml:span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000196"
          xlink:to="Footnote000233"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000197"
          xlink:label="Fact000197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000197"
          xlink:to="Footnote000233"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0198"
          xlink:label="xdx2ixbrl0198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0198"
          xlink:to="Footnote000233"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000199"
          xlink:label="Fact000199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000199"
          xlink:to="Footnote000233"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000203"
          xlink:label="Fact000203"
          xlink:type="locator"/>
        <link:footnote id="Footnote000236" xlink:label="Footnote000236" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    an aggregate of up to <xhtml:span
  id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--RangeAxis__srt--MaximumMember_zeJ1C2au4wtj"
  title="Sharebased payment award options forfeitures">37,500</xhtml:span> Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part
    by the underwriters (see Notes 5 and 7). The underwriters subsequently exercised the over-allotment option in full on January 6,
    2023 thus forfeiture condition has been removed (see Note 8).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000203"
          xlink:to="Footnote000236"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000204"
          xlink:label="Fact000204"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000204"
          xlink:to="Footnote000236"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0205"
          xlink:label="xdx2ixbrl0205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0205"
          xlink:to="Footnote000236"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0206"
          xlink:label="xdx2ixbrl0206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0206"
          xlink:to="Footnote000236"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0282"
          xlink:label="xdx2ixbrl0282"
          xlink:type="locator"/>
        <link:footnote id="Footnote000287" xlink:label="Footnote000287" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See
    Note 7 for the changes in the structure of Ordinary Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0282"
          xlink:to="Footnote000287"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000283"
          xlink:label="Fact000283"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000283"
          xlink:to="Footnote000287"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>40
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M8/.!TU7Q&H GRCE-BL4EP6+8RA7$[\^4\NT'N8'=JR<N_@-02P,$%     @
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MTJ&.X@M9*O0_V96VCD7"C9 L*\&H($ORXDGW92". &[[#, K 5X=T#D#:)>
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MP3'EE@7^2$!9!_R>2VEV&QM@^#7%?P%02P,$%     @ FJIW5I=0!4=Q!
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MY!XQ-*=E*3-I*6CR".X_X?(!L_\T,-=FF(]IFJN41 6X17EZ+CV=HTTNY-@
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MK5%SB&-2T!=;@'1-94R$+4-%\)9+@.ER3P5VLK\U$!79P)*9NW,5^O[ \[S
M7;5('#02!YT2I_299676G*@V&9T,;Y5Q(+(=L<-&[/"=2GIXR! <B&PG!*,F
M!*-W+>G1JRKLG8T&6U5827QMUM^QJGQWM_I*!G)IVZTBD2AS7;689K7IZ!>V
MD;E_S:O?@2F52X;N<T@0ZIV,<&]9M=AJHD5AN]1":.QY=ICB7PE(8X#?$R'T
M9F(V:/YSPC]02P,$%     @ FJIW5L$ O;["!   A1,  !@   !X;"]W;W)K
M<VAE971S+W-H965T."YX;6RM6$USVS80O?=78)1.IIVI38(2)4J1-!-+S32'
M))YHTAXZ/<#D2F)#$BP 6O:_[P*DJ2\(MF+Y8/$#^[!OE[MXP'C#Q7>Y!E#D
M(<\*.>FLE2I'GB?C->1,7O,2"GRSY")G"F_%RI.E )88HSSS M_O>SE+B\YT
M;)[=BNF85RI+"[@51%9YSL3C#61\,^G0SM.#K^EJK?0#;SHNV0H6H+Z5MP+O
MO!8E27,H9,H+(F YZ;RGHWG@:P,SXL\4-G+GFF@J=YQ_US<?DTG'UQY!!K'2
M$ Q_[F$&6::1T(__&M!..Z<VW+U^0O]@R".9.R9AQK._TD2M)YVH0Q)8LBI3
M7_GF#V@(A1HOYIDT_\FF&>MW2%Q)Q?/&&#W(TZ+^90]-('8,:/>$0= 8!(<&
MX0F#;F/0/33HGS#H-08]$YF:BHG#G"DV'0N^(4*/1C1]88)IK)%^6NB\+Y3
MMRG:J>E",0681R4)7Y(9DVOR ;\%2:[(M\6<_/+SKV-/X3QZM!<WF+,:,SB!
MV2.?>*'6DOQ>))!8[.=N>QHX #PDV+(,GEC. B?B'.)KTJ6_D< /J,VAEYL'
M#G>Z;="[!J]_ F\GS$O!<_*E!,%46JS(>UT&J4I!CFQQKV&[=EC=(D:R9#%,
M.M@#)(A[Z$S?OJ%]_YV-\X7 ]B+0:R/0<Z%//V-'R[B4-I*U9<]8ZK9U/[T:
M^C0:>_>[WEM&#:)>.VC/J[#U*G3G9<V*%4B2%EAZ0F!5$"8E8&VP(B%9RN[2
M['1RPDLFYT)@>V'HMV'H.Y-S*Z!D:4+@ 5<7"=8D.1'.)5N#A;NYC'K]OCV9
M@Y;%P,GB?1R+"A)L:TL0NK9B+IM,NH@Y0<\E-C@FUJ5A&-B912VSR,EL7@%1
M'%?=#'MW0DHFU*.-2G0TNZ6.C@?U_,@_X>&P]7#X;'G'NLE5$AW$<N)MAV-M
MA[.Y[(2U1Y_8 O]ZG#W>U-\NI_[SS$T;,5T$8V!=/YT@9_"\ - ^T1W=0)U$
M]1KV]DT4T.#=':S2HM#)10FAUD PV2FW+?PS-^@YQ%\/M$\\V!(/7DH<BN0%
ME)UPYU!^/= ^Y:U<H6Z]LJC*,C,JD64D266,2W<E0',O>&$*?9D6K(CW"]RZ
M2M*+:IA+H>T'9JMBJ%O&S '7%G&\R*1%G%5)W?J2%W;K9JK=3AQ$P9 &!PW;
M,JXWB+HGI _=:A_JU!3G<&'-TKJCB*R,PB-/*?5#&AXRLHU#,=<]06FK8ZA;
MR)RBQ))_<6>%SXWZ+E\@=]P3G5/$QUJG1T_E;BMUJ%OK?)2RPO(S%?E%)%B+
MXI$LUDPT8I;C/CTQ*S!NM7&,@*NR$KA.26,RRU#FDAO"GTRE,;7X?_.,(W_3
M?ZSA.Q9"0>C[_N&'\ /BR]GAMHJ*NB75#2\J#!6&$0C+,JYTL].?NN[MBQ+C
MQX656'2T#0F&AZR<4_\ *ZW"]K?!6WD2N.4)YF<!\!/!O\]< 1F0)1>&9+S=
M^^A;J405JZ;)'WQ2US;GO)TSB!S$RISE2/STJD+5.^/V:7M>=&-.28Z>#T<S
MY&AY$_BC67W$Y&VGJ ^H/C&!(D22#)8XG7\]P&]-U&<^]8WBI3D%N>-*\=Q<
MKH%A4>@!^'[),1[-C9Z@/7F;_@]02P,$%     @ FJIW5H&]:".2"P  ,!X
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M[^%WQ$SQKZN%#PXI\N]C%D=^9\?Y4=G\ZAM9J%<CU(57;J-&E[_\-'TZ>?&
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M?)"TT'C$;@G2R?C9DQ'&*/YQ(CX$V_ / @L;@JWYS[62 !ZZ@/=+BWDM/9"
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MB,0TCB_P388F)YYO_C]-=A23\Q1N-E:F1O@ZP,MO0#]!D+Y_%\WIQPL"IX/
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M .^7&M6Z6[" X=OFU?\ 4$L#!!0    ( )JJ=U8$Z+8*#P4  ,L+   9
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ML@#VUP97<_?#"OKY??D/4$L#!!0    ( )JJ=U:FHT8=K@,  -,(   9
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;)56;9/:-A#^SJ_8<3J99(;B%^ @
M%V &+NFDG4ER$YKV0Z<?A+U@363)D>0CUU^?E61\<.5H^@%;DG>???9%N\SV
M2G\Q):*%;Y609AZ5UM;7<6SR$BMF!JI&25^V2E?,TE;O8E-K9(57JD2<)<E5
M7#$NH\7,G]WJQ4PU5G")MQI,4U5,WZ]0J/T\2J/#P2>^*ZT[B!>SFNUPC?9S
M?:MI%W<H!:]0&JXD:-S.HV5ZO1HY>2_P!\>].5J#\V2CU!>W^;681XDCA )S
MZQ 8O>[P!H5P0$3C:XL9=2:=XO'Z@/Z+]YU\V3"#-TK\R0M;SJ-I! 5N62/L
M)[5_AZT_8X>7*V'\$_9!-B.+>6.LJEIEVE=<AC?[UL;A2&&:/*&0M0J9YQT,
M>99OF&6+F59[T$Z:T-S"N^JUB1R7+BEKJ^DK)SV[6)=,8ZE$@?KYLVF63EX;
M>/NUX?9^%EO"=U)QWF*M E;V!%::P7LE;4D(LL#B%" F8AV[[,!NE5U$?(/Y
M (9I'[(DRR[@#3MOAQ[OZ@F\X!G\M=P8JZD@_C[G9( 8GH=PE^3:U"S'>42W
MP*"^PVCQ_%EZE;R^0'#4$1Q=0O^?Z;B(=9[I!V6Q-X&?X6E+<$L7 [7&HF><
MD(&TGR2)^T$RH&<*4L%'77!)U[BW#C*_E]B[457-Y#WLF0'6V%)I_@\68!5P
M8QJD+":/D;)_G;SSG RH+=P(9@PL@<FB7:] M7:AY;9'C8#2<BN"*241[LA+
MH(X%R/(R2,)'V5MC;;':H(9LZFN**LN6".M:24/2&G.D'E&0PZ/AI#\F4MG8
M<WLX2*?A37"_,=DX)@$K"U@;Q73AR!><X*P*GK@OA^@X;XZL]H&B993 P#.D
MY)$.R=2U5D3-&=&JV97 P-28<R9Z% 8E&M?D H6M$M1KN=RUGN>LYI8)R$LF
M=VBNX05[V7OK(M-:.<K5IK'02)^NXER^7FQ.58\"TZT.HOG+WF?R$7)R0J!O
MP@>#&_(%C,7:]/^#04=@:7I, FZW%-43G/Y)=/D/EUY;:#W">EQ4[,=KZFP1
M/)#Q7A!O5A3<18#2D+45M/2FJ<6%DCRT.5\?76V2$5_A:7]R*,5T'"ISX!Y#
M?S>/B8P\S/"42*[D'6K;<JE4(WT,?X+A..L/QPF\:F/SJHO2N6X6'PV:"O7.
MCU-#Z(079DYWVDWL91A4#^)AW+]G>L>E 8%;4DT&DW$$.HS0L+&J]F-KHRP-
M0;\LZ5\':B= W[>*$M)NG('N?\SB.U!+ P04    " ":JG=6L1]C\ZT#  #E
M!P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6R-5=N.VS80??=7#)2@
M3XI%W7S9V@9V-RF: DD6V5X>BC[0TM@B(I$*25F[_?H.*5NUVXT1P*9XF3D\
M9S@<KGJEOY@*T<)34TNS#BIKVYLH,D6%#3=3U:*DE9W2#;<TU/O(M!IYZ9V:
M.DH8FT4-%S+8K/S<@]ZL5&=K(?%!@^F:ANOG.ZQ5OP[BX#3Q6>PKZR:BS:KE
M>WQ$^UO[H&D4C2BE:% :H21HW*V#V_CF+G/VWN!W@;TYZX-3LE7JBQN\+]<!
M<X2PQL(Z!$Z? ]YC73L@HO'UB!F,6SK'\_X)_2>OG;1LN<%[5?\A2ENM@T4
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MT[:&E2'@"%WM-#'?U_]WJ1&-+@4*#_D@N'S'/AYM/K5KW![GH>W XCJW"G3
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MQZHR)[SN,'-1327<IHK(+;)J]\M](%M6G3B2=]9ZNP;-=X#2&(IF#BUTOL/
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MQFJF\F+#NCB1+,MW9%=,2I;DAQM*0LIU _7YFC%Y.-$=5/\VL/@!4$L#!!0
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M';O+?UA>V I25',?E>:ATGQ46H!*"[%H3<74#P*<*7)!BOHL )7FH=)\5%J
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MBF=F<\4H*$LW@/U+SM7V@^Y@]Z;Z_!]02P,$%     @ FJIW5F]/6XI,#
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MT" 5JA&H1J$:@VH<J@FH%E::M@9HJ?HZ>[7-X:O^-K!=UIIF[-#0%:H%4(U
M-0K5&%3C4$U M;#2M(IW[?;93YW6VN:X]FYSG\G/&YGD5O!4_OOQO2QG0,U'
M9Z!1+50+H!J!:A2J,:C&H9J :B%*T\=&'0[;N^ .],%W&QH10[4 JA&H1J$:
M@VH<J@FH%J(T_>2B.IQVS,$=:MUL[J;OL*FTPU71><-'2@)HKP2J4:C&H!J'
M:@*JA2A-'Q!U6NR8T^(J#C;.H,Q$[V*'YL%0C4 U"M485.-034"U$*7I0Z*.
MC1T'.8-RH.DO5 N@&H%J%*HQJ,:AFH!J(4K31T<=$COFD+C^4$4TGR_+^5$4
MOYH^Y:F5[=Y6&L<+-#>&:@%4(U"-0C7F'$>NSG3B'WUX&MJK@&HA2M-'0ITM
M._VSY?:#KV:L=]E#8V6H1J :A6H,JG&H)IRNL7*'#?62KF-EQQPK?\/')<QB
M[[J&)LA0C4 U"M68TY"K-M4.AW8KNG8;=MA0+]DZ^'5.!+^O%K#6_ZQ>\8"9
M[UV_T!@8JA&H1J$:@VH<J@FH%J(T?;C4B;$S@2YNH9$Q5 N@&H%J%*HQJ,:A
MFH!J(4K31T<=+#LG@F54/ #-G)WC4TGMB>OXK],!:)@,U2A48U"-0S4!U4*4
MIH^'.DQVS*<:WVQD>31'R3C*B\)?1RK_:D6K=%-,JF9I\B15WK+:A<;*E7;X
M01+7=US_*!_KMAV!/CL*U1A4XU!-0+40I>G7!ZRC8-<<!7\HJO?7W^,XS5?E
M&N'#>GLY6=-2P0SV+6JH%D U M4H5&-0C4,U =5"E*8/D#H:=FWD4L&%IL10
M+8!J!*I1J,:@&H=J JJ%*$T?'75*[/8\N?@A50]RF6]4\XS(S/4>'M"8&*H1
MJ$:A&H-JO-*TA5E#B":@O88-O3J&0ZGNP263S=&N>4;4]\"JN;/>!0_->:$:
M@6H4JC&HQJ&:@&HA2M,'3YT&NQYTM@2-@Z%: -4(5*-0C4$U#M4$5 M1FCXZ
MZF#9-0?+WW]1(G,'O0?,<1[9^(GKCML1Z+.C4(U!-0[5!%0+49I>Y'44[9Z(
MHD'I@7M\D5YW.GE=<S<-FS77,#1%AFH4JC&HQJ&:@&HA2M,KO4Z17?-YQU2E
MQ61GK=*9E/-BZ:O2E26_2#5;9ML1D*Y;:QL:*+O'9YB>-UV,-8!V2Z :A6H,
MJG&H)J!:B-+T,5!GQ6ZG:T:_7/_1N!2&QL%0+8!J!*I1J,:@&H=J JJ%*$T?
M&75J[$)/07:A63%4"Z :@6H4JC&HQJ&:@&HA2M-OPE7GSEZ/ZV-WNP47-'>&
M:@%4(U"-0C4&U3A4$U M](Y/1S]QZP*O#I4]\_G&/6Y>8)9ZESTT4(9J!*I1
MJ,8J[>0M#*"]"J@6GMX'O9KK$-@SA\!-K^79YOX_<I:7AS6K2+CE51T:"$.U
M *H1J$:A&O,:PM26^\A .Q90+41I^CBHDV//G!QK:^%WQK6P6>I=]M!8&*H1
MJ$:A&H-J'*H)J!:B-'UD'-QS%QH+>]C;[6+OMXN]X2[VCKO86^YB[[F+O>DN
M-!9&:?KHJ&-AK__YQB?6PM 8&*H%4(U -0K5&%3C4$U M= [_@" 8UX*UW&Q
M9XZ+^RR%H2<I0[4 JA&H1J$:J[332V%H< S5PM/[H%=S'0E[YDCX^S_A8^Z@
M=Y%#SS6&:@2J4>_X=KBVYQY_#)EUW9!#GY^ :B%*T\N\3GT]<^K;^YYBUV:P
M=UE#PU^H1J :K;03]\QBT$XY5!-0+41I>N77J:[7_;;#O8]U0B->J!9 -0+5
M*%1CE6:<RU;# !K?0K40I6G#P*_C6]\<WQZ_ 22[]X#=75Z57&_4;!%ES0/!
MC/<="% M@&H$JE&HQOSC@+-Y(@3M5D"U$*7IXZ .<GUSD/O=UP$U^[V' C3>
MA6H$JE&HQOSC.R"W# 5HO@O50I2F#X4Z!?8[I<"OTZ_RA,D.5U<WX[W' 30'
MAFH$JE&HQJ :AVH"JH4H31\L=53LN\A S(?&Q5 M@&H$JE&HQJ :AVH"JH4H
M31\==5SLFZ\IC3J%S-Q-[V$#S9&A&H%J%*HQJ,;]ALL^-TW5!+3;$*7I(Z*,
MB/6?U+F9;\[-/MI_\V06;^8R^R%*K.CQ4<G'*-^.F\VZ7'78T\F;[:_EN/]A
MMI ROXGRZ.IB)=6CO)9QG%FS\I)V99<'/RW6\@_E_=;>OG,&P^.?^_Y;4>Q&
MTR/CXI%Q^<BP[N+J8AT]RO>1>EPFF17+AZ*[T=FD^&NJY>-B_TV>KB\'Q73V
M/LWS=+7]<B&CN53E!L7C#VF:OWQ3=O"<JD_;7;KZ/U!+ P04    " ":JG=6
MY%@&IQ$,  !JF@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R]G5UO
MXS86AN_W5PC>Q:(%VEB?_IA-#,S$XL=BIQ,TF/9BT O%9F)A9,F5Y*0#],>O
MI"BF:<F,F+Z[-Y/8UGF.-'Y#D><EQ<NG+/]:;(0HK3^V25I<C39EN7LW'A>K
MC=A&Q46V$VGUR7V6;Z.R>ID_C(M=+J)U$[1-QJYM3\;;*$Y'B\OFO9M\<9GM
MRR1.Q4UN%?OM-LJ_?1!)]G0U<D8O;_P</VS*^HWQXG(7/8A;47[>W>35J_&!
MLHZW(BWB++5R<7\U>N^\XY.@#FB.^"463\71[U9]*7=9]K5^P==7([L^(Y&(
M55DCHNK'H[@625*3JO/XO86.#CGKP./?7^BDN?CJ8NZB0EQGR:_QNMQ<C68C
M:RWNHWU2_IP],=%>4'."JRPIFG^MI^=CI_[(6NV+,MNVP=49;./T^6?T1_L?
M<13@>&<"W#; /0TXE\%K [RA 7X;X \-"-J 8&C I V8G 8$9P*F;<#T-&!R
M)F#6!LR&GM*\#9@W<GC^_IHO?QF5T>(RSYZLO#ZZHM6_- IJHJOO/$YKL=^6
M>?5I7,65B]O]72%^WXNTM,+'ZM_"^FXIRBA."NNG*,^C6HK?6S]:GV^7UG?_
M^/YR7%9)Z]#QJDU GQ.X9Q+XUL<L+3>%%:9KL>Z)9_IXQ]4 QM75'B[9?;GD
M:U=+_'>47ECV_ ?+M5VOYX260\(G9\/#(>'^V7"B#U^*U87EV4VXV_=M# EW
MFG"G[\L8'MZ7G0^Y]J#OVI5OTCN(UVMXDX'BM;[\ISK"XJ78%K_UG-[U,\[K
MQ]7WE7?%+EJ)JU%UXRA$_BA&BW_^W9G8_^J3"1(6(F$$":-(&$/". BF2,\_
M2,_7T1?O'QYR\1"5PDKWVSN16]F]M4_CJOV,BV+?V]!=:XFFZD/"0B2,/,."
M!E;WM1X7P<RV[<OQX[&LD"D9$L9!,$56P4%6@596MU$B:BE5]_W5UR-I%9NH
M2M9JRXI3J\RCM(B:#F.?U+193*6&A(5(&$'"*!+&@LX?@>,$P>E? 0?E5+0V
M.6AMHM7:K]4H)$X?K%6TB\LHZ9.1%F J(R0L1,(($D:1,/8,\X]E%#CSV8F*
M0"D5%4T/*IKJ6ZRZ97IIF'9YO!+6KFJSF@:K3U):FJFDD+ 0"2-(&$7"V+0C
M*?=$3J!TBIQF!SG-!O:K'J-D+SKWOIXK^J G?G%ZAP+:(%,=(F$A$D:0,#KK
M2B?H].P8,B4'P10MS@]:G&N5LQ3W(L^K9FV?KD7^E,=E<[O,MMM*BV<Z7EJB
MJ:R0L! )(T@8G7=DY3LSWYV>Z*I[6##S ^?T9@@Z-44QCBW+:;;^=M@I27P4
M=2>^MPW2LTS5 J6%4!J!TBB4QJ TCJ*I^CLJYSK8DEC+0VD020NA- *E42B-
M06D<15,UZ$H-NO^7(H8^C;$TW<Z0?&[;G>Y+",U*H#0*I3$HC:-HJNBD%>!H
MR[V+ZZC86!N1-,(2Q:H"]&H*:@% :2&41J T"J4Q*(VWM..>X70ZMSW_\)>M
M:DK6^!U]D7] A:PE*)U7NU/G6^H3&0L%6J^'TBB4QJ T[G2M"7\6V,$YH<BJ
MO:,OV_\BTG66%U:V+XLR2M>U:.ZB)$I7HNA5#;0^#Z6%4!J!TBB4QJ T[G1+
M_A-G,G/.:$M6Z1U]F?Y3CZ:>>T[/U8E>?4$+]U!:"*41*(U":0Q*XT[7"W#G
MWGQFGQ&8+. [KU3PSY4LK#^MVUV6%EFNKV) 2_I06@BE$2B-0FD,2N,HFBI)
M:0(X,W 5 UK.A])"*(U :11*8U :1]%4#<KBOZ.O_JM5C '.IIYGK,%NN=L]
MK51 2_I0&H72&)3&431U]JFT"-Q7+ )0>4R?QE1O+4V9L3+UW.!$<]"D!$JC
M4!J#TCB*IFI.V@*NMN2[6.Z%5696+I*HK.=I1'GYS8JVV;ZZMZZR]%'D9?](
M0L\U%IG3:=2\P/6"TQKLP.,(].PHE,:@-(ZBJ?J1)7U77])_OU['=3L4)2^J
M68M=5L2UF.Z^28.\;LE2ZTYLHN2^;M,4P?7J"UKC;VF*;OQ)5U[0$C^41J$T
M!J5Q%$T5H2SQN_H2/[_YI!V(ZL.-M02M[4-I!$JC4!J#TCB*IDI..@"NCQV(
MNM!)_E!:"*41*(U":0Q*XRB:JD%I+K@F:P(&#$3U/&,-0MT%*(U :11*8RU-
MF;M].OT?E5%5EK067+VU8#IW6X\S%A;45H#2")1&H336TF:*L"XZ\R!1255M
M25?!U;L*QYVUVD@PF1>I1QOK#.HH0&D$2J-0&H/2.(JFRE$Z"B[847"AC@*4
M%D)I!$JC4!J#TCB*IFI0.@JNWE%XRYIA/=)8AM 5!2U-F?%@]TRI)-"T%$IC
M4!I'T=3'(4AKP3.Q%@;TZ/0\4WE!:6%+TW6@"30CA=(8E,91-%59TD#P] ;"
M39ZMA%@7UGV>;:VBU5G3>O7J"FH;0&FAUS47VF:KHRZHO0"E,2B-HVBJNJ2]
MX.GMA;>LM-,CC26&I(5>=ZV!ZSO=M9($FI9":0Q*XRB:JK"C)P7IO8.;/'ZL
M>UXW295C>SK+S61PJD]DK#NHRP"E$2B-0FD,2N,HFBI.Z3)X8)?!@[H,4%H(
MI1$HC4)I#$KC*)JJ0>DR>'J7P;2#!_48H+30ZU;>?7ON]MQ]H?8!E,:@-(ZB
MJ>*21H.G-QK>=O<=./]<G]M8BE!7 DHC4!J%TAB4QE$T5:_2O/"FX!LRU+&
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M2P$"% ,4    " ":JG=6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )JJ=U9V\3_L[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M )JJ=U:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ FJIW5N*3#)$:"0  AD(  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M )JJ=U:19#OO)P4  ),8   8              " @5T1  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " ":JG=6C:2P6^($  "J(P  &
M            @(&Z%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ FJIW5NKKS.0W P  QPD  !@              ("!TAL  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )JJ=U83(2:VCP(  *8&
M   8              " @3\?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " ":JG=6EU %1W$$  "Y%0  &               @($$(@
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ FJIW5J' C;?0
M @  \P@  !@              ("!JR8  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( )JJ=U;! +V^P@0  (43   8              "
M@;$I  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " ":JG=6
M@;UH(Y(+   P'@  &               @(&I+@  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ FJIW5J@6?2:@"@  +1H  !D
M     ("!<3H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )JJ=U:FHT8=K@,  -,(   9              "
M@7I8  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ FJIW
M5K$?8_.M P  Y0<  !D              ("!7UP  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " ":JG=6]')H06<+  "Q'P  &0
M        @(%#8   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( )JJ=U;-IB8Y'1$  &W%   9              " @>%K  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ FJIW5N5Z1Q\0 P  '0D
M !D              ("!-7T  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " ":JG=6ZSB>(N $  !Y)0  &0              @(%\@
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )JJ=U9,0\,6
MAP0  $(@   9              " @9.%  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ FJIW5K0Z7CQ6%@  8T8! !D
M ("!48H  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " ":
MJG=6CXJU\!P(  "U/@  &0              @('>H   >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )JJ=U9O3UN*3 P  /.C   9
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ":JG=6?ME0(CP!  "R#P
M&@              @ %7R0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " ":JG=6*]!RCG(!  "?$   $P              @ '+R@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     (0 A -X(  !NS      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>91</ContextCount>
  <ElementCount>145</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>21</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/StatementsOfOperations</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Statements of Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Statements of Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Statements of Changes in Shareholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical</Role>
      <ShortName>Statements of Changes in Shareholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Description of Organization, Business Operations and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern</Role>
      <ShortName>Description of Organization, Business Operations and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Private Placement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/PrivatePlacement</Role>
      <ShortName>Private Placement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Shareholder???s Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholder???s Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative</Role>
      <ShortName>Description of Organization, Business Operations and Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Initial Public Offering (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative</Role>
      <ShortName>Initial Public Offering (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/InitialPublicOffering</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Private Placement (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative</Role>
      <ShortName>Private Placement (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/PrivatePlacement</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Shareholder???s Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>Shareholder???s Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/ShareholdersEquity</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alphatimeacquisitioncorp.com/role/SubsequentEvents</ParentRole>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 10032, 10033, 10995</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 10941, 11189, 11235</Log>
    <Log type="Warning">[dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. form10-k.htm </Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentTransitionReport -  form10-k.htm 26</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="form10-k.htm">form10-k.htm</File>
    <File>atmc-20221231.xsd</File>
    <File>atmc-20221231_cal.xml</File>
    <File>atmc-20221231_def.xml</File>
    <File>atmc-20221231_lab.xml</File>
    <File>atmc-20221231_pre.xml</File>
    <File>ex31-1.htm</File>
    <File>ex31-2.htm</File>
    <File>ex32-1.htm</File>
    <File>ex32-2.htm</File>
    <File>ex4-7.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form10-k_001.jpg</File>
    <File>form10-k_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="280">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>46
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-k.htm": {
   "axisCustom": 0,
   "axisStandard": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 280,
    "http://xbrl.sec.gov/dei/2022": 47
   },
   "contextCount": 91,
   "dts": {
    "calculationLink": {
     "local": [
      "atmc-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "atmc-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "atmc-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atmc-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "atmc-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 242,
   "entityCount": 1,
   "hidden": {
    "http://alphatimeacquisitioncorp.com/20221231": 3,
    "http://fasb.org/us-gaap/2022": 30,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 37
   },
   "keyCustom": 17,
   "keyStandard": 128,
   "memberCustom": 8,
   "memberStandard": 12,
   "nsprefix": "ATMC",
   "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://alphatimeacquisitioncorp.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ATMC:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Initial Public Offering",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://alphatimeacquisitioncorp.com/role/InitialPublicOffering",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ATMC:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ATMC:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Private Placement",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://alphatimeacquisitioncorp.com/role/PrivatePlacement",
     "shortName": "Private Placement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ATMC:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Shareholder\u2019s Equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://alphatimeacquisitioncorp.com/role/ShareholdersEquity",
     "shortName": "Shareholder\u2019s Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://alphatimeacquisitioncorp.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "17",
     "role": "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Description of Organization, Business Operations and Going Concern (Details Narrative)",
     "menuCat": "Details",
     "order": "18",
     "role": "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
     "shortName": "Description of Organization, Business Operations and Going Concern (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Significant Accounting Policies (Details Narrative)",
     "menuCat": "Details",
     "order": "19",
     "role": "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "shortName": "Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
     "shortName": "Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-12-292022-12-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Initial Public Offering (Details Narrative)",
     "menuCat": "Details",
     "order": "20",
     "role": "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
     "shortName": "Initial Public Offering (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ATMC:InitialPublicOfferingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2023-01-04_us-gaap_SubsequentEventMember_us-gaap_IPOMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Private Placement (Details Narrative)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
     "shortName": "Private Placement (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Related Party Transactions (Details Narrative)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "Related Party Transactions (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "ATMC:CashFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-12-292022-12-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-12-292022-12-30",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Shareholder\u2019s Equity (Details Narrative)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
     "shortName": "Shareholder\u2019s Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-072022-01-08",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-12-292022-12-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Subsequent Events (Details Narrative)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "Subsequent Events (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2023-01-05_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:EscrowDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
     "shortName": "Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember_us-gaap_CommonClassAMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations",
     "shortName": "Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-272021-09-28_us-gaap_OverAllotmentOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Statements of Operations (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical",
     "shortName": "Statements of Operations (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Statements of Changes in Shareholders' Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity",
     "shortName": "Statements of Changes in Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31_us-gaap_AdditionalPaidInCapitalMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_OverAllotmentOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Statements of Changes in Shareholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
     "shortName": "Statements of Changes in Shareholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31_us-gaap_OverAllotmentOptionMember_srt_MaximumMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2021-09-152021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000008 - Statement - Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInPrepaidExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Description of Organization, Business Operations and Going Concern",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern",
     "shortName": "Description of Organization, Business Operations and Going Concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-k.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 21,
   "tag": {
    "ATMC_AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Amount Deposited By Underwriter On Behalf Of Related Party.",
        "label": "Additional amount deposited by underwriter on behalf of related party"
       }
      }
     },
     "localname": "AdditionalAmountDepositedByUnderwriterOnBehalfOfRelatedParty",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_BonusIssueAllotmentToSponsor": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonus Issue Allotment To Sponsor.",
        "label": "BonusIssueAllotmentToSponsor",
        "verboseLabel": "Bonus issue allotment to the Sponsor"
       }
      }
     },
     "localname": "BonusIssueAllotmentToSponsor",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_BusinessCombinationInitialPublicOfferingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Initial Public Offering Description.",
        "label": "Business combination description"
       }
      }
     },
     "localname": "BusinessCombinationInitialPublicOfferingDescription",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ATMC_CashFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Fee.",
        "label": "Cash Fee"
       }
      }
     },
     "localname": "CashFee",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_CommonStockSharesSubjectToForfeiture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares subject to forfeiture.",
        "label": "Common stock shares subject to forfeiture",
        "verboseLabel": "Common stock shares subject to forfeited"
       }
      }
     },
     "localname": "CommonStockSharesSubjectToForfeiture",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ATMC_DeferredOfferingCostsAdjustedFromPrepaidExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Offering Costs Adjusted From Prepaid Expenses.",
        "label": "Deferred offering costs adjusted from prepaid expenses"
       }
      }
     },
     "localname": "DeferredOfferingCostsAdjustedFromPrepaidExpenses",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_DeferredOfferingCostsIncludedInDueToAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Offering Costs Included In Due To Accrued Liabilities.",
        "label": "Deferred offering costs included in due to accrued liabilities"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInDueToAccruedLiabilities",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_DeferredOfferingCostsIncludedInDueToRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Offering Costs Included In Due To Related Party.",
        "label": "Deferred offering costs included in due to related party"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInDueToRelatedParty",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_DisclosureInitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering"
       }
      }
     },
     "localname": "DisclosureInitialPublicOfferingAbstract",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "ATMC_DisclosurePrivatePlacementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement"
       }
      }
     },
     "localname": "DisclosurePrivatePlacementAbstract",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "ATMC_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company [Policy Text Block]",
        "label": "Emerging Growth Company Status"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ATMC_InitialPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering [Disclosure Text Block]",
        "label": "InitialPublicOfferingDisclosureTextBlock",
        "verboseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingDisclosureTextBlock",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ATMC_IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance Of Ordinary Shares In Consideration Of Repurchase Of Class B Ordinary Shares.",
        "label": "Issuance of Ordinary Shares in consideration of re-purchase of Class B ordinary shares"
       }
      }
     },
     "localname": "IssuanceOfOrdinarySharesInConsiderationOfRepurchaseOfClassBOrdinaryShares",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_OrdinarySharesParValue0.0001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares, par value $0.0001 per share"
       }
      }
     },
     "localname": "OrdinarySharesParValue0.0001PerShareMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_OutstandingBalancesTransferred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Balances Transferred.",
        "label": "Outstanding balances transferred"
       }
      }
     },
     "localname": "OutstandingBalancesTransferred",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance.",
        "label": "Percentage of fair market value of business acquisition"
       }
      }
     },
     "localname": "PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ATMC_PostBusinessCombinationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post-business Combination [Member]",
        "label": "Post-business Combination [Member]"
       }
      }
     },
     "localname": "PostBusinessCombinationMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_PrivatePlacementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement [Disclosure Text Block]",
        "label": "PrivatePlacementDisclosureTextBlock",
        "verboseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementDisclosureTextBlock",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ATMC_PromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promissory Note [Member]",
        "label": "Promissory Note [Member]"
       }
      }
     },
     "localname": "PromissoryNoteMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights, each right entitling the holder thereof to one-tenth of one ordinary share"
       }
      }
     },
     "localname": "RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor [Member]",
        "label": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_UnderwritersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriters [Member]",
        "label": "Underwriters [Member]"
       }
      }
     },
     "localname": "UnderwritersMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one ordinary share, one redeemable warrant and one right"
       }
      }
     },
     "localname": "UnitsEachConsistingOfOneOrdinaryShareOneRedeemableWarrantAndOneRightMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_VendorsOutstandingBalances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendors Outstanding Balances.",
        "label": "Vendors outstanding balances"
       }
      }
     },
     "localname": "VendorsOutstandingBalances",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ATMC_WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share"
       }
      }
     },
     "localname": "WarrantsEachWholeWarrantExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ATMC_WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of shares common stock subject to forfeiture",
        "label": "Shares subject to forfeiture"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToForfeiture",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ATMC_WorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital",
        "label": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://alphatimeacquisitioncorp.com/20221231",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r308",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r308",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r308",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r308",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r308",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r204",
      "r251",
      "r267",
      "r277",
      "r278",
      "r289",
      "r293",
      "r296",
      "r339",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r204",
      "r251",
      "r267",
      "r277",
      "r278",
      "r289",
      "r293",
      "r296",
      "r339",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r146",
      "r252",
      "r290",
      "r295",
      "r334",
      "r335",
      "r340",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r146",
      "r252",
      "r290",
      "r295",
      "r334",
      "r335",
      "r340",
      "r354"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r202",
      "r204",
      "r206",
      "r207",
      "r208",
      "r250",
      "r251",
      "r267",
      "r277",
      "r278",
      "r289",
      "r293",
      "r296",
      "r333",
      "r339",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r202",
      "r204",
      "r206",
      "r207",
      "r208",
      "r250",
      "r251",
      "r267",
      "r277",
      "r278",
      "r289",
      "r293",
      "r296",
      "r333",
      "r339",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r330",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued offering costs and expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r6",
      "r294"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r326",
      "r327",
      "r328",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdministrativeFeesExpense": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.",
        "label": "Administration fee"
       }
      }
     },
     "localname": "AdministrativeFeesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r71",
      "r82",
      "r94",
      "r109",
      "r140",
      "r142",
      "r144",
      "r147",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r223",
      "r225",
      "r231",
      "r294",
      "r337",
      "r338",
      "r346"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r91",
      "r99",
      "r109",
      "r147",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r223",
      "r225",
      "r231",
      "r294",
      "r337",
      "r338",
      "r346"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Cash in trust accouint"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r222",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r57",
      "r58",
      "r222",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business combination, net tangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r32",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Description of Organization, Business Operations and Going Concern"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r273",
      "r274",
      "r294",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash in bank account"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r24",
      "r29",
      "r31"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash\u2014end of the period",
        "periodStartLabel": "Cash\u2014beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r24",
      "r66"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC insured amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r109",
      "r125",
      "r126",
      "r128",
      "r130",
      "r133",
      "r134",
      "r147",
      "r157",
      "r160",
      "r161",
      "r162",
      "r166",
      "r167",
      "r184",
      "r185",
      "r188",
      "r192",
      "r199",
      "r231",
      "r279",
      "r317",
      "r322",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/Cover",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Warrants to purchase common shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r17",
      "r78",
      "r86"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (See Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r41",
      "r151",
      "r152",
      "r275",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r326",
      "r327",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock par or stated value per share",
        "terseLabel": "Common stock, par value",
        "verboseLabel": "Ordinary share par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued",
        "verboseLabel": "Common stock shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding",
        "verboseLabel": "Common stock shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r294"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common stock voting rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r80",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Estimated expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r72",
      "r74",
      "r81",
      "r110",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r239",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r67",
      "r68",
      "r168",
      "r239",
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Loan amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Description of maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r16",
      "r110",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r239",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred offering costs",
        "terseLabel": "Deferred Offering Costs",
        "verboseLabel": "Deferred underwriting commission"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r11",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r167",
      "r244",
      "r325"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r77",
      "r87",
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r167",
      "r244",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to related party amount converted"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r106",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r124",
      "r125",
      "r128",
      "r129",
      "r130",
      "r131",
      "r229",
      "r230",
      "r265",
      "r266",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic and diluted net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r45",
      "r89",
      "r103",
      "r104",
      "r105",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r132",
      "r148",
      "r201",
      "r209",
      "r210",
      "r211",
      "r220",
      "r221",
      "r228",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r76",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Cash held in escrow"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Accrued for interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "verboseLabel": "Accrued offering costs and expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due to Related Parties",
        "verboseLabel": "Due to related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in current assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r109",
      "r147",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r224",
      "r225",
      "r226",
      "r231",
      "r282",
      "r337",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r75",
      "r85",
      "r294",
      "r324",
      "r331",
      "r343"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholder\u2019s Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Shareholder\u2019s Equity:"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r92",
      "r109",
      "r147",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r224",
      "r225",
      "r226",
      "r231",
      "r294",
      "r337",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r24",
      "r26",
      "r28"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r19",
      "r28",
      "r79",
      "r88",
      "r90",
      "r100",
      "r101",
      "r105",
      "r109",
      "r114",
      "r116",
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r127",
      "r140",
      "r141",
      "r143",
      "r145",
      "r147",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r230",
      "r231",
      "r283",
      "r337"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Formation costs"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDeferredCostsNet": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.",
        "label": "Other offering costs"
       }
      }
     },
     "localname": "OtherDeferredCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.",
        "label": "Payments for underwriting expense",
        "verboseLabel": "Underwriting discount"
       }
      }
     },
     "localname": "PaymentsForUnderwritingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Transaction cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock par or stated value per share",
        "verboseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r294"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r98",
      "r149",
      "r150",
      "r280"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from sale of units"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Number of additional units",
        "verboseLabel": "Gross proceeds from exercise of option"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r203",
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r203",
      "r243",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r52",
      "r84",
      "r271",
      "r272",
      "r294"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r89",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r148",
      "r209",
      "r210",
      "r211",
      "r220",
      "r221",
      "r228",
      "r268",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of stock, value",
        "verboseLabel": "Proceeds from sale of units"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Sale of stock value issued"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "auth_ref": [
      "r61",
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.",
        "label": "Description of sale of shares"
       }
      }
     },
     "localname": "SaleOfStockDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of stock number of shares issued in transaction",
        "terseLabel": "Number of stock exercisable, shares",
        "verboseLabel": "Number of private units sold, shares"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of stock, price per share",
        "terseLabel": "Sale of price per share",
        "verboseLabel": "Sale of stock price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r69",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r95",
      "r96",
      "r97",
      "r133",
      "r184",
      "r185",
      "r186",
      "r188",
      "r192",
      "r197",
      "r199",
      "r289",
      "r317",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "auth_ref": [
      "r54",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.",
        "label": "Option description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Sharebased payment award options forfeitures",
        "verboseLabel": "Number of shares forfeitured"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares issued price per share",
        "terseLabel": "Shares Issued, Price Per Share",
        "verboseLabel": "Share issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r32",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SponsorFees": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.",
        "label": "Sponsor fees"
       }
      }
     },
     "localname": "SponsorFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r109",
      "r125",
      "r126",
      "r128",
      "r130",
      "r133",
      "r134",
      "r147",
      "r157",
      "r160",
      "r161",
      "r162",
      "r166",
      "r167",
      "r184",
      "r185",
      "r188",
      "r192",
      "r199",
      "r231",
      "r279",
      "r317",
      "r322",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/Cover",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r18",
      "r45",
      "r89",
      "r103",
      "r104",
      "r105",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r132",
      "r148",
      "r201",
      "r209",
      "r210",
      "r211",
      "r220",
      "r221",
      "r228",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/Cover",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r132",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/Cover",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Number of additional shares issued to sponsor"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r45",
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of Ordinary Shares to Sponsor, shares",
        "terseLabel": "Aggregate number of units issued",
        "verboseLabel": "Issuance of share to sponsor, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Bonus issue allotment to the Sponsor, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r45",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of Ordinary Shares to Sponsor",
        "terseLabel": "Number of shares issued, value",
        "verboseLabel": "Aggregate value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Bonus issue allotment to the Sponsor"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r45",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Number of units option exercised, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r4",
      "r5",
      "r45",
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Number of shares repurchased",
        "verboseLabel": "Number of shares in issue were repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r39",
      "r294",
      "r324",
      "r331",
      "r343"
     ],
     "calculation": {
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total Shareholder\u2019s Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder\u2019s Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r53",
      "r108",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r201",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Shareholder\u2019s Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r238",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r238",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r238",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r238",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r247",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/BalanceSheetsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/ShareholdersEquityDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical",
      "http://alphatimeacquisitioncorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/InitialPublicOfferingDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/PrivatePlacementDetailsNarrative",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of noncash financing activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r2",
      "r73",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes payable and less interest to pay dissolution expenses"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/DescriptionOfOrganizationBusinessOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r212",
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r135",
      "r136",
      "r138",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r124",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average ordinary shares outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alphatimeacquisitioncorp.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r297": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r298": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r299": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r301": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r302": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r303": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r304": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r305": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r306": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r307": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r308": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r309": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r311": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r312": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r313": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r314": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r315": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r316": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>47
<FILENAME>0001493152-23-008751-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-008751-xbrl.zip
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MWU"^+::0D7\"]_[@2\*PE%M_'S#W$U=5Q5#QP()5@7DZYSU9ADP9F2@/8-X
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M?U@^ZR^U1MG3'9O3:<2GY%[OH"4ZCE#,97@YP3A+5?0(&QN@:X0H3K()SJ(
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M2??]E68>R'J56E#41D^^1RCY0?.[+'@:41)@S!U#Z>*=U#A\:0W@ 3SZ?(#
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M,K<<*%UD61=9UD66=9%E7619%UGFG@NHBRRS&EF6TJR"$ONT1(A]N+[@&UY
M!;+?*S\_2W579]&,K54'$? -F1,\;V!8.0GE1<2D&=(V+8K327VA+W*3"D A
M]2_H,9KF4YG<:TU,+^S 7"4P=>[Y87R/ [9T,:$S<<"R6PY=C -&Z>0L)@]
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M#TYF-]G.35C'))5=5BEL[@L:$N)!8"KG?BCI=O8]_]\-2C'[YO\!4$L#!!0
M   ( )JJ=U93<@5J4C   !B; @ 5    871M8RTR,#(R,3(S,5]L86(N>&UL
MY7WYD^.XE>;O&['_ [8\L6M'9-:Y<W2W/1/*JR=CJDJYE=G=N]NQT0&1D)(N
MBE2#5![^ZQ<'29'$2:4$O/(XPG:6^#WP _'AX7[X\[\]K7/T0&B5E<5?7KU[
M_?85(D52IEFQ^LNKGVY/9[?GU]>O4%7C(L5Y69"_O"K*5__VK__UOR#VGS__
MM]-3=)61//T>793)Z76Q+'] G_&:?(]^) 6AN"[I#^AGG&_Y+^55EA.*SLOU
M)B<U80_DB[]'__CZW;]@='KJD>[/I$A+^M.7ZR[=^[K>5-^_>?/X^/BZ*!_P
M8TF_5J^3<NV7X&V-ZVW5I?;VZ6WS'VG^YSPKOG[/_V>!*X+8]RJJ[Y^J["^O
M^'N;USY^>%W2U9OW;]^^>_._/WV\3>[)&I]F!?]N"7G56O%4=';OOOONNS?B
M:0M5D$\+FK?O^/"FI=.ES)YF%GR/295]7PEZ'\L$UZ+8G:]!1@3_UVD+.^4_
MG;Y[?_KAW>NG*GW5?GSQ!6F9DR]DB40VOZ^?-TQ*5<:5\*KY[9Z2I9Y,3ND;
M;O^F("M<DY2_Z#O^HG?_Q%_TA^;GCWA!\E>((YD^C/GZ;I!68_0F--D;0K,R
MO2SV8SVVCD2?U1U:OR #??O@6;@K:YSO1;YO&9SV9[+?%]_9A?_2S,^3_;YT
MS_(HM&N5\N3/J_^N.?_Q(_MK0)$\U:P!(VE+DB=A\<#B#:)A:-+N4B^30;HY
M]^8E5?/.6T:1YA)7"Y'PMCI=8;QA+WC__@W)ZZK]Y93_(CY"\\-OO&TD:U+4
MYSFNJOGRMBZ3K[.GK&K?(S+YEU<>^#?C#'#+&6US@6GB^!0-XDU2LH9L4Y_F
M\J-+\R4MUUXTFF]6>H!_RQ==^O(C,PJ&C Q@E%3EEB9D4AGW<^/[51N&ZYQ9
M\ X;*4Y_NGWUKP*&RB420/0KA_Z_/[_9);V/EG"]3H1 WKV7S?L?9G>?SG_[
MJ<CJZA(G]^=E4655S3J.\^6\('/*^I"8/M_>8TK8O[^0E+!.QR(GOV!*<5'/
MBI3_G*WNZT]DO2!TE/F#IQY"@$?Z)%RN!TXZNKB/DY]Q51 O.$&$O0(EW3MX
MW6!C&50VKT$5?\^)^(UVKT*/\EV(C7WD(_ZZ(]6C08ZK&TS%<.3M:S8.><?Z
M2N)G<SV98AVL'DS/4J=S?U,8.I[,=ZS3-@$D4SA!&TS1 T\$_8-,!FW8T%GH
M]$@*;&J6J(Z_W)==5;M\(C3)*EXCKDHZKIRS]CFYH5E"YLMW[U[_XUNW8H_Y
MMF */_XGZVK$\5X%HP8=/7_C&M>^L&D<'OD[.X]/=F]%RY)J&@N$>;O0 @G:
M\/?S=N4?!(6CUU;1](FO)?ZZ+.JL9E:K?R_SE-"[>T))N;PKV0=CXXWZ7FU5
MS57S8$D'JX<'_AA=I3M0NC!JV&$S,ZY.,O6F,HF.$B+M&U!]3]"]> W_D[\'
MU26O5*?B5?KNV$LKSHL'O^?E>ET68C UT]86&S#D<-=,M#_.55'1=>FDIHQL
M!1#) >X,_2K!+Q[;'E(J9[Y2.8LLE3,OJ9S!E<J9OU3.X$BEF\RY_'V;U<]\
M,8SY/M81\9E6T]M$F5JST==.K^D,P,C*A^5881**=M@#S;0=R!N)R3\/9S3
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M]U]2 -:U=/(T+2C F*T^^/U'X.:G/?FJ1^=[=^VD67606'F'B3HN=&9;0FD
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MQT,CQ#9H#R9R!2X(=,PZ=?'$#U.Q>7<>XMW^R^DAQ84HA]_*]? R"0_V=N^
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M"1HS"12T[@)QFX,&$4;+JEMLYYD+F@4LFI=S<<0>2!+]);_HK,BBA&;9^A'
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MH/38[L;-H>NLV( //C:J65IZ";@MTB6-3YK4)BMTDW?/5J=#@G$KH4_JUB9
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MER)G8&C0Z#K0'%/:@=AF::?X>] 2EQ5H7F;Z[P[VE 0?"B]3.A(@EPZ>I@.
M"FS9@D:&!@(Z#_ ,LOS2ER^9=#4O#K+FCG!8D#7/1;48CUZ1;G&0)Q^Q/ F;
MF; +X'-PR4&))(XNYN4,&0Z:D%=5:XE9631%V8Z\M 5:T.0P!(;0XBCP\PG_
MFKZ:K!*>%)1@X:I52@OSR'6*X-^$BR9F.A'55A<6Y1>*$).A.0 B8EJ8ING3
M!@(19&?+DS+\=.PL52)1I2*KG]CDW%DOQ-[/TTPDUA98+;I^86G,<@D<DV1:
M)%5E:1XK'QZ/'J%54,<_;]IJ^@9EYZ4I+X [=X45/<#,YXZ\ME?6S]# $OQ>
M@<!9Z7Q[MD*0Y+QS+J(3UVJ)Y%ETF< 3*%%X29-]7EO&[!$]!I(!7JH:"'L\
M9/_D';AM(I" EJKH1*UA\>-0S#4-KUB+UN'0%-OKZJ2]=/6LN=D40>F!WTPJ
MPZ=K!F1,VZKV!B1\<N5FM/,D<FLKAPK7V9)/#1YC"ND1L--L#:<-WF?K*RN>
M"]00>$-Q@)4U] ;T=Z%W R^6G-28A(DEQ:B /_GHT9W#ATDO07VKR4K0ZKI%
M5] RC$<P*7Q(M 5<3N^'H8'$<^9?(HH%.9ELTQ4MKT]P)A%-<+#1S 1C^O[9
MW_1@RGKRWN,TXY?0LH2I3.%1^HHNH@S@O^9-2+A0G_>HXPP,7CKXO"TE;//U
MI85+99AE.'BIA:6LHV,RL+E5UQ(OZ7" PE[0?IDKXPIVU.'BPHP.FLL=$G<2
M_X*#^7X,/$0)V>>*?F53LH'0+?&L;HL0X@F]MO#?VI('G$+@S%S,H!,[QY^C
M>_1H9I= M#BP\,ULC,%KB14//WZ,/"SFX:Z<UA8=PC@"NU(Y5-ACD\+2+-W$
M*#"*0Y G7;A$ TN9M;#T> 7[O%_8,I,[1)[G36];\F_!^QIKW\2#B-0!H>#0
M*"E+X6+,/I%Y#[G^[P:>8?!6PFS^U\E)]I,#M>N[[(6YL ]A@']W:!?"@]G)
MB0"3OG_R['^4C%V3>8"?3<BWZ#_[L3"@7)R?WH>U G'L9C"UUX]^_/EI]OCI
MSS^_>/3DR;-?_L]_?7;V&?W]ZL6CQ_JWO%3&FU9%898-$*?_]A!V;]9>XC3/
M_C9D:KQ^J6-<V9H\"KK(,(-TU9%IXA-/](EHZ+""KY\@/NLE_A_. /X)BS.P
M3A.X'&].)LC]@9HE+6Z\=@\V0JA>I$LM'^O[7Z1OC#;P2]Q!WK3XG YAN3[H
MV3U(C]O,\!EH-&:*1@CQ>F(^OSQZ]>31_X-#72\K<L1?@')<E_0#8;GH=&UR
M9:,8#(QY,<420#,R9=D!?UM82\I;!WH/1@ZS A$=K'>ABHB:'VJ]^"$YE%S=
MM/#_#3K<\$N0)K,(*X*_*5S3BLA@<E/5,2)3O&V)R9&AQ8&J7==$]"*QXY$H
MNDIU(P9"!;(LUNQ^I<E<V_YD>X_GZC9*Q(="4B9DSR WF4EL!N$GZ,9:D12=
MP1IT+ &6:)O CXU3%1NV%VX83G&CL@^+L5G/OZ&B#CO#L^_IZJ1+T%_\Y)%X
M.EEC1J];&"B,L*Q=15&>L-'#"W=,=@9NL6&R3_B8H'( IA<=6;2%5QR4UA4E
M9QZ9<6:EX8*P4&H[Z7IZ:CBJ)9Z_&T;A#TKTW6&#OX'62F8N^2EFED[)T,WU
M5F5T5=F.0_<]6X%H&..7<H[8BQP/UFP"?L!;,1:Z^= )M@&4#W91D9\<>(Q9
MD8&'FJ1I+L&"_W<7@A7FXJ(&6Q 8N5E474GZ+7)>,"F758.X.=&[:XS<HC3H
M4&<UC3@> B4SLVJV7QI<MZT3 #V]Z$C;1X: -@HPD;ID-PNA1LAX)=^; ^&T
M1ACQ';SJR]I>N:IK@'_58(.;AH4/LW18$0XTF[>X[\H%V7:.H!:\%%T+IA+;
M(,D^>:@(<6-\DL)3' 6) CHH>5S)4159XZ$U)80A+P[:Y1A2<DLC#CN4!6@1
MO'48?(#O$;5T_@UN=D+4Z7A$P1M_!N2%UX() IG1 E4=N0[A=5>PQ.3XN:SP
M="\1?Z/'E8]F['(4J03?=U->KYEB.7U8!Y<)MG0!]A)'@_35N.@^0.9C0.(&
M&8SA$+LF+5!%E '%EWQO'E;#=ZYK4)0&! [;<?"JE?!\_/F,]NG:. \^P(DN
M&/$@L(J^"PGE0.I\S7U *7+:DKA([C =43Y0B]2&0UXB;&+M?F] =/U:%NX-
MB:I5-BE,^2:;7EJP4GRTBOU7I&S$1B0:HHTBVV#/\%I4;U=DUTSUI!*^ K[_
MO2LC&S.-;@V1Q0,K2T3!#A>-SFM85F(2Z<+@#Y$-,9<+*T#V.-GTVU]JK^!.
MHOM+G=BDT[6):[DPU^1S,&NKL>'7-!4XJ+-J/,*O9W:*D_+:W_HX. U/((8Q
MR0M/7K4,70WLP^6CGY[-&WIB@,5N\J7K9K+_,JSULH=!:RV=6XI)LI=<G9"O
MGC[.Z>5S5_1^-ZNF'2GP= Z8Q<+/ V/7+1-=>SL6\?E[NIUB3SG1TFPDETAC
M$#?P9639PDJ]PV;NT$Q!8@G]2#L6X[S-!%VDC/[>/"G&3J9KK^S#-$GT(!@7
ML()?U W&V!NY@[0?I]FS>0YG[!I.=9T/.X!DRPB]P &$^!WCD9YWV!T\P?[D
M5A->BZ$Q;W=Z=S"?G+="L*TD.N2N#S$6,\"#UDYNM$1!HN\\W;B:V[UI?E)Z
MBNUNG81L(->/(Y&6%VD&/4\BQ23L+(XJE=G<7%6J5VRX+X\R.",U7 K<(0XV
MB7TL5!- 6<=000G*3F-9K0 )WB#1-7(V6D;)B0BDLF(@0ZBQ4UL9A(VJ_E0E
MPK*$DTHS(%6V/V;3'S2*9?""H(8:SPI#HG+V:=N)#:#6$XE$CR#A8 M()0R!
M%< @^(2)."Y6)XI"P1>&VP+&9XRO(7&7HG>/65B4*V2M73'3H)!H:?%-W"2C
M62RMG9)-A@*N18Y(3WC'S$T#EA+5WE)]Q/0KT%W@&C>R;L.G!F:B:!9VC</Y
MIWWL\9"U0&C8P378*1_;'*Y>><)Z!)U 4J?**K-P[3 P>XLEJM!%9/2 8SH.
M<2@,1_YF>>:LHEV@AI:JNU^=L7EQ!*HK<0,*49.3Z%R^*F$10LCN 7]Z+'(+
ME4T8'Q\56%.(YJHOQLT]5X6]@9/*6J2H&; J'!MMS1M;1H'A+7K;:Y)7,F'D
M8W*-T&71X%EH<H^+DJ^\8HL;R6&;(=TX)Y_& DBA)":<-G)IDG:FC;B<XI5V
MR^J#Q^+N>"QVR<$;&>->)]8$.5(Z8X7S%K&I\6BW_,[?%V:BUHCB'09X;XX<
M1C SK(^PYY0%BH\KQHN&+AOX$>M((E_I43":%^L_!\:&@H=\&+@\"/X0^(M1
M1.9%775+ 5V.1RR?Y@2F9)7QE2SI^5?*NI\JVN71M#W./5!#H:P(1JB!&M:_
MZ.4(057;/35J Y?$_ZK_A_2$\_L>Z="7!S? L^8A@$J@3>*2C=*/)^*5Y&5Z
ML8^<BF2N]RT(-I=$4B^R*BHT*.JP7>Q:8ZW"PRN"P^(H^)*2=Q\SZK3V<G4S
M^^[C,^3UJ$%$% 1O2?HBM5W05^*E^[R@B&6&,1,^[6&@1"4=CHKCV>\?N 93
M-7 %FXZND@DYL475-*+%T-O1VT-.$S=GYTAC@40:,"5=Q'JU!$D'/.V-;4$U
MG<T<)VRA6WV "N\B\K"58!]YOY/@G]:!.BD!#!CP*[)%82YGC(,1I2T7U&_/
M+\NR,,UG(1X1G'UR;C!08>G8X%TP.'R<?P(3(=!P>$DC!SB%'  9EE.)]4C2
M,&%!$Q4U!\V:%#_V_2'KPKW[= /Z]PX!_4- _Q#0_]/UPEMH='FVR3B)?>Y>
M1C,G%&,^03SW_>G 4)%U$KBQ[U;7S-Y9-NMJ]KMD 1NP*<TF]KU$1(]'&V1*
M)$[P62.23[VW0W-6U:0?+ CZ#2[&O?S^^?W\[_<>D+ONJP>G]_^6D]Z% NY!
M_JW@Y](YWR21*$:>Q[/=$::.1=MX1-NVVRQ@LW>&;A4P+LEH'?8&>>?7<5][
M(&3 NG*.1NUXQ)#9H%FA)INNB*M%>:"L<D0BLT(/IC"[*GHJGK@447 GKJ'L
M*$H32P-XXU$OW1M' +V&PX"FAM-MEI?'!ZOY#G''#UM;AU58*N10:B6$G2H^
ML5PX;]^"D5:VEZ!5'R$0B1"VY]_(AZ@@DFFT!-6QJGU@@9.W\S2=D*//QVP>
MDG,6-$OBG/,=IISXD([<,29@(GJ6[CE8P!J*BS$]UN?3X85TS BZ90[/NV,D
M"2X@& .HWC828X!5 ?X.>J[#Y6'/7F2<HK\N 1=0  @>)7X?W=S"7,^[%,S.
M. &%M.>QD=:+X;\#9F(\>B?0Q"W1#0,#K(,;QJ,=Z(;LB#RE?((^/U> ]CR0
M($^ 8:/9)["Q8*<T8"O? AN!#IYD8=D5$-F 2=REP-(7:.5WKAD2!5Z@ALA:
MHF)$YGVKM4)(B*GQ.>]J#FHYL,EFAAPRB16J3O_CM.1'2#.BJ!HN.9S@FQUA
MCT(4(S1,/GG'D,>\M@N055YX^HP0#%0.PO=RV;$K+K:ETXP*F"! AB%XA'QG
MEE;!0E_(_65-Y;%9 7/,GC6%H<00<TU'(HKK3POC&',_A1DY!NWY&&B ?-)<
M.!LM6<73\6@[QB.HB@DZ@W<>+_BF/0Q<+;TH6V <VU3/%+1!_'L.'.6=./<N
MACL>]76X6W/Z@_9QE[0/L<T"\,N'<F) L%<D;AS8Z1],S:W)\:2'E$,]GC\B
MIR&;Y$E@-1(: W'!HB ZDSFGL3 W #GJ*N)3E!RC*@1744BHWF68T$5 @8^8
MY)97CI@99HX&DPQE,OU$[LN19!Y6+;/6_GVZI19TG"LCQ,@D;$<^ $.0?*3W
MSK"2-11.Y@%N;-H)# Y]S_0!5UCHF(T]6@"UF&WXBC)C7VNABR_,8OD0_L0!
M'TM,'M[T!$0DB?&OSJ@0T+W(Q:G*'"<W!7W*P^'#'J;1R4V)3A/)<YIA,#DZ
M-X/A?/B,*T5:W&]"B,U1(*#VYYW_LRM*-I!0+L5W/0(S$CPS:V8%D)1SS:&@
MF>G&)1+C\P??LFJ$7/CSL]-S*@K&@N$XY'[35!KV?A#*(L:[@LTH,:0-I'!(
M81@Y'."5<08HIY+5@Y#, 5^-!K5!\"NA!QEQEV2$8)X1;2))R_&5(L\)W=*(
M)]--CC6832F7!-#%@QMX*ULW#5V%WOEG&)S>JMZ!%ZN(DJA+NY)+AQ>.@3Y*
ML(3(6&,WA#7Q=LD$;",R1+N2"HE1?DB%N.*J)GEHV2@+=]^_U&,[E#S2]4#/
M]:N6PIFIDHQ87-'2KIOO!=6+V1#@EFJ)9'32@VS.!2:*UI*3\H<I]\' 4I4U
MU2D(H@$J=(6$Y9$0B_?=\\C=W##$21EJ1(>%L3R8K1[8V[5"<J+D5P*:-0JH
MQ]P<H'Y*1@L#=Q6\9!"@8YI6!?AZ:L @=WP6!/N-","!8&CQ &^:<2 3%"SQ
M% (AN/N1T6TP@H? 'K@NQ4I/CM9*T)6F='LT1X=EED]X$S.+F3B^82B'8N">
MQG+VA@#%T^QUG$[,AZ:I%B#X%"QE$,6IQ3Y24X(+2@R*WP EW:SAW4X5E;#Q
MAC>.1ZCHQAP%3U/(8=#H*L(\AUQKM]:(B1B:!L\J0%XIOR6V]GM>JC9R4X&F
MD*; !">5]SMA%&\ =#< C2=X+!5\T"PA'Q_8X1W*(__2^BC*%M_=\\3(^-OD
MU8A&6W*\B8/G QZ+% TR8.Q$22NLW*A8BN+^Y)T8\%.P%PH'1=P>\R!"0%X)
MQP@/;0!K]GBR_#!RE[$D]#X*/.;M>LTT%#CV[9+.<TEH@6O8F4L4&0<5[2ZI
M:(+:#(7OIESGIQ?"*F\4NLP9IZ-PK]@TV.T4 PFSU2O&Y?%2LM[-Z27A,8TY
M1#SUTX6P?'6 L!P@+ <(RQ]K E-]MT3TQG$LLC U$ME/3F'>N\D87BOJTZ_-
M15^.1UR:BZH)& *M-+9MHFA.ZD*+^;180@LA1,U3H!)T8T*%.LTNY1]HD3Q$
M&"_,+%0D'(]\>0:I8:_I+)?FBGL=^!*J7N_IEY%?KT:FJ1[P] F%L;B$/T=X
M,,7.]V21\MJ4>UQKU0^L1DA9*&3^1"7^(AM-C,&U>E$264YR&6Z:? _B=S#[
MOAW(M/?)J'%XU]5!>TYRI6X5]>7**:27;\[GWVDM;4"G#*27[Y$.^='WZ_KS
MY_B3!B=?A>"DEFA^-=@=0[^E NAW>''NOD1[2LR.7 [A5E,E;C8D>\5?AR"3
M0U7(^_D;[!T(<#:V2[G<9@0Q'(\VFB*]\K0]NGP/"<JUCE%] <(QP+=39G_D
MCN,Y;\6)WJ+*>[Z[Q+H/FKV,GD/FONUJTN5+BJ<_9+S3=FCLN]>T(-TG*6J1
M'3TZ7D-._.%U+8B.Q5 (ZEWDW-&/[S %^MUX=(-9K%G>:V&S]?H.47XGAILQ
MKJO1V$V!WO'HAI%>&./('&>+:@;LA:\,%RR8<H\DMX@BTP&PTX?EM&D)@L2#
MY2_.8)!P1\)['6E-L>=RR%7@LP.W>*LQ0>F=<3)K4.<!F(R"+;=&O8;1WFN-
MG?#5+^T%*NK\@U>XN;CWQ[@R1Y/CP<O$6K'/O(K47:J*(ACMP6PR.=\43+8G
MV['7"'D&M59P:8_7K\T[8Z:D+,U6'G%C@-1M\"AK!\ W<?S0)V##FNXX ,#X
M_0F =2_:RZJ[N'P?O]P-P&KI5<-WC4>4M/:>B]X/>3R, 8YKU:>C6^!-/(Z]
M<#7YW:\5=CEDKW&T@VL<W"B3Y$CB"<CUE]A\I/65'M"ZU8Q+^O7Q&DYG3<CZ
MY-'U8[X+&BBBL0=YW9*<TFX]SC$N.$D1C.C87-[BF"I:#.6W'/+\[W9C$E59
MQZ,-.FNV264]V(L?L;WX'$22MO+[BCOY[304)0B)WKDE]D53VZ/,4/15UUX8
MH=^2J[(@M]L*+!R/4F2A5#T >:IC7E#YV=<W(8V8>^3B"+T#CSU8)Q^R]Z)6
M8-AYRLL#K.*"6C=B"V8Y6[A<HXZ#UB2,A5"QB DG#RP4C="HY<-M:<?4[T \
MUS4FC[6I"\=9Y-5TBJK]_#NRWAKWUN.]/9(EAA+>MHXF9A>.1V15^9'*4!31
M:]J^Q]=0RQ!RB9):RBGQ3?;Y^3UIEBI^42Q<P3U2I1D&?]PL"X<%H,5%[KM6
M(!RBJB],Z?YC0@7!VDK#<?V4X99XHNZ=^?:5A*P0)0:_^NKL)/I*82E8>-(R
M(BF$5K=F>ZK^<RSFE/KMWV/_L_7M#SNLI:P_Q!;KB2+XKG5D@> 91F68[DI#
MP4AOM&ZURW(NN!  VO$ 280%>,(%5:M+V_"$T #8KX6IDT1+309"J$:CP1*M
M:=O7^/I)/>$="?Y5G?=YM."!"JYFVJ[N2 !ZFQ]\>QSZZT,<^A"'_K/CT)](
MV(;]!-),YI^45''0K3]FW?I7=O6OYT0R-A'5W3?6+@EVR%M/('?>>04\UC9V
M#)&GO^4H[7=[=##^$N,[2(M8.O2EQZW7).'PR%$C>7'S408DRV?*GX,TN355
M'_Z4]M861-F'HO*/9R'_^]L'?__V0]'^!Q-+:!(DKC0+C8C-9IB"8'VM6[G[
M.2K,ZB?N-0M4WR%ET/#OLR/6B+FJZ(S[U5 J?-1B%'L;@[:L_<J0D*.FRHJ*
MK6S_!M"9$0C-OSM^B%H\]HB,DV(HPZ6JHTSK"6O[8)DA?S+<3CE/GI5D?ZH?
M#S.[J+!5*5(!TXOGTBMAJO&,>5(DC8PD3;^@+]*?XSRPQJ2D'ATG1X0TM3VY
MUWMZD?]DL@8%RG[0>C@L?SWG_#C9_+JG#!F_ILYHZ5=T<(I:)[@^KPL2'V:N
M2)&UP['<9[(./&P/9KJ_;.$N\+"(;TU]LAZFU@F7.AT^=.(3^P0-U$_$F9%(
MK<B#T6N!Z"AK>V&RN9DZS+G 0,[4!RT6!C$53=;8-I/6.>CER([<J3U-7T(>
M,GT+I_T;UVA*=Q<P;/ FWU9"QZ^URQB&+">(R9-<^]I..D2!'+-MI@:)OC2
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M'8=*AF\+-5$84#GJ(3/N#CMG*4X7E9?3 +3@(4!DSRTE$86>KE'HL [1Q=E
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MT9_.:OUI(:F^4G]J/JC^-#,NN#D=_KZ=_!*%5XO!!(^M&#UT*</?L%]^=[C
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M I:@Y!=.T==H'Y2GGI\&P:Q),B8(>*2AC@.10O(D[RLL1_5#\VH\+*ICL,]
ME168M4_>>.</R24MJ?A&5!^!,+X4&@\K&W@$4F'PXFC^U>]KY* JQ0A\"'+#
M#[E@ER+TBIV FT*F-J+0:Q^+%>2-*T%LB437]NN$(:PRQ_(;,0#2<LDFL["$
M G&=U,6WCS3]]T,JV<$B$X$GV[B+@*MB]XYDF409&U3?01)($0N%G>1 AG0]
MN'[L9GTLOG9EHNI1D&R03^$_*"@B%VC$(#P1X1'APR!$Z,,H4S*^>LI:Z%QF
M G$/*#NMJZG8EI1\T^ LB,='I"IP?E[59:E);J$(S'CD&VJQUIVCE@'7-APB
MRP.6_G#9\+NE51&">V%DMB4E^L+#=Y!@RBXO99+FA5I37=J%0KH-4.I,!+]!
MYX5PEJ066A?+/+8 SPNK?Q!9+%091>G4*LE(F2#OG;62PK0TN76D1BACV*:J
M'R#Z&%JJ"=5"IPJZ"418)W9>O<,ZLZ66"!/*\4=KP-MU#?A3JP%_-B7*#U)B
MOO_Q])?]B^-/AZLK^P?__G)\?HP5Y\[!R=GI3 O)GWBE_M')V:?5%=3SY[]K
M-36;8[C8?_\1*/GD" CX\\7,T1 60U-_0E6F,!#<M)=4=H6#1?$;)[[LO&@W
MMQKMS=U&>WO[Y0/X3(73BQ&CZ;_WS[XVFZU9'MGI_MF%<VR.3"RZ(W6F#OK1
M$^:+^*'YOO6@+OLR$OT#VTI\7]\E70R][8</#P$*9@?/M;7QH.[](E^U9VKU
MJT3LC1FRUMW)M7A@RTV\<Y"O#T&Y^_,DW<U9+@(=O8[V\SX*^<Z48)M+*&[G
M1Z;OYT2FYZU9:RY?PE@FZ"SUG/-4=+M8\L*N^T>BV9W=!W 1U5)V$OFVYTF]
M,]4/3F/TQZ)/?_E%+!!^+6(K:71SGC0Z4T7@H[S$+!3.!P4[O2;5YR-9M^9)
MM5NS7,,GL+N<<]&5Z9!P)H,HR>):S#Y-,;O<^9I+1X)S2#E];!<K":3MV;M8
M:Q_K7&7E7BTKJR_W[7E>[CLSO=SSNL"2MC3<,,,Y_">C])@SRH]"]T#D?NM%
M 2;(?<*^EJI"_QB[5,3.:1:[/9%PWA+_ULD1H)^ WC!_7EA.G7=GGFSQ>I9K
M^+]G,I'QE?3^W_*3Z^O:83N!1E_/DT9W9RNZ[]4&P+E#%X":Z)^-C'X]K[@:
M,<#>+!?Q;VP[2ITSKC@9&CX(]-\M3X6SW\$V&TK5P6C<$Z#OG5JH5Q/U[AQI
MNM6<Y1IR,7UN501@NY1L, CH[UB:\T&DHB;B9R.D]^9)SS,-*A\H(&:?M0V0
MRN(REE;_(&>?2^I%R/61ZJ]8+X$_R/DA%^@UX3]MZ;TW3Y6D-=,H-.C66 C+
M(IL"?=[3B)74HOJNQ#O/!*#63,/3)U1.>YS7SM9D^\0%[<$\:76F0>E<&T"_
MM8BI/^)1%$N8@O-K%OL)=K:C@G>JMSV-J:07J)M;N#P-)T<ME.M8]L)0XR/%
MLA]*WA:%UT,$L.L(]ER%Y>M:6-XMA;TY3ZU@IM'L#QHBON$<WD@W(T_PB0TB
M?Q#%@XA@&WZ.X!31N? 4_ GSI^TE4G-;\ZIZ(X*>:1PZI^*#J(^]@YZ(7;:[
M70OCN]'N/"LR6C.-3ZN4GZ%S<AV"^.WY PPR'S#XDO->AA+D,GIV^7L2SWE,
M6P6G*Q..G@ /U+Z)280_SS*/UDSCTIK$B7K1TP"DGQ3H^2(6(,I=!4S%@1'6
M7)SCD ''Y)-03'9KI?N.Y#[/^I#V3$/6I[$?(N1H8,?NCA"VCN+6,KX"]?LI
MR.LZ!;IVL3U+%]LRB53VK?U>D^1DDJQ%6,D=/,\RCO9,TVP.;WI^QR>CJ>&4
MY) YYVY/>EGP>/?P7K.65[>0WSS+)=HS37O)0<[/LWY?Q,/EU_;V*A+(32L(
M&T>P $0Z#D,Z!FPY :!VLP:H?6H M4\<^I1?YGL_K1DT1>8<5,565XZ?( +G
MTDQ__'C:YGB.+PX1LG;#>?_E_/CSX?E3A$I=FNF_]=\=A]C7P$^<?8:"/R,H
M>,R)SJ_7%XA&K_J'F$]5ZY"7#0?N=^R40NT)(L=Z%J-'(ASJ)B/4.2#27U[+
MAOY"?9(E^A/N9Z,^CK)8/T@CX3OV@T%/X.*<?:OG-H9900?PEY>>X$ T22WS
M*CKO?J9.Z<'<F7NDZ=/,@3.7G.$-WZRNC#*.@^T@G$X@PF\.F&V@Z+G,OMRU
MA_,7J"/)N1R ^8!]FUK;#:<-1F6#V^$<B"%,PCE.X"5>XL@;V1_@;_2+L-X?
MQ<,@@]=1F]+5%6E:3 FG+^-+&3><I(?=+>2-2V4<^/)$8A=$,V']R$#5_*,,
MBN)+$?K_$=P'"51#'[9(Q$Y'0;CB+#I@H]+W5 -B=3M:7=&/P7:^$%KT:/A7
MC(/KWVJY1QU6L"4&3"+)L!30GB$U5ITPMG!2( "9<HG*T#Q)K8A,XP]*(N6.
M71BW-+VHJ!,5ZKP)ER"Z8B Z?L!M@E3WI7X>U$REZ&\X)_ A[#9(=RJ,\9%#
M@+QPZP=QQ FJ5U+-J[ AU/E+=?[(FU+!&JC7I)OA-E_*Z#(6@Y[OPEE<TAF)
M(.U%V26U+<%^LBS^![$/M.]CNY;(S:CZQAH*)K:?^((V%UN+K:Y<DB3!(</(
MH7S:C"\:C]J@P$OA]5Y$\^/V::8W&<U;_UYW98'EFK>(E#=3Q(&/S6XQC!#@
M+[&S"MJ4^#/8MO?F="Q"H(YJSH%F$@P\T)N&P*FHP>/4))(T#GD91]=P[)H3
MR&,"/)-D;J]!<[#>8S7W%+  ;L2E>PDE2>3ZN!VK*T1(=QNQ@("Q;$)KR67N
M"6A8N<AL[VJ1B81U/@!"0U'A<@,PI]78VGS=V&XVX3W<"XPD74*R$T7,Y26P
M%]*EEGW(4"ZUX?FAO=UH-IO Z:'SJP!M#B0(C]9N<(^BL>%$WLX(=+_V;N70
MV"\P?Y :#WFJ;K^A^O\@T?EA85F8/,$U=?G$0<)U89FO>;(C8]5$^EB*04+G
M\D&Z3*:;+4TX*%3,Q2VQ@Q/?0N-:@/,"- 5)#?]>PN,QR?Z2-]KBKB<\DMQ#
MN I=0OYU4;11%\$<& +T_0!;C?E7F-DSV]EP^S5CNE@V"X);4#\MKDM2G<_P
M+N/&K@-N[!J9QJZ6Z5/1_%4;,K "_>#IB=8H: #[6C9* LP!]L0I4T>*MY"Y
MJ<VM9^VD??/Q32>ZJ>2]Q&LBD+J'I \J0ME@#9A%\<HL&=X,'4;A>CZT:B2O
MN]2A&8DCC?29-PJ.Z5\/PL%'=&CSC=K:U961O2U.I8>WJPRX4Z1U['CKXO*Z
M?N+"^0QA(0YH)K7@>:3I4QO=6(& $?V9AG6&T4=XLK*S\C5U5G9!'84S5X8%
M=J@++0)H,M\7F/7,&AXN23U^KNE;%^J6^KTMQ')MT;,I=&Q^0.\[>.G1Q9>%
M2(;V-+[@)[8'I,&V@NJ"JB64NI51S<<"-)R4^DAUD35=8>F%Z*GW&K9;1DWK
MG'Z4NW& LW]H-3=@:L"S]-N&T;Z50IDD.5^BPK'3U,O9H!_HCH0\.S*O[!EJ
M55;M6P/M!^=*!& ]_8 #-ULT-#]K[\R)>@T<SLBD<1 X;2G[%'.X%C%"R>4_
M;NW\^ =_EA3$+/W.O^RE14+ 3ZRW*PW;[3GTC6JF"YM!O4 =E1N*!:P2EX;V
MB2N9Y.0Z]F7LZ8W0*^!=APO-*%/!$%=AZ&N'Z&N3#XQ4H^O8)ZR[;H8]+L&H
MCET_84J#._M*QL"=0902QT2#PDV%Q8J*\.CB2I+,]/!,1& .Q%+MF&:HHVC,
MYKZ>V1[/C,5L&J7PL*74F7>K)IN:-V"$/47Q_&H@,V'IK$6*4ZJD(F$:HX3L
M]@S5/6I#\=<;K[=GVU-\R67YN=^'PQ.AC+(D&"H#M80.*^1C8Z)0U?0*I'.%
MVH7^^^;K)ADMX_+TE)\$12$0+M\HMHA]:1S)U"SV%V6K?#PMO$29,KGP(/(=
MM[UR.E;#.L51)\K2HNY)[]MLO&XJ<^XXQ,T(58MOLZF6<# WHY8.:J?]V"D5
M$#"9<<:>O/VCVUZT'#=W8;I-LW3:YH9C+=AZMKAV,CM^V 3+<^[\7'-NG@\"
M>D_>UQC.GL2_U5?XSBQ<\&H$243J!Q+X 5Q\'DSW0 Q\E.L,C 9S^OCQP&F!
MU69Y'E97E$93Q6UMS6RL*]S).0(FWY3LM+IR5WXJN2>+6T&[4.29UNN&L]G>
M'O6VE"R9>>0>:][<:NQLUURU!!VBMWYT3HB4DC<XP#E3YX_.[Z@=P_N>6W[.
MA&9XG+-C;Z;>QA^=B^$ QM^/1<=W?W0^B[[DK?X<X0:V"FDV^E?XS7/*_:GY
M=,Q#WV5[+M?'+$5(F73C#J@Q\UY;7;9E5:X,PEQ^ +6UO=4FP^@%:H^MW=45
ME.[*JTA"_J5R:0S@[F6CB,)N7S;.-]8[@HS &+;#$5P"@W?'>XS?PN#[?9B4
M*Q3:'?\EY))&+@3#3(K_$7U@Q MZAS;*01%0\=B$WRZE,H3% #;HQD>=$ S1
M'V#N>Z\;V]M;3D?B\UG"8<&!&#I=78B#$;E0!?;*;MURM6+,M]=0O@T:1U_4
M^!?T&?N$/<RF8:NQTVJC*L&.ZQ^V=D&)-E,45\(/2/CA[7D=Q=_H'4HCZ8)@
MBZ[Q$S*M*XYYPSF\0;_RF&_&N#*EB$,VG<G3F6$LO ?LK=TRQ3.C8"7&D3OH
MR0BD4-M(<]!$J+85+9Q4W#@1S.A2J$*^ N7.DDAI:D .H&S8)%BR!CM ;-9@
MIE)\ECW/A; KK(X<#CB?%^+EN$,:%* L-G[WLJAZPWG1X1^B-Z@_T)YLW#R;
MH\CP #;#F&G6Z?NI6M,H;0I^7'EXKB(T(Y'W^AC%QLG0GRB"YB$1I&0H43@\
M8.><CM3B*U_X9&SV(P\D%V]_UH'?X.V#/DZ_KW@ WYP?KHH 1]?H(36K*IGM
M;;M#@T3*4487J!ZLN#=^UPJFJQ.0'#J<^'J<!$QK#U88ICV+"@OL39#@.E8"
M,\H&.*G6KOI50PT/LEXJ(DTQPRN-5E?,7,IS*E[B E_XL,NC3$GF-"',P;E?
M^0123A$?8O/(/N5$J?WL%TSPE8-8KOM:))6NW 2ED Y>N&4D6+7-R%=92-((
M)F+O=ND:V9WR@+OLW+;)<#78J0F# 2R)IA^(Z]K&>#2?6T@&(E#-\>D)&YV@
M^\O\" V)8DBL(V4Q]8<N:?3!,TLDF<_6@9W+E.:%XYB-Y/F8>I.P(SC*4E*)
M24J3WG3R^_&']=8>D$X,=NZ5#]*?AK9=NZB7>,"E\$L/[D;,%'+<V,>N 70?
MXO/" [,A055#4"A'.:(D"+^H[RO]HFNJCOKL3\!;/?#P[0W.(AU$Z(C')U0P
MU63$T*WK44II1$% QS.=#%3"A?7KZEPN6-]U3Y*0H4R)--\#GGE".^-;?&W'
MMB]ZBAN)K:Y[OMO+7^##7%T41GBL<&'"=]U)J65P#W,E/ZH?W2S-Z/*^DD$T
M(/1CV!0> :5/#P0=;&\&%,38 9Q+%JJ;'$X'X0RE9VM?(5"FGX-UJOGB3E+F
M$:5.P>M"I4;!I.$4D?H0A<-L2^@QL0B-EHC2)Z0YF(?PS@+Z2$GKX7T I0ZD
MV"5+]"5.%GG;,6)GB9/?814GJ!I8\"D74O3KG-_%.J8C3![!)-<"WRKKA/)(
M?:F#@GE58T4::0,86BK&Y@N!8Z+2I.OGU+"A@B9+NW-+?O# GWGBZCGF-\C+
MX5)+G"4_D#\D*O%P10,/?:,[CST/\(CFQP2NO/!2Y0U497'CGPJI%CD7VQI1
MHD!0&MKV)D<*W;T!]80&DZ@K2=T1@4($2F3HP\6;IVU)C05' ^6ZDYW8Y6#8
MUP?; 3;-PD#>< ZB(. D',IR( L_AT5<7?$T<B+E>F/NCO#DR(KH_508P!J?
MI9CR!_E,\EQG3!_OR,"7F-#>XYPU/Z9] !O'3WJL#/$LT%CTN^B?QEGRDSK^
MI91G'W>1C@[T(A=]3Y@\-I)%+U+@,4XY*E0"#+"B"L/3-+-C..@L#MEODV>^
MHS[$6>OZE?F VD8L5 ' 6O#LE)J%+D'CR-*JL/;U%(L%0IFBYZN*PE97?HFN
M46EK<&(+9J1C]F^29#$Y+ K9];?8C$RO]J$[(V<>4D4 ZM_YB9O8,V7:5.BZ
MK :K2\<J6]$IEBK5?GF5Q"47=A=(/.P]I,(-D&P:&UW).JMD)(A<H?TE;*8E
M5(8!<^'RFJIJ$N6= 2N&J C^ K*4*TB T?+Z%+1[[-^IVI,1JRHLS7K%^>KT
MAUP JDH5;:]>\7<R"$AJLI'J,LF[ 6:9#D3:2\B+2+Y42A/+19=(8 Y!= T*
M%IP(B2,4/UCYI$5S1AS?S8)1GE5&,VXUWBPDB^A9G5A"TD'YH)20 )60I<2&
M8_A=,S5[_THK8 K[PIY2I0(.T6 SG$I?'?3@2<O6I9=B7%)EE5!.-C+X[\>'
M>/-E;EIHM+-L)+_D'(LU 'B:NH*(":3!9(X>&5O-B"5^33<35QIM.(?&,Z-Y
M@]C"_E4"LP8C7U)@2(2)\F=CC"U,*1F;[N[5E<+E3>^":XCBP)P8CVX(("M2
M%12OJ7DTE$OB6NIR,*)I]CZ1[RF_ILNYW;ZO*?_?R<HU"EUC10/D=6UP8WN8
MLQYB+J3)FV*@1;-LN%VEVPNC(+I4ND087:E0AA^ZL10)JS3(A@-V *O4RK[O
M>1B_#T Z- S?P#O,3K#?"[@=PY=H\ZFK5_:-Q'7S%EDD+I>6:I><Z2C_W?+0
MV2F.DKM8X]%A&Q'TY6D5+]=+#;-1MA5%.5"'SI0,'M$^$2R1VY:HJP%_NGXJ
M2 %>7=&10-4_6X$!4,([)O@"WP(-OD<W'8>.32:W_9K1^?LA6 ^D\6&@ L-D
MR/ P#2?,*"D?ENQ)F#XN!4MW0 <]RF+4/M%MT5 Q%9H*!=K4?<?O-;"]\@94
M8\XFQW)AE!#HX$Q,&8&I2T6_,0(WQ<(G)HNQ&#D),.P#[(L97CB-)DSC TQ+
MO5,Q)0JQ_((.AEP(J];S0WMOQ^F -*!QLH&SC9$V_3X:>+>M/N&PK;SRHPRK
M4:[D.M6B@,2,X6Z?$S\^.%C@DLU^BHRM[3HY:Z;)6>TZ.>NAL)*>1JS! JQ8
M73F@1%U?S&]1]<E4),]A"&C$(%6&=F)9VJ&#UR?'F.W,&KI;0:D()%U\Y%!,
MDQ'_'VF]9HA&;E(V[" P.HM E;#0)-!!T$>5B$,6$OU0^%**1EIV*5@,('/]
MONIU3)-D?[G/;\%:4:FK9QV&&B%_(8[_BO0++C"VO9.@/R@4"^W3\U4,.\\T
MXQ*)@'R*2,^TGLL,G@]P$98QHXT/M/)AIJ ,H8, -L>*WH_C>%B[@=.A=18<
M(5E">Y/(JBE,&")_-_D..)Q^A>@4)C>E^KV8XQ]E <%W8$R)2=-W3>:3A[4#
M3\TNR6]W^S8?O>VG7F+ALJ]4"M9FBH$Z,WS3$16BN=&>>0!W;^?UWI( AI^G
M<822#.<W$EEGL^< BVA0EDKGW'(5DC)*MLX%<[YV;I#KHA!VTA$&RYM)MF)"
M0YN\7>6TX:F4NQRM& !_U;.=FH1G8!EIMT(4C?I8M N8C5J>B' &@4@)/T ;
M=F#Y)2E[K(K7$*Q5W2MR--H]80ID2(_Y>LRR>!IY3*7\3>BONI:XZ9G&2[+V
MJ4]YJ2.9228!<72O"PB],\<RGC$?+RQ2^=Q1U9_722V1B#UC/4[)$Q!2AX(2
MUA+G9W;HGFK.')>="CK)!H\K:)PF&D3^'</A74*DRZ6U5B4I $WR1$]!^92-
M0EG,X^XB$'4OEW@<T+U&$>EE;FKG^C4LEY7ZFA,X4?%(APU=FX'IROQ=OB')
M,,0@ (SA*F5U/0J+H?<"Z%,^4B[]M>0MEUZH"RTH5UAPT+.FX5&DZ07>A6<J
M&PSK\Q21;UDC<XYBL%(.,$Y[!/S@_*R*VS')849" GYIP)-8%VOP+!(R&QI*
MH3+!H2[.R(H<Y^'N8.@4\!M!9*AL7K(_M/3!;"-A@D-H1E,Z/ZQNI#8JEPPZ
M $'"P_,I*!%+6B[EU!A83"[^5ALRB#/4.8.AK8^!AF0F3\AQL<?HOC+L4:;)
MF*.@5H26@(-J16AIA!VWPTR5J$.7S7NND]1E@RJ^1TR=^XRB$!U?2L99Z5E6
M HBT#<1"WAI78G(R"H;/8J'*Z'@6[.]"J\\ >&&)0NI3EF2>UM*)(T&H"6![
MN2HY4<=&,4M0I[M@CB,ZO4R&3(Z@RG)158::&?$TU+3&DLC*NW+,S"N%J>MW
MR7%??P@GR;+'T1/0Z(VS414QYD3;0?._)W#D*P3@ @-<NS5':@+)VXQ%*US'
M::,<ER:,J.)=*LAN4+EBFI?T8#GLE2"G=:@<HMKG:_E8A7(6P'^Y6K& L K+
M[@K589SN8+U((FI*8M.(*_!M[CV B: G@OVRLF_FPDFH.,<K&>9PR9YT84B^
M@!$7DJO-*W+BBBC61@30N[Q()K3[?2E3+F06'73"5WNYE0*%!5B8(Y"[748'
M&'NW,_)J!4%KZPY8))Z%RK6<8#$M-T1%45:1VZ8<[P32K*K"N'(-?V#C!>;=
MKN GY,_NC(%<8MG\D(*^8'@I0R[&PR'<%ZK6=##3#J9/>=B)55S9R/-MZ>TD
MS$SY/"7VJ9;'NB3N4.&FXW)4;7S#49ZR\\.#I^917YKI%\HQ+%*K0YBS ./;
MFBT2GRG5(#.-:Z@G%EY3 6X%Y@)7-^ITV@J):N7AJOIP, JQPRU!#R@9@*)<
M56?FA>-W2]2U*L=UM*Z!@==8@F#*[&+U]Y&(O0(('GUB8#%75V""://)).6,
M,.L*:MB5Y0JA&9.Z8;N-E&?3]RZ;HG8^[:&EF_*1$1YG9TBYJA:<%C^C3N@%
M5P<P@B0,/U($/^T)OFSH&(1'XKC!6>F"KEA6&("Q^B:P40H.T9?]*(9/LCYK
MJ!58$;IH0Z%F7,*J*!) O*LQ8#HRO<9*[HQ%OL9WP3*O6P%><E-;QT_H<(K8
M*%ER5]K2JA7=9IX"FM?Z" ^ E3==N+A\RMV#SSR)OE")IYD-L)8#H\F>&)H(
MB/"NR , M(Y89EPAHG;: A[PI/!0@V@X?5RA0BGA+2*UHP@]\L..0B)%7(0?
MFALM"T_M)2V;:(O6DFA8-X*!L(:GMA,:-W5\*ESQ8N,]*'0))4\4]YJJ27@K
MHHO@, J>@S?,0/J.0Y.$0^H;D<^S3)^SM4*"P:8#Y6-B!95._7;8AP8ASXR@
MQ(H^;FA"VS>Z9^Q,XI,8V23^&>X>\*$<(JH([BH>$F=YZAFKE&T&TQ6$)&[@
M=3I2,"10%B:H^;![&S6=*";I2(FG[$ZC\<V@9N?T]"A/6@R5KFSL58-D,Q"^
M0;PIZLHCX!VDLU84*F5AP)HQ%E,1<A\A N7\%F5I0HKW.,6:-(ARC5WOD&(3
MDFKVP1N^NI6#<H!#LIA8KK$%3A4>^?$6RV\2:GV#SL4DT= _#B((9)20P]O-
MKR3AECKX2*JD]9VFMH%03$Z.3GF'"3"?#BU\^[(E6],<P6^P<)N$QY@9R"WH
M'#!(2,SHMN%%Z,;E<L[A,JA4@_LPX^,098A0T1@ZBRV2F5L9\J.B(T#D6!8H
M$4L2]4%*=K*49B&"H*'OJB0'N"4(V4I);9F'9G8$669?\7>[-!I,%U6;Q09K
M+D&0>&+#R,K;# =PK'%T5E=L()T[ZT,T"9HVK\+8H62#H5 9H,L:_QR!'=4A
M5!7>07+IP\Z&H"]:S9N(H(G3B?0:99!+R.XIHJ@8-UBAQPN.ZX!MB=@CL:F)
MNQU(S +IP)*JLK=P,Z][H911G!'6K3/6@V$!K(QI$R\*7&$J;F2BX%?@5:$)
M W@HI(,KKD,-?#A'O$V+%6@E*JZ'UK8/6R\5W:C;AYJ.J<(>]/\%PF<=S,58
M!U4<D!6/^8EPA8EO4E<)#O,<_/Q7HT!-ZN(>D;WJ05Y*9E0VO1HN[;$ DQF7
M&JD*X60'1,@A>0FNX61Z>#<\+HSYC"VG1[#2'WA%4Q0%[-1% 3,M"MBLBP)J
MQOV^U/1RESW>;8PY.=H*<CQQ6CFCHTO6$<E[44#>[@H_5M6R*J$=+UNMZNXV
M_T5YZ:2&4CWWA'OVA;S12%N$3(;6327@*=RW^HK$*ZG0+83N7KR']5/8NL R
M_/2$C'^AZ/;'[\J5RV.^_SKD)/+9%Z]G@0>):0$<ZO<D.D50TR8-(]^DU16S
M2V4N_D(8,8\-1!V%4>9$ S\D" C"P0CM8>U\TXX(*8>AZ\<J=99:G/:E*CKD
MW3@R>"G'NNWFF;S, I&B.;F?I3U6&%[H!LC'G\_VK08T\>@,<K 5'KFTAP]L
M9M(5*NL*]H'T&AW#4*:%I8/86I'Q1*D0C!L-J)Z!7J&VI@$/*RL:AAO:RE2,
M\=0H+#Q>*R +O2*J$0YE6NB",\GA7 ;R6]1'1Y3W*JS>@3(/E)N42+72JE)Q
M4,*!%DDQA*G- T8."P*D:0JNCC(_$;4I>BF@HE9T83V>,"4?Q9_O*?N9D#FX
M)IGLS4[J)"9VUM#&OPB"HLE5@6B,0-G*.(K5JG$8Y4_2KRCN0@5V;SD.09R_
M]!9$648WP?U7Y3P@^P*ATMQI%IAG=;<S+Z!@&_\X3L+4*NENT+J1<U*P/?'1
MOB 7C08XSL$>BG57FC2C)%VW049M\4\/Y'L*9!QB5"1PHC@W9KV,$+20 3NI
M])A*_% UL:)=9SAI=/57.B5LEXSIIH$S5B%Y@WT5E^&'UT)TH5=4;'&CV*5C
MDA<Y&T"I&+FCVY06W@' _I80B6)FQ5VL?-R-O2@)02:@'G10M&*^ \'&&G N
M:LHM-%811:"HUH;0"1#E0(LRG56.8^N.;234<['(?UH/_/ ;8AWDN056E6,0
M"4Q*45$:^HIYQ&; :81=08#HV!I7C\;7J&@:=C0**^N)8#XG8,79'ZNCM939
M7*3ER&*Y)*W"^5]=.<_1KADWCN29[H6@_<G6%@7B6BFLE*M!>7+F"B.%*Z>G
MI- LS2*H0B?6J,J$V7#V4\ZA176^H6,2=(%1QM)0PY]3^T-53A0I*\$X($U$
M"5Z%VTP_'-58%4X&M^6UF6.,IK3"420;HHUKH,(-YW,4FHHIU?@H02*VN5 I
MN#2M?+_XTO)#!(,?(:I8.?JK/>)V3K)B\OS-A0#$'?D9E\XN^-$N$B$I:*2!
MV;#9$4(U5G!$ 8+,&Z> BD6=Y)%F]K5.&VHV8#$<T\[9Y#;=LKAC%D]-5!!S
M4XZMF)[?H=(X4D10&HTTBK.(B ->Q%0J<DI#:^LHS3MP8JL%%18#580(M$+1
MT2T#*/Q*KF1"5,J/I>B<Q\84Y.L=5JIKU((BXCXIRD> Q]/7\;3O30W Y=V\
M' L.7<O2C(J*+@(=.8S@U_=.9IEI3P&@6_MJFYA?QTT>AB]5$PZ58"<O(U66
MSMT=,*6  ZXO)L7.S<$HYPE,Y/X'\Q(7SVE\%3$$54&JH9B&5C<.CKKR;W3?
MNUJ57.@531$0>%T'!&8:$-BJ P)/F7$?HCV!A1ODG*(#+4GJE-L%)#>3<JN+
M?2B+!_YXB2S>P+9,F%YJT"G*P1?R+D[2X-1HP A.@>.B#UD)OP"7L )A)UM.
M?-.>* 8;M^ 4"U@:C#"(5217V%H^^:8T"03[-E5(NB/9:$\:5/TK%?VG=,A/
M3QE LE5H\1CSXK(C%2,$95-ARU>E!GJCM3YW04S'*!=</KZ7$0150OF=9 2.
MNM/Y;270)-AMQP\S]CU0_W-QC?X#]+".MSPJ4'VC$"V%'QAO/>=M)7[,S?(8
MN7M"OR).2-/F"Z[K!8:MJ/E3.*11V"#HR)X(NB\I&X]5>.J>1ZQF]6QJJ*T*
MANP<UG]KJ%;T^-/2<U"[-M8\;D+I4U8KZ8N]HD.!B5\ZYZZ<GS!KE/D6:(X%
M/#4,I+!$WY1Q<1LMI&[F:^.B:#A=8$*P F.B.&0JA);&Y&.K12?;_N0?)><%
M@_;J,#]_07("6W*PR[?00,+5B?N(17"Z?^#8#E)F/@[F\B(IMJ66B*RN L%H
M^8^XV6CQ56G+EK5JP09CAPR_JW>IL+76L-AG#MZ%GFLM5825)5DQC%H+3-ET
MH5.H_ I@WBRW1_(G00^0(-LZ7-<-.^YR( T' ZKJ#5R1$I'@X=W"\[C+:^Q-
M5-'T@H'/2?HT]2HY3,[,VP6QE=0PM2AV[B*):UFVT"LZ^4X'5='3RY4#E/LN
M5>M8%4;UV;^91Z!LBB8'%VH9*JY@9$QDA(!VO8UQ@T^(GIBC'Y@7&18!73[!
MA)0HP-04F(/%AQJMB!VTUI HVI6X8SFDI*1NE3$V/G**"I)0]R/&[K1Y&YN(
M8,)2JM+S23NCK&%\4(5T="B#0X<")HZ"2K<)R)FMYJB%7A%QE+FZ.!2,-Q:E
MEY7<H\IPN_-E;9*S**10C(C%Y-Z6)K6/0\%6%;>IX-YW*>>AM;>YQ67A?5UD
MQ[GK]H,-RD]WV*U%WGBKB)_1?;CI3)[RA^F+W R@,LQ(VH-2T+O"#VPDPRDJ
M3J>-,JRNS#3,X$P199@=X[(W$1X?\^'29S4._T0G5^%E-)J'31;HN-XPXV 5
MU]H[K&N5J<^E]&JY,_2,/9M3G+D+]D>KG2@&'Z+X#2JHJ>1D'*MU7L-&F.8V
MA-0WD(!Y1C,$M:]L4D?Z1IX%0L%>J>H:$]6EB\F%I!)< T73#&0=#YR[/R@-
M!&5GXL-&B%@%#>V\-W4U6(WH\H2QQFA'%-R3 1NC&@_-PP;SPRA+.:M">QLU
MF**5C:Y;?&F$<K<(.HZ@P=J$362^+$&W M@ZDM#D?+!]6)=439JHP!.#YC;T
M^FBC<(9DLN9C;WI2<+\8 $M3Y =3@ZLIHD*O?F&2^DS()H]PE6 971+&<9PW
MM%0MDS *!19<UA=<><4;CS &C 1%57F9<GU9>5 :L"I >HI+TOQU:@)E4QE@
M U"\\\IXDRMNAL-$+!_M>4Q!@#O52L6ZY*Z9.+V$D@$P72K%Z)"OVMKI+,M"
MN\B2K-@-Q^Z'PWDGN2&J<VLIR;,BQ:0L)GW=PU).&;L^)XWZA3S3&-OAL&I$
M *%2>;CU-IM=(8,@NQM?*H BD\M^Y<MKS  15R#9.XA:",M0S<C' >QYJ_'G
M@T"XDM /4D9(999&\O7\I+#1>=L\>'TH+Z/4UW)FXE1KG)RIM/5*43]3I> (
MC$'&$'^$Z-<<EOA4CZX8)*'L<*'4<--@6-E=Q-/;S:9SY'=!>.T34BF\&6'4
MG;WV;H.&_0L[V'[^B])@*;G.B)\L45GOZ$<<H)CPM;L5+UGET_VAQ4@@"&!!
MUH73E3E #54J1$4H!>/EX+<V.$QI4+? OHLEB"Q? Q!Z?9 N;%^@XJ!Z,5,J
MH@[XL"#7GDO[[?!SQ+!(I5F6><IDS\_;PU"3__=(KD,P4*.AK 77<JVK*+@X
MS?(Z&HDGC4)-FN@O*AWKY*.0^OA'<V='4WTGJB2K*Y^H>+&J@T8YS(@G.<75
M#D?GG1=[:,AH:=<7*5:/<F"6*@?S5>G7@&K>YW"34AII@1R'44"3H'["U#%Z
MHK->NUC^F3A8%QD8AY+VVGBWKYSD?([D@T,JQ!Z3TJG<R(PCR7-5_FR:H (J
MH:^O<&H=QJL/#?C+N*F)T25"?]$A]DHEMQC4TO5W6F@GI(RJ:J=2O7C B4FU
M3%^:=4V1!+I;)X'.- ETNTX"K9EX5HK9*=T+F'O/W8ZUK\O&!<#D03%?K-;Z
M=&>84:HC;@HFPT_A1R<8^4(]X)Q+J)UK*I1+6:=3WB].T!L-M>5NT]B03"&]
M)/<*L\_,M,?(D5PI'52$88;.3##U8IB>#DDKK8%?GN2E@8C>C&!4@K)Q\F+$
MD4%,774Q/$AZ& V("-CZU4% (7"K(@XKKW0T##8#UI&:K /\%2M-"O75!KZP
MXIK*W4@_CN):K5F>=1F>T56819<Q1;452932BT&;J.Q$2GAZ0.\&_J44!IWR
MLTJ T\T#3J*JMXIU5A'FO?B$,,D9?(+""9H7QQSK%Q2 *%U*7PS'DN:H<E'"
M]#F./,*)%)BG7P!/N2I:WF"4]I_W]T_QZ^.CLW,$4Z3V.2@X%,*&'[M9'[-:
M7>51H@)'6$F$T+[ LU5S'"UB1ZP7=4+C,W1.#_9/WCM4_RMB;](&%$4*#D2Q
M#<Y6&$114,Q1*XFGJ*);%7?I2%>@<PZA*'7*O<$,,?"-ANRL:NGBDOU0F7]Y
MRHUI&S#Q5Z-;T94>%=PSE<59H#:^D-TP,9K!60YJ1V*38$#V9C<&K77#X9:[
MJ0Y<T!8ZY3M8.H2+A=J(DLB%Y<K7,-*=$EZ>QYT4_W:DX95:_"[-NHSX'6%J
M4[5B\O5"P3=W' 7L/? RC2%*2<L^]JQVAE)@:)LDS0?I,O359JOAM)OM-DIB
M,TB'2UC.1=P10(7K)S<!(C2#ZK#AG(2<F)>C8*I,.O3VY%*'0ZO4I">@+F;<
MKB)6(%ECGS<4K*@31"&&9!&U&4MI*/_?@3?'U ^<.R*2AX7SH&F#KN7H'I%&
M=MO^*-&XX>R/W4M67%(CQOA%)2NO,C:(;L7](NTP3ZMB+[X[S'UEHU-C 6RW
M;=37XMB3!01K3BOF7$RW1[*@;,(EL\-5ZG:->0X5RSW$*"CX[O*\*E,XG8>J
MZPCI(DJ/+JD=HB*]#=6-(VQ+L[N^7S L\ LC(-I[2D 0.GV0A1C8(LA?RXZR
M,AK93#I720>MMN$.VP(!ELOQ>@M8$$F.LT*FC+F)8P;B8[##..IG 3NUR\TR
MBJVI4B)M1!'$O (?ASEA*@KE]M >M+8Y!SE!78S69-ES&M+&3OBO, ?9I8_U
M!%DG(6]4FCOX2\ Q%B?MH+ZKOY/;J*-<J/NDC%Q9IG)'P45R&BJHIZR::WYI
M$[2(NDYRIB*C'7[1CSR_Z^<W]*\G[\\-/Z%,9O0WG EHA9>^4J0Y<=UDPB J
MMDJLD3<JQT>EY5X!<T=98A%_0?//.^?EF$>FH$D9^B;530=E5!QJXK[ XWIC
MC,,DQZC765AH0/&M;,TLST*VD).4M\'!&%:B=>%1OXC>]*WFEE-YA3=4RI.G
M+0NL_[(%07[%Y^D+E(44)D(#_5':E7$N:H\+P^>066N,$UW47#R6,J\.FKDL
MP+ E1L</E9H!6@FBE7(GD;!J4M1DT6Z,QD@UW"(';_A+_#A$ZQR4"H1;5\![
MR2CVNX*X80Q^,NBX1 D3^("^O=$+@JI"X%RPTH*RM(1]%1!\CS8%A7I8^0YB
M04M4Z+HZ_)846YXI?$O5!W+D ?5>*I&"RPRV(IA[=48M96>$VV=TC.9KS;Y:
M'C*Z5['2Z5;1K 40-AP=EYAI+^]LA*U9$,22P[4<3#90O)8T?PW2_$7[Y8OW
M%3*=:)A%EP%@"V$W".43^!B5MQQ!V'+4'(<L<T':1S%G"$^Q.$\&IHU/9)!$
M]950-J(*UJ<]<JR83T?JH.!P!BB%R77#2<Y&NH^TC2W?7]4<-C%)6WK#G;']
MKKEV:=9EA5[Z"K6[@D@-F4EL21+XG)7RHO62/@H001U;^6A$7LNM@6I3$:VV
M2RF#(@SAZHC)AM4HW^.)-A651PU"<?/#O)168:MQ9V$,G^ "J-D0-U&WL=Y_
M:&V 8.K PGW5=?.%F[_-Z&EW<YNH'J1.7XJ0$<1&,>9Q'0=48;;O1#J>I?#J
MC!Y&8/.=(6D,>3+^Z@HUR4H8GI=1I7]XS?W1*#-26+Y\-&]^S4+I;#;?)MG@
M7=H#BH7_LN("THZQ6@1K'\6=HPY-GM4P!_=(;Q'E8^+$T%"B[ +NT-1!2-]8
M'ZM*F<*64>MT\K4X6+)U39$LLU<GR\PT66:G3I:IF7@FZ]HWN"<,J<-WF=!*
M:-(7B.MON1%&U-"B]^,XI;YH+[HO\:Z'J^;,./N<\_7?-ISSBO=IFP[5230-
M2CP<DZWWANUN$/W(%.]A,.\RT;U>.3B+JNUU1 H'>^ G!+\W5E?^D$Y![7$J
M=\72>R8I.483T1I1F0XP<O>OKI3?^4[)E=_>;CI]OHRM*Y_\H5W6(7 :ICM@
M@I%M3\]0Y:WD:D">8Z+5(ZUH8-:('A;^_ ,(-#.NNNJY!XK)";9W006U[K#V
M[U=WIEM[K80LS;K>=MY]1.2/U953[J."W%YG]"W3NJCI 1@-U/5 IS<X6(;%
MLATD4=SQ==0+FRI@N7&(TED$NGT."6%3TZ'S<,0E"&R0PUG"X>JA:A1556NA
M2\G\(D@-"K$Z,/IXD*]G?O)M=>5(, S9.<;>XB$9K2VV6>?.\$M^/G. SV0U
M,I37E&5BT*<\HRK17=SCGE*@V>%7P/]6(R%.R$U4#Q7UO=9 -IPONNQH8FI7
MH88G#U#KB/+(</2='L_ZGH)4>N!C3%@DM(8A-8V5+J6/F)(CZIEWI:"WBG$+
MT+#A-Z#5D+^5?*>,Y:/:%U"9%ZFGU.Y)B]X*:<5Q-?*04Y\.A6"$.+64J->E
MHE,,RHPC6 QK+*N%7M&Y3UU\5+HE4W4U%!*'2SGU2?-73KI A@=@!8D&$JP.
MG5GY&59[#L(X[K*@U6FDJLYZ=05;>6.AH>"\<-5.L:':),-=J6*>6%KAJG13
MI,4-S,P #5T@GS8,93*=BMCG;DDZ/$I ;DXR3%+.]553MWH)J1^&F#.BK$.-
MP:4"N*SRY], _L$V/BJN"'*G/!U%CT;!%94+ DMSO^F(-"@EV*9$]4A:70%^
M]5W)^?LFG(6#XVMP[W)519TC:#<@1R1CV78#]MN0R6-)HC2O<*2-@S6RKU7G
MOE&CZTAYMQEP4HE0_":1E&SGO>(2=PG'9J--ZE6N<[$D^7*Q/)1-4I=$DVK
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MMZRW60I;7G$XXEAB(&MLQ0CDZH>9S#^TTL3LM+#ID7,I'V-<7!;?7YPL>B&
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MLNM6H52F(CN+>9HH0GN)0O=<CV70?4UM\5CJ+8"'& ? .YRU:Q^WP_3Y19U
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MIJR:K]9;K9O(=Q)U#V0[1)0>[^PZ9Z=7A9G+XX=[';$(7O=+S*1WV&^6Y_$
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MD"8^EVA^N<:7)\_[X7K>G\?Y.:;CRW4%.Y_;CX*<:PDX@RHD8(2!:MN]EW2
MX\.];N-X(/O$-=WUOO.;.LOG9[\.8$$^A)9O+HK8?SE2=+Z7LP\LSV&'/XMG
M__,Y,8\_A_3SX'+0Y<+!44A:K)]G@_*Y/X]]*,MT_(L^C\T(F#*AESE=$P]Q
MT[\1#@$V'9%JJ3"YWEK,.84P*(4Z0_!1.9$<8IR;-9GBY:8R-"K9GR4@E/1G
M!JL&5&4DHW" TECM-(D;_(M/D?.#&+(CD-@B ? :W2=G8Y!K 89YB4Y-KHOJ
M+1.:_!5<[$1[+_IY%)L=4+J/)5!:KC#41R12SL^\FIZ,-T% [,RFR.F+#8B+
M#<ZX0%(5E31(JP0GU"=6SL^F,BM\]-NBNE7:#H<&BVF684HE^\",BA1WQE(J
MT(D8QX?IQSUD;P2]K%VK;:'H<'FDO5.<=1##1G32=0U=86"9 RA=P&+YIKLF
M-^"?BM[ERA-(#_KG1BM=P@"XZ1(G@:'CJY*)9XR(T>2#[Z"3<,A^S@[;SA$[
M=[4I*X%V,K/?<HG(W#E,[A[)N0M!>#[[I&G?@Z@2@M@K6DJ:4E01^5M+SK<)
M0%S']9HL /W8F[:B+YQJX _KXON+T/B%>R+M@4ZQ%*:V/0.A6MUDVG*A3$CS
MD;Y,!U#G?8R^S/W0Q/,SX!(5;1_/0=X&Z6;N&Z:WDAX2)GUK#9'K!MP;CQ$1
M19K!D]_R((\5D\7YPF( M>[B;6-[%F3J[9XJI4DZZ,2C_X+W[D7V'TY<R>Z/
MF</!*UV8 *F/Y N;P>B'6^'@GB)ZIO2679*M?)?133]_9^\"[B/E$PCOAR^M
MZU7)Q+MN7V=_B?2< ;6]+;B=JBIP^==*)27NQ*YC/%"KF69:=RUGESEWY+._
MR8"SW*J"AEKYT,/;NK><<9J*'30)ON._J_(P.9/TO\5S*QGJ'\7F _>2-M_@
MW1B4G@1&T,C:LVXSD+H9Q1A=J'/5N5]OZ!UK\C[D!8.:O5JOR*4?24_3=A[Y
MD>(B^Y&I,0Q_(PUK^C>C*0@OQLQ4&^[#1&+$T?5SNP0W_'']<?Y.&,J1 B&7
MK>4=P'YL W$T\&ELA)J$[O$U?3AAF_4OR6\R^GY.N Y^5GQ)M'"Z 6=AO/ Y
M%O3K57T#?Z(%E86,V]&P)!AR4)Q%(!:85^G<,OB'=A]3N;GM-QQJOF/+[6I,
M,*/!% E%@R8*NYL4\<AO+L1FOJ6TQU!J($=[G'CGB^)_9,BER=3I)DQ4I&AC
M^ !" I"E.;IX4UTQ)]<G3ORZ:^I*+%M5\$]JBQ\?7.MGZ6K[H/)_69?8_%JZ
M?!4[6X=?DT;2A1*CLVM(;SFA^P;%-YE;P$^3R94T(^W.E:X2CUK4+_ ;#.E6
M7Q2QI'K90^$T>8IV/?)BRTYQ3\>!$@["^H:UYS;HI$% &0!:,]DIHV9;7J[7
M]QAHTBP,XEA"(66(&5>\4=) R8)?B8-&?TLCSPTH]T;0[![:ZZE_N1:1EA40
M+@L0+A(9\;B*Q38T\&@5P'X!3S^Y[P_*__M;W@J,G+EP0%:OJ8:>9HKD%XQ&
M,82^@;;==1+19 /7>%L(?A&-WOX7)'9,#^CFY$H_S"W^9HUUDZPMDT/"1F7I
MCIGU!7W4D^6F1*L3]$5X!EM(2Y4#=05ND%=^+O ?A/&P@BM%A(S_DT;$BXRW
M<[9_-P]_7&M+N6,Z4'P5MV8(5'G>]V6U!79"8U<='B\1JYT<R8WM>N^J>HZ*
M$OU8J> /&B@8[ _J%+PX/_NI1R]K;LXLS5+%DQR<^VMP989I O5%&<4FX=S3
M[^J$>YXG%ON@FR^W+A&Y@&YH*2ZR_Z8KN;T6#8^:$=DL/".7S77)-ROC39SO
M.+)8YKBG)BC$XDVRD/;/ND)H2/3[(6][]@E?/M1&9:8X"@[2UM90>2N*+%R(
MLXP\+-$HOJI5SO..CDX_:3OV&[85QWR874HGCQ<Y]MBOT2.P8E^?L&+WBA5[
M^?R$%3L=RFG)B) %]/=5#-2D*]S2>Z7D+%K+!81>12U]J8/;BX;C=1523'07
MY/SGP!]U<FX?I'/[F\DI&,'[5)#^ 4L.UHB),#QX==Z]5=8>:W?I]:,)^43X
M(ECS42AWK)KC>WP;?,= Q9%DPGK$J.=G+OV5[<M^I2G7W6][2#K,4E><ASPP
M(Y:(4?=S0X,?VI<:XN_TTT-8&>.0FL@/Z9.F:&UVIH_R=+EVYHX2O<\XMST-
M YI.Y.E=T8Q_W^^/N*/1<,B%[1W;.VSK/IFN?4(TX63G.ULI+RPZE8:W X]N
M:UM+<^@AP3L+F%47ZB&32#NA6 1-IA^9O/?%\V?_F<6H%'GC@U_%M 6-J:<J
M;E5" ?@3]K.[7 0,=9;"_K8]&R894\LD*Q[V<7[6.U\C?"MQPQ^: >[M][UY
M0]HQAR4.ITM+]Y4WQ.(<D#C,3GG#!^X/V V"NK\0._)4"1&5Q+YTJX+SJ\QQ
MHJ\V](F*]U8X/<8N!6*@%1O 7&RRF09.-.VBW[&J$M]9 92VET_)J+GE:1A,
MD&=:%87=M>.#%_.4>W 7T$EXF,L$I:6X8X9G1D*.1J<]D2W*6,B?P%EIN\ R
MSD_L3[G49N*P3P[H@S0$'W6,EE \./2DC+$^#$IK[ Y_Z+X-[I.I6L1B(N,!
MQ4,-V]GT0\?XQJ82JGO/K8-0AM^>/,=RRD<.WB72A)';C3U12!H/AI+Z Q@,
M!J(#&#N8O6'TVF&5398\UPVRE7Y1/W16#A@% U2OR&WBQ5YO5I="2C3 BAL1
M+1*\9:+.)"R2,Q<SFX[BHN04-!/\1B%%F2201PI2-,(ITM=))U@):UMYROF9
M.@\4)$$^C_F&H)8J0 !SIE(IJ^&$3XFC=3W-M;*-C+F7:,/FO"].KG*-19W=
MT6<N79$D*GP(_8GB2H-^@56CQV:/#M'4;P26XITGM5RZ.RM^Y.AMLUL#6+S?
MW12"A^C6CLG<]]A*D(!'=%9.2>32:-9CQ%=#=>??0YA7$E-3RKRIG+ 4'#Z-
M,*^6:CZQ:-9>8=[SL[W*O-G#$>8]!0?WDW@UU&61,_Y)L%J:HII-0;P^ )(&
MFZB8M!XD#9>5!;?2PB<F]K9F0JFJ&,6R96!;4KL,B&A3\-GG$;PKN.&Q:;E1
MKCHYW0_R@/U:*X/C.$CS@-AQ=,^J$E$+KZUX9CM.MZCZ-0:-#TAC\F)0!]^_
MY6>?$(9I6%-!%P[!IBG\,DF%36!.?W4H0M/BD+1G(%--'L'-+;FD6]?.TUW5
MY&MH[PS]CDV?PPY$3"Y=ZCE:K;AD.C$!"O?4PZOE'W':9#(7\3"?GZ6G^8,
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M9\P\@X9@6T2@AC20E^"&&/-0Z(-D8-9#$HK][BP7UME7.C\3_YT+!JT*?S4
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MOVM3Q9A95,>300F9J6^K-ZT4ANZOI6%$D)<B4"AF-HS1!L?6<,,L_86Q(3C
M-9.WP.)?%LAZ:.$R/(0OM?"6Q7MFL%.*V;P%H%Q5!B3!HG!Q5O?.-VWXJ?
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M:1Q"^ULQ[+WV;5_R<,&>\&.+A> [8G4.7Q?2*&.F@31)(:!?,M%T1AHKL,%
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MLX7CM3AP'>XKQIV? <J=.#X2P10!ULE?&X>>^R123]!-2A!=%':+22AX>US
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M^LR8>XU]QLGG1<VCD>0CL[QQ<*KLVVR^R_7@(BJ72:;[F!LH-!X&3[P+.K(
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M;Z8&^P0SYK6BZ/X)\T9W65%*&DIG0;_.2WL(4YP M\C52$G@\]N\K&"4DO<
MF1O8"IWIB#IEPFN3>O5-$?!"/'/@L,^=3G#GW Z#NK'OFMZ!U^0E\VJFX<$
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MZMY;=A6MM?,ZF>S=*H\3[WIW,TG%F4W=OVY!)"@A!@$.0$KF?OK?><Y+]VD
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MFJDZ]FUZOBT1DF]:]%><MYQX7ZB<IF;AF9$$ARH#,H"$UZP@"M^T;[ME'O'
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M" )Q0KBV$Z>8*52;%W&[X.^.,!GPTEPV28N'%8B E/10TT!,WM]P_ RRZ[B
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M4CF<5WFYF@">T_8]EJDZ.H"G;6(NLM>[FR+ED;V>+_)U2%Y+=OR]8$@LC>:
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M-5>-_$^*_7E]&C\-=_XDB3G,Q7+97>)8"BPVRGW+N\OO.SOIPI4'V(8TJ2:
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M%/G@84^&@6#W)$A.LGN*X5@_)1G;8JV3*L^VAT<[@67@2>E?IJV4T3ME1AI
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MY&TL':T+CZUF'+CWD!,?_'S'E"^7A;( +1U%8*^-><">=$?60.U1W4<;F-W
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MYU5!=O>RN1Y:O"B6JF7G^#?3W.6"HN51FIZAZTF9:@8EC+Q8X(70@($*21Y
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M]5*N$"ZM5!I>+V0</ZYI32O,Z"VP<Z+D2!9PN:5QM+1V%\UUC3^_J>1(>QL
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M%\__[[/$!$@ K,D%R>&E*VJ/273X=J#R;C:G@$]Z#5U\RS0@0LO!AO5 @5B
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M%R,OD#UBLD&T&\VS&W<357IX\.[.LK]WB48RVC%5F!@)"13P[/W24]7SDDF
MQG)84JZG5RK-I3$D+^K N$C;=\^K5!$I^%-=XKV.!!!"^T+7*$R24'MB>J J
M"EZV<\Z(,.:=Y[EE83Q=(/H(]QR/C =;MJO=?K+M!(CSZ'[*]FRGP8<0=^&%
M&CV*8;+ISCCMYB;)(E&'A4D4( TNS0;V3@FCQQDI'-U30*%YA)E*Y97%1EC"
M#L&]NN+\"<D7AX9]G7[%6-FA'3J_N;25\&+H0>X^A51T./+]RHT5?&6)L?U_
MOHL=_%J::HM#4;D*XNU+I5M*G+?N'A/=#7BO<JUE#ZWT\+.VZ?CCH:G?8&BB
MK:=E) PCMKFK-X$>+4O8\TW'87Q[QP[ (AXN\;3$)+'9H5<(W@>NA!;2?,%V
MBD]I>TQ'1L"B!CQA9#46L[YW]^4W^$2:3ZF]/SQ3O,  LP7V)?H+<AELE9PZ
M<:]JZ&XV.W0K%<(.]C^T7UG!;.]+TP9AI7WA)ST]"759>!QZDP2=J'49 RE:
MT<T!B7'3$5#BI]87<G1/<;A8(_68;MX6/)FR3GH5CL,+-23D0@JNZ^?@YOFZ
MW "7+8Y' '/+S26VFQ>!2R.D"#DW..Y81T=8B\C2Y]]MA*##2.O(X%1(V%(@
M@5XL\Q)42;YNM/P/+X2M*:,%DOJC[P,LJJZ0;*I:M>NFK1:SM$8Y^'JL5\HF
M%OU2G!V%TJ84[YU+%56'C:(%QX3+5N^/)2+Z8I^7!EBEIZ'4=4&1>'*X')[.
MO2G5;GS]W&A5A=P&%R5[F;_?0^$C@(L]56*%,M%5X%C#N/=M6WU[FR;<+8\
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MUR\?&*W"#84S@Z$MA8=6)8YN8JO6BD?@+LY>AE0KBY=C5SDSPL9B](UI%AA
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MZ>V@VB/*6+%]T]3:V"FI(W9(>Y.A.G^NK!W<4[2(_D2\AS5DS<9=A1EMH;I
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MWC8I)4<6BSUJ2FES(ZB\1 F:.!3N-$5!PG%E5MQP4JI3PP8Q=(V0C-&*!GF
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M6$T;2:!_\$8F$6TDVJ^G<R-MXRDD>]C;5QF)Y_"I(E44][H''=0:3S,M> T
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MD'&'G9.^>&J)P,8W4"/W2,0Q3065<I(E[DT4-,H:UO$*"%/L>A<N25\<C#P
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M=RJEN8R$S-V2@SS>I7;WA""4*\3R*%M.$)7]Z4L!$)^,3;$N6E%^$2(S''2
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MAN=ENP*SS 15L;0F5:1%.0_=*HVGHH(ZD\9.,]#+5>ZVLTP3=6-#LY)CQ^-
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M[C87E'6B>Y/J7]]>E.BJRJL)0"@"AM=V)&]Z1?MO?TO\(F6_-XX F?@J&V1
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ML4"_C2+&T>?/)!59SNSXD] XU&P4\AAH;I\GZ30A\@QOL&8ZL9(NY97B:!1
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M[Q41I)#$(+$#J4\0^AWPUB9EU''GYWU,=[JJP"J&;I;0B1>VZZ<)%?:I44Z
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M36ZV_QKB@ VY$&,)X#H;4]"8RJ89 4+&G$O^N8$5^+?'S[V_:W7#AV,!;4Y
MT3OG57DU\T*% M*NQR@ 5P([SJ75#G\WH?LX2T5"E"%+P:DBUB&"F!*LA".0
M(:1 D4%$)X7O!J'4!*?_L:F6D42DEVZ%>Z6ISK'G GU:-G9!/>:Z,]%WPMD
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M<F^?["?HTVPN8Y1A9#_L]U[L<287E5GAA4*ZJ_%5RI/^\/KE06_/W04E76)
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ML*6;C@@$1U+_W HZ6S?@N73QLQL.NP6=>&B'W.1/6OZ8V?D@9" +QB"/!MR
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MZRU%>S9Q.U'X$/@W,BF9MWV$_Z3<"(H1VA'B3G.[971S?#?5=*<<+(9_U;F
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MDTJW1*6T).?RTRZIT@X$,R\$PX$&EK>=]\O<$%B^-VV."Q[3&7J6E?+6;Z_
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M4)"6H+ADG4BDPM3HATV&G#]1WD3Y09RS8)46FM%[2FED'2P[]PD=:P//")/
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MT.\821 S#=(= *_&R!+T[IEW$A8E)]N;@'/5T6GO.M 3'D'<P3'9)O/7X&]
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M<<'WF55H&/U1;ZB:NC5RP#1!]P_=-&*C2#A1Q(3S)AJ8&\="8_Q2Q'2Y+D?
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M5+_<MF6@,'$)(2W:4V&A;O$5X"Q8%/&=1>!QD L"$[C/E'HKW.F%,O+M%Q2
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M_WS0 _K0W/=9_;*[@YDDQB<,>Q/P"P&JA4@M6L(9H)^X>I#GP:!V"YI9(R5
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MR>PS=*=&9V143>W2,MG #+GY(5D\W@2,T>F-?3K.CVZN!X^"6P[HX'$^N'&
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M9OB0Y3R=V=/@'67 IVSM>/:4,X%5B<],]+3B'AW/:MJ[.RT5?.Z9/PFZT@M
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MX?.IXQ302@WDG"U4 ^+KN)K_<?Y-S.0$ZKA%AQJ %C.1FY_(LBV@MQJH/#K
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MKUKNP:T'MV[I/^QRU.WP*_XR?L)](U,%DJ:IBR.G:/0 /2_^!;BP66?\GC4
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MYC.LAQD>'4&Y?1-6$ *_;KA,EX%>6''#@:Y(\4"Z38M E"UV&^C\HN#9*OI
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M!*N!?\A#Z#^E )@P<,-XS#\F(N@?UC,']W8.AX"EUT?.GK)>X(_9(6MC[)\
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MSHA6>C<5(Y]&#:_B5D(_<R09*7@#&LWH&=0JO^3D [%*B63YYI.!;S7!4"7
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MI;.0;,R;AYP)*N(F0'R1'^)-LS7^8I=AO(&MTG^F7!HB9S8TQ\+V(784L83
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M,=D'Y5X[JX24!H_=I U/H3LS4(<(30='42=MNM.3 +H4=?.?H-YAMJ3#_JH
M/!+(Z\'2@Q&+^)$/C4K:H5=\Z!2S\]G/.O&8_/IMAAWQT87RZS!'>+!8:D0M
M=5>9?SEV(4SPLC)D^IS&XXZ&(F==L5FI-.&M@=6V$6"BW$U<B3#:OGI[-L/5
MK-N!98?EC\7W'\.S6-529HO?U[O&">"IA^ \$DW7\?F,>4N?_#E,55EM4@/O
MV.^8$!L,D$Q0)X(F..CL;&44H9??Q^P[RI<YJ8$396E.>Q9_8HS%H?67\,F5
M7&HHDG[@\,'K?U0L@W]<[^0&R)AFM6?8A=/"Q;X:"FE5_.#3*6D^NGX:JUCQ
M?=G+6R^!,)[7.N@KK0&#([)>-4N[M2@8$W,Y]S&"A$7 ,N.2P8YPK/MLV8TZ
MZ8?A8E]J__E58Z0S N/^+;7FO?86BK'":20G)QLO/G0B\_J@,DX9GY3S6R!F
MRGW?ALHS^O>0_"Y\JWZ/Z(0_2!+!::QIM:D<@V'V;FR28KOD+Y#JK =UI,3V
M:MAE^E^-;(75]C_N937-<?'3&/6(*'X'DBI>IY/3CJF<WY<N_0WT\#'1K? ?
MQ-5_Y[[Q9(_O?W4)V;679%9P?[HXV'FP_#169UY"(3C0'RGY0^7TAKO,'5]P
M^FM&?'G-L'_4*M#W(1A\,N*5_LO=5?K?]P%.PP%TT9A 65SX(YFW##FQ[]&U
M.EEZ0FP#G%2YQ3W_2LY%YP 7S?8ADLLO2;'<2*OII!X0;)4Y@)MXY1U/3%#(
MIDXER8N7_7Y <W\OE=GB/V-+WU;AC*W<^=/.-V.-XD_ATZU_"G$]0YQI&*/;
M)UZ^$_M5"/OOYN<Q93;*8'C[DKCJ"<6I2T#O+UVVA54XSGF%O#9D8/?CQUOS
M2U%F(KXD96S:>2JRYF+*:',&R<CP#E/DL7XK=]G::X=,MRSRT!@^'5%(@3Z^
M2NQV%4O-?AIR+&,6]*"SWSBN4\W3=7/:LIH.73< [8 =.DOZRHS"F7E.R?43
M&*;0]?>5E+QQJ6'Z_1[A],1S[1_6#J\=%'#IN04"A%UVHNA$XR<M7-\<#N$1
MY"A(I-S$V] [='ZNX4=C8 _T3D/73,,E^(1P,^)C7)N8-N(7KN5#5?,>NAFS
M!=?J0F9^X";!,S^E\)'@KMO?N%%N]F/(&H)>:M4G;282<#H/.M0M>JA[>/>,
M(=R[ZQR+\[(2XTN.1O0^N3N:.3YJH]S,C7DAW_GBEAI(=HQ3'BAS%;I^UHQ^
ML'BT]]9MVQ@LAF#-T>O]>!L$8WV)]+)U\/(ZBMG#CA'[-7]*W_8NF;^K.B\Z
M+TJP:W2GH=<1X,=7-P%'91_\9P],L <#[T>'!7=Z;.SF+7A6YRUN="_(NWO%
M.K,HJ7N$*7,H"DAU;BFN2XG[\]F^,=GXS]*:>4B'W/=.%U-F;3A!M7Y:V41/
MA:1O^8_F98N</\/'HO:^NI@S'>_G]"K@L'9CIJO7V<9&IX7PM;[DV(CNWC;Z
M"7Y=$9+9M^]8V+-M0TXV&.74"UQU>-^699"7IQYOFF%\RM >>% 8Q1[A&'UE
MV";5L,W-::>V/O-^77=O60(Q>)JD3+[!\L))P-528[0S(I>56R=(OKZ%@_46
MG'+CF" B#^LM'5/5U6S\HJ9V>Y59DR9R:RG![@9AN<^9T[B*OE70N[9]J/\!
M;#<3"E/S>CSSNTLK^+=(UQZ9[CAQ)3[ICC%^I8:&6<GHAQ>[;DQW_&$9ZJ?]
M[P9A#IH('RH=<+=#S>#\HF\+D\<=W845R^NXW?/1%;5(X=[S45#@ P_*+X#.
M.+1Y-N!\QW6!L_EHM1HP/@#A5/FE09C+E$(R^BJB(V6#[DLVU$, R$/T3B:4
M\_MKHY==A'\ZDNX5 (#/_ME"Z'_&:%IY8X'[ M)\NJO@+OW4R-G)ZCR0=C1-
MYE])NCS%\P@&C6RV8$K3)0N<D\K5 [X3(\'5*W$JLQ3=GB'<9PJ2Q,H@C!,3
MR<@J$&LWGQ-9_W2$=YYSC&<,KH?+2LCQ_%Z%K/NQYRV5+1(BIV8?(FDW-+:+
M,NY2'$#[-F+:[7T]&ICB09BF=8OV:47=^[KJS"63&I6=8D!W"F_'4IFRS9F_
MRJO^\0#GVM"E_ZN]+XUJ(NO:#2)$QC#/$!4%!2$.# HQ!:(B3G%&08B*"IC&
MO HT$6,B\TRD;;7;@8BHH AI)8A#2" !XM#*I*"@9&H;!&FJ1+$DE<HMWG7_
M?-_;WUKWWO5^ZZYUU_UQ_A0KQ1GV?O;SG+/W*<*O@+*.@N-T0M4ZG-((\M3A
M?KW]-X^FCA;BOI_]?^6505H12F'J<)/[M5PL+I-*,*BG.#'S5'UMI!FL%9#/
M='*V/DQ=-YTUM*,)>MBUKO/KE2/S<5@P6J'<M1:BEL2\O:O0VOV(QU7^@+;*
M'<AQFA#TJ;@^#7-*9V9D%$@HI7BRB*!G,2M-"5@,CRFUT:'0KJ9KBRZ.E-C<
M7:A4\RL8!K\>$[>\<#[_;F =?L^_V4+_*[./Y,)<U7B&R /9J;U\A^(R.%H^
M7]R)+H0O[7Y]OJ\%7=)SEMH=+M'AW(:) TZ]]7PX<>VRNH2<^@GKLL?[BDGR
ME/^-.F;;H7Y>$6O%S9&I\)QQUIJ;T3 OIOXUPX]C'GODT3;FI9@>04A>9)!'
M@4 DL+"8/W?9A_'XI,Q &[UAOZU[CS"SPG@QKUC^AORJYW4?+\:6W3G2O^=1
MZ*W$J=B'E$:[@MNVAP:*LBKH1<Z'?JDK_/"CP:J08"_OYX@GI-^"^I[:)9<,
M+@*'BJ@Y2-@MV+N5 Y:.1NVZ/4B$UF8_\:^UCW'RF+C&+&/*E4]G/%GL*/EK
M^9<]?^;.*O[\_(]0QK<"A2D.MV*F&N^ ^R/Y\A:#1]ZGP;0BH;]:;/X170B&
MYPMH]LS(V/KH#@(S3_KHY=E;,'U+S^X%^#6]7US&BS,7_W%WV_49QA:/HE[>
MNL'DK'_E_^*X9G.7H#:@=7#PR*,;P]U?1GW\9^0FT7:?>^:5F?Q\G^M#TN-Y
M^K77A*N>JR-;-"\"AEHQV4O*<[J0-[;VG):O\O&4E9N]\JL-UOR#!X?GUM>2
M"AT(\/J=A?"*!Q/A[Y_MQV^_"LM;4._N>,@^C[SU&ERTKL<W-=CYQ7;IU,VS
MMSZFLV]4+C-+-/_MSI9S3ZR4#_3GW?ZM7V_X5>2O,$,5*>79/Y\DX&',QF-]
M']AQCMJ)B) ;]_;2C\UQZ5>,Y DCMIN/R6=/?/SY/Y[6_;.Q69C07_^%41@[
M3UL@3O#Q5)SB%S:0\NTI+MWN@FZ6J:4PM8YY ' <7LK:WHG8!'Q@A:EX>?AV
MU"GTI[ -S;B:+?C!WP;#EE,V]C;BN_L_$?]XTZ&.\O_> C%4]E(]\#BIB(-O
M< V3;C_%:Z814OCY (%L2&J@ZC.C98 5V>PJ<>R%22O%Z9)F%G/7II^\F#42
MBA=E5@@K9=!T7XD-SX"U0%NIP_U +-+A;.JNUL.--5%R9!$4B%B/;NMEF[6!
M]9+THSS5N"F+T=4J%F3"[^AL%PP ZL-H1G"JO[A UHH)$#TEP6'8< ;7F3C3
M@C!L/,@DS9VX>M'D$EM^:,ASQ&A(O/SC^/;OX EQ_,35B;N\^@_)O+VGQGMJ
M.60=SA!=P.Z.=/,%QUNY!7)KBM_PHW0VYJ..!VG&3(ZRKN0F/(=ULH+]5C0'
MQ",>-8H*<,A;M1W\(+16'6BV.."C7B5:9AKUF/8F;'HOQX?=1[&$+T#QX="I
MF^)4#8%%!3??O7-DT.*U<,5-^1&VH?8AZ\35A*5';@^Z@-=(^:SMX'A8)XMZ
MM\MP['BX)67',SV-;/(!65Y_ CQ5283&'QSMB+V2_DVFW#7Z67^2\ACR:<RF
M!,">ZH8;?][5[/D("&2R#N?8CZ*%6;NZOQ)</Y9 I%:GH4_OZV#OJ.GT9X([
M[,6VA0_/!V\QR8[:+)788&/Y08IWQ\M(CB!M3'R,V*)-DSK)"\*ST$51Z--(
MGGTJQX+ET]7@2E6$MP,N[,Y8-S!0!F0YF>>+7.<QDR4\<W$C:Z.ZK;(-]0,3
MP.]0/?.M&CI^'H=F>0>._1@;_Q;M8DQ>CO\D/^*(U/<-,&CIB &4U\KMYTD*
M0$V;'9'(7C)RL2/7C\\EFJ*OTQ3 S)%8!^@!"(QU@6>5'GEJCLLPFP@?+7?"
MV&"VO+ZN@<^\1+'"ECZ\I>W+6J@#F3V2<3_=OHT.E*1?:/?!-[O-ACO4[X.(
M.7(!4>IJOUI;62MR@8,C((^\F_#X) D6IKZ@QZ2"SY&E?>=$[CK<_K\8MLPE
MB ,^GY Q>=<Y0?^;U^T3?V,DRW?1!)Z(#0VU)F6YV<)%*FHAQ?@UZOZ1> ^&
M//.F<WQ;JC;@9113;=T70I'3RSP=SD[=IL.!W',40^T5\F;6] 5VIRG&4%U3
M5A:FA%?5-, ,:&+R$GP*U"C(@6[+X+/J,4=Q'.<M9R]\2\VP8RWO3B46#%I#
M0"F0*"; !#6O^&M3*MLMC@81)-R\J)?W99('7D^O!I:4 X[V9=7Z4];7Q)>I
M^30! ['1EUZ0N^SK%FY7T[EXQ!F4%V)61FT-X)FP7%5[@ 2:*=-],@..N)J0
MWE'RCOF/>X&%B#\?'I)<A4.%SEA?"Q/<928Y.,*[$K8SUXH5!>:>_>.];YDB
MAK@3NO&Z?PQ]V011'F(^B^9=5]YSX)KSG*W6S0G=$AE\3R]M3R[(V@5S_HB!
M^TU2P;Y6?D-4HMTAH5EZ&V)H*V346&=#QM8\@^5Z&(%8,)/GVW11&!9[AH1-
M&*YEDFB^EPB'(>EKW@_ETS9!_OE[$$/'%("0:4\#D8>R8MHQAM%=4)J="L42
M&COU_JY@003R,6$?3_M.)L$+\K2EQ'HN6H]FA!"9_PJ1_VQZ:L"QP?TF:P%\
MZ3:F-V(2\C:"Q$+&YMK$RL "?[.9O@7\LCLE)C=%SUO<G+U"!^H_+*HX)C(=
M/1:#6,#[52N^\L>\Z>(\-WQO=%O0S7.>68 @C F$[:^E1UDNX>?%;E)>DN(_
M%/UL<(:!3:ZM:AEK*5RI=P_MMZ?H0]TEB^!?A0ZIBU-6'N0<Y$B.?6,M:_KF
MB<P3\F:YK*\R*82EDWD@M9@U?9 P (FE#'T6Y34Y0L6Q9K\,XN0B_J!F/61W
M3NVS<:1$,6:;$F,!RVE]/Y$L67_\ *TX<"AL,NO!G>/+\<.VWPK(*ZJB:33:
MZ,653:)?$QC^T8]KWB]9DWM9_^R?2UT6Q1_5._.#)\[JY6WZJ!-Z3GF%M+7/
MGZX%UG;[/=\4&?7Z:W2WWUB ;%.7H39Y5Z_#)X>=VTZX4@Y(Z9;?]32A+$]X
M',)/9G6A%)8K' ?I*]NS0-ED /P5?%(4K"5*!U? ?"A8U5%"L>+I?73RS:M@
M_KRT2L*#0[YV6'.MX5OK:^"L(S,J?DD;](7C-)&)(@/M(S*)KA(7L^?Q-H+R
M,7L5YVT@[3[42;6"^3M@-=B^B=$L-_N9:'$B1QROP^4_KV52FX?:QC_\\K7#
MA+S7^\15XDUU6[E+B2 5?=>MX%B]OT0URZKY&$+_E!)7F]OY=!?Z#B]5T:PN
MG^ ]?OIN1UF,EFT CTII]W?5JGBSZ&>117!#+;(9ID*[X3[EKMNI)>ZH;2/B
MO?+DI!UDGT'\DV,=F)M"S.> C_Q?)$L&_:BVU3N@TL>8#TF&E/"6*T K;2;[
M%>H-F'WEY9Y%W]BYF4/A4NY ?!O;%^04D_=C'#"\5(A7OZ<I^=(_84<% G-4
M8<S+WSE6?E1'<<8QE=S!YD(LY'N0IO?H'HXMBV5>".UIV$3<V/0ZY?G)]\E;
M7OW@1P\NZHJK'NV_G@Y,OG6:R[NP-T%@-?!L*/[\TK?.D=>;7MWYX<_?&A\T
M-3;RMC'N[8EZSWD^&O?7[=)DP9#KK.4K7GJ#C]MB';1WV/-&.,;^5 <X63V4
MS28A*R!NJXF&5!!E=IZK(I@Q-V CU%[TU^JW!$WF*"(A*SB^-6@*OA1#,X4'
MI/LYRB5)@_/*]ISKZGBOP]U[P6LO"=_<Q><D\(WW,AEM@S,;H<"<VKH[PK#:
M(^6&T.$J%=&9_A#B95K3(B$@#R&C;ETI<Q0=ILP'GL5"2V+^I9:CSRP>XTYI
M_E?9+>V\^'Y@_@?,5HB@^X[.U TQP>U.]I\:-$R8)[U .^A4>B/N=D*Y.;PZ
M)89Q.CDSVHL-/6O<1O_J=??/GD4,XLOR9_TJA5[N8\%,=15D+CQ^ AG6__X)
M9(PE:P[2UN#S!*0BB@D47\PZJ;'!V%60.%%L'L6*N@=RI#2S(X"-:#FRI4\8
M#,4I^C+)25>9"40]8I&;,PB#C1D'H;0LX2%LP>.+4Q5/VASLOC"LV ,<:[)K
MTDF5:^1N*#Z;;%3-C)\D4%U&Y!;"8,4KJ/$3= ,YKKTJ3F1DZW NK'AU4IQ4
M-$V!:*WZDO!F$1Y\Q+QU&OPA;B]E^=:&EYSCV,3[\;]#/5.G+J#DOJIO;)$6
MZ*_4!+1^U^$>-NIP$?4:1]FI90[]I\+G3<7CR4XXE";"LU]U(E8P5[.1N0[M
M= J4\G,!A^GBL/L?\HJ!(^\W][0T3D7FD$]6(/:P 1\QZVJHW2\D4^SA4\C>
MR/:6C>56#'@C_O2LM5L^UZ,7T%ZQ!9*HX!>+P?4UVNVJ=KX2F(D!6<9KH0^4
MW)J^/='-$0SD-B1Q)@_"0I9)Q6@5+?\<U8ZU9C<WD[4XYUN 4N#PJG&$-^G/
M?2MJFS0+U@!'*<\G-P<-+>^(?=M^3+9>?(PQL]FHHO$2]SMS)[!Q1C%^<_,6
M_,1"S5RT2T317D$)[-^#?&L@]VT-\)(Z5$)S9?O YWN'6M*]$L7&_H1LL:!#
M LSP+/J2ULGR&UQ89JW\UL9U?:[>!84Q!7C0'O&X;N%AQ:XF6L3 9R<M, JN
M6LE04_. A!BG467\F,L4T Z8,QGA/7X\.]A6P'=]>NT0F3)=R<TP@5D<R6)6
MI#*$3%0'=%Y1SWG_"SM'ASN82)M05WW1D) 3?.I?VE-3G(;P-W?8&,6_&ZW-
M8R G3Y4 ]5#Y@X%BMD/'#]AP?,7U6P5:KC@>&/#>"6W*:=!V?,* ;F:3]C(K
M4)GDO:[73VX2<%$ND']ZKJY7DPK=V>,6S"*)V]R=8$<FNH;;PC8]VSJP1][6
MG:UFSQY&EW<#A\?A!=_R2)70_+PQ0,49H"G&VSD#\8IOT@'2)SEFQ/>.8UB'
MS_LZ[H2^O.B5!'ER43-6)$9DS-6RV/EO,6SCE;!^8'LRG67[6?<(7\.T5_9/
M,MP_!<@/R[ AG#O&V_10IN:V7WB6]4(3?I8QR8._:#8;'OO8LWRL>(@<[[(%
MG\NT;N48((G3F>5%%)=15 _R:>C(XMQG&=UF;M=8;[%B+>MK/;"L(B!+ B>[
MKPZI7G6^R_RX1)1S9X//LO4]V7^V/^NCVI/?-=SXI><S1QBR4Y]_M.H,_>AI
MXP77_F.#^(4\.TSUQRG["BD+8<W>F$")F^F+O^I/GMZY-29ECJ,CWD<U8VWZ
M0NF^.H.3/B<(K>^M6RGS039?*39NS 'NIU(_C08_!EP2%ZH TR-1U$E)0-/U
MT72+V4+V0E ]NN3HEC>'MS5?7HZ#7E G?P$#<NJ8GF&0;Y&:1HB!QU78LDM=
MO=0T09>@B:2AKH+C@+8?^YQWN\WAF(ESHZ7I?N6T I;?Q.INSR?5(P>/5DK$
M!(H%0H;/0=&JTG/5B?V,5F[Q^7*;)KCJ9)HJ(,+?-;@YR.^B9V;4)ON8OM_9
M1*HI?'+/EH$#)>N%V2["1)H93$>-OI.RVD1EBE-I4C<GF):D"86KU.&Y%+/:
M^W=O,SV5:R^H.:<I*^%0U4IGY=YTT%/:!?-4U-*OW((.Y66>0>5#-\/=S=O>
M$"V!_?QBU/_^*S\>3$7M!UIN, F8+AUS^SR^%KHX@M\ 9V@\$P!<C^;(+F]K
MGA'S;"C%BV%5(RA?MMUM>TNM<O>Y9B!"R(%.-A/-V$[,(55Y56WB16Z>T%XQ
M[@*C(SW2QO3-%;?H%^,S4GQ.QO1=""GYS?_]/WPS:DZ7+=GV09JT[_=4(1$B
MMJ#^X%&N^H5[=$^DM/_/HNNC!_X<W=5M\R;@\76SXRO=]QXJLU[5=\[_SE,W
M54M WNS?UB(=T'1-LXI0Z,\KB9I[1&S@+\\3VZ($YO$.Z8_H;#"M* XB-'.+
M@P@M?$N6!SH [_9;<4G* [GP.?^?H7D_694O!I.?JD[8L@Z4+YYK[&:MPV4R
MX7&)W Z#^/A0^)QRA?,J^!:X3.6)S%:'O^[(3!US;R;>O9 /'.01AQ^I6'4<
MY?RS,=0"+&@$54;87+1)]/KK>*O^E]6L5-!?)HLYJ; ,NM%8( 3 &HG8R3>5
M7N/C0[;%W**OE$Q7$?6&\\+[&C.G)N"BT-ZULA"C[0^O6\W>S39$.\OUM!44
M:Z:S&I\U7C=][2*R1O":) Q,5#5T"SJL+"OHZ6A6K6%7Z#X'5T*4;\3QD,/]
MMI<8$AW.'-A'<&;9]PFM3RJX!4Y _A?>#)85' R^?+X.ND?W9>V\S22H=3@N
MQ6?T:>VGM?@06:E8Z03Z)8FH>,X^.*'=T=ZDG=TA!JGR M[,HR@13FN+DDN(
MA1R"T$=9&_2]]+&2[P 48)H/D [ZP5)^0K]<4GVAM4HZ1<P3;E>.%QKGL#99
M-V;1UD(..U.ADS_CM(ZP6K,>F:OEH29(.(:VZI5'U7O@5)"WSJFO^"ABB<&>
M45U5?)4!;JS+S[3>XM%ORY]X+'9LD;F]#6BZ$95X?JJNYEC2M8%W_83OQH-F
M@8XXQ5!%R\OP%YFS7(K1-&2'-A<)APBH48.*\(:WOH]LJP1<F)<45;D4AT%F
M?\_ZWO#<M3459CC.#_<JW.;OBPPSK7B;OVB6<8A[MV@>LA!N@=QE' -A<L M
M<.0=RQ(ZSZ^EL8!-86V#<T%9J3!03<T-TN$RD%"[!]'2$>=6MDT2?2U$RIQD
MAOYL4S;O(,W.!7<JD[6FHO7#YL;*T"7W@MK-[]Z8D5*:%?E\HU%G_9,'BO@S
MX5M]?^4GI'])LQI.+[]2:Q)]-S&]-ZVHNLAC^9-F3]/E*U?\D?F/UQ@^\V%/
M8BO5Z W+'Z3D0.&21[PLU 6QA>12[VBQ14)_#?/\^"ZX!GRN(IS^^J%O(-DS
M7P@0"\F'KC&+6HI4A\MZ)$[&L$O.MGN$W\0'Y6^C6WGU%PHIB^E1?44IFX[*
M5.P+H-/+G@V@MK2VBA-_A&.$FC)/*C>+:S[;Z*FT)]=@%*1X:>8S_N/SCK.)
M[&D9I1R<?=(=RFM>LN&8TK(Z,(L]WR1XP[CYAFKFS2]DT8REK@3:HN=7F2Q?
M0$DJ.L"SC\#,_,D[:\D?G@_Z2IG9+]D+6916M\4!0Q+ FMV7=CVF3%%D15.B
M0..%F26LB6GBA/,BV@:&S)H,PGDK=+BW?2C5!#6>H\/%Y7W"#/:.#G<U<M 6
MY'P:U>$\,> UL-#A[DHGC^EPO9S.!?KC_Q(<_F<C!ZM);P'E5F0UVHNV:PB(
M-\=5*T:MJ6,,> VG7H=36O1^T^$DR5JNI@->>Q?[TTK>Y_''\1V3Z1#5$MG3
M@PE.\9M[Q))=%/LN(?4ZX@N;*1F.49@<F7K:P_*I_1A%R/);&V/?W"_/W_RZ
M\]ALFD%C84C9S^TO \;<!]%%WKQ<'<[BHB.R@1Z(S"XGM\ESDLQOJ"XM3MFT
M]TXYL6MGCX8>NZ64[*J7?^(>[KCA:A&QEN5Y5WN-$U<)TF(@6HE@PW3"IH&?
MV&2DW*NI^TL,2;7F_)7:X:@50>WUU^82S!/*YWUN_^A^L,PR=[B1?#0$;W^'
M_:9#02HR MU5?1E?:'D<"__QG%@O^"G8V!K548J#([!)-87M]X+?\H2I-XC.
MTUOMA (*D8Y:NBT'MS\A;U>T69'R0_.+YP("5JBVFF+ 6E8D?:$2YP^Z""B>
M\%D%)_MB4'^L[TUG&3NH+W5,7SH5.IOX:X,6'ZV/_^#DG*F'([A@(<26&:FZ
M4-S R4<I<)DZ*5Z6I8@L%!G U)TG@5E[,)Y@QC)1:Y-#^X3)=Q*"5H 3"R!2
MX4UP;1$1F5>^8)F7#K=OT8+J@(S?Y9P6@$)\H7H1)YOBE @W* $;.$L=V2(O
M?71O6']=]_1&AT8)%'\=MT@($C4IDFJ5YR#/HEQ,LLWJ*$$V*5>#K/)EF_2E
MJV]N/7\ZF%; :9!+&0;,9>UNBT!:(6J';'E-QL=#JS218"VO+<E3>O'*9"58
MU8*NA-P>7AV.)J]05?#A D+&UR<\B10 "^8R2_Y\1YY[P.VN@M$?J)!Q?;YH
M:JU5_-.IWB5AK?U5.3WK[D$>W.HC 6RO+J$-&M3W947 DP]?IR]9#>]E;7S6
ME4,S6C.9N\INI7C%$> W^RPLC+T >S%"FE8BOGM4M)C=);;C,Q;5LIQ23=Y3
M)TM!3CN!,-J_T$?9ME4Y7814ZC3!]/,RY,;GOGY[7Q8]@;8]<KU0G(1Z);)7
MOOJBPQ7KRP9G0'5\M2:&N*XL51NLC&\1N[&,.LE.+*LNGADI[P!\"J+*5ML\
M*6IW@L]4?[<-6>F-O7KL&&8[W +65@4W1VS)FJ]Z']\2R3,E%!S]A(1D;3X5
MJ!*5#LX&-SZR:W &D'D43AXT>^O$P1(I.^0ODCB!E[&EC4,6V[%=HJ,3(R\"
MDVU=T/F"(N+86)I&/^S]F8CI?+%6 -I4&GI@_:T._\_B%A+L>2%+A!^>*BVX
MCFR Q@O\KAQ_KEA36I.D,@'P2T2TC*F IJLL:0CXBHG]FB_M?SIQP.SQK(=S
M\FU+KDUG4*..81AVS&(N0ZW'[8X$ J84.R9-096,6\1&#X^I&$8L5S"PG:''
MBJ(9T&=>*9_3D4^Q81*E7-76ALR$5=MNO,O%::*;Y4ZH-?/;)P#,1E:#O"*@
MD91ZKAM0$GN_E$3P<[-J1R\:"K8?J O/%89>'2UW.76C,*+"9GZI8J5$I ?3
M- 1FL%)<@@#J!^1#JI5A>SHIF"B 7\2EGDBJ_#C5\AI(T.&<X+,R]G(P?G*P
ML.*2<I29UWZH3VK61$0MQ\U=/U6[4<7_JZ7R_X=-Q-%6-B11I;SZ;S*2)9,]
MI0Z'##- FBJW\=I([\#FRJHC4Y@YOO7;%&.N=SC"8OV='8N#0V;?6JC@F>EP
MAV,"=\-IBA+&3GA<LY-:31^T $4-)U+D D[K-=K6/K_5[R)_J'1Y&/-[I5G)
M<X$O2! -\\^(E3_Y4:=\. U4=!ZCE8<&AR-+UV+(MH8_>4N':RV9/DJ3)>B/
M]GO_08(/EEBC1;2Q[3I<@?/T<6/I]/VW9=<X773M;0[DSIZGPT']N.]G6VGW
M9=)JCN(FT42\/PODJ-5('#638\V>G4BT=I:$;89=*(XC0\W6]*"79^L""SQ0
M>2<A7[ ;\9W(SX*!=C%8#"]<S-J5";PNA(]0WXB;I=M[D/# -F+_JE,G0^M?
M"TH\6^T!5^%A_V#79;0DHX8Q!_KR03_#(+?<WW/2[#K!#8OWI7/_M;^=^+X&
MV%\S WU7;@B/8?B-86SF&98].-XRW@](8I> _ *V_7M8N@N^ CX4^BLYLW@S
M$7]P_#06V1IJ$X7KE;RV6JX-TVC]78B7=4R]>DZTYY=*U-%]M0YWK4^S T.)
MM0CF1^J&]D3.7:*TR7,/%%[H)R[@"0Y?4O%=!C\&EE,@LRH9S2&QGU<X$-*5
MFZ&<J!LU\K[_0&0/@E1SZ4]M[GLC[D+3&ZBT.1SIO 3>EZCIRT"1=?(" /GQ
M[T<EB'Q" Y\Z>6KMQ/U5.IQ5H(JJP[G^7<<$>E_';#_;_]TJZW"YZ[J X0;T
M-0"7B:TX\!CNU,DUK)R_663@/YM-"#&VZ[^GNQ_E3E<U- FAL/?SV[VTV@XI
MP^7M^S?]1VIOT.2Y("-?/T&ZUWGMZ9?&M^&S:7\]77OHASHZ8IYK0LT"\/LS
M6P2P#X8X,Z,2 V/G<IR/.!WGX1,J4N+4IW^$RU[=KF16%%!\#ASV=KH?W=[
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ME)'E*.6Y$/204WRM5#LDBN)"F^$8]DB,"A)$;P9,(/>QGZ;W)T^"V(!N.<S
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MC89!8)#&G:KU:CW5;U*%;M]O2X,CK"C<.=JQ-_G8NU<L/].4-9._$!-,-:+
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MUFF[Z4KEJR&/&B9]>3V?X$D"HX+/_HC[677+90AP3<.2<-@>-E[@)B2,(D5
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M4+CMR(*G#6 G\%LL6]$X_#:>Q6*Q)'I?#C DG_?R\R^"%4]1L(:$@9[?D.Z
M'R5N4Z]F["WM_E3;=07)-[5>1I6"-U<)'7LDI=,.M(N=:4] 7#FQM0==QS.
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M-L?XT=HS%73TR'T90.[J>]VS.+%#D<FTMH7D(+O\3]>NWOY&M-Z>2P5)<7=
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M+3(P,C(Q,C,Q+GAS9%!+ 0(4 Q0    ( )JJ=U9K7,Y4A <  &%/   5
M          "  ;8)  !A=&UC+3(P,C(Q,C,Q7V-A;"YX;6Q02P$"% ,4
M" ":JG=6[QZV5LHC  ">L@( %0              @ %M$0  871M8RTR,#(R
M,3(S,5]D968N>&UL4$L! A0#%     @ FJIW5E-R!6I2,   &)L" !4
M         ( !:C4  &%T;6,M,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M )JJ=U:#.9OW>R@  )KF @ 5              "  >]E  !A=&UC+3(P,C(Q
M,C,Q7W!R92YX;6Q02P$"% ,4    " ":JG=6;=$W$VD(   Q1   "@
M        @ &=C@  97@S,2TQ+FAT;5!+ 0(4 Q0    ( )JJ=U;: %B!40@
M  !&   *              "  2Z7  !E>#,Q+3(N:'1M4$L! A0#%     @
MFJIW5@X'YV6H!   <QT   H              ( !IY\  &5X,S(M,2YH=&U0
M2P$"% ,4    " ":JG=600/")GL$   N'   "@              @ %WI
M97@S,BTR+FAT;5!+ 0(4 Q0    ( )JJ=U97C7.]<SL  $)X 0 )
M      "  1JI  !E>#0M-RYH=&U02P$"% ,4    " ":JG=6(S@46F_! @!O
MMQ0 #               @ &TY   9F]R;3$P+6LN:'1M4$L! A0#%     @
MFJIW5M=O:I!-;0  GWX  !               ( !3:8# &9O<FTQ,"UK7S P
M,2YJ<&=02P$"% ,4    " ":JG=6UX>810$W  #\10  $
L@ '($P0 9F]R;3$P+6M?,# R+FIP9U!+!08     #0 - !@#  #W2@0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
